User Image Cart Icon 0 Search Image

Glycation

  1. GLYCATIONย and diabetic complications
  2. Role ofย GLYCATIONย in aging
  3. Mechanisms ofย GLYCATIONย in atherogenesis
  4. The pathological implications of proteinย GLYCATION.
  5. GLYCATIONย products and the pathogenesis of diabetic complications
  6. Free radical generation by earlyย GLYCATIONย products: a mechanism for accelerated atherogenesis in diabetes
  7. Advancedย GLYCATIONย end-products and atherosclerosis
  8. Inhibition of proteinย GLYCATIONย and advancedย GLYCATIONย end products by ascorbic acid and other vitamins and nutrients
  9. Advancedย GLYCATIONย endproducts in ageing and Alzheimerโ€™s disease
  10. GLYCATIONย and oxidation: a role in the pathogenesis of atherosclerosis
  11. Recent progress in advancedย GLYCATIONย end products and diabetic complications
  12. Proteinย GLYCATIONย and oxidative stress in diabetes mellitus and ageing
  13. Tobacco smoke is a source of toxic reactiveย GLYCATIONย products
  14. Hydrogen peroxide production during experimental proteinย GLYCATION
  15. Diabetes, advancedย GLYCATIONย endproducts and vascular disease
  16. Atherogenesis and Advancedย GLYCATION: Promotion, Progression, and Preventiona
  17. Advancedย GLYCATIONย end products in Alzheimerโ€™s disease and other neurodegenerative diseases
  18. Recent progress in advancedย GLYCATIONย and diabetic vascular disease: role of advancedย GLYCATIONย end product receptors
  19. Lipoproteinย GLYCATIONย and its metabolic consequences
  20. Advancedย GLYCATIONย end products, oxidant stress and vascular lesions
  21. GLYCATIONย of collagen: the basis of its central role in the late complications of ageing and diabetes
  22. Formation of crossline as a fluorescent advancedย GLYCATIONย end productin vitroandin vivo
  23. Advancedย GLYCATIONย end products contribute to amyloidosis in Alzheimer disease
  24. GLYCATIONย of proteins as a source of superoxide.
  25. Advancedย GLYCATIONย end products increase retinal vascular endothelial growth factor expression.
  26. Renal catabolism of advancedย GLYCATIONย end products: the fate of pentosidine
  27. Survey of the distribution of a newly characterized receptor for advancedย GLYCATIONย end products in tissues
  28. Plasma levels of pentosidine in diabetic patients: an advancedย GLYCATIONย end product.
  29. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advancedย GLYCATIONย endproducts
  30. Advancedย GLYCATIONย endproducts and cigarette smoking.
  31. Cytotoxicity of advancedย GLYCATIONย endproducts is mediated by oxidative stress
  32. GLYCATIONย induces expansion of the molecular packing of collagen
  33. In vitro kinetic studies of formation of antigenic advancedย GLYCATIONย end products (AGEs): novel inhibition of post-Amadoriย GLYCATIONย pathways
  34. Lipoproteinย GLYCATIONย and its metabolic consequences.
  35. Enhanced cellular oxidant stress by the interaction of advancedย GLYCATIONย end products with their receptors/binding proteins
  36. Determination of advancedย GLYCATIONย end products in serum by fluorescence spectroscopy and competitive ELISA
  37. Effect of phosphate on the kinetics and specificity ofย GLYCATIONย of protein.
  38. Pathways of formation of glycoxidation products duringย GLYCATIONย of collagen
  39. Breakers of advancedย GLYCATIONย end products restore large artery properties in experimental diabetes
  40. Implication of an increased oxidative stress in the formation of advancedย GLYCATIONย end products in patients with end-stage renal failure
  41. Non-enzymicย GLYCATIONย of individual plasma proteins in normoglycemic and hyperglycemic patients.
  42. Role of fructose inย GLYCATIONย and cross-linking of proteins
  43. The Advancedย GLYCATIONย End Product, NโˆŠ-(Carboxymethyl) lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (โˆ—)
  44. Advancedย GLYCATIONย end products up-regulate gene expression found in diabetic glomerular disease
  45. Vascular hypertrophy in experimental diabetes. Role of advancedย GLYCATIONย end products.
  46. Orally absorbed reactiveย GLYCATIONย products (glycotoxins): an environmental risk factor in diabetic nephropathy
  47. The role ofย GLYCATIONย cross-links in diabetic vascular stiffening
  48. The relationship between accumulation of advancedย GLYCATIONย end products and expression of vascular endothelial growth factor in human diabetic retinas
  49. GLYCATION-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.
  50. Advancedย GLYCATIONย end products in age-related macular degeneration
  51. Modification of low density lipoprotein by advancedย GLYCATIONย end products contributes to the dyslipidemia of diabetes and renal insufficiency
  52. Increased serum levels of advancedย GLYCATIONย end-products and diabetic complications
  53. RAGE: a novel cellular receptor for advancedย GLYCATIONย end products
  54. Identification of the site ofย GLYCATIONย of human insulin
  55. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advancedย GLYCATIONย end products.
  56. Advancedย GLYCATIONย end products induce glomerular sclerosis and albuminuria in normal rats
  57. Cellular receptors for advancedย GLYCATIONย end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.
  58. Proteinย GLYCATIONย in the kidney: role in diabetes and aging
  59. Alzheimerโ€™s diseaseโ€“synergistic effects of glucose deficit, oxidative stress and advancedย GLYCATIONย endproducts
  60. Expression of receptors for advancedย GLYCATIONย end products in peripheral occlusive vascular disease
  61. GLYCATIONย and advancedย GLYCATIONย end-product formation with icodextrin and dextrose
  62. Advancedย GLYCATIONย end products in vitreous: Structural and functional implications for diabetic vitreopathy.
  63. Oxidativeย GLYCATIONย and free radical production: a causal mechanism of diabetic complications
  64. Oxidation conspires withย GLYCATIONย to generate noxious advancedย GLYCATIONย end products in renal failure.
  65. ELISA of pentosidine, an advancedย GLYCATIONย end product, in biological specimens
  66. Failure of commonย GLYCATIONย assays to detectย GLYCATIONย by fructose
  67. GLYCATIONย and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites.
  68. Characterization and functional analysis of the promoter of RAGE, the receptor for advancedย GLYCATIONย end products
  69. Immunohistochemical detection of imidazolone, a novel advancedย GLYCATIONย end product, in kidneys and aortas of diabetic patients.
  70. Evidence for theย GLYCATIONย hypothesis of aging from the food-restricted rodent model
  71. Clearance of pentosidine, an advancedย GLYCATIONย end product, by different modalities of renal replacement therapy
  72. Nonenzymaticย GLYCATIONย of collagen in aging and diabetes
  73. Immunochemical approach to characterize advancedย GLYCATIONย end products of the Maillard reaction: evidence for the presence of a common structure
  74. Advancedย GLYCATIONย endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with โ€ฆ
  75. GLYCATIONย alters collagen fibril organization
  76. Advancedย GLYCATIONย endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits
  77. GLYCATION, glycoxidation, and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction
  78. GLYCATIONย (non-enzymic glycosylation) inactivates glutathione reductase
  79. GLYCATION-induced inactivation and loss of antigenicity of catalase and superoxide dismutase
  80. Advancedย GLYCATIONย endproducts stimulate interleukinโ€6 production by human boneโ€derived cells
  81. Advancedย GLYCATIONย end product-induced activation of NF-ฮบB is suppressed by ฮฑ-lipoic acid in cultured endothelial cells
  82. Specific fluorescence assay for advancedย GLYCATIONย end products in blood and urine of diabetic patients
  83. N. epsilon.-(Carboxymethyl) lysine is a dominant advancedย GLYCATIONย end product (AGE) antigen in tissue proteins
  84. Advancedย GLYCATIONย end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
  85. Effect of curcumin on the advancedย GLYCATIONย and cross-linking of collagen in diabetic rats
  86. Rapid formation of advancedย GLYCATIONย end products by intermediate metabolites of glycolytic pathway and polyol pathway
  87. GLYCATIONย of amino groups in protein. Studies on the specificity of modification of RNase by glucose.
  88. Analysis of microtubule-associated protein tauย GLYCATIONย in paired helical filaments.
  89. Role of protein-bound carbonyl groups in the formation of advancedย GLYCATIONย endproducts
  90. Immunochemical evidence for the presence of advancedย GLYCATIONย end products in human lens proteins and its positive correlation with aging.
  91. Role of advancedย GLYCATIONย end-products (AGE) in late diabetic complications
  92. GLYCATIONย and Glycoxidation of Histones by ADP-ribose (โˆ—)
  93. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimentalย GLYCATIONย model of diabetes โ€ฆ
  94. The receptor for advancedย GLYCATIONย end-products has a central role in mediating the effects of advancedย GLYCATIONย end-products on the development of vascular โ€ฆ
  95. Advancedย GLYCATIONย end products in neurodegeneration: more than early markers of oxidative stress?
  96. GLYCATION, oxidation, and lipoxidation in the development of diabetic complications
  97. GLYCATIONย of skin collagen in type I diabetes mellitus: correlation with long-term complications
  98. Nonenzymaticย GLYCATIONย of type I collagen. The effects of aging on preferentialย GLYCATIONย sites.
  99. Site-specific and random fragmentation of Cu, Zn-superoxide dismutase byย GLYCATIONย reaction. Implication of reactive oxygen species.
  100. Immunohistochemical and ultrastructural detection of advancedย GLYCATIONย end products in atherosclerotic lesions of human aorta with a novel specific monoclonal โ€ฆ
  101. Long-term fructose consumption acceleratesย GLYCATIONย and several age-related variables in male rats
  102. Molecular identity and cellular distribution of advancedย GLYCATIONย endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins
  103. Advancedย GLYCATIONย end products induce crosslinking of collagen in vitro
  104. Decrease in skin collagenย GLYCATIONย with improved glycemic control in patients with insulin-dependent diabetes mellitus.
  105. Increased levels of advancedย GLYCATIONย endproducts in the lenses and blood vessels of cigarette smokers
  106. GLYCATIONย products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages
  107. Localization in human diabetic peripheral nerve of Nษ›-carboxymethyllysine-protein adducts, an advancedย GLYCATIONย endproduct
  108. A microassay for proteinย GLYCATIONย based on the periodate method
  109. Advancedย GLYCATIONย end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
  110. Nonenzymaticย GLYCATIONย of type IV collagen and matrix metalloproteinase susceptibility
  111. GLYCATION, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis
  112. Prevention of cardiovascular and renal pathology of aging by the advancedย GLYCATIONย inhibitor aminoguanidine
  113. Increased pentosidine, an advancedย GLYCATIONย end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory โ€ฆ
  114. Role ofย GLYCATIONย in modification of lens crystallins in diabetic and nondiabetic senile cataracts
  115. Advancedย GLYCATIONย end-products in diabetic nephropathy
  116. Advancedย GLYCATIONย end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS
  117. Specificย GLYCATIONย of albumin depends on its half-life
  118. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advancedย GLYCATIONย end-products: comparison with aminoguanidine
  119. The effects of ageing onย GLYCATIONย and the interpretation of glycaemic control in Type 2 diabetes
  120. Nonenzymaticย GLYCATIONย of collagen in aging and diabetes
  121. Chromatographic evidence for pyrraline formation during proteinย GLYCATIONย in vitro and in vivo
  122. Influence of advancedย GLYCATIONย end-products and AGE-inhibitors on nucleation-dependent polymerization of ฮฒ-amyloid peptide
  123. Standardizing the immunological measurement of advancedย GLYCATIONย endproducts using normal human serum
  124. Significance of fructose-induced protein oxidation and formation of advancedย GLYCATIONย end product
  125. Production and characterization of antibodies to advancedย GLYCATIONย products on proteins
  126. Involvement ofย GLYCATIONย and oxidative stress in diabetic macroangiopathy
  127. Nonenzymaticย GLYCATION: a central mechanism in diabetic microvasculopathy?
  128. Reducing sugars trigger oxidative modification and apoptosis in pancreatic ฮฒ-cells by provoking oxidative stress through theย GLYCATIONย reaction
  129. Hyperglycemia in hummingbirds and its consequences for hemoglobinย GLYCATION
  130. Advancedย GLYCATIONย End Product (AGE)โ€“mediated induction of tissue factor in cultured endothelial cells Is dependent on RAGE
  131. GLYCATIONย of proteins by ADP-ribose
  132. Proteinย GLYCATIONย Inhibitors from Thyme (Thymus vulgaris)
  133. GLYCATIONย of monoclonal antibodies impairs their ability to bind antigen
  134. Receptor for advancedย GLYCATIONย end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins
  135. Advancedย GLYCATIONย end products induce expression of vascular endothelial growth factor by retinal Mรผller cells
  136. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advancedย GLYCATIONย end products.
  137. Advancedย GLYCATIONย end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
  138. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advancedย GLYCATIONย end-product formation
  139. Advancedย GLYCATIONย endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells
  140. The Receptor for Advancedย GLYCATIONย End Products (RAGE) Is a Cellular Binding Site for Amphoterin: MEDIATION OF NEURITE OUTGROWTH AND CO โ€ฆ
  141. Factors in human serum interfere with the measurement of advancedย GLYCATIONย endproducts.
  142. Changes in biomechanical properties, composition of collagen and elastin, and advancedย GLYCATIONย endproducts of the rat aorta in relation to age
  143. Cross-linking and fluorescence changes of collagen byย GLYCATIONย and oxidation
  144. Accumulation of carbonyls accelerates the formation of pentosidine, an advancedย GLYCATIONย end product: carbonyl stress in uremia.
  145. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on proteinย GLYCATIONย in NIDDM
  146. Non-enzymaticย GLYCATIONย of peripheral nerve proteins in human diabetics
  147. Effects of advancedย GLYCATIONย end-products on the proliferation and differentiation of osteoblast-like cells
  148. Possible involvement of advancedย GLYCATIONย end-products in bone resorption
  149. Immunohistochemical localization of different epitopes of advancedย GLYCATIONย end products in human atherosclerotic lesions
  150. Activation of the receptor for advancedย GLYCATIONย end products triggers a p21 ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress
  151. GLYCATIONย of rat sciatic nerve tubulin in experimental diabetes mellitus
  152. The serum concentration of the advancedย GLYCATIONย end-product Nฮต-(carboxymethyl) lysine is increased in uremia
  153. Enhanced interaction of advancedย GLYCATIONย end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in โ€ฆ
  154. Autoxidative glycosylation: free radicals andย GLYCATIONย theory.
  155. Role of the Maillard reaction in aging of tissue proteins: advancedย GLYCATIONย end product-dependent increase in imidazolium cross-links in human lens proteins
  156. Proteinย GLYCATIONย by ADP-ribose: studies of model conjugates
  157. Non-enzymicย GLYCATIONย of human extracellular superoxide dismutase
  158. In vitro formation of advancedย GLYCATIONย end products in peritoneal dialysis fluid
  159. Advancedย GLYCATIONย endproductsโ€”associated parameters in the peripheral blood of patients with Alzheimerโ€™s disease
  160. Advancedย GLYCATIONย end products in diabetic complications
  161. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advancedย GLYCATIONย end products blocks hyperpermeability in diabetic โ€ฆ
  162. The relative UV sensitizer activity of purified advancedย GLYCATIONย endproducts
  163. Nฮต-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advancedย GLYCATIONย End Products of the Maillard Reaction
  164. Advancedย GLYCATIONย endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human โ€ฆ
  165. Recombinant advancedย GLYCATIONย end product receptor pharmacokinetics in normal and diabetic rats
  166. โ€ฆ characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advancedย GLYCATIONย endproduct-modified serum โ€ฆ
  167. Decreased platelet membrane fluidity due toย GLYCATIONย or acetylation of membrane proteins
  168. Identification of polymorphisms in the receptor for advancedย GLYCATIONย end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.
  169. Free radicals generated during theย GLYCATIONย reaction of amino acids by methylglyoxal: a model study of protein-cross-linked free radicals
  170. The role ofย GLYCATIONย in aging and diabetes mellitus
  171. Advancedย GLYCATIONย end products-driven angiogenesis in vitro: induction of the growth and tube formation of human microvascular endothelial cells through autocrine โ€ฆ
  172. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advancedย GLYCATIONย endproduct formation and prevents hyperglycemia-induced โ€ฆ
  173. Immunohistochemical localisation of advancedย GLYCATIONย end products in pulmonary fibrosis.
  174. Nonenzymaticย GLYCATIONย of bovine serum albumin by fructose (fructation): comparison with the Maillard reaction initiated by glucose
  175. ฮฑ-Lipoate can protect againstย GLYCATIONย of serum albumin, but not low-density lipoprotein
  176. Oxidative alterations in the experimentalย GLYCATIONย model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed โ€ฆ
  177. Accumulation of advancedย GLYCATIONย end products of the Maillard reaction with age in human hippocampal neurons
  178. The relative roles of advancedย GLYCATION, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley โ€ฆ
  179. Advancedย GLYCATIONย end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the โ€ฆ
  180. GLYCATIONย of insulin results in reduced biological activity in mice
  181. The generation of superoxide anions inย GLYCATIONย reactions with sugars, osones, and 3-deoxyosones
  182. Cytotoxic effects of autoxidativeย GLYCATION
  183. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advancedย GLYCATIONย end products of the Maillard reaction
  184. Amyloid-ฮฒ peptideโ€“Receptor for Advancedย GLYCATIONย Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory โ€ฆ
  185. Sites ofย GLYCATIONย of human and horse liver alcohol dehydrogenase in vivo.
  186. Proteinย GLYCATION: measurement and clinical relevance
  187. Kinetic analysis ofย GLYCATIONย as a tool for assessing the half-life of proteins
  188. Advancedย GLYCATIONย end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
  189. Influence ofย GLYCATIONย on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells
  190. Characterization of in vitroย GLYCATIONย sites of tau
  191. Non-enzymaticย GLYCATIONย of apolipoprotein B in the sera of diabetic and non-diabetic subjects
  192. Histones from diabetic rats contain increased levels of advancedย GLYCATIONย end products
  193. The contribution ofย GLYCATIONย to cataract formation in diabetes.
  194. Immunochemical detection of advancedย GLYCATIONย end products in lens crystallins from streptozocin-induced diabetic rat
  195. Role of polyol pathway in nonenzymaticย GLYCATION
  196. Increased Aggregation of Human Platelets Produced by Advancedย GLYCATIONย End Productsin Vitro
  197. DNA-GLYCATIONย leads to depurination by the loss of N2-carboxyethylguanine in vitro.
  198. Immunohistochemical localization of advancedย GLYCATIONย end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimerโ€™s disease and aged โ€ฆ
  199. Neurotoxicity of advancedย GLYCATIONย endproducts during focal stroke and neuroprotective effects of aminoguanidine.
  200. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advancedย GLYCATIONโ€“modified proteins to a conserved motif
  201. Nonenzymaticย GLYCATIONย alters protein structure and stability. A study of two eye lens crystallins.
  202. Non-enzymicย GLYCATIONย of fibrous collagen: reaction products of glucose and ribose
  203. Advancedย GLYCATIONย end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with โ€ฆ
  204. DNA cleavage induced byย GLYCATIONย of Cu, Zn-superoxide dismutase
  205. โ€ฆ in post-translational modification of collagen in normal human articular cartilage: the age-related increase in non-enzymaticย GLYCATIONย affects biomechanical properties โ€ฆ
  206. Advancedย GLYCATIONย endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
  207. Identification of pentosidine as a native structure for advancedย GLYCATIONย end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related โ€ฆ
  208. GLYCATION, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells
  209. Mutual interaction betweenย GLYCATIONย and oxidation during non-enzymatic protein modification
  210. Upregulation of mesangial growth factor and extracellular matrix synthesis by advancedย GLYCATIONย end products via a receptor-mediated mechanism
  211. Modification of vitronectin by advancedย GLYCATIONย alters functional properties in vitro and in the diabetic retina.
  212. ADP-ribose inย GLYCATIONย and glycoxidation reactions
  213. GLYCATIONย and microglial reaction in lesions of Alzheimerโ€™s disease
  214. Progressive changes in lens crystallinย GLYCATIONย and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats
  215. The receptor for advancedย GLYCATIONย end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via โ€ฆ
  216. Advancedย GLYCATIONย endproducts and diabetic nephropathy
  217. Site specificity of proteinย GLYCATION
  218. The advancedย GLYCATIONย endproduct pentosidine and monocyte activation in uremia.
  219. Advancedย GLYCATIONย end products and their recognition by macrophage and macrophage-derived cells
  220. Toxic action of advancedย GLYCATIONย end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy
  221. GLYCATIONย of crystalline in lenses from aging and diabetic individuals
  222. Increased serum levels of advancedย GLYCATIONย end products (AGEs) in children and adolescents with IDDM
  223. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advancedย GLYCATIONย and diabetic complications
  224. Roles of advancedย GLYCATIONย end-products in the progression of diabetic nephropathy
  225. The advancedย GLYCATIONย end product Nepsilon-(carboxymethyl) lysine is increased in serum from children and adolescents with type 1 diabetes.
  226. Type II alveolar epithelial cells in lung express receptor for advancedย GLYCATIONย end products (RAGE) gene
  227. Deposition of advancedย GLYCATIONย end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
  228. Relative contributions of advancedย GLYCATIONย and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats
  229. GLYCATIONย of insulin in the islets of Langerhans of normal and diabetic animals
  230. Advanced nonenzymaticย GLYCATIONย endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
  231. GLYCATIONย changes the charge distribution of type I collagen fibrils
  232. Age-related increase in an advancedย GLYCATIONย end product in penile tissue
  233. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advancedย GLYCATIONย end products
  234. GLYCATIONย of brain actin in experimental diabetes
  235. Enhanced binding of advancedย GLYCATIONย endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimerโ€™s disease
  236. Advancedย GLYCATIONย endproducts are associated with Hirano bodies in Alzheimerโ€™s disease
  237. GLYCATIONย accelerates the oxidation of low density lipoprotein by copper ions
  238. Relationships betweenย GLYCATIONย and oxidation related fluorescences in rat collagen during aging. An in vivo and in vitro study.
  239. ฮฒ2-Microglobulin modified with advancedย GLYCATIONย end products modulates collagen synthesis by human fibroblasts
  240. Nonenzymaticย GLYCATIONย of peripheral and central nervous system proteins in experimental diabetes mellitus
  241. A preliminary note on inhibiting effect of alpha-tocopherol (vit. E) on proteinย GLYCATION.
  242. Acid-stable fluorescent advancedย GLYCATIONย end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or โ€ฆ
  243. โ€ฆ of methylglyoxal-modified serum albumin. Competition with advancedย GLYCATIONย end product-modified serum albumin at the advancedย GLYCATIONย end product receptor.
  244. GLYCATIONย increases the permeability of proteins across the blood-nerve and blood-brain barriers
  245. Immunochemical detection of advancedย GLYCATIONย end products in renal cortex from STZ-induced diabetic rat
  246. Advancedย GLYCATIONย end products co-localized with astrocytes and microglial cells in Alzheimerโ€™s disease brain
  247. Site specificity ofย GLYCATIONย of horse liver alcohol dehydrogenase in vitro
  248. The influence of advancedย GLYCATIONย endproducts (AGE) on the expression of human endothelial adhesion molecules
  249. Prevention of lens proteinย GLYCATIONย by taurine
  250. Inhibition ofย GLYCATIONย of albumin and hemoglobin by acetylation in vitro and in vivo
  251. Kinetics of nonenzymaticย GLYCATIONย of ribonuclease A leading to advancedย GLYCATIONย end products. Paradoxical inhibition by ribose leads to facile isolation of protein โ€ฆ
  252. Cellular contraction of collagen lattices is inhibited by nonenzymaticย GLYCATION
  253. Nonenzymaticย GLYCATIONย of human lens crystallin. Effect of aging and diabetes mellitus.
  254. Comparison of advancedย GLYCATIONย endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control
  255. Lens protein composition,ย GLYCATIONย and high molecular weight aggregation in aging rats.
  256. Effects of metformin on collagenย GLYCATIONย and diastolic dysfunction in diabetic myocardium
  257. The endothelial cell binding site for advancedย GLYCATIONย end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide
  258. Thiamine corrects delayed replication and decreases production of lactate and advancedย GLYCATIONย end-products in bovine retinal and human umbilical vein โ€ฆ
  259. Are advancedย GLYCATIONย end-products associated with amyloidosis in Alzheimerโ€™s disease?
  260. Evidence for an increasedย GLYCATIONย of IgG in diabetic patients
  261. GLYCATIONย of very low density lipoprotein from rat plasma impairs its catabolism
  262. In vivoย GLYCATIONย of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification ofย GLYCATIONย sites
  263. The receptor for advancedย GLYCATIONย end products mediates the chemotaxis of rabbit smooth muscle cells
  264. Atherosclerosis andย GLYCATION
  265. Inhibitory effect of metformin on formation of advancedย GLYCATIONย end products
  266. Advancedย GLYCATIONย of rat liver histone octamers: an in vitro study
  267. The role of metal-catalyzed oxidation in the formation of advancedย GLYCATIONย end products: an in vitro study on collagen
  268. Characterization of insulinย GLYCATIONย in insulin-secreting cells maintained in tissue culture
  269. Glutathione inhibits theย GLYCATIONย and crosslinking of lens proteins by ascorbic acid
  270. GLYCATIONย of human serum albumin: inhibition by Diclofenac
  271. GLYCATIONย of lens proteins by the oxidation products of ascorbic acid
  272. Immunohistochemical detection of advancedย GLYCATIONย end products in dialysis-related amyloidosis
  273. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advancedย GLYCATIONย endproducts in lesions, and extent of atherosclerosis in LDL receptor โ€ฆ
  274. Effect of alpha-tocopherol on LDL oxidation andย GLYCATION: in vitro and in vivo studies
  275. Advancedย GLYCATIONย endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis
  276. Decrease inย GLYCATIONย of lens proteins by lysine and glycine by scavenging of glucose and possible mitigation of cataractogenesis
  277. The site of nonenzymicย GLYCATIONย of human extracellular-superoxide dismutase in vitro
  278. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advancedย GLYCATIONย end products in human tissues.
  279. Structural and functional changes of laminin and type IV collagen after nonenzymaticย GLYCATION
  280. Advancedย GLYCATIONย end products (AGE)-modified proteins and their potential relevance to atherosclerosis
  281. Plasma proteinย GLYCATIONย as measured by fructosamine assay.
  282. Immunohistochemical study of advancedย GLYCATIONย end products in aging and Alzheimerโ€™s disease brain
  283. Pathophysiology of advancedย GLYCATIONย end-products in renal failure
  284. Advancedย GLYCATIONย endproductsโ€“receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B
  285. Inhibition of lens crystallinย GLYCATIONย and high molecular weight aggregate formation by aspirin in vitro and in vivo.
  286. Oxidative stress caused byย GLYCATIONย of Cu, Zn-superoxide dismutase and its effects on intracellular components
  287. Advancedย GLYCATIONย end product (AGE): Characterization of the products from the reaction between Dโ€glucose and serum albumin
  288. Hb himeji or ฮฒ140 (H18) ALAโ†’ ASP a slightly unstable hemoglobin with increased ฮฒN-terminalย GLYCATION
  289. Age-dependent accumulation of advancedย GLYCATIONย end-products in adult Drosophila melanogaster
  290. Characterization of the non enzymaticย GLYCATIONย of high density lipoprotein in diabetic patients.
  291. The advancedย GLYCATIONย endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells
  292. Interaction between ฮฒ2-microglobulin and advancedย GLYCATIONย end products in the development of dialysis related-amyloidosis
  293. Fragmentation of ceruloplasmin following non-enzymaticย GLYCATIONย reaction
  294. CARNOSINE PROTECTS PROTEINS AGAINST IN VITROย GLYCATIONย AND CROSSโ€“LINKING
  295. Non-enzymic glycosylation (GLYCATION) of lens proteins by galactose and protection by aspirin and reduced glutathione
  296. Role of advancedย GLYCATIONย end products in aging collagen
  297. The role of oxidative stress in the longโ€termย GLYCATIONย of LDL
  298. Imidazolone, a novel advancedย GLYCATIONย end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes
  299. Plasma proteinย GLYCATIONย in Alzheimerโ€™s disease
  300. Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymaticย GLYCATIONย of collagen in mice
  301. Localization of advancedย GLYCATIONย endproducts in the kidney of experimental diabetic rats
  302. Nonenzymaticย GLYCATIONย of immunoglobulins leads to an impairment of immunoreactivity
  303. Depletion of reactive advancedย GLYCATIONย endproducts from diabetic uremic sera using a lysozyme-linked matrix.
  304. GLYCATIONย of cataractous lens in non-diabetic senile subjects and in diabetic patients.
  305. Non enzymaticย GLYCATIONย of apolipoprotein AI. Effects on its self-association and lipid binding properties
  306. Two-dimensional stress-relaxation behavior of human skin as influenced by non-enzymaticย GLYCATIONย and the inhibitory agent aminoguanidine
  307. The relationship of glycaemic level to advancedย GLYCATIONย end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster
  308. Isolation and characterization of advancedย GLYCATIONย end products derived from the in vitro reaction of ribose and collagen
  309. GLYCATIONย of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehyde measured using four methods
  310. A fluorescamine-based assay for the degree ofย GLYCATIONย in bovine serum albumin
  311. Effect ofย GLYCATIONย on the properties of lipoprotein (a)
  312. Aminoguanidine and its pro-oxidant effects on an experimental model of proteinย GLYCATION
  313. โ€ฆ -alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not proteinย GLYCATIONย in patients with โ€ฆ
  314. Generation of active oxygen species from advancedย GLYCATIONย end-products (AGE) under ultraviolet light A (UVA) irradiation
  315. The relative extent ofย GLYCATIONย of haemoglobin and albumin
  316. Monocyte/macrophage response to ฮฒ2-microglobulin modified with advancedย GLYCATIONย end products
  317. Aminoguanidine inhibits advancedย GLYCATIONย end products formation on beta2-microglobulin.
  318. Evaluation of the fructosamine test for the measurement of plasma proteinย GLYCATION
  319. D-lysine effectively decreases the non-enzymicย GLYCATIONย of proteins in vitro.
  320. Inhibition of matrix-induced bone differentiation by advancedย GLYCATIONย end-products in rats
  321. Effect of Matrixย GLYCATIONย on Expression of Type IV Collagen, MMP-2, MMP-9 and TIMP-1 by Human
  322. DNA damage by theย GLYCATIONย products of glyceraldehyde 3-phosphate and lysine
  323. GLYCATIONย mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro
  324. Accelerated formation of Nฯต-(carboxymethyl) lysine, an advancedย GLYCATIONย end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons
  325. Localization of identified advancedย GLYCATIONย endโ€product structures, Nฮต=(carboxymethyl) lysine and pentosidine, in ageโ€related inclusions in human brains
  326. Effect of advancedย GLYCATIONย end productโ€“modified albumin on tissue factor expression by monocytes: role of oxidant stress and protein tyrosine kinase activation
  327. Membrane fluidity is related to the extent ofย GLYCATIONย of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes โ€ฆ
  328. Advancedย GLYCATIONย endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells
  329. Role ofย GLYCATIONย in human lens protein structure change
  330. The effectiveness of putative anti-cataract agents in the prevention of proteinย GLYCATION.
  331. Good glycaemic control reduces oxidation andย GLYCATIONย end-products in collagen of diabetic rats
  332. Human erythrocyte bisphosphoglycerate mutase: inactivation byย GLYCATIONย in vivo and in vitro
  333. Association between theย GLYCATIONย of erythrocyte membrane proteins and membrane fluidity
  334. Impairment byย GLYCATIONย of immunoglobulin G Fc fragment function
  335. Induction of macrophage growth by advancedย GLYCATIONย end products of the Maillard reaction.
  336. Decreased interaction of fibronectin, type iv collagen, and heparin due to nonenzymicย GLYCATION. Implications for diabetes mellitus
  337. GLYCATION: a pathological modification in neuropathies?: a hypothesis.
  338. The effects of aminoguanidine on theย GLYCATIONย (non-enzymic glycosylation) of lens proteins
  339. Nonenzymaticย GLYCATIONย of transferrin: decrease of iron-binding capacity and increase of oxygen radical production
  340. Modification of ฮฒ2m with advancedย GLYCATIONย end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum
  341. Nonโ€enzymaticย GLYCATIONย of histones
  342. Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advancedย GLYCATIONย end products
  343. beta 2-Microglobulin modified with advancedย GLYCATIONย end products is a major component of hemodialysis-associated amyloidosis.
  344. Nonenzymaticย GLYCATIONย and extractability of collagen in human atherosclerotic plaques
  345. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due toย GLYCATION
  346. The erythrocyte calcium pump is inhibited by non-enzymicย GLYCATION: studies in situ and with the purified enzyme
  347. Tetracyclines inhibit proteinย GLYCATIONย in experimental diabetes
  348. Identification of the site of non-enzymaticย GLYCATIONย of glutathione peroxidase: rationalization of theย GLYCATION-related catalytic alterations on the basis of three โ€ฆ
  349. Identification of galectin-3 as a high-affinity binding protein for advancedย GLYCATIONย end products (AGE): a new member of the AGE-receptor complex
  350. GLYCATIONย of human lens proteins from diabetic and (nondiabetic) senile cataract patients
  351. GLYCATIONย and inactivation of sorbitol dehydrogenase in normal and diabetic rats
  352. Circulating advancedย GLYCATIONย peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains
  353. Changes in solubility, non-enzymaticย GLYCATION, and fluorescence of collagen in tail tendons from diabetic rats
  354. Advancedย GLYCATIONย end products modulate transcriptional regulation in mesangial cells
  355. Increased serum levels of advancedย GLYCATIONย end products in NIDDM patients with diabetic complications
  356. Presence of dopa and amino acid hydroperoxides in proteins modified with advancedย GLYCATIONย end products (AGEs): amino acid oxidation products as a possible โ€ฆ
  357. Reaction of advancedย GLYCATIONย endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: an ultrastructural study using colloidal gold โ€ฆ
  358. Nonenzymaticย GLYCATIONย of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus
  359. โ€ฆ of methylglyoxal, glyoxalase I inhibitor diesters and SD-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advancedย GLYCATIONย โ€ฆ
  360. Possible significance of advancedย GLYCATIONย end products in serum in end-stage renal disease and in late complications of diabetes
  361. Molecular chaperones protect againstย GLYCATIONโ€induced inactivation of glucoseโ€6โ€phosphate dehydrogenase
  362. Association of elastinย GLYCATIONย and calcium deposit in diabetic rat aorta
  363. Nonenzymaticย GLYCATIONย of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge
  364. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advancedย GLYCATIONย end product, in uremia
  365. Accumulation of advancedย GLYCATIONย endproducts in the rat nephron: link with circulating AGEs during aging
  366. Immunohistochemical study of human advancedย GLYCATIONย end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with โ€ฆ
  367. Advancedย GLYCATIONย end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients
  368. Distribution of advancedย GLYCATIONย end products in the cerebellar neurons of dogs
  369. Specific detections of the early process of theย GLYCATIONย reaction by fructose and glucose in diabetic rat lens
  370. Growth modulation of retinal microvascular cells by early and advancedย GLYCATIONย products
  371. Amyloidosis, advancedย GLYCATIONย end products and Alzheimer disease
  372. Flavonoid treatment reducesย GLYCATIONย and lipid peroxidation in experimental diabetic rats
  373. A study on in vitroย GLYCATIONย processes by matrix-assisted laser desorption ionization mass spectrometry
  374. Effect of extracellular matrixย GLYCATIONย on endothelial cell adhesion and spreading: involvement of vitronectin
  375. Spectroscopic study on the effects of nonenzymaticย GLYCATIONย in human alpha-crystallin.
  376. GLYCATIONย ligand binding motif in lactoferrin
  377. โ€ฆ isomerization (Amadori rearrangement) potential at the individual nonenzymicย GLYCATIONย sites of hemoglobin A: preferential inhibition ofย GLYCATIONย by nucleophiles at โ€ฆ
  378. New hypothesis on etiopathogenesis of Alzheimer syndrome. Advancedย GLYCATIONย end products (AGEs)
  379. Ascorbic acidย GLYCATION: the reactions of L-threose in lens tissue
  380. Evaluation of IgGย GLYCATIONย levels by matrixโ€assisted laser desorption/ionization mass spectrometry
  381. Identification of Deoxy-D-Fructosyl Phosphatidylethanolamine as a Non-enzymicย GLYCATIONย Product of Phosphatidylethanolamine and its Occurrence in Human Blood โ€ฆ
  382. Tauย GLYCATIONย is involved in aggregation of the protein but not in the formation of filaments.
  383. GLYCATIONย of albumin, not glomerular basement membrane, alters permeability in an in vitro model
  384. Immunochemical quantification of crossline as a fluorescent advancedย GLYCATIONย endproduct in erythrocyte membrane proteins from diabetic patients with or without โ€ฆ
  385. Temporal association between lens proteinย GLYCATIONย and cataract development in diabetic rats
  386. Fluorescence and immunochemical studies of advancedย GLYCATION-related lens pigments.
  387. ฮฒ2-Microglobulin modified with advancedย GLYCATIONย end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis โ€ฆ
  388. Differentialย GLYCATIONย of rat ฮฑ-, ฮฒ-and ฮณ-crystallins
  389. Receptors for advancedย GLYCATIONย end-products (AGE)โ€”expression by endothelial cells in non-diabetic uraemic patients
  390. Monitoring the progress of nonโ€enzymaticย GLYCATIONย in vitro
  391. GLYCATIONย of human lens proteins: preferentialย GLYCATIONย of ฮฑA subunits
  392. Free alanine, aspartic acid, or glutamic acid reduce theย GLYCATIONย of human lens proteins
  393. In vitro non-enzymaticย GLYCATIONย and formation of browning products in the bovine lens ฮฑ-crystallin
  394. Nonenzymaticย GLYCATIONย of human platelet membrane proteins in vitro and in vivo.
  395. Amyloid ฮฒ2-microglobulin is modified with imidazolone, a novel advancedย GLYCATIONย end product, in dialysis-related amyloidosis
  396. Role of Albuminย GLYCATIONย on the Erythrocyte Aggregation: An In Vitro Study
  397. Site-specificย GLYCATIONย of lens crystallins by ascorbic acid
  398. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advancedย GLYCATIONย end products
  399. Proteinย GLYCATIONย and fluorescent material in human atheroma
  400. Reduction of plasma apolipoprotein-B by effective removal of circulatingย GLYCATIONย derivatives in uremia
  401. Identification of advancedย GLYCATIONย end products of the Maillard reaction in Pickโ€™s disease
  402. D-Lysine reduces the non-enzymaticย GLYCATIONย of proteins in experimental diabetes mellitus in rats
  403. GLYCATIONย of calmodulin: chemistry and structural and functional consequences
  404. Proteinย GLYCATIONย in the aging male Sprague-Dawley rat: effects of antiaging diet restrictions
  405. Involvement of beta 2-microglobulin modified with advancedย GLYCATIONย end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human โ€ฆ
  406. Nonenzymatic glycosylation (GLYCATION) of lens crystallins in diabetes and aging.
  407. Nonenzymaticย GLYCATIONย of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells
  408. GLYCATIONย of Human. beta. 2-Microglobulin in Patients with Hemodialysis-Associated Amyloidosis: Identification of the Glycated Sites
  409. Immunochemical evidence for increased formation of advancedย GLYCATIONย end products and inhibition by aminoguanidine in diabetic rat lenses
  410. Amadori rearrangement potential of hemoglobin at itsย GLYCATIONย sites is dependent on the three-dimensional structure of protein
  411. The effect of ฮด-gluconolactone, an oxidised analogue of glucose, on the nonenzymaticย GLYCATIONย of human and rat haemoglobin
  412. 3-Deoxyglucosone, a promoter of advancedย GLYCATIONย end products in fluids for peritoneal dialysis
  413. A highly specific method for the characterization ofย GLYCATIONย and glycoโ€oxidation products of globins
  414. The In Vitroย GLYCATIONย of Lysozyme and the Influence of Buffer Concentration Investigated by Mass Spectrometry
  415. Biochemical alterations in collagen IV induced by in vitroย GLYCATION
  416. GLYCATIONย and autoxidation of proteins in aging and diabetes
  417. Role of reactive oxygen species in the generation of fluorescence byย GLYCATION
  418. GLYCATIONย of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus
  419. Potential benefit of inhibitors of advancedย GLYCATIONย end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice
  420. Inhibition of advanced proteinย GLYCATIONย by 8-quinolinecarboxylic hydrazide
  421. GLYCATIONย increases the vascular clearance rate of IgG in mice
  422. GLYCATION-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, ฮฑ-crystallin
  423. On glucose transport and non-enzymicย GLYCATIONย of proteins in vivo
  424. Effect of nonenzymaticย GLYCATIONย on the structure of immunoglobulin G
  425. Effects of matrixย GLYCATIONย on mesangial cell adhesion, spreading and proliferation
  426. GLYCATIONย of lens membrane intrinsic proteins
  427. Differential expression of receptors for advancedย GLYCATIONย end products on monocytes in patients with IDDM
  428. Nonenzymaticย GLYCATIONย of cartilage proteoglycans: an in vivo and in vitro study
  429. The role of oxidation andย GLYCATIONย in the pathogenesis of diabetic atherosclerosis
  430. Fructose-relatedย GLYCATION
  431. Advancedย GLYCATIONย end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats
  432. Sites ofย GLYCATIONย of ฮฒB2-crystallin by glucose and fructose
  433. Advancedย GLYCATIONย end products of the Maillard reaction and their relation to aging
  434. Acceleration of fructose mediated collagenย GLYCATION
  435. Advancedย GLYCATIONย modification of Rosenthal fibers in patients with Alexander disease
  436. In vitroย GLYCATIONย of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications
  437. Effect ofย GLYCATIONย of albumin on its renal clearance in normal and diabetic rats
  438. Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymaticย GLYCATIONย and their inhibition by dibasic amino acids arginine and โ€ฆ
  439. Expression of receptors for advancedย GLYCATIONย end-products in occlusive vascular and renal disease
  440. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and โ€œin vitroโ€ย GLYCATIONย of lipoproteins enhance the transfer rate of cholesteryl ester from HDL โ€ฆ
  441. Glyburide protein binding and the effect of albuminย GLYCATIONย in children, young adults, and older adults with diabetes
  442. Formation of advancedย GLYCATIONย end (AGE) products in diabetes: Prevention by pyruvate and a-keto glutarate
  443. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advancedย GLYCATIONย endproducts in bovine endothelial cells.
  444. Nonenzymaticย GLYCATION* of Basement Membranes From Human Glomeruli and Bovine Sources: Effect of Diabetes and Age
  445. GLYCATIONย of proteinous inhibitors: Loss in trypsin inhibitory activity by the blocking of arginine and lysine residues at their reactive sites
  446. Advancedย GLYCATIONย endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with Rheumatoid Arthritis (RA).
  447. Evidence for a relationship between proteinย GLYCATIONย and red blood cell membrane fluidity
  448. Advancedย GLYCATIONย end products in peritoneal dialysis
  449. Ribozyme targeting of receptor for advancedย GLYCATIONย end products in mouse mesangial cells
  450. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advancedย GLYCATION
  451. A study of the age-related acceleration ofย GLYCATIONย of tissue proteins in rats
  452. Some physicoโ€chemical properties and structural changes of bovine ฮฒโ€casein uponย GLYCATION
  453. GLYCATIONย index of hair for non-invasive estimation of diabetic control
  454. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skinย GLYCATION, and pancreatic islets
  455. Non-enzymaticย GLYCATIONย reduces heparin cofactor II anti-thrombin activity
  456. Non-enzymaticย GLYCATIONย of lipoprotein (a) in vitro and in vivo
  457. Post-translational non-enzymatic modification of proteins II. Separation of selected protein species afterย GLYCATIONย and other carbonyl-mediated modifications
  458. Inhibitory effect of nonenzymaticย GLYCATIONย on ubiquitination and ubiquitin-mediated degradation of lysozyme
  459. Ascorbic acidย GLYCATIONย of lens proteins produces UVA sensitizers similar to those in human lens
  460. Nonenzymaticย GLYCATIONย of Na, K-ATPase. Effects on ATP hydrolysis and K+ occlusion.
  461. GLYCATIONย of myofibrillar protein in aged rats and mice
  462. Ageing promotes the increase of earlyย GLYCATIONย Amadori product as assessed by ฯต-N-(2-furoylmethyl)-l-lysine (furosine) levels in rodent skin collagen: The โ€ฆ
  463. GLYCATIONย and inactivation of aspartate aminotransferase in diabetic rat tissues
  464. Amino terminalย GLYCATIONย of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells
  465. GLYCATIONย of glucagon-like peptide-1 (7โ€“36) amide: characterization and impaired action on rat insulin secreting cells
  466. The principal site ofย GLYCATIONย of human complement factor B
  467. Computer models of albumin and haemoglobinย GLYCATION
  468. Interactions between the sorbitol pathway, non-enzymaticย GLYCATION, and diabetic vascular dysfunction
  469. Angiogenic effects of advancedย GLYCATIONย end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells
  470. Nonenzymaticย GLYCATIONย of human blood platelet proteins
  471. GLYCATIONย of albumin with aging and diabetes in rats: changes in its renal handling
  472. Increasedย GLYCATIONย of plasma lipoproteins in diabetic cynomolgus monkeys.
  473. Nonenzymicย GLYCATIONย of human immunoglobulins does not impair their immunoreactivity.
  474. GLYCATIONย of the human erythrocyte glucose transporter in vitro and its functional consequences
  475. Age-and diabetes-acceleratedย GLYCATIONย in the human aorta
  476. Purification of ฮฑ-ketoaldehyde dehydrogenase from the human liver and its possible significance in the control ofย GLYCATION
  477. Aging of the vitreous body. Role ofย GLYCATIONย and free radicals
  478. Non-enzymaticย GLYCATIONย of epidermal proteins of the stratum corneum in diabetic patients
  479. Non-enzymaticย GLYCATIONย and altered renal structure and function in the diabetic rat
  480. Primary Sequence andย GLYCATIONย at Lysineโ€548 of Bovine Serum Albumin
  481. Age-related acceleration ofย GLYCATIONย of tissue proteins in rats
  482. Change in the functional properties of actin by itsย GLYCATIONย in vitro.
  483. Site selectivity in theย GLYCATIONย of ฮฑA-crystallin and ฮฑB-Crystallins by glucose
  484. Fructose-induced fluorescence generation of reductively methylated glycated bovine serum albumin: evidence for nonenzymaticย GLYCATIONย of Amadori adducts
  485. Identification ofย GLYCATIONย at the N-terminus of albumin by gas chromatography-mass spectrometry
  486. Hyperglycemia and non-enzymaticย GLYCATIONย of serum and tissue proteins in chickens
  487. The influence ofย GLYCATIONย on the peroxidase activity of haemoglobin
  488. GLYCATIONย of erythrocyte superoxide dismutase reduces its activity
  489. Determination ofย GLYCATIONย crosslinking by the sugar-dependent incorporation of [14C] lysine into protein
  490. Non-enzymaticย GLYCATIONย of phosphoglucoisomerase.
  491. Impaired agglutination of IgM resulting from non-enzymaticย GLYCATIONย in diabetes mellitus
  492. Theย GLYCATIONย hypothesis of atherosclerosis
  493. Improvement of physicochemical and enzymatic properties of bovine trypsin by non-enzymaticย GLYCATION
  494. Non-enzymaticย GLYCATIONย of elastin
  495. In vivoย GLYCATIONย of bovine lens crystallins
  496. The pyridoindole antioxidant stobadine inhibitedย GLYCATION-induced absorbance and fluorescence changes in albumin
  497. โ€ฆ may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymaticย GLYCATION.
  498. Peripheral nerve proteinย GLYCATIONย and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS.
  499. Nonenzymaticย GLYCATIONย alters properties of collagen as a substratum for cells
  500. Free lysine, glycine, alanine, glutamic acid and aspartic acid reduce theย GLYCATIONย of human lens proteins by galactose.
  501. In vitro studies of histoneย GLYCATION
  502. Post-translational non-enzymatic modification of proteins I. Chromatography of marker adducts with special emphasis toย GLYCATIONย reactions
  503. Crystallin composition of human cataractous lens may be modulated by proteinย GLYCATION
  504. NA+/K+ ATPase Impairment and Experimentalย GLYCATION: The Role of Glucose Autoxidation
  505. Contribution ofย GLYCATIONย to human lens coloration
  506. ADVANCEDย GLYCATIONย TOXICITY AND DIABETIC COM PLI CATIONS
  507. Proteinย GLYCATIONย and in vivo distribution of human lens fluorescence
  508. GLYCATIONย of platelet protein in diabetes mellitus: lack of correlation with platelet function
  509. GLYCATIONย of serum albumin and its role in renal protein excretion and the development of diabetic nephropathy
  510. Polyclonal immunoglobulin M: location ofย GLYCATIONย sites
  511. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advancedย GLYCATIONย endproducts proteins in diabetic โ€ฆ
  512. โ€ฆ of a serine protease in erythrocyte cytosol that is adherent to oxidized membranes and preferentially degrades proteins modified by oxidation andย GLYCATION
  513. IgGย GLYCATIONย and function during continuous ambulatory peritoneal dialysis.
  514. The Role of ฮฑ-and ฮต-Amino Groups in theย GLYCATION-mediated Cross-linking of ฮณB-crystallin: STUDY OF THREE SITE-DIRECTED MUTANTS
  515. Characterization of theย GLYCATIONย of albumin in freeze-dried and frozen human serum
  516. Effects of continuous ambulatory peritoneal dialysis and kidney transplantation on advancedย GLYCATIONย endproducts in the skin and peritoneum.
  517. L-Arginine inhibits in vitro nonenzymaticย GLYCATIONย and advanced glycosylated end product formation of human serum albumin
  518. Matrixโ€assisted laser desorption/ionization mass spectrometric studies on proteinย GLYCATION. 2. The reaction of ribonuclease with hexoses
  519. The effect of fructose on collagenย GLYCATION.
  520. GLYCATIONย of lens MIP26 affects the permeability in reconstituted liposomes
  521. The in vivoย GLYCATIONย of diabetic tendon collagen studied by neutron diffraction
  522. Increasedย GLYCATIONย and pigmentation of collagen in aged and young parabiotic rats and mice
  523. GLYCATION-induced crosslinking of calf lens crystallins
  524. Some factors that influence the nonenzymaticย GLYCATIONย of peptides and polypeptides by glyceraldehyde
  525. In vitroย GLYCATIONย of red blood cell proteins: high levels of glucose lower lipid fluidity of erythrocyte membranes
  526. Relationship between lens proteinย GLYCATIONย and membrane structure in human cataract
  527. Comparison of the effect of different inhibitors on the non-enzymaticย GLYCATIONย of rat tail tendons and bovine serum albumin
  528. GLYCATIONย and diabetic complications
  529. Nonenzymaticย GLYCATIONย of platelet proteins in diabetic patients
  530. Identification of the site ofย GLYCATIONย of ฮณ-II-crystallin by (14C)-fructose
  531. Nonenzymicย GLYCATIONย of apolipoprotein B in patients with insulin-and noninsulin-dependent diabetes mellitus
  532. Non-enzymaticย GLYCATIONย and protein recognition.
  533. Theย GLYCATION-associated crosslinking of lens proteins by ascorbic acid is not mediated by oxygen free radicals
  534. Inhibition of protein non-enzymicย GLYCATIONย induced by Bendazac.
  535. Defects of copper deficiency in rats are modified by dietary treatments that affectย GLYCATION
  536. Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymaticย GLYCATION
  537. Nonenzymicย GLYCATIONย of albumin by acyl glucuronides in vitro comparison of reactions with reducing sugars
  538. Importance of advancedย GLYCATIONย end productsโ€“AGE products
  539. Identification of furoyl-containing advancedย GLYCATIONย products in collagen samples from diabetic and healthy rats
  540. GLYCATIONย of human lens crystallins: effect of age and aspirin treatment
  541. The nonenzymaticย GLYCATIONย of proteins and nucleic acids, their importance for the development of diabetic complications, possible molecular basis of aging and โ€ฆ
  542. Non-enzymaticย GLYCATIONย of antithrombin III in vitro
  543. Nonenzymaticย GLYCATIONย of immunoglobulins does not impair antigen-antibody binding.
  544. Lysine vasopressin undergoes rapidย GLYCATIONย in the presence of reducing sugars
  545. Kinetics of theย GLYCATIONย of bovine serum albumin by mannose and fucose in vitro
  546. Non-enzymaticย GLYCATIONย of human albumin does not alter its palmitate binding
  547. Theย GLYCATIONย and cross-linking of isolated lens crystallins by ascorbic acid
  548. Reduced membrane fluidity and increasedย GLYCATIONย of membrane proteins of platelets from diabetic subjects are not associated with increased platelet adherence to โ€ฆ
  549. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different fromย GLYCATION
  550. GLYCATIONย and oxidation of human low density lipoproteins reduces heparin binding and modifies charge
  551. In vitroย GLYCATIONย and acetylation (by aspirin) of rat crystallins
  552. Matrixโ€assisted laser desorption/ionization capabilities in the study of nonโ€enzymatic proteinย GLYCATION
  553. Effects of aminoguanidine on serum advancedย GLYCATIONย endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane โ€ฆ
  554. Bendazac decreases in vitroย GLYCATIONย of human lens crystallins
  555. GLYCATIONย of human tissue and serum creatine kinase
  556. Nonenzymicย GLYCATIONย of isolated human glomerular basement membrane changes its physicochemical characteristics and binding properties
  557. Inhibitory effects of some Chinese herbs on the non-enzymaticย GLYCATIONย of proteins [J]
  558. GLYCATIONย decreases the stability of the triple-helical strands of fibrous collagen against proteolytic degradation by pepsin in a specific temperature range
  559. GLYCATIONย reaction of aspartate aminotransferase by various carbohydrates in an in vitro system
  560. Prevention and reversible solubilization of advancedย GLYCATIONย and products (AGE) by organic germanium compounds as derivatives of amino acids
  561. GLYCATIONย of hemoglobin C in the heterozygous state in diabetic patients
  562. Improved metabolic control in patients with nonโ€insulinโ€dependent diabetes mellitus is associated with a slower accumulation ofย GLYCATIONย products in collagen
  563. High galactose levels in vitro and in vivo impair ascorbate regeneration and increase ascorbate-mediatedย GLYCATIONย in cultured rat lens
  564. Determination of the non-enzymaticย GLYCATIONย of hemoglobin by isoelectrofocusing of its globin chains
  565. Lowย GLYCATIONย level and browning in human cataracts
  566. Localization of advancedย GLYCATIONย end products of Maillard reaction in bovine tissues and their endocytosis by macrophage scavenger receptors
  567. Advancedย GLYCATIONย end products induce specific glycoprotein alterations in retinal microvascular cells
  568. Amyloid, advancedย GLYCATIONย end products, and dialysis related arthropathy
  569. Role of Glycine 1 and Lysine 2 in theย GLYCATIONย of Bovine ฮณB-Crystallin: SITE-DIRECTED MUTAGENESIS OF LYSINE TO THREONINE (โˆ—)
  570. Lens proteinย GLYCATIONย and the subsequent degree of opacity in streptozotocin-diabetic rats
  571. Proteinย GLYCATION: Effects upon protein recognition by the proximal tubule
  572. Variableย GLYCATIONย of serum proteins in patients with diabetes mellitus
  573. Colorimetric assay of glycoproteinย GLYCATIONย free of interference from glycosylation residues
  574. GLYCATIONย mediated crosslinking between ฮฑ-crystallin and MP26 in intact lens membranes
  575. Advancedย GLYCATIONย end-products reduce the viability of human peritoneal mesothelial cells
  576. The permselectivity of glomerular basement membrane can be compromised byย GLYCATIONย or by exposure to low levels of hypochlorite
  577. Rapid assessment of earlyย GLYCATIONย products by mass spectrometry
  578. Captopril inhibits the fluorescence development associated withย GLYCATIONย of proteins.
  579. Advancedย GLYCATIONย end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells
  580. Immunochemical detection of N2-[1-(1-carboxy) ethyl] guanosine, an advancedย GLYCATIONย end product formed by the reaction of DNA and reducing sugars or L โ€ฆ
  581. Aging of aorta and atherosclerosisโ€“role of nonenzymaticย GLYCATIONย of collagen
  582. Plasma proteinโ€™sย GLYCATIONย is decreased in Sprague Dawley rats under caloric restriction
  583. Retinol binding protein: a short half life determinant of protein non enzymaticย GLYCATIONย in diabetes.
  584. Hepatic advancedย GLYCATIONย endproduct binding is increased in experimental diabetes.
  585. Effects ofย GLYCATIONย process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus
  586. Effect of creatine onย GLYCATIONย of albumin in vitro
  587. Effect of alpha-glucosidase inhibition on the nonenzymaticย GLYCATIONย of glomerular basement membrane.
  588. โ€ฆ by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advancedย GLYCATIONย โ€ฆ
  589. โ€ฆ chromatofocusing and column affinity chromatography of in vitro14C-glycated human serum albumin: Demonstration of aย GLYCATION-induced anionic heterogeneity
  590. Studies on advancedย GLYCATIONย end products by recent mass spectrometric techniques
  591. Effect ofย GLYCATIONย on the heterogeneity of human serum albumin analysed by reversed-phase high-performance liquid chromatography in a solvent containing formic โ€ฆ
  592. Hair proteinย GLYCATIONย as a long-term index of blood glucose in diabetics
  593. Effects of advancedย GLYCATIONย endproducts on the generation of macrophage-mediated oxidized low-density lipoprotein
  594. Susceptibility of Gammaโ€Irradiated Proteins to In Vitroย GLYCATION: Exposure to Oxygen Free Radicals Increasesย GLYCATIONโ€Induced Modifications
  595. Clinical application of hair proteinย GLYCATIONย in the assessment of blood glucose control and diabetic neuropathy.
  596. Comparison of normal and in vitro aging by non-enzymaticย GLYCATIONย as verified by differential scanning calorimetry
  597. Effects of aminoguanidine and pyridoxal phosphate onย GLYCATIONย reaction of aspartate aminotransferase and serum albumin
  598. Structural elucidation of a novel lysine-lysine crosslink generated in aย GLYCATIONย reaction with L-threose
  599. โ€ฆ of synthesis and secretion of interleukin 1ฮฒ in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advancedย GLYCATIONย โ€ฆ
  600. Immunohistochemical study with antiโ€advancedย GLYCATIONย endโ€products antibody in murine amyloidosis
  601. The lysineย GLYCATIONย 1. A preliminary investigation on the products arising from the reaction of protected lysine and D-glucose
  602. GLYCATIONย of hepatocyte cytosolic proteins in streptozotocin-induced diabetic rats
  603. Advancedย GLYCATIONย end products and ฮฒ2-microglobulin. The story unfolds
  604. Quantitation of theย GLYCATIONย intermediate 3-deoxyglucosone by oxidation with rabbit liver oxoaldehyde dehydrogenase to 2-keto-3-deoxygluconic acid followed by โ€ฆ
  605. Reduction of advancedย GLYCATIONย endโ€product (AGE) levels in nervous tissue proteins of diabetic Lewis rats following islet transplants is related to different durations of โ€ฆ
  606. Polypeptide-polysaccharide conjugates produced by spontaneous non-enzymaticย GLYCATION
  607. GLYCATIONย of fibrinogen in diabetic patients: a practical colorimetric assay
  608. The role ofย GLYCATIONย in cataract lens in diabetic patients
  609. GLYCATIONย of granulocyte and monocyte membrane proteins in diabetic patients
  610. Reactivity of 6-phosphogluconolactone with hydroxylamine: the possible involvement of glucose-6-phosphate dehydrogenase in endogenousย GLYCATIONย reactions
  611. Effect of proteinย GLYCATIONย on subsequent volatile formation
  612. Calmodulinย GLYCATIONย in diabetic rat lenses
  613. Spectrophotometric determination of browning products ofย GLYCATIONย of protein amino groups based on their reactivity with nitro blue tetrazolium salts
  614. Lens glutathione, lens proteinย GLYCATIONย and electrophoretic patterns of lens proteins in STZ induced diabetic rats
  615. GLYCATIONย of collagen in hypertriglyceridemic rats
  616. Evidence forย GLYCATIONย of horse liver alcohol dehydrogenase in vivo
  617. Automated fructosamine assay with improved accuracy used to quantify nonenzymaticย GLYCATIONย of serum proteins in diabetes mellitus and chronic renal failure
  618. Serum levels of 3-deoxyglucosone and tissue contents of advancedย GLYCATIONย end products are increased in streptozotocin-induced diabetic rats with nephropathy
  619. Application of the Time-Resolved Immunofluorometric Assay to the Study of C3 Complement Componentย GLYCATIONย in vitro and in vivo
  620. โ€ฆ and HDL-cholesterol independent of fasting triglycerides in a Caucasian population: evidence for enhanced cholesterol ester transfer induced by in vivoย GLYCATION
  621. The adverse effect ofย GLYCATIONย of human serum albumin on its preservative activity in the freeze-drying and accelerated degradation of alkaline phosphatase
  622. โ€ฆ staining of renal biopsy samples in patients with diabetic nephropathy in nonโ€insulin dependent diabetes mellitus using monoclonal antibody to advancedย GLYCATIONย โ€ฆ
  623. The effect of non-enzymicย GLYCATIONย on ligand binding to human serum albumin
  624. Parent ion spectroscopy in the identification of advancedย GLYCATIONย products
  625. Proteinย GLYCATION: Its role in the changes induced by diabetes in the properties of the serum insulin-like growth factor-I binding proteins
  626. The effect of non-enzymaticย GLYCATIONย of serum proteins on their permeation into peripheral nerve in normal and streptozotocin-diabetic rats
  627. Molecular characterization of a mouse genomic element mobilized by advancedย GLYCATIONย endproduct modified-DNA (AGE-DNA)
  628. Crossline-like structure accumulates as fluorescent advancedย GLYCATIONย end products in renal tissues of rats with diabetic nephropathy
  629. Nonenzymaticย GLYCATIONย of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells
  630. Influence ofย GLYCATIONย on cis/trans isomerization and tautomerization in novel morphiceptin-related Amadori compounds
  631. Protection by acetylsalicylic acid against hyperglycemia-inducedย GLYCATIONย and neural tube defects in cultured early somite mouse embryos.
  632. Effect ofย GLYCATIONย upon activity of liver alcohol dehydrogenase
  633. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advancedย GLYCATIONย end products in renal failure
  634. โ€ฆ monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advancedย GLYCATIONย โ€ฆ
  635. GLYCATIONย of H1-histone
  636. Relationship between vascular endothelial growth factors and advancedย GLYCATIONย end products in the human vitreous
  637. Kinetics of histone proteinย GLYCATION.
  638. GLYCATIONย of MP26 and MP22 in bovine lens membranes
  639. An Electrospray Investigation on in vitroย GLYCATIONย of Ribonuclease
  640. Effect ofย GLYCATIONย of low-density lipoprotein on the immunological determination of apolipoprotein B.
  641. Non-enzymicย GLYCATIONย of proteins: analysis of N-(1-deoxyhexitol-1-yl) amino acids by high-performance liquid chromatography
  642. GLYCATIONย in neuropathies
  643. GLYCATIONย of myofibrillar proteins and ATPase activity after incubation with eleven sugars
  644. Effect ofย GLYCATIONย of albumin on its binding to renal brush-border membrane vesicles: influence of aging in rats
  645. Decreased actin activated myosin ATPase activity by non-enzymaticย GLYCATION
  646. Phosphate promotesย GLYCATIONย of antithrombin III which interferes with heparin binding
  647. Scheimpflug densitometric analysis of cataracts in diabetic rats: correlation withย GLYCATION
  648. 132 Total antioxidant status, proteinย GLYCATION, lipid hydroperoxides in non insulin dependent diabetes mellitus
  649. Immunochemical determination of advancedย GLYCATIONย end products in erythrocyte peripheral-membrane proteins from diabetic patients
  650. โ€ฆ -6-(2-formyl-5-hydroxymethyl-pyrrol-l-yl)-hexanoic acid (โ€˜pyrralineโ€™) as an early-stage product or advancedย GLYCATIONย end product in non-enzymic proteinย GLYCATION
  651. Specific non-enzymaticย GLYCATIONย of the rat histone H1 nucleotide binding site in vitro in the presence of AlF4โˆ’. A putative mechanism for impaired chromatin function
  652. Mass spectrometry in the study of advancedย GLYCATIONย processes, responsible for longโ€term diabetes complications
  653. The role of bound lipid and transition metal in the formation of fluorescent advancedย GLYCATIONย endproducts by human serum albumin
  654. GLYCATIONย of tau protein
  655. Evidence that dimethyl sulfoxide inhibits defects of copper deficiency by inhibition ofย GLYCATION
  656. Formation of early and advancedย GLYCATIONย products of lens crystallins with erythrose, ribose and glucose
  657. Enhanced nonenzymaticย GLYCATIONย of eye lens proteins in experimental diabetes mellitus: an approach for the study of protein alterations as mediators of normal aging โ€ฆ
  658. Acceleratedย GLYCATIONย of the aorta in diabetic rats
  659. Nonenzymatic advancedย GLYCATIONย in the lens membranes
  660. Influence of blood proteins on biomedical analysis. XII. Effects ofย GLYCATIONย on gliclazide (oral hypoglycemic drug)-binding with serum albumin in diabetics
  661. GLYCATIONย and Oxidation of Proteins: A Role in the Pathogenesis of Atherosclerosis?
  662. Theย GLYCATIONย of bovine lens ฮฒL-, ฮฒS-and ฮณ-crystallins demonstrated by isoelectric focusing and lectin staining
  663. Kinetic behaviour of liver glucokinase in diabetes. II. Possible role of non-enzymatic proteinย GLYCATION.
  664. Experimental effect of puerarin on the formation of advancedย GLYCATIONย end products and expression of RAGE in the arota of diabetic rats
  665. Diagnosis of the diabetic metabolic status using fructosamine (and HbA1c) determination. Theย GLYCATIONย quotient Glyc-Q, theย GLYCATIONย nomogram
  666. Inactivation of glucose-6-phosphate dehydrogenase byย GLYCATION
  667. GLYCATIONย of proteins and methods of its assessment
  668. Nonโ€Enzymaticย GLYCATIONย of Fetal Tissue in Diabetic Pregnancy: Estimation of the Glucitollysine Content of Umbilical Cord Extracts
  669. Formation and ways of detecting advancedย GLYCATIONย end-products in isolated human glomerular basement membrane and human serum albumin nonenzymatically โ€ฆ
  670. Effect of germanium-132 on galactose cataracts andย GLYCATIONย in rats
  671. Studies on L-threose as substrate for aldose reductase: A possible role in preventing proteinย GLYCATION
  672. The Use of Solid Phase Extraction Cartridges as a Pre-Fractionation Step in the Quantisation of Intermolecular Collagen Crosslinks and Advancedย GLYCATIONย End โ€ฆ
  673. The stable products of the non-enzymaticย GLYCATIONย of pig crystallins: new findings related to the pathogenesis of diabetic cataracts.
  674. Isotope effects in the non enzymicย GLYCATIONย of hemoglobin catalyzed by DPG
  675. GLYCATIONย of hair protein in the assessment of long-term control of blood glucose
  676. The effect of non-enzymaticย GLYCATIONย on mechanical properties of articular cartilage
  677. Differences in nonenzymaticย GLYCATIONย of histones.
  678. [48]ย GLYCATIONย of copper/zinc superoxide dismutase and its inactivation: Identification of glycated sites
  679. Synthesis of novel imidazolidinones from hexoseโ€“peptide adducts: model studies of the Maillard reaction with possible significance in proteinย GLYCATION
  680. Investigations on protein nonenzymaticย GLYCATIONย by a new and effective mass spectrometric method
  681. GLYCATIONย precedes lens crystallin aggregation
  682. Diabetic erythrocytes bearing advancedย GLYCATIONย end products induce vascular dysfunctions
  683. Mass Spectrum in the Study of Advancedย GLYCATIONย End Products
  684. Pancreatic bile-salt-dependent lipase activity in serum of diabetic patients: is there a relationship withย GLYCATION?
  685. The advancedย GLYCATIONย endproduct, pentosidine, in the carpal ligament in patients with carpal tunnel syndrome undergoing hemodialysis: comparison with idiopathic โ€ฆ
  686. AL0671, a new potassium channel opener, inhibits nonenzymaticย GLYCATIONย of protein and LDL oxidation.
  687. Enhanced binding of advancedย GLYCATIONย endproducts (age) by apo e4 isotype linkt mechanisms of plaque deposition in alzheimerโ€™s disease
  688. Identification of N2-(1-carboxymethyl) guanine (CMG) as a guanine advancedย GLYCATIONย end product
  689. The assessment of proteinย GLYCATIONย in human atherosclerotic plaques by affinity chromatography
  690. The effects of 5% and 25% galactose diets on lens polyols, glutathione and proteinย GLYCATIONย in male and female pigs
  691. GLYCATIONย of blood proteins during pregnancy and lactation in the rat.
  692. Non-enzymicย GLYCATIONย of collagen inhibits binding of oxidized low-density lipoprotein
  693. Influence of factors affectingย GLYCATIONย on defects of dietary copper deficiency
  694. Analysis of furosine as an indicator of lysine residueย GLYCATIONย in milk protein by HPLC
  695. The role ofย GLYCATIONย and autoxidation on crystallin aggregation
  696. GLYCATIONย of human serum albumin in long-term incubation with low and high concentrations of glucose
  697. Massiveย GLYCATIONย of protein HC, a low molecular weight lipocalin, in non-diabetic individuals
  698. Alterations in biological activities induced byย GLYCATIONย of leucine-enkephalin with different monosaccharide moieties
  699. Accumulation ofย GLYCATIONย products in ฮฑโ€H pig lens crystallin and its bearing to diabetic cataract genesis
  700. Quantification ofย GLYCATION-Induced Browning in Lens Crystalline
  701. The effects of silymarin on the inhibition of nonenzymaticย GLYCATIONย and oxidation in aorta of streptozocin-induced diabetic rats
  702. The 32nd Annual Meeting off the European Association for the Study off Diabetes: Neuropathy, health care, andย GLYCATION
  703. GLYCATIONย of Copper, Zine-superoxide Dismutase and Its Effect on the Thiol-Metal Catalyzed Oxidation Mediated DNA Damage
  704. โ€ฆ of the Maillard Reaction by Organic Germanium Compounds. Molecular Mechanism on the Prevention and Reversible Solubilization of Advancedย GLYCATIONย โ€ฆ
  705. Effects of parathyroid hormone and 1, 25 (OH2) D3 on proteinย GLYCATIONย in moderate uraemia
  706. Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of proteinย GLYCATIONย in vitro
  707. Increasedย GLYCATIONย of human erythrocyte Cu, Znsuperoxide dismutase in diabetic patients with cataracts and retinopathy
  708. Effects of nonenzymaticย GLYCATIONย on molecular interactions of basement membrane molecules
  709. Theย GLYCATIONย of bovine lens ฮฒ L-, ฮฒ S-and ฮณ-crystallins demonstrated by frozen-sectioning and isoelectric focusing
  710. Higherย GLYCATIONย of ฮฒL-and ฮฒS-Crystallins in the Anterior Lens Cortex and Maximumย GLYCATIONย of ฮณ-Crystallins in the Bovine Lens Nucleus, Demonstrated by Frozen โ€ฆ
  711. Characterization of theย GLYCATIONย of human insulin by reversed-phase HPLC
  712. Proteinย GLYCATIONย and diabetic vascular disease
  713. GLYCATIONย of lysozyme in a restricted water environment.
  714. Effect of a low protein diet on the relationship of nonenzymaticย GLYCATIONย to altered renal structure and function in diabetes mellitus
  715. 2-D electrophoresis distribution of stable 14C-GLYCATIONย products from pig lens crystallins in relation to diabetic cataract formation
  716. The effects of silymarin on the inhibition of nonenzymaticย GLYCATIONย and oxidation in aorta of streptozocin-induced diabetic rats
  717. Effect of aminoguanidine on theย GLYCATION.
  718. Failure of glucose-binding lectins Con A and Lentil Lectin to identifyย GLYCATIONย of haemoglobin
  719. The pro-oxidant activity of aminoguanidine and proteinย GLYCATION
  720. 23ย GLYCATIONย and Diabetic Complications
  721. Inhibitory effect of pycnogenol on generation of advancedย GLYCATIONย end products in vitro
  722. Effect of sialic acid onย GLYCATION-induced fluorescence of albumin
  723. Expression of advancedย GLYCATIONย end products receptors on human joint synovial cells
  724. Diabetic Atherosclerosis andย GLYCATIONย of LDL (Low Density Lipoprotein)
  725. AMINOPHOSPHOLIPIDย GLYCATIONย CAUSES LIPID BILAYER STRUCTURE ALTERATIONS AND INHIBITION OF MEMBRANE-BOUND
  726. โ€ฆ changes in pancreatic islets obtained from obese Zucker rats (fa/fa) on a diabetogenic diet. No evidence for non-enzymatic proteinย GLYCATIONย in endocrine cells
  727. Alzheimers disease synergistic effects of glucose deficit, oxidative stress and advancedย GLYCATIONย endproducts
  728. Relation between dialysis-related amyloidosis and advancedย GLYCATIONย end products (AGEs)
  729. Interaction of glycyl-phenylalanine with carbohydrates as a model of N-terminalย GLYCATIONย of proteins
  730. The detection of an early advancedย GLYCATIONย product which co-elutes with the Amadori product on aminophenylboronate affinity chromatography.
  731. GLYCATIONย and inactivation of rat aldehyde reductase, a major 3-deoxyglucosone reducing enzyme
  732. Influence of aspartic acid and glutamic acid on non-enzymaticย GLYCATIONย of lens proteins in vitro
  733. Advancedย GLYCATIONย end products-induced TNF-? and IL-6 production by peripheral lymphocytes of diabetic patients
  734. Nonenzymaticย GLYCATIONย of human fibrinogen and myelin basic protein
  735. The effect of phenobarbital on the nonenzymaticย GLYCATIONย of hemoglobin.
  736. Alterations of retinal microvascular cell glycoproteins by advancedย GLYCATIONย end products
  737. The effect of non-enzymaticย GLYCATIONย on recombinant human aldose reductase
  738. Establishment of a quantitative RT-pCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advancedย GLYCATIONย โ€ฆ
  739. GLYCATIONย of human serum albumin by dl-glyceraldehyde: a fluorescence quenching study
  740. Covalent modifications of eye lens proteins by oxidation andย GLYCATION
  741. Diabetic control: Studies of proteinย GLYCATION, microangiopathy and diabetic pregnancy.
  742. International diabetes federation meeting, 1997: nephropathy, retinopathy, andย GLYCATION
  743. Non-enzymaticย GLYCATIONย of human serum albumin: influence on thebinding kinetics of the benzodiazepine binding sites
  744. Neuroelectrophysiological abnormalities are related to metabolic and advanced non-enzymaticย GLYCATIONย changes in prospectively evaluated diabetic Sprague โ€ฆ
  745. Blocking effect of quercetin on the nonenzymaticย GLYCATIONย of aortic collagen [J]
  746. Dietary restriction diminishes earlyย GLYCATIONย adducts on murine hepatic cytosolic proteins
  747. Depolymerization of hyaluronan induced byย GLYCATIONย reaction: possible role in vitreous liquefaction
  748. The effects of Silymarin on the inhibition of nonenzymaticย GLYCATIONย and oxidation in kidneys of streptozocin-induced diabetic rats [J]
  749. Monocyte/macrophage receptors for proteins modified by advancedย GLYCATIONย end products: role in normal tissue remodeling and in pathology
  750. Flavonoids and flavonoid metabolites inhibit monosaccharide-induced protein damage of the advancedย GLYCATIONย end product (AGE) type
  751. PREVENTION OF THE MAILLARD REACTION AND REVERSIBLE DESTRUCTION OF ADVANCEDย GLYCATIONย END PRODUCTS (AGE) BY NOVEL ORGANIC โ€ฆ
  752. GLYCATIONย and the Development of Arteriosclerosis
  753. Alteration in coagulation and fibrinolytic activities of glycated fibrinogen from diabetic patients and inhibitory effect of drugs onย GLYCATIONย of fibrinogen
  754. Factors affecting theย GLYCATIONย of proteins
  755. The Effect of Vitamin E on Proteinย GLYCATIONย in NIDDM Patients
  756. Method for analyzing theย GLYCATIONย of hemoglobin
  757. GLYCATIONย and the Development of Diabetic Retinopathy
  758. Cellular Receptors for Advancedย GLYCATIONย Endproducts
  759. Pharmacologic importance ofย GLYCATIONย of plasma proteins
  760. Faba bean albuminsย GLYCATION
  761. In vitroย GLYCATIONย of dried serum
  762. GLYCATIONย of liver alcohol dehydrogenase.
  763. GLYCATIONย Inhibitors and the Prevention of Diabetic Complications
  764. Role of Fructose inย GLYCATION
  765. GLYCATIONย of proteins and development of vascular disease in diabetes mellitus
  766. GLYCATION: A vascular enemy of many faces
  767. Nonenzymicย GLYCATIONย of Hemoglobin: Structural Determinants of Site Selectivity
  768. GLYCATIONย of H1-histone.
  769. The possible role ofย GLYCATIONย in the pathogenesis of atherosclerosis
  770. IN VITROย GLYCATIONย OF HEMOGLOBIN (HB): CHOOSING THE APPROPRIATE MODEL
  771. Enzyme-linked immunosorbent assay development for advancedย GLYCATIONย end products and brochocin-C.
  772. Advancedย GLYCATIONย end-products induce global endothelial activation
  773. GLYCATIONย of apolipoprotein E in vitro and its binding to heparin
  774. Evidence for Nonenzymicย GLYCATIONย of Antithrombin III in Diabetic Patients
  775. GLYCATIONย of basement membranes: Location of advancedย GLYCATIONย end products within type IV collagen and their effect on degradation by matrix proteases.
  776. Influence of Albuminย GLYCATIONย on the Protein Binding of Drugs
  777. Bendazac decreases in vitroย GLYCATIONย of human lens crystallins
  778. Effects of vitamin E on secretion of inflammatory mediators of human monocytes by advancedย GLYCATIONย end products
  779. Impaired glucose tolerance, angiopathy and advancedย GLYCATIONย end products
  780. ADVANCEDย GLYCATIONย END PRODUCTS MODIFIED PROTEIN UP-REGULATES EXPRESSION OF ADHESION MOLECULES ON HUMAN ENDOTHELIAL CELLS
  781. GLYCATIONย and the Maillard Reaction in vitro: Implications for Diabetes Mellitus
  782. THE RELEVANCE OF PROTEIN GLYCOSYLATION TO DIABETES AND AGEING (ADVANCEDย GLYCATIONย ENDPRODUCTS, GLYCAEMIC CONTROL).
  783. Impaired Immunoglobulin G Fc Fragment Function in Diabetics is Caused by a Mechanism Different fromย GLYCATION
  784. The influence of aging andย GLYCATIONย on protein-thiol mixed disulfides in the eye lens.
  785. GLYCATION-dependent, Reactive Oxygen Species-mediated Suppression of the Insulin Gene Promoter Activity in HIT Cells
  786. The role ofย GLYCATIONย and free radicals in hyperglycemia-induced malformations
  787. Participation of advancedย GLYCATIONย end products in actinic elastosis.
  788. Advancedย GLYCATIONย end products cross-links and diabetic-induced endothelium dysfunction
  789. Advancedย GLYCATIONย Dependent Formation of Modified o-Crystallin and High Molecular Weight Aggregates
  790. Advancedย GLYCATIONย End Products and Loss of Pericytes in Early Diabetic Retinopathy
  791. Advancedย GLYCATIONย endproducts stimulate interleukin-6 production by human bone-derived cells
  792. In vivoย GLYCATIONย of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification ofย GLYCATIONย sites
  793. Effect of advancedย GLYCATIONย end-products on the generation of macrophage-mediated oxidized low-density lipoprotein
  794. Structural and functional consequences of non-enzymaticย GLYCATIONย of apolipoprotein AI and its impact on the reverse cholesterol transport
  795. The Effects of Nonenzymaticย GLYCATIONย on Human Antithrombin III in vitro
  796. The receptor for advancedย GLYCATIONย products (rage): Implications for the pathogenesis of diabetic complications.
  797. GLYCATIONย and inactivation of sorbitol dehydrogenase in normal and diabetic rats
  798. The Receptor for Advancedย GLYCATIONย End Products Mediates the Chemotaxis of
  799. Aminophospholipidย GLYCATIONย Causes Lipid Bilayer Structure Alterations and Inhibition of Membrane-Bound Na+,K+-ATPase
  800. Diabetic erythrocytes bearing advancedย GLYCATIONย end products (age) bind to the receptor for age and increase vascular permeability
  801. Advancedย GLYCATIONย endproducts and the development of accelerated atherosclerosis in diabetic apolipoprotein E deficient mice
  802. Identification of Deoxy-D-Fructosyl Phosphatidylethanollamine as a Non-enzymicย GLYCATIONย Product of Product of Phopshatidylethanolamine and its Occurrence in โ€ฆ
  803. Effects of pro-inflammatory mediators on advancedย GLYCATIONย end product receptors in type-b synovial cells
  804. Advancedย GLYCATIONย End Products (AGEs) Induce Glomerular Sclerosis and Albuminuria in Normal Rats
  805. The Advancedย GLYCATIONย End Product, N-(Carboxymethyl) lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
  806. Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by advancedย GLYCATIONย end products
  807. Relationship of non-enzymaticย GLYCATIONย to altered renal structural and functional changes in the diabetic rat
  808. Advancedย GLYCATIONย end-products decreases THP-1 macrophages expression of peroxisome proliferator activated receptor-?
  809. GLYCATIONย of lens proteins in relation to aldose reductase activity and galactose-induced cataracts
  810. Advancedย GLYCATIONย End Products Induce Expression of Vascular Endothelial Growth Factor by Retinal Mรผller Cells.
  811. Evidence that L-Arginine inhibitsย GLYCATIONย of human serum albumin (HSA) in vitro
  812. Effects of advancedย GLYCATIONย end products on the survival and the morphology of bovine retinal endothelial cells and pericytes
  813. Effects of advancedย GLYCATIONย end products on protein and mRNA expression of macrophage inflammatory protein-1? in cultured human umbilical vein endothelial โ€ฆ
  814. Site-specific and random fragmentation of Cu, Zn-superoxide dismutase byย GLYCATIONย reaction: Implication of reactive oxygen species
  815. Localization of advancedย GLYCATIONย end products (AGE) in actinic elastosis.
  816. Puerarin reduces serum levels of advancedย GLYCATIONย end products and monocyte chemoattractant protein-1 in diabetic rats
  817. Mechanism of migration of vascular adventitial fibroblasts enhanced by advancedย GLYCATIONย end-products and the inhibition effect of candesartan
  818. Immunohistochemical demonstration of advancedย GLYCATIONย end products in synovial amyloid deposits of patients on long-term hemodialysis
  819. Receptor-mediated endocytosis of serum albumins modified by methylglyoxal and glucose-derived advancedย GLYCATIONย endproducts.
  820. Serum lipoprotein and atherogenicityโ€“relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation andย GLYCATION
  821. The Effects of Nonenzymaticย GLYCATIONย on Human ฮฑ2-Plasmin Inhibitor in Vitro
  822. Advancedย GLYCATIONย end products-induced MCP-1 expression via its receptor RAGE in mouse podocytes
  823. Effects of advancedย GLYCATIONย endproducts on proliferation of pericytes of bovine retinal capillary vessels and expression of transforming growth factor?
  824. Cholesteryl ester-HDL transfer rate to apoB-containing lipoproteins is distinctly influenced byย GLYCATIONย of the HDL components and of CETP
  825. Nonenzymaticย GLYCATIONย of phosphatidylethanolamine in erythrocyte vesicles
  826. The effects of Silymarin on the inhibition of nonenzymaticย GLYCATIONย and oxidation in kidneys of streptozocin-induced diabetic rats
  827. Study on human gamma-crystallins: V. Non-enzymaticย GLYCATIONย of fetal lens gamma 1-and gamma 3-crystallins in vitro
  828. Some Factors That Influence the Nonenzymaticย GLYCATIONย of Peptides and Polypeptides by Glyceraldehyde
  829. The relationship between nonenzymaticย GLYCATIONย of lens crystallins and diabetic cataract formation
  830. Nonenzymaticย GLYCATION: A study of the post-translational modification of proteins by the nonenzymatic, covalent attachment of glucose and fructose.
  831. Identification of N ฮต carboxymethyl lysine as a native structure for advancedย GLYCATIONย end products in circulation and amyloid fibrils in chronic hemodialysis patients
  832. Screening and identification of proteins that interact with receptor for advancedย GLYCATIONย end products (RAGE) via T7 select phage display system
  833. Blood glucose and non-enzymaticย GLYCATIONย of proteins in rats injected with low-dose streptozotocin and fed diets either high in sucrose or starch
  834. Isolation of glycated and non-glycated D-glyceraldehyde-3-phosphate dehydrogenase and detection ofย GLYCATION
  835. Diabetes and advancedย GLYCATIONย endproducts
  836. Negative consequences ofย GLYCATION
  837. Advancedย GLYCATIONย end-products: a review
  838. Novel inhibitors of advancedย GLYCATIONย endproducts
  839. Proteinย GLYCATION, diabetes, and aging
  840. Advancedย GLYCATIONย end products in diabetic corneas
  841. Advancedย GLYCATIONย end products: a Nephrologistโ€™s perspective
  842. Increase in the advancedย GLYCATIONย end product pentosidine in Bruchโ€™s membrane with age.
  843. Role of advancedย GLYCATIONย end products in diabetic nephropathy
  844. Effect of collagen turnover on the accumulation of advancedย GLYCATIONย end products
  845. Use of aminoguanidine (Pimagedine) to prevent the formation of advancedย GLYCATIONย endproducts
  846. GLYCATIONโ€”a sweet tempter for neuronal death
  847. GLYCATIONย in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options
  848. Angiogenesis induced by advancedย GLYCATIONย end products and its prevention by cerivastatin
  849. Advancedย GLYCATIONย end products and the progressive course of renal disease
  850. Quantitative screening of advancedย GLYCATIONย endproducts in cellular and extracellular proteins by tandem mass spectrometry
  851. GLYCATIONย impairs high-density lipoprotein function
  852. Advancedย GLYCATIONย end products and diabetic complications
  853. The role of advancedย GLYCATIONย in the pathogenesis of diabetic retinopathy
  854. Chelating activity of advancedย GLYCATIONย end-product inhibitors
  855. Metformin inhibition ofย GLYCATIONย processes
  856. Advancedย GLYCATIONย end products and nutrition
  857. Advancedย GLYCATIONย end products and mortality in hemodialysis patients
  858. Glucose, advancedย GLYCATIONย end products, and diabetes complications: what is new and what works
  859. Advancedย GLYCATIONย end products and endothelial dysfunction in type 2 diabetes
  860. Advancedย GLYCATIONย in D-galactose induced mouse aging model
  861. The biology of the receptor for advancedย GLYCATIONย end products and its ligands
  862. GLYCATIONย as the glucose link to diabetic complications
  863. Regulation of vascular endothelial growth factor expression by advancedย GLYCATIONย end products
  864. Immunological detection of a novel advancedย GLYCATIONย end-product
  865. Differential accumulation of advancedย GLYCATIONย end products in the course of diabetic retinopathy
  866. The effect of advancedย GLYCATIONย end-product formation upon cell-matrix interactions
  867. Exploitingย GLYCATIONย to stiffen and strengthen tissue equivalents for tissue engineering
  868. Proteinย GLYCATION: creation of catalytic sites for free radical generation
  869. Improved arterial compliance by a novel advancedย GLYCATIONย end-product crosslink breaker
  870. Renoprotective effects of a novel inhibitor of advancedย GLYCATION
  871. GLYCATIONย in food and metabolic transit of dietary AGEs (advancedย GLYCATIONย end-products): studies on the urinary excretion of pyrraline
  872. High and low hemoglobinย GLYCATIONย phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control
  873. Advancedย GLYCATIONย end-products and advanced oxidation protein products in patients with diabetes mellitus
  874. Glyoxalase Iโ€“structure, function and a critical role in the enzymatic defence againstย GLYCATION
  875. Changes in myosin structure and function in response toย GLYCATION
  876. The role ofย GLYCATIONย in the pathogenesis of diabetic polyneuropathy
  877. A role for advancedย GLYCATIONย end products in diminished bone healing in type 1 diabetes
  878. Advancedย GLYCATION: an important pathological event in diabetic and age related ocular disease
  879. GLYCATIONย induces formation of amyloid cross-ฮฒ structure in albumin
  880. Differential effects between amphoterin and advancedย GLYCATIONย end products on colon cancer cells
  881. Structural requirements of flavonoids for inhibition of proteinย GLYCATIONย and radical scavenging activities
  882. Amadorins: novel post-Amadori inhibitors of advancedย GLYCATIONย reactions
  883. Increased proteinย GLYCATIONย in cerebrospinal fluid of Alzheimerโ€™s disease
  884. The enzymatic defence againstย GLYCATIONย in health, disease and therapeutics: a symposium to examine the concept
  885. Detection of noncarboxymethyllysine and carboxymethyllysine advancedย GLYCATIONย end products (AGE) in serum of diabetic patients
  886. Advancedย GLYCATIONย end products cause epithelial-myofibroblast transdifferentiation via the receptor for advancedย GLYCATIONย end products (RAGE)
  887. Advancedย GLYCATIONย endproducts and osteoarthritis
  888. Advancedย GLYCATIONย end products in nondiabetic patients with coronary artery disease
  889. Restriction of dietary glycotoxins reduces excessive advancedย GLYCATIONย end products in renal failure patients
  890. Advancedย GLYCATIONย end products, their receptors and diabetic angiopathy
  891. Mechanisms of stiffening and strengthening in media-equivalents fabricated usingย GLYCATION
  892. Neurotoxicity of advancedย GLYCATIONย end-products for cultured cortical neurons
  893. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advancedย GLYCATIONย end product formation
  894. Novel inhibitors of advancedย GLYCATIONย endproducts
  895. Reduction of the accumulation of advancedย GLYCATIONย end products by ACE inhibition in experimental diabetic nephropathy
  896. A breaker of advancedย GLYCATIONย end products attenuates diabetes-induced myocardial structural changes
  897. Serum levels of advancedย GLYCATIONย end products are increased in patients with type 2 diabetes and coronary heart disease.
  898. Advancedย GLYCATIONย end-products pentosidine and Nฯต-carboxymethyllysine are elevated in serum of patients with osteoporosis
  899. Advancedย GLYCATIONย end products in human optic nerve head
  900. Novel inhibitors of advancedย GLYCATIONย endproducts (part II)
  901. Receptor for advancedย GLYCATIONย endproducts (RAGE) and the complications of diabetes
  902. Influence of nonenzymaticย GLYCATIONย on biomechanical properties of cortical bone
  903. GLYCATION, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond
  904. Dietary glycotoxins correlate with circulating advancedย GLYCATIONย end product levels in renal failure patients
  905. Lipid peroxidation and advancedย GLYCATIONย end products in the brain in normal aging and in Alzheimerโ€™s disease
  906. Increased levels of advancedย GLYCATIONย end products in human cataractous lenses
  907. Genotoxicity of advancedย GLYCATIONย end products in mammalian cells
  908. Serum levels of advancedย GLYCATIONย end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
  909. The receptor for advancedย GLYCATIONย end products is induced by theย GLYCATIONย products themselves and tumor necrosis factor-ฮฑ through nuclear factor-ฮบB, and by 17ฮฒ โ€ฆ
  910. Therapeutic potential of breakers of advancedย GLYCATIONย end productโ€“protein crosslinks
  911. Effects of glucose intolerance on myocardial function and collagen-linkedย GLYCATION.
  912. Proteinย GLYCATIONย inhibitory and antioxidative activities of some plant extracts in vitro
  913. Age-related changes in cells and tissues due to advancedย GLYCATIONย end products (AGEs)
  914. Scavenger receptors that recognize advancedย GLYCATIONย end products
  915. Antioxidative and Anti-GLYCATIONย Activity of Garcinol from Garcinia indica Fruit Rind
  916. Neurovascular disease, antioxidants andย GLYCATIONย in diabetes
  917. Alternative routes for the formation of immunochemically distinct advancedย GLYCATIONย end-products in vivo
  918. The role of advancedย GLYCATIONย end products in retinal microvascular leukostasis
  919. Impairment of vascular endothelial nitric oxide synthase activity by advancedย GLYCATIONย end products
  920. Advancedย GLYCATIONย end products in uremia
  921. Activeย GLYCATIONย in neurofibrillary pathology of Alzheimer disease: Nฮต-(carboxymethyl) lysine and hexitol-lysine
  922. Induction of advancedย GLYCATIONย end products and alterations of the tensile properties of articular cartilage
  923. Advancedย GLYCATIONย end product precursors impair epidermal growth factor receptor signaling
  924. Hyperglycaemia: the bridge between non-enzymaticย GLYCATIONย and oxidative stress in the pathogenesis of diabetic complications.
  925. The breakdown of preโ€existing advancedย GLYCATIONย end products is associated with reduced renal fibrosis in experimental diabetes
  926. Expression of advancedย GLYCATIONย end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease
  927. Advancedย GLYCATIONย end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses
  928. Methylglyoxal-derived hydroimidazolone advancedย GLYCATIONย end-products of human lens proteins
  929. Quantitative screening of protein biomarkers of earlyย GLYCATION, advancedย GLYCATION, oxidation and nitrosation in cellular and extracellular proteins by tandem mass โ€ฆ
  930. GLYCATIONย and diabetes: The RAGE connection
  931. Blockade of receptor for advancedย GLYCATIONย end-products restores effective wound healing in diabetic mice
  932. An advancedย GLYCATIONย endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
  933. Glucose,ย GLYCATION, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy
  934. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors ofย GLYCATION
  935. Characterization of the advancedย GLYCATIONย end-product receptor complex in human vascular endothelial cells
  936. Pyridoxamine, an inhibitor of advancedย GLYCATIONย reactions, also inhibits advanced lipoxidation reactions: mechanism of action of pyridoxamine
  937. Advancedย GLYCATIONย endproducts co-localize with inducible nitric oxide synthase in Alzheimerโ€™s disease
  938. Receptor for advancedย GLYCATIONย endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
  939. Advancedย GLYCATIONย endproduct-induced calcium handling impairment in mouse cardiac myocytes
  940. Advancedย GLYCATIONย end products induce bloodโ€“retinal barrier dysfunction in normoglycemic rats
  941. GLYCATION-induced matrix stability in the rabbit achilles tendon
  942. Activation of receptor for advancedย GLYCATIONย end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
  943. Serum levels of non-carboxymethyllysine advancedย GLYCATIONย endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes
  944. Expression of receptors for advancedย GLYCATIONย endโ€products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
  945. Pyridoxamine, an inhibitor of advancedย GLYCATIONย and lipoxidation reactions: a novel therapy for treatment of diabetic complications
  946. Immunological evidence that non-carboxymethyllysine advancedย GLYCATIONย end-products are produced from short chain sugars and dicarbonyl compounds in โ€ฆ
  947. Receptor for advancedย GLYCATIONย end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis
  948. Differences in Rates ofย GLYCATIONย (GLYCATIONย Index) May Significantly Affect Individual Hba1c Results in Type 1 Diabetes
  949. Identification of Nฯ‰-carboxymethylarginine as a novel acid-labile advancedย GLYCATIONย end product in collagen
  950. Role of oxidative stress in advancedย GLYCATIONย end product-induced mesangial cell activation
  951. Serum levels of low molecular weight advancedย GLYCATIONย end products in diabetic subjects
  952. Increased advancedย GLYCATIONย end products in atherosclerotic lesions of patients with end-stage renal disease
  953. High molecular weight hyaluronic acid inhibits advancedย GLYCATIONย endproduct-induced NF-ฮบB activation and cytokine expression
  954. RAGEโ€mediated neutrophil dysfunction is evoked by advancedย GLYCATIONย end products (AGEs)
  955. GLYCATIONย during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study
  956. Reactivities of d-glucose and d-fructose duringย GLYCATIONย of Bovine Serum Albumin
  957. The effect ofย GLYCATIONย on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
  958. Formation of advancedย GLYCATIONย end products during CAPD
  959. โ€ฆ of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advancedย GLYCATIONย end product inhibitor, OPB โ€ฆ
  960. Increased serum concentrations of advancedย GLYCATIONย end products: a marker of coronary artery disease activity in type 2 diabetic patients
  961. Effects of mesangiumย GLYCATIONย on matrix metalloproteinase activities: possible role in diabetic nephropathy
  962. Inactivation of cellular enzymes by carbonyls and protein-boundย GLYCATION/glycoxidation products
  963. Crosslinking by advancedย GLYCATIONย end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which โ€ฆ
  964. Accumulation of advancedย GLYCATIONย end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
  965. Blockade of receptor for advancedย GLYCATIONย endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
  966. CD36, serves as a receptor for advancedย GLYCATIONย endproducts (AGE)
  967. Receptor for advancedย GLYCATIONย end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities
  968. Role of advancedย GLYCATIONย end products in adynamic bone disease in patients with diabetic nephropathy
  969. Advancedย GLYCATIONย end products in end-stage renal disease and their removal
  970. Role of advancedย GLYCATIONย end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
  971. Immunohistochemical distribution of the receptor for advancedย GLYCATIONย end products in neurons and astrocytes in Alzheimerโ€™s disease
  972. Glucoseโ€mediated in vitroย GLYCATIONย modulates biomechanical integrity of the soft tissues but not hard tissues
  973. Advancedย GLYCATIONย endproducts accelerate calcification in microvascular pericytes
  974. Blockade of advancedย GLYCATIONย end-product formation restores ischemia-induced angiogenesis in diabetic mice
  975. Evolving concepts in advancedย GLYCATION, diabetic nephropathy, and diabetic vascular disease
  976. Effects of Oriental medicines on the production of advancedย GLYCATIONย endproducts
  977. The effect of flavonoid treatment on theย GLYCATIONย and antioxidant status in Type 1 diabetic patients.
  978. Advancedย GLYCATIONย end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human โ€ฆ
  979. Markedly elevated levels of plasma advancedย GLYCATIONย end products in patients with liver cirrhosisโ€“amelioration by liver transplantation
  980. Effect ofย GLYCATIONย of high density lipoproteins on their physicochemical properties and on paraoxonase activity
  981. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advancedย GLYCATIONย end products (RAGE) activation
  982. Inhibitors and breakers of advancedย GLYCATIONย endproducts (AGEs): a review
  983. Corneal advancedย GLYCATIONย end products increase in patients with proliferative diabetic retinopathy
  984. Advancedย GLYCATIONย end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes
  985. The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advancedย GLYCATIONย end-product accumulation
  986. Detection of autoantibodies against advancedย GLYCATIONย endproducts and AGE-immune complexes in serum of patients with diabetes mellitus
  987. Serum concentrations of advancedย GLYCATIONย endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with โ€ฆ
  988. Co-expression of receptor for advancedย GLYCATIONย end products and the ligand amphoterin associates closely with metastasis of colorectal cancer
  989. N ฮต-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advancedย GLYCATIONย end products that activate cell signaling pathways and modulate gene โ€ฆ
  990. Involvement of microglial receptor for advancedย GLYCATIONย endproducts (RAGE) in Alzheimerโ€™s disease: identification of a cellular activation mechanism
  991. Advancedย GLYCATIONย end products and advanced oxidation protein products in hemodialyzed patients
  992. Receptor for advancedย GLYCATIONย end products (RAGE)-mediated neurite outgrowth and activation of NF-ฮบB require the cytoplasmic domain of the receptor but different โ€ฆ
  993. Accumulation of fructosyl-lysine and advancedย GLYCATIONย end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats
  994. Longitudinal determination of skin collagenย GLYCATIONย and glycoxidation rates predicts early death in C57BL/6NNIA mice
  995. Inflammation and advancedย GLYCATIONย end products in uremia: Simple coexistence, potentiation or causal relationship?
  996. Ageโ€related decrease in susceptibility of human articular cartilage to matrix metalloproteinaseโ€“mediated degradation: The role of advancedย GLYCATIONย end products
  997. Crosslinking of ฮฑ-synuclein by advancedย GLYCATIONย endproductsโ€”an early pathophysiological step in Lewy body formation?
  998. Maillardย GLYCATIONย of ฮฒโ€lactoglobulin induces conformation changes
  999. Receptor for advancedย GLYCATIONย endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes
  1000. โ€ฆ system of human phagocytes generates Nฮต-(carboxymethyl)lysine on proteins: a mechanism for producing advancedย GLYCATIONย end products at sites of โ€ฆ
  1001. GLYCATIONย of bovine ฮฒโ€Lactoglobulin: effect on the protein structure
  1002. Advancedย GLYCATIONย end products induce angiogenesis in vivo
  1003. Enhancing effect of advancedย GLYCATIONย end products on serotonin-induced platelet aggregation in patients with diabetes mellitus
  1004. Amino acid specificity ofย GLYCATIONย and proteinโ€“AGE crosslinking reactivities determined with a dipeptide SPOT library
  1005. Anti-hypertensive agents inhibit in vivo the formation of advancedย GLYCATIONย end products and improve renal damage in a type 2 diabetic nephropathy rat model
  1006. Cd36, a member of the class b scavenger receptor family, as a receptor for advancedย GLYCATIONย end products
  1007. Relationship ofย GLYCATION, antioxidant status and oxidativestress to vascular endothelial damage in diabetes
  1008. Advancedย GLYCATIONย end products in human senile and diabetic cataractous lenses
  1009. Novel splice variants of the receptor for advancedย GLYCATIONย end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in โ€ฆ
  1010. Efficacy of benfotiamine versus thiamine on function andย GLYCATIONย products of peripheral nerves in diabetic rats
  1011. Chronic diabetes increases advancedย GLYCATIONย end products on cardiac ryanodine receptors/calcium-release channels
  1012. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advancedย GLYCATIONย end products.
  1013. Plasma levels of advancedย GLYCATIONย end products in healthy, long-term vegetarians and subjects on a western mixed diet
  1014. The receptor for advancedย GLYCATIONย end-products (RAGE) directly binds to ERK by a D-domain-like docking site
  1015. Ageโ€related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymaticย GLYCATION
  1016. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advancedย GLYCATIONย end products: biochemical โ€ฆ
  1017. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advancedย GLYCATIONย end products
  1018. Role of receptor for advancedย GLYCATIONย endโ€product (RAGE) and the JAK/STATโ€signaling pathway in AGEโ€induced collagen production in NRKโ€49F cells
  1019. Protecting the genome: defence against nucleotideย GLYCATIONย and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy
  1020. Effect of advancedย GLYCATIONย endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development
  1021. Effects of thermal denaturation on proteinย GLYCATION
  1022. Age-related accumulation of the advancedย GLYCATIONย endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative โ€ฆ
  1023. Accumulation of advancedย GLYCATIONย endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage
  1024. Effect of metformin on advancedย GLYCATIONย endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats
  1025. Nโ€Glycans on the receptor for advancedย GLYCATIONย end products influence amphoterin binding and neurite outgrowth
  1026. Advancedย GLYCATIONย end products inhibit de novo protein synthesis and induce TGF-ฮฒ overexpression in proximal tubular cells
  1027. Assay of advancedย GLYCATIONย endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl โ€ฆ
  1028. Earlyย GLYCATIONย products produce pentosidine cross-links on native proteins: novel mechanism of pentosidine formation and propagation ofย GLYCATION
  1029. Advancedย GLYCATIONย endโ€products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes
  1030. Reduction of advancedย GLYCATIONย end product levels by on-line hemodiafiltration in long-term hemodialysis patients
  1031. Protective action on human LDL against oxidation andย GLYCATIONย by four organosulfur compounds derived from garlic
  1032. Collagen structure and nonlinear susceptibility: effects of heat,ย GLYCATION, and enzymatic cleavage on second harmonic signal intensity
  1033. Advancedย GLYCATIONย end products (AGEs), free radicals and diabetes
  1034. Daily haemodialysis improves indices of proteinย GLYCATION
  1035. Membrane proteins of human erythrocytes are modified by advancedย GLYCATIONย end products during aging in the circulation
  1036. Advancedย GLYCATIONย end-products in diabetic nephropathy.
  1037. Familial amyloid polyneuropathy: receptor for advancedย GLYCATIONย end products-dependent triggering of neuronal inflammatory and apoptotic pathways
  1038. Advancedย GLYCATIONย and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism
  1039. Glyoxalase I deficiency is associated with an unusual level of advancedย GLYCATIONย end products in a hemodialysis patient
  1040. Advancedย GLYCATIONย end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications
  1041. Receptor for advancedย GLYCATIONย end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein Eโ€“null mice
  1042. Pigment epithelium-derived factor protects cultured retinal pericytes from advancedย GLYCATIONย end product-induced injury through its antioxidative properties
  1043. GLYCATIONย end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart
  1044. Increased formation of methylglyoxal and proteinย GLYCATION, oxidation and nitrosation in triosephosphate isomerase deficiency
  1045. Advancedย GLYCATIONย end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells
  1046. Identification of the advancedย GLYCATIONย end products Nฮต-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis
  1047. Evidence of theย GLYCATIONย and denaturation of LTP1 during the malting and brewing process
  1048. Modification of bovine ฮฒ-lactoglobulin byย GLYCATIONย in a powdered state or in an aqueous solution: effect on association behavior and protein conformation
  1049. Glycolaldehyde, a reactive intermediate for advancedย GLYCATIONย end products, plays an important role in the generation of an active ligand for the macrophage โ€ฆ
  1050. Receptors for proteins modified by advancedย GLYCATIONย endproducts (AGE)โ€”their functional role in atherosclerosis
  1051. Effect of advancedย GLYCATIONย end products on lens epithelial cells in vitro
  1052. Accumulation of advancedย GLYCATIONย end products decreases collagen turnover by bovine chondrocytes
  1053. Calcium antagonists as inhibitors ofin vitro low density lipoprotein oxidation andย GLYCATION
  1054. Expression and function of receptors for advancedย GLYCATIONย end products in bovine corneal endothelial cells
  1055. Plasma levels of advancedย GLYCATIONย end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality
  1056. Glucosylated glycerophosphoethanolamines are the major LDLย GLYCATIONย products and increase LDL susceptibility to oxidation: evidence of their presence in โ€ฆ
  1057. Antiโ€inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advancedย GLYCATIONย endproducts in murine microglia
  1058. โ€ฆ of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advancedย GLYCATIONย end-products through binding โ€ฆ
  1059. Interaction of the receptor for advancedย GLYCATIONย end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation
  1060. Effects of Advancedย GLYCATIONย End-products on the Proliferation and Fibronectin Production of Smooth Muscle Cells
  1061. Activation of protein-bound copper ions during earlyย GLYCATION: study on two proteins
  1062. GLYCATIONย and post-translational processing of human interferon-ฮณ expressed in Escherichia coli
  1063. GLYCATIONย of apolipoprotein E impairs its binding to heparin: identification of the majorย GLYCATIONย site
  1064. Upโ€regulated expression of the receptor for advancedย GLYCATIONย end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts
  1065. Effects of inhibition ofย GLYCATIONย and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats
  1066. Are advancedย GLYCATIONย endโ€productโ€modified proteins of pathogenetic importance in fibromyalgia?
  1067. Advancedย GLYCATIONย and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds
  1068. Advancedย GLYCATIONย end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.
  1069. Nitric oxide inhibits the formation of advancedย GLYCATIONย end products
  1070. Generation of active oxygen species from advancedย GLYCATIONย end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell โ€ฆ
  1071. Two Flavone C-Glycosides from the Style of Zea mays withย GLYCATIONย Inhibitory Activity
  1072. Plasma levels of advancedย GLYCATIONย end products in children with renal disease
  1073. Chromatographic assay ofย GLYCATIONย adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and โ€ฆ
  1074. Advancedย GLYCATIONย endproducts in human diabetic and non-diabetic cataractous lenses
  1075. Inhibiting effects of Achyranthes bidentata polysaccharide and Lycium barbarum polysaccharide on nonenzymeย GLYCATIONย in D-galactose induced mouse aging model.
  1076. Lowering of dietary advancedย GLYCATIONย endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
  1077. Effects of a diet rich in advancedย GLYCATIONย end products in the rat remnant kidney model
  1078. Increased concentration of pentosidine, an advancedย GLYCATIONย end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy
  1079. GLYCATIONย cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice
  1080. ฮฒ2-Microglobulin modified with advancedย GLYCATIONย end products delays monocyte apoptosis
  1081. Unusual susceptibility of heme proteins to damage by glucose during non-enzymaticย GLYCATION
  1082. Are advancedย GLYCATIONย end products cardiovascular risk factors in patients with CRF?
  1083. Non-enzymaticย GLYCATIONย of IgG: an in vivo study
  1084. The diabetic milieu modulates the advancedย GLYCATIONย end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
  1085. The role of mass spectrometry in the study of nonโ€enzymatic proteinย GLYCATIONย in diabetes
  1086. Skin collagenย GLYCATION, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of โ€ฆ
  1087. Effects of inhibition ofย GLYCATIONย and oxidative stress on the development of diabetic nephropathy in rats
  1088. Acetyl-L-carnitine decreasesย GLYCATIONย of lens proteins: in vitro studies
  1089. Identification of Nฯ‰-carboxymethylarginine, a new advancedย GLYCATIONย endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and โ€ฆ
  1090. Thermalย GLYCATIONย of proteins by D-glucose and D-fructose.
  1091. Proteomic analysis of the site specificity ofย GLYCATIONย and carboxymethylation of ribonuclease
  1092. Advancedย GLYCATIONย end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the โ€ฆ
  1093. Inhibition of nonenzymatic proteinย GLYCATIONย and lipid peroxidation by drugs with antioxidant activity
  1094. Receptor for advancedย GLYCATIONย end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation
  1095. Age-related increase of proteinย GLYCATIONย in peripheral blood lymphocytes is restricted to preferential target proteins
  1096. Advancedย GLYCATIONย end products: a highly complex set of biologically relevant compounds detected by mass spectrometry
  1097. โ€ฆ and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytesโ€”influence ofย GLYCATIONย products on lipid โ€ฆ
  1098. Inhibition of advancedย GLYCATIONย endโ€products protects against retinal capillary basement membrane expansion during longโ€term diabetes
  1099. Advancedย GLYCATIONย end products and receptor for advancedย GLYCATIONย end products in AA amyloidosis
  1100. Advancedย GLYCATIONย end products in children with chronic renal failure and type 1 diabetes
  1101. Advancedย GLYCATIONย end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis
  1102. Effect ofย GLYCATIONย on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells โ€ฆ
  1103. Advancedย GLYCATIONย end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro
  1104. Dietary G-rutin suppressesย GLYCATIONย in tissue proteins of streptozotocin-induced diabetic rats
  1105. Inhibition of advancedย GLYCATIONย endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol
  1106. An expeditious synthesis of pentosidine, an advancedย GLYCATIONย end product
  1107. Pigment epithelium-derived factor prevents advancedย GLYCATIONย end products-induced monocyte chemoattractant protein-1 production in microvascular โ€ฆ
  1108. An immunochemical study on tauย GLYCATIONย in paired helical filaments
  1109. Rat tissue collagen modified by advancedย GLYCATION: correlation with duration of diabetes and glycemic control
  1110. Application of monoclonal antibody libraries for the measurement ofย GLYCATIONย adducts
  1111. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advancedย GLYCATIONย end products
  1112. GLYCATIONย and glycoxidation of lowโ€density lipoproteins by glucose and lowโ€molecular mass aldehydes: Formation of modified and oxidized particles
  1113. Estimation of age of human cadavers by immunohistochemical assessment of advancedย GLYCATIONย end products in the hippocampus
  1114. Maillardย GLYCATIONย of -lactoglobulin with several sugars: comparative study of the properties of the obtained polymers and of the substituted sites
  1115. Monitoringย GLYCATIONย of lysozyme by electrospray ionization mass spectrometry
  1116. Helical peptide models for proteinย GLYCATION: proximity effects in catalysis of the Amadori rearrangement
  1117. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advancedย GLYCATIONย end-products (AGEs) and a proinflammatory response
  1118. Advancedย GLYCATIONย endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y
  1119. Low-molecular but not high-molecular advancedย GLYCATIONย end products (AGEs) are removed by high-flux dialysis.
  1120. Advancedย GLYCATIONย end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages
  1121. Induction ofย GLYCATIONย suppresses glucokinase gene expression in HIT-T15 cells
  1122. cDNA cloning of a novel secreted isoform of the human receptor for advancedย GLYCATIONย end products and characterization of cells co-expressing cell-surface โ€ฆ
  1123. Relationship between autofluorescence and advancedย GLYCATIONย end products in diabetic lenses
  1124. Induction of aldose reductase in cultured human microvascular endothelial cells by advancedย GLYCATIONย end products
  1125. Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advancedย GLYCATIONย endproducts Nฯต โ€ฆ
  1126. CD36-mediated endocytic uptake of advancedย GLYCATIONย end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes
  1127. Inhibition ofย GLYCATIONย reaction in tissue protein incubations by water soluble rutin derivative
  1128. Determination of membrane proteinย GLYCATIONย in diabetic tissue
  1129. Advancedย GLYCATIONย end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress โ€ฆ
  1130. Inhibition of lipid peroxidation, proteinย GLYCATIONย and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose
  1131. Development of a polyclonal antibody with broad epitope specificity for advancedย GLYCATIONย endproducts and localization of these epitopes in Bruchโ€™s โ€ฆ
  1132. Vitamin C supplementation decreases insulinย GLYCATIONย and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice
  1133. Advancedย GLYCATIONย endproducts (AGEs) as uremic toxins
  1134. ฮฒโ€Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferonโ€ฮณ and โ€˜advancedย GLYCATIONย endproductsโ€™ in a murine microglia cell โ€ฆ
  1135. Activation of astrocytes by advancedย GLYCATIONย end products: cytokines induction and nitric oxide release
  1136. Impact of metabolic control and serum lipids on the concentration of advancedย GLYCATIONย end products in the serum of children and adolescents with type 1 diabetes โ€ฆ
  1137. Nonoxidative proteinย GLYCATIONย is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
  1138. Advancedย GLYCATIONย endproduct precursor alters intracellular amyloid-ฮฒ/AฮฒPP carboxy-terminal fragment aggregation and cytotoxicity
  1139. Advancedย GLYCATIONย endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts
  1140. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advancedย GLYCATIONย end-product-induced cellular mitogenesis in โ€ฆ
  1141. Nonenzymaticย GLYCATIONย of histones in vitro and in vivo
  1142. โ€ฆ ) lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advancedย GLYCATIONย end products during inflammation
  1143. Advancedย GLYCATIONย end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal โ€ฆ
  1144. An evaluation of level of oxidative stress and proteinย GLYCATIONย in nondiabetic undialyzed chronic renal failure patients
  1145. Polymorphism screening of four genes encoding advancedย GLYCATIONย end-product putative receptors: association study with nephropathy in type 1 diabetic patients
  1146. Transition Metalโ€“Catalyzed Oxidation of Ascorbate in Human Cataract Extracts: Possible Role of Advancedย GLYCATIONย End Products
  1147. In vitro effect of advancedย GLYCATIONย endโ€products on human polymorphonuclear superoxide production
  1148. Glutathione reverses early effects ofย GLYCATIONย on myosin function
  1149. Evaluation of autofluorescent property of hemoglobin-advancedย GLYCATIONย end product as a long-term glycemic index of diabetes
  1150. The receptor for advancedย GLYCATIONย end products (RAGE) is elevated in women with preeclampsia
  1151. Incadronate disodium inhibits advancedย GLYCATIONย end products-induced angiogenesis in vitro
  1152. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymaticย GLYCATION
  1153. Intraneuronal advancedย GLYCATIONย endproducts in presenilin-1 Alzheimerโ€™s disease
  1154. Susceptibility of rhDNase I toย GLYCATIONย in the dry-powder state
  1155. Pharmaceutical intervention of advancedย GLYCATIONย endproducts
  1156. Autoantibody against N (epsilon)-(carboxymethyl) lysine: an advancedย GLYCATIONย end product of the Maillard reaction.
  1157. Regulation of receptor for advancedย GLYCATIONย end products during bleomycin-induced lung injury
  1158. Effect of diabetes and aminoguanidine therapy on renal advancedย GLYCATIONย end-product binding
  1159. Modulating cellular aging in vitro: hormetic effects of repeated mild heat stress on protein oxidation andย GLYCATION
  1160. Advancedย GLYCATIONย end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells โ€ฆ
  1161. Effect of age and menopause on serum concentrations of pentosidine, an advancedย GLYCATIONย end product
  1162. Isย GLYCATIONย of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL preโ€oxidative condition?
  1163. The effect of caloric restriction onย GLYCATIONย and glycoxidation in skin collagen of nonhuman primates
  1164. GLYCATIONย of the amyloid ฮฒ-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimerโ€™s disease
  1165. Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution ofย GLYCATION
  1166. Accumulation of advancedย GLYCATIONย endproducts in aging male Fischer 344 rats during long-term feeding of various dietary carbohydrates
  1167. Scanning force microscopy reveals structural alterations in diabetic rat collagen fibrils: role of proteinย GLYCATION
  1168. Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymaticย GLYCATIONย of IgG
  1169. Acute modulation of albumin microvascular leakage by advancedย GLYCATIONย end products in microcirculation of diabetic rats in vivo.
  1170. Inhibition of collagenย GLYCATIONย and crosslinking in vitro by methanolic extracts of Finger millet (Eleusine coracana) and Kodo millet (Paspalum scrobiculatum)
  1171. Inhibitors of advancedย GLYCATIONย end product-associated protein cross-linking
  1172. A systematic approach to evaluate the modification of lens proteins byย GLYCATION-induced crosslinking
  1173. The liver is the main site for metabolism of circulating advancedย GLYCATIONย end products
  1174. Role of megalin in endocytosis of advancedย GLYCATIONย end products: implications for a novel protein binding to both megalin and advancedย GLYCATIONย end products
  1175. Advancedย GLYCATIONย endproducts as UVA photosensitizers of tryptophan and ascorbic acid: consequences for the lens
  1176. Methylglyoxal-inducedย GLYCATIONย affects protein topography
  1177. Removal of advancedย GLYCATIONย end products in clinical renal failure by peritoneal dialysis and haemodialysis
  1178. Dysfunction of dermal fibroblasts induced by advancedย GLYCATIONย end-products (AGEs) and the contribution of a nonspecific interaction with cell membrane and AGEs
  1179. A novel inhibitor of advancedย GLYCATIONย end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes
  1180. Immunohistochemical distribution and quantitative biochemical detection of advancedย GLYCATIONย end products in fetal to adult rats and in rats with โ€ฆ
  1181. Advancedย GLYCATIONย end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol โ€ฆ
  1182. Advancedย GLYCATIONย end product receptor interactions on microvascular cells occur within caveolinโ€rich membrane domains
  1183. Expression of receptor for advancedย GLYCATIONย end products (RAGE) in human biliary cancer cells.
  1184. Selective formation of certain advancedย GLYCATIONย end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation
  1185. New therapies for advancedย GLYCATIONย end product nephrotoxicity: current challenges
  1186. โ€ฆ isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acidย GLYCATIONย during cataract formation
  1187. Advancedย GLYCATIONย end products in Descemetโ€™s membrane and their effect on corneal endothelial cell
  1188. Inhibitor for advancedย GLYCATIONย end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats
  1189. Receptor for advancedย GLYCATIONย end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis
  1190. Solidโ€stateย GLYCATIONย of ฮฒโ€lactoglobulin monitored by electrospray ionisation mass spectrometry and gel electrophoresis techniques
  1191. Inhibition of advanced proteinย GLYCATIONย by a Schiff base between aminoguanidine and pyridoxal
  1192. Food restriction prevents advancedย GLYCATIONย end product accumulation and retards kidney aging in lean rats
  1193. Clinical potential of advancedย GLYCATIONย end-product inhibitors in diabetes mellitus
  1194. Advancedย GLYCATIONย end product-induced peroxisome proliferator-activated receptor ฮณ gene expression in the cultured mesangial cells
  1195. Effects of OPBโ€9195, antiโ€GLYCATIONย agent, on experimental diabetic neuropathy
  1196. Isolation and characterization of a new advancedย GLYCATIONย endproduct of dehydroascorbic acid and lysine
  1197. Advancedย GLYCATIONย endproducts and proโ€inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology
  1198. Circulating advancedย GLYCATIONย end product levels in rats rapidly increase with acute renal failure
  1199. Serum levels of glucose-derived advancedย GLYCATIONย end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal โ€ฆ
  1200. Inhibiting albuminย GLYCATIONย ameliorates diabetic nephropathy in the db/db mouse
  1201. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advancedย GLYCATIONย endproducts and glycated basic fibroblast growth factor in cultured โ€ฆ
  1202. N2-(1-carboxyethyl) deoxyguanosine, a nonenzymaticย GLYCATIONย adduct of DNA, induces single-strand breaks and increases mutation frequencies
  1203. Role of advancedย GLYCATIONย end products and growth factors in peritoneal dysfunction in CAPD patients
  1204. Qualitative determination of specific proteinย GLYCATIONย products by matrix-assisted laser desorption/ionization mass spectrometry peptide mapping
  1205. Detection of N epsilon-(carboxymethyl) lysine (CML) and non-CML advancedย GLYCATIONย end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
  1206. GLYCATIONย of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity
  1207. Advancedย GLYCATIONย endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 โ€ฆ
  1208. High levels of urinary pentosidine, an advancedย GLYCATIONย end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress
  1209. Link betweenย GLYCATIONย and lipoxidation in red blood cells in diabetes
  1210. Mechanisms involved in the stimulatory effect of advancedย GLYCATIONย end products on growth of rat aortic smooth muscle cells
  1211. Advancedย GLYCATIONย end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis
  1212. Effect of advancedย GLYCATIONย endproducts on cell cycle and their relevance for Alzheimerโ€™s disease
  1213. Lysozyme enhances renal excretion of advancedย GLYCATIONย endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE โ€ฆ
  1214. Effects of advancedย GLYCATIONย end products on cytosolic Ca2+ signaling of cultured human mesangial cells
  1215. GLYCATION, carbonyl stress, EAGLEs, and the vascular complications of diabetes
  1216. Advancedย GLYCATIONย End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and โ€ฆ
  1217. GLYCATIONย proceeds faster in mutated Cu, Znโ€superoxide dismutases related to familial amyotrophic lateral sclerosis
  1218. Intracellular proteinย GLYCATIONย in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration.
  1219. Distribution of the receptor for advancedย GLYCATIONย end products gene polymorphisms in patients with chronic periodontitis: a preliminary study
  1220. Cellular oxidant stress and advancedย GLYCATIONย endproducts of albumin: caveats of the dichlorofluorescein assay
  1221. Non-enzymaticย GLYCATIONย in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro.
  1222. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in theย GLYCATIONย of proteins by glucose
  1223. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products ofย GLYCATION, in vitro: implication of inefficient glutathione โ€ฆ
  1224. FEEL-1 and FEEL-2 are endocytic receptors for advancedย GLYCATIONย end products
  1225. Effect of chronic aminoguanidine treatment on age-relatedย GLYCATION, glycoxidation, and collagen cross-linking in the Fischer 344 rat
  1226. Rate of formation of AGEs during ascorbateย GLYCATIONย and during aging in human lens tissue
  1227. Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advancedย GLYCATIONย end-products) for atherogenesis in โ€ฆ
  1228. Advancedย GLYCATIONย endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation
  1229. Advancedย GLYCATIONย endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism
  1230. In vivo treatment with stobadine prevents lipid peroxidation, proteinย GLYCATIONย and calcium overload but does not ameliorate Ca2+-ATPase activity in heart and โ€ฆ
  1231. Inhibition of nitric oxide synthase activity by early and advancedย GLYCATIONย end products in cultured rabbit proximal tubular epithelial cells
  1232. Amadori albumin and advancedย GLYCATIONย end-product formation in peritoneal dialysis using icodextrin
  1233. Renal proximal tubular metabolism of protein-linked pentosidine, an advancedย GLYCATIONย end product
  1234. Application of shielding boronate affinity chromatography in the study of theย GLYCATIONย pattern of haemoglobin
  1235. Fortification of milk with iron-ascorbate promotes lysineย GLYCATIONย and tryptophan oxidation
  1236. A new flavone C-glycoside from the style of Zea mays L. withย GLYCATIONย inhibitory activity
  1237. Reactive oxygen species accelerate production of vascular endothelial growth factor by advancedย GLYCATIONย end products in RAW264. 7 mouse macrophages
  1238. Structure of a synthetic glucose derived advancedย GLYCATIONย end product that is immunologically cross-reactive with its naturally occurring counterparts
  1239. Receptor for advancedย GLYCATIONย end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of โ€ฆ
  1240. Advancedย GLYCATIONย end products impair the scavenger function of rat hepatic sinusoidal endothelial cells
  1241. Non-enzymaticย GLYCATIONย and oxidative stress in chronic illnesses and diabetes mellitus
  1242. Accurate mass measurements by Fourier transform mass spectrometry in the study of advancedย GLYCATIONย end products/peptides
  1243. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advancedย GLYCATIONย end products, an interaction that may play a role in the โ€ฆ
  1244. Effects of advancedย GLYCATIONย end-product inhibition and cross-link breakage in diabetic rats
  1245. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advancedย GLYCATIONย end products in lipofuscin of human retinal pigment epithelium
  1246. Neurotoxicity of acetaldehyde-derived advancedย GLYCATIONย end products for cultured cortical neurons
  1247. Roles of advancedย GLYCATIONย endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth
  1248. Aminoguanidine inhibits albuminuria, but not the formation of advancedย GLYCATIONย end-products in skin collagen of diabetic rats
  1249. Serum levels of total homocysteine, homocysteine metabolites and of advancedย GLYCATIONย end-products (AGEs) in patients after renal transplantation.
  1250. Advancedย GLYCATIONย end-product levels in subtotally nephrectomized rats: beneficial effects of angiotensin II receptor 1 antagonist losartan
  1251. Pathogenic role of advancedย GLYCATIONย end-products (AGEs): an overview
  1252. Collagen as a model system to investigate the use of aspirin as an inhibitor of proteinย GLYCATIONย and crosslinking
  1253. Damaging effects of advancedย GLYCATIONย end-products in the murine macrophage cell line J774A. 1
  1254. Inhibitory effect ofย GLYCATIONย on catalytic activity of alanine aminotransferase
  1255. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advancedย GLYCATIONย end products and ways of protection
  1256. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation toย GLYCATION, oxidative stress and cytokine production in stz diabetic rats
  1257. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymaticย GLYCATION
  1258. Effects of eparlestat on plasma levels of advancedย GLYCATIONย end products in patients with type 2 diabetes.
  1259. Early and advancedย GLYCATIONย end-products are increased in dietary copper deficiency
  1260. GLYCATIONย of aspartate aminotransferase and conformational flexibility
  1261. Advancedย GLYCATIONย end product in familial amyloidotic polyneuropathy (FAP)
  1262. GLYCATIONย amplifies lipoprotein (a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells
  1263. Endocytic uptake of advancedย GLYCATIONย end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage โ€ฆ
  1264. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advancedย GLYCATIONย end products
  1265. Neuronal and glial advancedย GLYCATIONย end product [Nฮต-(carboxymethyl)lysine] in Alzheimerโ€™s disease brains
  1266. Augmentation of the neutrophil respiratory burst through the action of advancedย GLYCATIONย end products: a potential contributor to vascular oxidant stress
  1267. Differences in the modulating potential of advancedย GLYCATIONย end product (AGE) peptides versus AGE proteins
  1268. Antibodies to advancedย GLYCATIONย end products in children with diabetes mellitus
  1269. The role of galectin-3 in endocytosis of advancedย GLYCATIONย end products and modified low density lipoproteins
  1270. Enhanced plasma levels of advancedย GLYCATIONย end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after โ€ฆ
  1271. Role of advancedย GLYCATIONย endproducts in adynamic bone disease
  1272. Lens ageing as an indicator of tissue damage associated with smoking and non-enzymaticย GLYCATIONโ€“a twin study
  1273. Benfotiamine inhibits intracellular formation of advancedย GLYCATIONย end products in vivo
  1274. Inhibiting albuminย GLYCATIONย in vivo ameliorates glomerular overexpression of TGF-ฮฒ1
  1275. Site-Specific Quantitative Evaluation of the Proteinย GLYCATIONย Product N6-(2,3-Dihydroxy-5,6-dioxohexyl)-l-lysinate by LCโˆ’(ESI)MS Peptide Mapping:โ€‰ Evidence for โ€ฆ
  1276. Modification of bovine ฮฒ-lactoglobulin byย GLYCATIONย in a powdered state or in an aqueous solution: immunochemical characterization
  1277. GLYCATIONย of plasma low density lipoproteins increases interaction with arterial proteoglycans
  1278. Efficient total synthesis of pentosidine, an advancedย GLYCATIONย endproduct
  1279. Advancedย GLYCATIONย end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1
  1280. Antibodies against advancedย GLYCATIONย end product Nษ›-(carboxymethyl) lysine in healthy controls and diabetic patients
  1281. Protein carbonylation andย GLYCATIONย in human lenses
  1282. Increased proteinย GLYCATIONย in non-diabetic pediatric nephrotic syndrome: possible role of lipid peroxidation
  1283. Advancedย GLYCATIONย end-products as a potential target for treatment of cardiovascular disease
  1284. The effect of advancedย GLYCATIONย end-products and aminoguanidine on TNFฮฑ production by rat peritoneal macrophages
  1285. The human and rat recombinant receptors for advancedย GLYCATIONย end products have a high degree of homology but different pharmacokinetic properties in rats
  1286. Products of advancedย GLYCATIONย in patients with type 2 diabetes and vascular disease
  1287. Advancedย GLYCATIONย end products in adolescents and young adults with diabetic angiopathy
  1288. GLYCATIONย and glycoxidation in diabetic vascular disease
  1289. GLYCATIONย and glycoxidation studies in vitro on isolated human vitreous collagen
  1290. Matrix proteinย GLYCATIONย impairs agonistโ€induced intracellular Ca2+ signaling in endothelial cells
  1291. Lens proteins block the copper-mediated formation of reactive oxygen species duringย GLYCATIONย reactions in vitro
  1292. Effect of advancedย GLYCATIONย end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media
  1293. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advancedย GLYCATIONย end products (AGE)
  1294. Rapid determination of advancedย GLYCATIONย end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm
  1295. Induction of 1, 2-dicarbonyl compounds, intermediates in the formation of advancedย GLYCATIONย end-products, during heat-sterilization of glucose-based peritoneal โ€ฆ
  1296. Neurotoxicity of methylglyoxal and 3โ€deoxyglucosone on cultured cortical neurons: synergism betweenย GLYCATIONย and oxidative stress, possibly involved in โ€ฆ
  1297. Advancedย GLYCATIONย end products and the pathogenesis of diabetic nephropathy
  1298. Advancedย GLYCATIONย endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
  1299. Pathological significance and mechanism of advancedย GLYCATIONย end-products [J]
  1300. Advancedย GLYCATIONย and lipoxidation end products: reactive carbonyl compoundsโ€related uraemic toxicity
  1301. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advancedย GLYCATIONย end products (RAGE) in plaque psoriasis
  1302. GLYCATIONย by ascorbic acid causes loss of activity of ribulose-1, 5-bisphosphate carboxylase/oxygenase and its increased susceptibility to proteases
  1303. HPLC method for pentosidine determination in urine, serum, and tissues as a marker ofย GLYCATIONย and oxidation loading of the organism
  1304. GLYCATIONย decreases calmodulin binding to lens transmembrane protein, MIP
  1305. A food chemistโ€™s view of advancedย GLYCATIONย end-products
  1306. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advancedย GLYCATIONย end products in vitro
  1307. Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDLย GLYCATIONย in diabetes mellitus
  1308. Hemoglobin Goฬˆrwihl [ฮฑ2ฮฒ25(A2)Proโ†’Ala], an Electrophoretically Silent Variant with Impairedย GLYCATION
  1309. ฮฑ-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advancedย GLYCATIONย end โ€ฆ
  1310. Modification of lipoproteins in uremia: oxidation,ย GLYCATIONย and carbamoylation
  1311. Effect of nonenzymaticย GLYCATIONย of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro
  1312. ฮณIII-Crystallin is the primary target ofย GLYCATIONย in the bovine lens incubated under physiological conditions
  1313. Importance ofย GLYCATIONย in the acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus
  1314. The effect of UVA light on the anaerobic oxidation of ascorbic acid and theย GLYCATIONย of lens proteins
  1315. Advancedย GLYCATIONย endproducts induce changes in glucose consumption, lactate production, and ATP levels in SH-SY5Y neuroblastoma cells by a redox-sensitive โ€ฆ
  1316. Is diabetic hypercoagulability an acquired annexinopathy?ย GLYCATIONย of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients
  1317. Nonenzymaticย GLYCATION/enzymatic deGLYCATION: a novel hypothesis on the etiology of diabetic complications
  1318. Mechanism of the inhibitory effect of OPB-9195 [(ยฑ)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide] on advancedย GLYCATIONย end product and advanced โ€ฆ
  1319. Evaluation of high temperatureย GLYCATIONย of proteins and peptides by electrospray ionization mass spectrometry.
  1320. Carnosine prevents theย GLYCATIONโ€induced changes in electrophoretic mobility of aspartate aminotransferase
  1321. ALT-946 and aminoguanidine, inhibitors of advancedย GLYCATION, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat
  1322. Comparison between modifications of lens proteins resulted fromย GLYCATIONย with methylglyoxal, glyoxal, ascorbic acid, and fructose
  1323. Hyper-vascular change and formation of advancedย GLYCATIONย endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite
  1324. Advancedย GLYCATIONย end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce โ€ฆ
  1325. Oxidative modification of serum albumin in an experimentalย GLYCATIONย model of diabetes mellitus in vitro: effect of the pyridoindole antioxidant stobadine
  1326. Immunolocalization and quantification of advancedย GLYCATIONย end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization
  1327. Analytical strategy for the assessment of the proteinย GLYCATIONย status in uremic patients by high-performance liquid chromatography
  1328. Erythrocyte membrane and cytoskeletal proteinย GLYCATIONย and oxidation in short-term diabetic rabbits
  1329. Advancedย GLYCATIONย end-products/peptides: a preliminary investigation by LC and LC/MS
  1330. Astrocytic hyaline inclusions contain advancedย GLYCATIONย endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation โ€ฆ
  1331. Early-GLYCATIONย of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates
  1332. Synthesis of a novel radical trapping and carbonyl group trapping anti-AGE agent: a pyridoxamine analogue for inhibiting advancedย GLYCATIONย (AGE) and lipoxidation โ€ฆ
  1333. Study of degradation pathways of Amadori compounds obtained byย GLYCATIONย of opioid pentapeptide and related smaller fragments: Stability, reactions, and โ€ฆ
  1334. Pentosidine in advancedย GLYCATIONย end-products (AGEs) during UVA irradiation generates active oxygen species and impairs human dermal fibroblasts
  1335. Glycosphingolipid changes induced by advancedย GLYCATIONย end-products
  1336. Hemodialysis techniques and advancedย GLYCATIONย end products
  1337. Novel anti-GLYCATIONย therapeutic agents: glyoxalase I mimetics
  1338. Peptide mapping and characterisation ofย GLYCATIONย patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients
  1339. โ€ฆ converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advancedย GLYCATIONย end product formation
  1340. The molecular chaperone ฮฑโ€crystallin incorporated into red cell ghosts protects membrane Na/Kโ€ATPase againstย GLYCATIONย and oxidative stress
  1341. The role of nonenzymaticย GLYCATIONย and glyco-oxidation in the development of diabetic vascular complications
  1342. Collagenย GLYCATIONย and skin aging
  1343. Formation of advancedย GLYCATIONย endโ€productโ€modified superoxide dismutaseโ€1 (SOD1) is one of the mechanisms responsible for inclusions common to familial โ€ฆ
  1344. Suppression of early and advancedย GLYCATIONย by dietary water-soluble rutin derivative in diabetic rats
  1345. Serum levels of advancedย GLYCATIONย end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c.
  1346. Local application of advancedย GLYCATIONย end products and intimal hyperplasia in the rabbit collared carotid artery
  1347. [11] Advancedย GLYCATIONย end products: Detection and reversal
  1348. Modification of bovine ฮฒ-lactoglobulin byย GLYCATIONย in a powdered state or in aqueous solution: adsorption at the airโ€“water interface
  1349. Hereditary ceruloplasmin deficiency increases advancedย GLYCATIONย end products in the brain
  1350. The involvement of advancedย GLYCATIONย endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and โ€ฆ
  1351. Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advancedย GLYCATIONย end products and NF-ฮบB in aorta of streptozotocin treated โ€ฆ
  1352. LR-90 a new advancedย GLYCATIONย endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats
  1353. Catalysis by organic phosphates of theย GLYCATIONย of human hemoglobin
  1354. Signal transduction pathways in mouse microglia Nโ€11 cells activated by advancedย GLYCATIONย endproducts (AGEs)
  1355. Renal clearance ofย GLYCATIONย adducts: anti-GLYCATIONย defence in uraemia and dialysis
  1356. Advancedย GLYCATIONย end products (AGEs)โ€induced expression of TGFโ€ฮฒ1 is suppressed by a protease in the tubule cell line LLCโ€PK1
  1357. Diabetic nephropathy and advancedย GLYCATIONย end products
  1358. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced nonโ€enzymaticย GLYCATIONย and polyol pathway activation
  1359. โ€ฆ in tail tendon collagen of streptozotocin-diabetic rats: temporal relation to biomechanical properties and advancedย GLYCATIONย endproduct (AGE)-related โ€ฆ
  1360. Advancedย GLYCATIONย end products impair protein turnover in LLC-PK1: Amelioration by trypsin
  1361. Beneficial role of amino acids in mitigating cytoskeletal actinย GLYCATIONย and improving F-actin content: in vitro
  1362. Advancedย GLYCATIONย end product-modified ฮฒ2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis
  1363. Effect of intraperitoneal administration of heparin on advancedย GLYCATIONย end-products in CAPD
  1364. Phosphatidylinositol 3โ€ฒ-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advancedย GLYCATIONย end products
  1365. Whole-body metabolic rate appears to determine the rate of DNA oxidative damage andย GLYCATIONย involved in aging
  1366. STAT5 activation induced by diabetic LDL depends on LDLย GLYCATIONย and occurs via src kinase activity
  1367. Erythrocyte membraneย GLYCATIONย and NA+โ€“K+ levels in NIDDM
  1368. Ultrastructural localization of advancedย GLYCATIONย end products and beta2-microglobulin in dialysis amyloidosis.
  1369. The role of antioxidants in the long-termย GLYCATIONย of low density lipoprotein and its Cu2+-catalyzed oxidation
  1370. GLYCATIONย of human serum albumin by acylglucuronides of nonsteroidal anti-inflammatory drugs of the series of phenylpropionates
  1371. Effects ofย GLYCATIONย on erythrocyte carbonic anhydrase-I and II in patients with diabetes mellitus
  1372. Effect of carnosine and related compounds on glucose oxidation and proteinย GLYCATIONย in vitro
  1373. Substituted Guanidine Compounds as Inhibitors of Nonenzymaticย GLYCATIONย in vitro
  1374. An inhibitor of advancedย GLYCATIONย end product formation reducesNฯต-(carboxymethyl) lysine accumulation in glomeruli of diabetic rats
  1375. Lipoproteinย GLYCATIONย and glycoxidation: their importance in diabetes mellitus
  1376. GLYCATIONย induced crosslinking of link proteins, in vivo and in vitro
  1377. Synthesis of hexose-related imidazolidinones: Novelย GLYCATIONย products in the Maillard reaction
  1378. High glucose and advancedย GLYCATIONย end products induce phospholipid hydrolysis and phospholipid enzyme inhibition in bovine retinal pericytes
  1379. Suppressive effects of tea polyphenol and conformational changes with receptor for advancedย GLYCATIONย end products (RAGE) expression in human hepatoma cells.
  1380. Multicomponent analysis by off-line combination of synchronous fluorescence spectroscopy and capillary electrophoresis of collagenย GLYCATIONย adducts
  1381. Oleate, not ligands of the receptor for advancedย GLYCATIONย end-products, promotes proliferation of human arterial smooth muscle cells
  1382. Advancedย GLYCATIONย end-products in anterior chamber aqueous of cataractous patients
  1383. Advancedย GLYCATIONย end products quench nitric oxide in vitro
  1384. Formation of a protein-bound pyrazinium free radical cation duringย GLYCATIONย of histone H1
  1385. Possible participation of advancedย GLYCATIONย endproducts and their receptor system in the development of diabetic vascular complications
  1386. Pathological significance and mechanism of advancedย GLYCATIONย end-products
  1387. Capillary electrophoresis separation of autocondensationย GLYCATIONย products of glucosamine.
  1388. Nโ€phenacylthiazolium bromide decreases renal and increases urinary advancedย GLYCATIONย end products excretion without ameliorating diabetic nephropathy in โ€ฆ
  1389. N-terminalย GLYCATIONย of cholecystokinin-8 abolishes its insulinotropic action on clonal pancreatic B-cells
  1390. Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the formation of advancedย GLYCATIONย endproducts (AGEs) in โ€ฆ
  1391. Vascular permeability increase as induced by histamine or bradykinin is enhanced by advancedย GLYCATIONย endproducts (AGEs)
  1392. Advancedย GLYCATIONย end product (AGE) inhibition as a possible pharmacotherapeutic strategy in the treatment of Alzheimerโ€™s disease
  1393. Levels of mature cross-links and advancedย GLYCATIONย end product cross-links in human vitreous
  1394. Effects of vitamin E and vitamin C on nonenzymaticย GLYCATIONย and peroxidation in experimental diabetic rats
  1395. Decreased Na, K-ATPase activity byย GLYCATIONย at the catalytic center
  1396. Beraprost sodium, a prostaglandin I 2 analogue, protects against advancedย GLYCATIONย end products-induced injury in cultured retinal pericytes
  1397. The earlyย GLYCATIONย products of the Maillard reaction: mass spectrometric characterization of novel imidazolidinones derived from an opioid pentapeptide and glucose
  1398. Isolation and identification of the 3-hydroxy-5-hydroxymethyl-pyridinium compound as a novel advancedย GLYCATIONย end product on glyceraldehyde-related Maillard โ€ฆ
  1399. Advancedย GLYCATIONย end products are involved in microvascular permeability changes observed in microcirculation of diabetic rats in vivo
  1400. Role of nonenzymaticย GLYCATIONย and oxidative stress on the development of complicated diabetic cataracts
  1401. Determination of advancedย GLYCATIONย end products
  1402. Modulation of physico-chemical properties of bovine b-casein by nonenzymaticย GLYCATIONย associated with enzymatic dephosphorylation
  1403. Advancedย GLYCATIONย end-products in corneas of patients with keratoconus
  1404. The-429 T/C and-374 T/A gene polymorphisms of the receptor of advancedย GLYCATIONย end products gene are not risk factors for diabetic retinopathy in Caucasians with โ€ฆ
  1405. Effect of aminophospholipidย GLYCATIONย on order parameter and hydration of phospholipid bilayer
  1406. Pyridoxamine, a versatile inhibitor of advancedย GLYCATIONย and lipoxidation reactions
  1407. Ultrastructural changes and immunohistochemical localization of advancedย GLYCATIONย end products in the heart of streptozotocin-treated Mongolian gerbils
  1408. A practical method to study functional impairment of proteins byย GLYCATIONย and effects of inhibitors using current coagulation/fibrinolysis reagent kits
  1409. Gramicidin S: a peptide model for proteinย GLYCATIONย and reversal ofย GLYCATIONย using nucleophilic amines
  1410. Non-enzymatic glycosylation (orย GLYCATION) and inhibition of the pig heart cytosolic aspartate aminotransferase by glyceraldehyde 3-phosphate
  1411. Advancedย GLYCATIONย alters expression of the 67kDa laminin receptor in retinal microvascular endothelial cells
  1412. Evaluation of the site (s) ofย GLYCATIONย in human proinsulin by ion-trap LCQ electrospray ionization mass spectrometry
  1413. Inhibition of aspartate aminotransferase byย GLYCATIONย in vitro under various conditions
  1414. Study of autoantibodies against advancedย GLYCATIONย endproducts of the Maillard reaction
  1415. Molecular heterogeneity of amyloid ฮฒ2-microglobulin and modification with advancedย GLYCATIONย end products
  1416. 3-Deoxyosone-related advancedย GLYCATIONย end products in foods and biological systems
  1417. Formation of advancedย GLYCATIONย endproducts from low molecular weight model compounds
  1418. Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advancedย GLYCATIONย end product-modified fibronectin to vascular โ€ฆ
  1419. Methods for studying the binding of advanced glycated proteins to receptors for advancedย GLYCATIONย endproducts (AGE receptors)
  1420. Nitric oxide, advancedย GLYCATIONย end products, and uremia
  1421. Proliferation-inhibiting effect of advancedย GLYCATIONย end products modified human serum albumin to vascular endothelial cell ecv304
  1422. The potential role of advancedย GLYCATIONย end product and iNOS in chronic renal failure-related testicular dysfunction
  1423. Impact of chronic renal failure and peritoneal dialysis fluids on advancedย GLYCATIONย end product and iNOS levels in penile tissue: an experimental study
  1424. Intraperitoneal infusion of glucose-based dialysate in the ratโ€”an animal model for the study of peritoneal advancedย GLYCATIONย end-products formation and effect on โ€ฆ
  1425. Prediction of possible sites for posttranslational modifications in human gamma crystallins: Effect ofย GLYCATIONย on the structure of human gammaโ€bโ€crystallin as โ€ฆ
  1426. Effects of aging and advancedย GLYCATIONย on gene expression in cerebrum and spleen of mice.
  1427. RAGE engagement and vascular cell derangement by short chain sugar-derived advancedย GLYCATIONย end products
  1428. Advancedย GLYCATIONย end products, their receptors and diabetic angiopathy
  1429. In vitro-prepared advancedย GLYCATIONย end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular โ€ฆ
  1430. Induction of GM-CSF production of macrophages by advancedย GLYCATIONย end products of the Maillard reaction
  1431. Changes inย GLYCATIONย of fibrous type I collagen during long-term in vitro incubation with glucose
  1432. Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advancedย GLYCATIONย end-products in vascular smooth muscle โ€ฆ
  1433. The relation between impaired wound healing and advancedย GLYCATIONย end products [J]
  1434. Role of lipid peroxidation products in the formation of advancedย GLYCATIONย end products: An in vitro study on collagen
  1435. Effect of physical load on serum proteinย GLYCATIONย in rats with induced diabetes
  1436. โ€ฆ anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement ofย GLYCATIONย in motoneuron diseases
  1437. Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advancedย GLYCATIONย end โ€ฆ
  1438. Advancedย GLYCATIONย end products inhibit production of nitric oxide by human endothelial cells through activation of the p38 signal pathway
  1439. Proteinย GLYCATIONโ€“clinical and chemical aspects
  1440. Advancedย GLYCATIONย end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio
  1441. Nonโ€enzymaticย GLYCATIONย of lens proteins and haemoglobinโ€“inhibition by pyruvate: an inโ€vivo study
  1442. Effect of non-enzymaticย GLYCATIONย on biological properties of morphiceptin.
  1443. Limited effects of parsley (Petroselinum crispum) on proteinย GLYCATIONย and glutathione in lenses of streptozotocin-induced diabetic rats
  1444. In vitroย GLYCATIONย of aminotransferases: A process closely depending on the employed experimental conditions
  1445. Advancedย GLYCATIONย in uraemic toxicity
  1446. The effects ofย GLYCATION/glycoxidation on the liberation of 8-epi-PGF2ฮฑfrom low density lipoprotein during its in vitro oxidation
  1447. The effect of Somac, Cinnamomun and black pepper on albuminย GLYCATIONย in-vitro
  1448. Study of theโˆ’ 429 T/C andโˆ’ 374 T/A receptor for advancedย GLYCATIONย end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular โ€ฆ
  1449. Inhibitory effect of peptide-free forms of advancedย GLYCATIONย end products on the proliferation and extracellular matrix protein production of cultured cells
  1450. โ€ฆ colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advancedย GLYCATIONย end products, carboxymethyllysine and โ€ฆ
  1451. Biochemical properties and clinical significance of proteinย GLYCATIONย products
  1452. Age-dependent accumulation of advancedย GLYCATIONย endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine
  1453. Increased levels of circulating advancedย GLYCATIONย end products in a model of acute renal insufficiency in rats
  1454. Expression of receptor for advancedย GLYCATIONย end product mRNA by human peritoneal mesothelial cells
  1455. Aย GLYCATIONย inhibitor, aminoguanidine and pyridoxal adduct, suppresses the development of diabetic nephropathy
  1456. Effects of Advancedย GLYCATIONย Endproducts (AGE) on Rat Glomerular Epithelial Cells (GEC): Roles of Reactive Oxygen Species (ROS)
  1457. L-lysine reduces nonenzymaticย GLYCATIONย of glomerular basement membrane collagen and albuminuria in diabetic rats
  1458. Advancedย GLYCATIONย end products stimulate human endothelial cells to produce monocyte chemoattractant protein-1
  1459. Detection ofย GLYCATIONย end products in the urine of diabetic patients
  1460. Capillary electrophoretic separation by double-strand polyaniline-coate capillaries of the advancedย GLYCATIONย endproducts formed from N-alpha-acetyl-L-lysine with โ€ฆ
  1461. Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advancedย GLYCATIONย end-products
  1462. Evidence for accumulation of advancedย GLYCATIONย end products in acute renal failure
  1463. Advancedย GLYCATIONย end products induce apoptosis and expression of apoptotic genes in cultured bovine retinal capillary pericytes
  1464. GLYCATIONย and Age in Diabetes and Complications
  1465. Activation of smad signaling and collagenโ…  synthesis in NRK52E cells induced by advancedย GLYCATIONย end products
  1466. Effect of vitamin C and E on nonenzymaticย GLYCATIONย and physico-chemical properties of isolated erythrocyte membranes in diabetic patients
  1467. Identification of Nฯ‰-carboxymethylarginine, as a new advancedย GLYCATIONย endproduct in serum proteins of diabetic patients
  1468. Inhibitory effect of dilazep hydrochloride on the formation of advancedย GLYCATIONย end products
  1469. Effects of advancedย GLYCATIONย end-products on cell cycle distribution and apoptosis in neonatal rat cardiac myocytes
  1470. ADVANCEDย GLYCATIONย END PRODUCT LEVELS IN EYE LENSES, AORTA, AND TAIL TENDON IN TRANSPLANTED DIABETIC INBRED LEWIS RATS1
  1471. Autoantibodies against advancedย GLYCATIONย products in patients with type 1 diabetes mellitus
  1472. Detection of structural alterations in LDL isolated from type 2 diabetic patients: application of the fructosamine assay to evaluate the extent of LDLย GLYCATION
  1473. Advancedย GLYCATIONย end products and coronary heart disease in type 2 diabetes.
  1474. The effect of ethanol on histoneย GLYCATIONย in diabetic rats
  1475. Outer Blood-retinal Barrier Alteration Induced by Intraocular Ad vancedย GLYCATIONย Endproduct
  1476. GLYCATIONย of radioiodinated octreotates increases renal excretion and tumor uptake
  1477. Effect of advancedย GLYCATIONย end products on rat aortic vascular smooth muscle cells
  1478. Expression of receptors for advancedย GLYCATIONย end products at surface of peripheral blood monocytes and relationship thereof to plasma proinflammatory cytokines in โ€ฆ
  1479. Effect of some essential oils on albuminย GLYCATIONย in vitro
  1480. Platelet protein damage by free radicals andย GLYCATIONย in vitro: the pathological consequences
  1481. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advancedย GLYCATIONย end products and neointima hyperplasia โ€ฆ
  1482. Repression of fibroblast migration into the collagen gel incubated with glucose is due toย GLYCATION-mediated cross-linking of collagen
  1483. In vitro glycoxidation of insoluble fibrous type I collagen: solubilization and advancedย GLYCATIONย end products
  1484. Inhibitory effect of HXMTZG on the deposition of advancedย GLYCATIONย endproducts (AGEs) and the role of downregulating RAGE mRNA transcription in the renal cortex โ€ฆ
  1485. Assessment of nonenzymaticย GLYCATIONย in protein by FTIR spectroscopy
  1486. Assessment of nonenzymaticย GLYCATIONย in protein by FTIR spectroscopy
  1487. A modulatory role for advancedย GLYCATIONย end-products (AGEs) in retinal microvascular leukostasis
  1488. Advancedย GLYCATIONย end products-induced TNF-ฮฑ and IL-6 production by peripheral lymphocytes of diabetic patients [J]
  1489. An in vitro evaluation of theย GLYCATIONย potential of a natural disaccharide, trehalose
  1490. In vitro effects of flavone from leaves of Diospyros kaki on rat cardiac myocyte apoptosis induced by hypoxia-reoxygenation and advancedย GLYCATIONย end products.
  1491. Effects of flavone from leaves of Diospyros kaki on adventitial fibroblast proliferation induced by advancedย GLYCATIONย end-products in vitro
  1492. The pathobiological effect of ฮฒ_2-microglobulin modified with advancedย GLYCATIONย end products on human type B synovial cells [J]
  1493. Induction of Age-related Macular Degeneration (AMD) by Advancedย GLYCATIONย End (AGE) Products and S100B
  1494. Immunohistochemistry of advancedย GLYCATIONย end products in neurofilamentous axonal spheroids induced by ฮฒ-ฮฒโ€ฒ-iminodipropionitrile in lower motor neurons of rat
  1495. Proteinย GLYCATIONย reactions
  1496. Comparison of in vitro protein modification with advancedย GLYCATIONย endproduct (AGE) precursors methylglyoxal, glyoxal, 3-deoxyglucosone and glucose using mass โ€ฆ
  1497. Autoantibodies against advancedย GLYCATIONย endproducts (AGEs) in IDDM
  1498. Influence of some natural antioxidants onย GLYCATIONย of aminotransferases
  1499. Assay of early and advancedย GLYCATIONย adducts by enzymatic hydrolysis of proteins and HPLC of 6-aminoquinolylcarbonyl adducts
  1500. Intracellular changes in astrocytes and NG 108-15 neuroblastoma X glioma cells induced by advancedย GLYCATIONย end products
  1501. Effect of iron on peroxidation and non-enzymaticย GLYCATIONย in diabetic rats
  1502. Synthesis of [5-(4-pyrrol-1-yl-benzoyl)-1 H-pyrrol-2-yl)]-acetic acid and in vitro study of its inhibitory activity on aldose reductase enzyme and on proteinย GLYCATION.
  1503. GLUCOSAMINE INHIBITS FORMATION OF ADVANCEDย GLYCATIONย ENDPRODUCTS IN HUMAN ARTICULAR CARTILAGE: A MECHANISM FOR โ€ฆ
  1504. Effect of drinking green tea onย GLYCATIONย and oxidation of aortic collagen in diabetic rat
  1505. Role of genetic variability in systems of receptor-mediated and enzymatic defence againstย GLYCATIONย in the long-term consequences of diabetes mellitus
  1506. Inhibitory effects of radix puerariae on theย GLYCATION
  1507. Effect of Wenjintong Composita on mRNA expression of receptor of the advancedย GLYCATIONย end products in sciatic nerve of streptozotocin-induced diabetic rats
  1508. Effects of sodium ferulate on the nonenzymaticย GLYCATIONย and oxidation in kidneys of diabetic rats
  1509. Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile: effects of hyperglycemia, lipoproteinย GLYCATION, and comparison with standard lipid profile
  1510. Effects of advancedย GLYCATIONย end products and hypoxia on endothelin-1 secretion by bovine retinal microvascular pericytes
  1511. Polymorphism 2184A/G in the gene encoding Receptor of Advancedย GLYCATIONย End products (RAGE) is a newly identified risk factor for diabetic nephropathy
  1512. Effects of advancedย GLYCATIONย end products on changes of glomerulus of STZ-induced diabetic rat
  1513. Selective increase in decorin core mRNA level in cultured vascular smooth muscle cells after exposure to advancedย GLYCATIONย endproducts
  1514. The effects ofย GLYCATIONย on the material properties of porcine meniscus
  1515. Advancedย GLYCATIONย end-products and diabetic renal disease
  1516. Soluble receptor for advancedย GLYCATIONย endproducts (sRAGE) effectively reduces tumor growth as a single agent and in combination with doxorubicin in a โ€ฆ
  1517. IR spectroscopic investigation of the inhibition of theย GLYCATIONย process by acetylsalicylic acid
  1518. Dietary Copper Deficiency Causes Elevation of Early and Advancedย GLYCATIONย End-Products
  1519. Effect of advancedย GLYCATIONย end products (AGEs) on proliferation of vascular endothelial cells cultured in vitro
  1520. Determination of Earlyย GLYCATIONย Products by Mass Spectrometry and Quantification ofย GLYCATIONย Mediated Protein Crosslinks by the Incorporation of [14C]lysine into โ€ฆ
  1521. byย GLYCATION
  1522. โ€ฆ on the Processing of Herbal Medicines (V)-Quantitative Analysis of Puerarin and Inhibitory Effects on the Formation of Advancedย GLYCATIONย Endproducts (AGEs) in โ€ฆ
  1523. Effects of Zhixiaotongmaining Extract on Renal Advanceย GLYCATIONย End Products in Diabetic Rats
  1524. Advancedย GLYCATIONย end products induce apoptosis in corneal endothelium
  1525. Effect of Different Advancedย GLYCATIONย End Products on Proliferation of Vascular Smooth Muscle Cell
  1526. Diabetic nephropathy and low molecular weight advancedย GLYCATIONย end-product in urine
  1527. A new model of age-related macular degeneration induced by advancedย GLYCATIONย end products
  1528. Processing of collagen gels using non-enzymaticย GLYCATION
  1529. Recombinant human interleukin-10 inhibits proliferation of rat vascular smooth muscle cells stimulated by advancedย GLYCATIONย end products [J]
  1530. Effects of advancedย GLYCATIONย end products on the expression of plasminogen activator inhibitor-1 in rat mesangial cells
  1531. The role of lens proteinย GLYCATION, oxidation and enzyme inactivation in cataract formation
  1532. Two advancedย GLYCATIONย molecules, carboxymethyllysine and pentosidine, and dialysis membrane in dialysis-related amyloidosis
  1533. Advancedย GLYCATIONย end-products-LDL stimulates adhesion molecule expression by human aortic endothelial cells
  1534. Nonenzymaticย GLYCATIONย increases the severity of osteoarthritis in the canine ACLT model: a biochemical basis for age as a risk factor of OA
  1535. Chronic or delayed treatment with an oral dithiocarbamate analog decreasesย GLYCATIONย and protects diabetic arteries
  1536. Recombinant Lapemis hardwickii phospholipase A2 inhibits rat vascular smooth muscle cell proliferation stimulated by advancedย GLYCATIONย end products
  1537. Inhibitory effect of total flavones of buckwheat flower on the non-enzymaticย GLYCATIONย of protein in vivoand vitro
  1538. Enhancement of inhibitory effects of glycoprotein IIb/IIIa antagonists in patients with diabetes: Effects ofย GLYCATIONย on the kinetics of fibrinogen binding
  1539. Advancedย GLYCATIONย endproducts accumulate in RPE lysosomal compartments and induce widespread alteration in gene expression: possible role in age-related โ€ฆ
  1540. Endocytic uptake of advancedย GLYCATIONย endproducts by mouse liver sinusoidal endothelial cells is mediated by a receptor distinct from the class A scavenger receptor
  1541. In vitroย GLYCATIONย and advancedย GLYCATIONย endproduct formation with icodextrin and oligosaccharides
  1542. Expression of receptor for advancedย GLYCATIONย end products (RAGE) and its ligands S100/calgranulins and amphoterin is increased in the vitreous cavity of patients โ€ฆ
  1543. Gly82Ser polymorphism in the receptor for advancedย GLYCATIONย end products (RAGE) gene is not associated with the progression of diabetic nephropathy and โ€ฆ
  1544. Advancedย GLYCATIONย End Products in Nephrology
  1545. Influence of advancedย GLYCATIONย end-products in the development of atherosclerosis
  1546. Methods for measuring the proteinย GLYCATIONย products formed in the human organism
  1547. ADVANCEDย GLYCATIONย ENDPRODUCTS IN THE DEVELOPMENT OF JOINT DISEASE
  1548. Structure-Function Relationship of Advancedย GLYCATIONย Endproducts (AGEs)
  1549. In vitroย GLYCATIONย of aminotransferases: a process closely depending on the employed experimental conditionsโ€ฆโ€ฆโ€ฆโ€ฆโ€ฆ. 89
  1550. The effect of an insulin releasing agent, BTS 67 582, on advancedย GLYCATIONย end product formation in vitro
  1551. Advancedย GLYCATIONย of proteins. Molecular characteristics and cellular responses.
  1552. Study of the proteinย GLYCATIONย in Alzheimerโ€™s disease
  1553. Advancedย GLYCATIONย End Products Act As A Skin Tumor Initiator in Mice
  1554. Chromatographic assay of advancedย GLYCATIONย endproducts and application to the study of human disease.
  1555. Postprandial glucose/GLYCATIONย supplements?
  1556. Effects of Advancedย GLYCATIONย End Products on Rat Bladder Fibroblast
  1557. Interaction of reactive oxygen species in atherogenetic properties of advancedย GLYCATIONย end products in diabetes
  1558. Implications of Advancedย GLYCATIONย Endproducts in Oxidative Stress and Neurodegenerative Disorders
  1559. GLYCATIONย Of Matrix Proteins Alters Endothelial Cell [Ca. sup. 2+] Signaling
  1560. The occurrence of a novel hydrophilic hydroperoxide, 3-hydroxy-5-hydroperoxy-2-methyl-5, 6-dihydropyran-4-one, as a reactiveย GLYCATIONย product in human plasma
  1561. Effect of advancedย GLYCATIONย end products on inflammation in cultured cardiomyocytes
  1562. ADVANCEDย GLYCATIONย ENDPRODUCTS REDUCE TURNOVER OF HUMAN ARTICULAR CARTILAGE IN VITRO
  1563. Role of advancedย GLYCATIONย end products (AGE) in the development of diabetic microangiopathies and the beneficial effects of AGE inhibitors
  1564. Isolation and characterization of low-density lipoprotein lipidย GLYCATIONย products
  1565. GLYCATIONย as a post-translational modification of myosin structure and function; Role of glutathione;ย GLYCATIONย and aging
  1566. Biochemical Analysis of Inter-Connection between Types of Nuclear Opacity, Oxidative Stress andย GLYCATIONย in Cataractous Lens
  1567. EFFECTS OF ADVANCEDย GLYCATIONย END PRODUCTS (AGES) ON ADHESION AND MULTIPLICATION IN E. coli
  1568. Circulating Advancedย GLYCATIONย Endproducts (AGEs) An Indicator Of Long-Term Glycemic Control
  1569. Effects of advancedย GLYCATIONย end-products on skin keratinocytes by NF-? B activation
  1570. Advancedย GLYCATIONย endproducts and microvasculopathy: A pathogenic basis for initiation and progression of diabetic retinopathy.
  1571. Plasma proteinย GLYCATIONย and its correlation to the levels of magnesium and manganese in diabetic patients
  1572. The demonstration of the thesis of nonenzymaticย GLYCATIONย inducing aging
  1573. INHIBITORY ACTION OF PROCESSED HERBAL MEDICINES ON THE PRODUCTION OF ADVANCEDย GLYCATIONย ENDPRODUCTS (AGEs)
  1574. The effect of advancedย GLYCATIONย and products on the proliferation of vascular smooth muscle cell.
  1575. The presence and activity of the receptor for advancedย GLYCATIONย end products in osteoblasts
  1576. Effect of Advancedย GLYCATIONย Endproducts on Rat Aortic Vascular Smooth Muscle Cells
  1577. Effects of advancedย GLYCATIONย end products on activi ty and expression of matrix metalloproteinase-2 in renal cortex of rats
  1578. Thermalย GLYCATIONย of Proteins by D-Glucose and D-Fructose
  1579. Expression of advancedย GLYCATIONย end product (AGE) receptors in corneal endothelial cells
  1580. Cellular oxidant stress mediated by advancedย GLYCATIONย endproducts: the role of native albumin
  1581. Advancedย GLYCATIONย end products (AGE) enhance vascular endothelial growth factor (VEGF) production in promonocytic leukaemia THP-1 cells
  1582. Effect ofย GLYCATIONย by acyl glucuronides on protein function
  1583. GLYCATIONย and tubulointerstitial injury; in vitro and in vivo studies
  1584. HP-Lysine-A New Advancedย GLYCATIONย Endproduct in Cataractous and Aged Human Lenses
  1585. GLYCATIONย of Leucine-Enkephalin: Imidazolidinones and Amadori Compounds
  1586. Glyoxalase I deficiency is associated with an unusual level of advancedย GLYCATIONย end products in a hemodialysis patient
  1587. Advancedย GLYCATIONย and Ubiquitination of Cytosolic Proteins in Experimental Diabetes San Francisco, CA
  1588. FGF2 (bFGF)ย GLYCATIONย induced by TGF-beta1 in human lens epithelial cells
  1589. EXPRESSION AND REGULATION OF THE BINDING PROTEINS FOR ADVANCEDย GLYCATIONย END PRODUCTS ON HUMAN JOINT SYNOVIAL CELLS
  1590. Effect of iron on peroxidation and non-enzymaticย GLYCATIONย in diabetic rats
  1591. Advancedย GLYCATIONย End Products (AGEs) Reduce Vesicular Transport in RPE Cells
  1592. Low density lipoproteinย GLYCATIONย mediated modifications in diabetic atherosclerosis
  1593. Effects of Benazepril on Nonenzymaticย GLYCATIONย in Diabetic Rats
  1594. Inhibition of Advancedย GLYCATIONย Endproduct (AGE) Formation by the Alcohol Metabolite Acetaldehyde: Role in theโ€ French Paradoxโ€
  1595. The role of advancedย GLYCATIONย end-products in pericyte dysfunction and death during diabetic retinopathy.
  1596. Effects of advancedย GLYCATIONย end products on the expression of plasminogen activator inhibitor-1 in rat mesangial cells
  1597. Rates of Skin Collagenย GLYCATIONย and Glycoxidation Predict Early Death in Nondiabetic C57BL/6NNia Mice: A Longitudinal Study
  1598. Advancedย GLYCATIONย of mesangial matrix induces endothelins secretion and gene expression in mesangial cells
  1599. Activation of Receptor for Advancedย GLYCATIONย End Products A Mechanism for Chronic Vascular Dysfunction in Diabeโ€ฆ
  1600. Improvement of ฮฒ-casein functionality by non-enzymaticย GLYCATIONย in relation to its structural changes.
  1601. Estimation of the genotoxic properties of novel class of advaneedย GLYCATIONย and products (AGE) by measuring in human lymphocytes in vitro
  1602. The Receptor for Advancedย GLYCATIONย End Products Is Induced by theย GLYCATIONย Products Themselves and Tumor Necrosis Factor-ฮฑ through Nuclear Factor-ฮบB, and by โ€ฆ
  1603. Advancedย GLYCATIONย End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
  1604. Biodistribution of the 18F-labelled Advancedย GLYCATIONย End Products Ne-carboxymethyllysine (CML) and Ne-carboxyethyllysine (CEL)
  1605. Basement Membrane-immobilised Advancedย GLYCATIONย Endproducts Induce Capillary Endothelial Dysfunction And Apoptosis
  1606. Formation of advancedย GLYCATIONย end products by glyceraldehyde and glyceraldehyde-3-phosphate with proteins
  1607. Advancedย GLYCATIONย end products (AGEs) lower the clearance function of hepatic scavenger endothelial cells (SEC)
  1608. Dialysis-related amyloidosis: role of advancedย GLYCATIONย end product-ฮฒ-microglobulin in joint inflammation
  1609. Effects of Advancedย GLYCATIONย End-Product Inhibition and Protein Cross-Link Breaking in Diabetic Rats
  1610. Relationship between the advancedย GLYCATIONย end products content and expressions of RAGE, ICAM-1 in vascular tissue of diabetic rats
  1611. Human Erythrocyte Bisphosphoglycerate Mutase: Inactivation byย GLYCATIONย In Vivo and In Vitro
  1612. Advancedย GLYCATIONย end products-induced inflammatory reaction in human monocytes: cellular receptor pathway & intracellular signaling
  1613. < SYMPOSIUM: Biology of Aging and Age-associated Skin Disorders> POSSIBLE ROLES OF ADVANCEDย GLYCATIONย END-PRODUCTS IN PROMOTING SKIN โ€ฆ
  1614. Effects of Probenecid on the Elimination of the Advancedย GLYCATIONย End-products Ne-Carboxymethyllysine (CML) and Ne-Carboxyethyllysine (CEL) Using โ€ฆ
  1615. Specific detections of the early process of theย GLYCATIONย reaction by fructose and glucose in diabetic rat lens
  1616. The expression of receptor for advancedย GLYCATIONย end product in gingival tissues of type 2 diabetic patients with periodontitis
  1617. Effects of Wen-Jin-Tong on the formation of advancedย GLYCATIONย end products and expressions of RAGE and ICAM-1 in cardiovascular tissues of diabetic rats
  1618. NON-ENZYMATICย GLYCATIONย ALTERS THE CREEP AND VISCOPLASTIC PROPERTIES OF HUMAN CORTICAL BONE
  1619. Effect of aminoguanidine on mRNA expression of specific receptor of the advancedย GLYCATIONย end products in diabetic kidney tissue in rats
  1620. Inhibitory effects of taurine on oxidative stress and nonenzymaticย GLYCATIONย in kidney of diabetic rats
  1621. Prevention of CML Accumulation by A Novel Inhibitor of Advancedย GLYCATIONย Ameliorates Nephropathy in Spontaneous Diabetic Rats
  1622. Effects of tetramethylpyrazine on the expression of nuclear factorkappa B induced by advancedย GLYCATIONย end products in retinal pigment epithelium
  1623. THE EFFECTS OF MATRIX STABILIZATION USING GLUTARALDEHYDE ANDย GLYCATIONย WITH RIBOSE ON THE MATERIAL PROPERTIES OF PORCINE โ€ฆ
  1624. N-acetylcysteine inhibits advancedย GLYCATIONย end products-induced VCAM-1 expression in mouse cardiac microvascular endothelial cells
  1625. In vitro Inhibitory Effect of Coptidis Rhizoma before and after Processing and Berberine on the Advancedย GLYCATIONย Endproducts (AGEs) formation
  1626. Advancedย GLYCATIONย end products inhibit pressure-induced vasorelaxation in rabbit femoral artery in vivo
  1627. Immunohistochemical detection of products of lipid peroxidation and proteinย GLYCATIONย in the cerebellum of Menkesโ€™ kinky hair disease patients
  1628. Nonenzymatic formation of advancedย GLYCATIONย endproducts by glucosamine autocondensation and glucosamine with proteins
  1629. The advancedย GLYCATIONย end-product inhibitor pyridoxamine traps intermediates formed during lipid peroxidation reactions in vitro and in vivo: Mechanism of โ€ฆ
  1630. GLYCATIONย Proceeds Faster in Mutated Cu, Zn-Superoxide Dismutases Related to Familial Amyotrophic Lateral Sclerosis
  1631. Matrix stabilization using glutaraldehyde andย GLYCATION: Effects on the material properties of the knee meniscus
  1632. Advancedย GLYCATIONย endproduct (AGE) receptor interactions on microvascular cells occur within the caveolae membrane system
  1633. Modification of enzymatic antioxidants in bovine retinal capillary pericytes by advancedย GLYCATIONย end products
  1634. Inhibitory effect of total flavones of buckwheat flower on the non-enzymaticย GLYCATIONย of protein in vivoand vitro
  1635. N-(carboxymethyl) valine adduct in hemoglobin: a biomarker of advancedย GLYCATIONย end product formation and oxidative stress
  1636. Ginkgo biloba extract attenuates advancedย GLYCATIONย end products-induced TGF-? _1, CTGF mRNA expression and oxidative stress in NRK-49F cells
  1637. Functional and immunochemical characterization of advancedย GLYCATIONย end-product (AGE)-modified low-density lipoproteins (AGE-LDL).
  1638. Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advancedย GLYCATIONย End Products in Patients with Coronary Artery Disease: Results from a โ€ฆ
  1639. Effects of advancedย GLYCATIONย end-products on expression of acyl coenzyme A: cholesterol acyltransferase-1 in THP-1 macrophages
  1640. Functional Hyperhomocysteinemia in Healthy Vegetar-ians: No Association with Advancedย GLYCATIONย End Products, Markers of Protein Oxidation, or Lipid โ€ฆ
  1641. Pioglitazone reduces expression of advancedย GLYCATIONย end product receptor mRNA in renal cortex of streptozotocin-induced diabetic rats
  1642. FAILURE OF PANCREAS TRANSPLANTATION TO PREVENT DEPOSITION OF AN ADVANCEDย GLYCATIONย END-PRODUCT IN TRANSPLANTED KIDNEYS โ€ฆ
  1643. Induction of Decorin Core Protein Synthesis by Advancedย GLYCATIONย Endproducts in Cultured Vascular Smooth Muscle Cells (PROCEEDINGS OF 24TH SYMPOSIUM โ€ฆ
  1644. โ€ฆ Retinal Microvascular Pathology is Prevented by Sulindac, a Non-steroidal Anti-inflammatory Drug, without Inhibition of Advancedย GLYCATION, Polyol Pathway Activity โ€ฆ
  1645. NONENZYMATICย GLYCATIONย IMPAIRS MMP-AND AGGRECANASE-MEDIATED MATRIX DEGRADATION BY BOVINE ARTICULAR CHONDROCYTES โ€ฆ
  1646. Macrokinetic Regularities of Chemiluminescence Development in the Course of Non-Enzymaticย GLYCATIONย in Aqueous Solutions of Glycine and D-Glucose (Maillard โ€ฆ
  1647. The protection of aminoguanidine, silymarin and anisodamine on growth and cytosolic free calcium changes of retinal capillary pericytes cultured inย GLYCATIONย products
  1648. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products ofย GLYCATION, in vitro: Implication of inefficient glutathione โ€ฆ
  1649. 39. Synthesis of Labelled Advancedย GLYCATIONย End Products Using N-Succinimidyl 4-[18F] Fluorobenzoate
  1650. Biodistribution of the 18F-labelled advancedย GLYCATIONย end products Nฮต-carboxymethyllysine (CML) and Nฮต-carboxyethyllysine (CEL)
  1651. Biodistribution of the {sup 18} F-labelled advancedย GLYCATIONย end products N {sup {epsilon}}-carboxymethyllysine (CML) and N {sup {epsilon}}-carboxyethyllysine (CEL โ€ฆ
  1652. Galectin-3,[Beta]-Galactoside-Binding Lectin, as a Receptor for Advancedย GLYCATIONย End Products
  1653. Advancedย GLYCATIONย endproductsโ€”role in pathology of diabetic complications
  1654. Advancedย GLYCATIONย end products and the kidney
  1655. Simple non-invasive assessment of advancedย GLYCATIONย endproduct accumulation
  1656. Advancedย GLYCATIONย in health and disease: role of the modern environment
  1657. Advancedย GLYCATIONย end products: sparking the development of diabetic vascular injury
  1658. Analysis and prediction of mammalian proteinย GLYCATION
  1659. Advancedย GLYCATIONย end-products and the progress of diabetic vascular complications
  1660. Inhibitory effect of naturally occurring flavonoids on the formation of advancedย GLYCATIONย endproducts
  1661. The role of advancedย GLYCATIONย end products in the development of atherosclerosis
  1662. GLYCATIONย endproducts in osteoporosisโ€”is there a pathophysiologic importance?
  1663. Advancedย GLYCATIONย endproducts (AGEs): pharmacological inhibition in diabetes
  1664. Glucose,ย GLYCATIONย and aging
  1665. Advancedย GLYCATIONย end products and diabetic complications: a general overview
  1666. Proteinย GLYCATION: a firm link to endothelial cell dysfunction
  1667. Advancedย GLYCATIONย endproduct crosslinking in the cardiovascular system
  1668. Advancedย GLYCATIONย end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
  1669. Importance of measuring products of non-enzymaticย GLYCATIONย of proteins
  1670. GLYCATIONย products as markers and predictors of the progression of diabetic complications
  1671. Advancedย GLYCATIONย end product interventions reduce diabetes-accelerated atherosclerosis
  1672. Advancedย GLYCATIONย end products and bone loss during aging
  1673. Randomized trial of an inhibitor of formation of advancedย GLYCATIONย end products in diabetic nephropathy
  1674. Understanding RAGE, the receptor for advancedย GLYCATIONย end products
  1675. Advancedย GLYCATIONย end products and diabetic nephropathy
  1676. The clinical relevance of advancedย GLYCATIONย endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation
  1677. Role of advancedย GLYCATIONย end products and their receptors in development of diabetic neuropathy
  1678. Advancedย GLYCATIONย end products in renal failure
  1679. Advancedย GLYCATIONย end product ligands for the receptor for advancedย GLYCATIONย end products: biochemical characterization and formation kinetics
  1680. Advancedย GLYCATIONย end products (AGEs) and diabetic vascular complications
  1681. Involvement of advancedย GLYCATIONย end-products (AGEs) in Alzheimerโ€™s disease
  1682. Importance of advancedย GLYCATIONย end products in diabetes-associated cardiovascular and renal disease
  1683. Association between serum levels of soluble receptor for advancedย GLYCATIONย end products and circulating advancedย GLYCATIONย end products in type 2 diabetes
  1684. Possible participation of advancedย GLYCATIONย end products in the pathogenesis of osteoporosis in diabetic patients
  1685. Accumulation of advancedย GLYCATIONย end products as a molecular mechanism for aging as a risk factor in osteoarthritis
  1686. Toxic advancedย GLYCATIONย end products (TAGE) theory in Alzheimerโ€™s disease
  1687. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenicย GLYCATIONย and oxidative damage
  1688. Advancedย GLYCATIONย and endothelial functions: a link towards vascular complications in diabetes
  1689. Characterization of advancedย GLYCATIONย end products for biochemical studies: side chain modifications and fluorescence characteristics
  1690. Advancedย GLYCATIONย end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
  1691. Role of advancedย GLYCATIONย end products (AGEs) in thrombogenic abnormalities in diabetes
  1692. Advancedย GLYCATIONย end product receptorโ€mediated cellular dysfunction
  1693. Positive association between serum levels of advancedย GLYCATIONย end products and the soluble form of receptor for advancedย GLYCATIONย end products in nondiabetic โ€ฆ
  1694. Soluble receptor for advancedย GLYCATIONย end products: from disease marker to potential therapeutic target
  1695. Advancedย GLYCATIONย End Product Crossโ€Linking: Pathophysiologic Role and Therapeutic Target in Cardiovascular Disease
  1696. Assessment of proteinย GLYCATIONย markers in infant formulas
  1697. Association between acute-phase reactants and advancedย GLYCATIONย end products in type 2 diabetes
  1698. Advancedย GLYCATIONย and retinal pathology during diabetes
  1699. The receptor for advancedย GLYCATIONย end products is highly expressed in the skin and upregulated by advancedย GLYCATIONย end products and tumor necrosis โ€ฆ
  1700. Inhibitors of advancedย GLYCATIONย end product formation and neurovascular dysfunction in experimental diabetes
  1701. Advancedย GLYCATIONย end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study
  1702. Relationship of serum advancedย GLYCATIONย end products with deterioration of periodontitis in type 2 diabetes patients
  1703. Purification and characterization of mouse soluble receptor for advancedย GLYCATIONย end products (sRAGE)
  1704. Soluble receptor for advancedย GLYCATIONย end products in patients with decreased renal function
  1705. Plasma levels of soluble receptor for advancedย GLYCATIONย end products and coronary artery disease in nondiabetic men
  1706. Inhibition of advancedย GLYCATIONย end product formation on collagen by rutin and its metabolites
  1707. Receptor for advancedย GLYCATIONย end-products is a marker of type I cell injury in acute lung injury
  1708. Advancedย GLYCATIONย end products in clinical nephrology
  1709. Pseudophosphorylation andย GLYCATIONย of tau protein enhance but do not trigger fibrillization in vitro
  1710. Advancedย GLYCATIONย endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
  1711. Age-related changes in theย GLYCATIONย of human aortic elastin
  1712. RAGE (receptor for advancedย GLYCATIONย end products): a central player in the inflammatory response
  1713. Profound mishandling of proteinย GLYCATIONย degradation products in uremia and dialysis
  1714. Degradation products of proteins damaged byย GLYCATION, oxidation and nitration in clinical type 1 diabetes
  1715. GLYCATIONย of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation
  1716. Assay of advancedย GLYCATIONย endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection
  1717. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advancedย GLYCATIONย end products
  1718. Advancedย GLYCATIONย end products and nephrotoxicity of high-protein diets
  1719. Effect of nonenzymaticย GLYCATIONย on functional and structural properties of hemoglobin
  1720. Skin autofluorescence, a measure of cumulative metabolic stress and advancedย GLYCATIONย end products, predicts mortality in hemodialysis patients
  1721. Advancedย GLYCATIONย End Products in Human Cancer Tissues: Detection of Nฮตโ€(Carboxymethyl)lysine and Argpyrimidine
  1722. Advancedย GLYCATIONย end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process
  1723. Preventing activation of receptor for advancedย GLYCATIONย endproducts in Alzheimerโ€™s disease
  1724. Enzymatic digestion and mass spectrometry in the study of advancedย GLYCATIONย end products/peptides
  1725. Protein-bound advancedย GLYCATIONย endproducts (AGEs) as bioactive amino acid derivatives in foods
  1726. Increased accumulation of skin advancedย GLYCATIONย end-products precedes and correlates with clinical manifestation of diabetic neuropathy
  1727. Fructoseโ€mediated nonโ€enzymaticย GLYCATION: sweet coupling or bad modification
  1728. Decreased plasma levels of soluble receptor for advancedย GLYCATIONย end-products in patients with essential hypertension
  1729. Peptide and amino acidย GLYCATION: new insights into the Maillard reaction
  1730. Advancedย GLYCATIONย endproducts in nondiabetic patients with obstructive sleep apnea
  1731. Oxidative stress, advancedย GLYCATIONย end product, and coronary artery calcification in hemodialysis patients
  1732. Receptor for advancedย GLYCATIONย end products (RAGE) regulates sepsis but not the adaptive immune response
  1733. Hyperglycemia, lipoproteinย GLYCATION, and vascular disease
  1734. Oxidative stress and proteinย GLYCATIONย in diabetes mellitus
  1735. Age-and stage-dependent accumulation of advancedย GLYCATIONย end products in intracellular deposits in normal and Alzheimerโ€™s disease brains
  1736. Receptor for advanced-GLYCATIONย end products: key modulator of myocardial ischemic injury
  1737. Interactions between renin angiotensin system and advancedย GLYCATIONย in the kidney
  1738. Receptor for advancedย GLYCATIONย endโ€products is a marker of type I lung alveolar cells
  1739. Roles of the receptor for advancedย GLYCATIONย endproducts in diabetes-induced vascular injury
  1740. Flavonol glycosides from the leaves of Eucommia ulmoides O. withย GLYCATIONย inhibitory activity
  1741. Tomato paste fraction inhibiting the formation of advancedย GLYCATIONย end-products
  1742. Advancedย GLYCATIONย end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings
  1743. Diabetes increases formation of advancedย GLYCATIONย end products on Sarco (endo) plasmic reticulum Ca2+-ATPase
  1744. The effect of non-enzymaticย GLYCATIONย on the unfolding of human serum albumin
  1745. Advancedย GLYCATIONย end products and vascular structure and function
  1746. Increased levels of serum advancedย GLYCATIONย endโ€products in women with polycystic ovary syndrome
  1747. Thiazolidinediones reduce endothelial expression of receptors for advancedย GLYCATIONย end products
  1748. Measurement of proteinย GLYCATION, glycated peptides, andย GLYCATIONย free adducts
  1749. Characterisation of advancedย GLYCATIONย endproducts in saliva from patients with diabetes mellitus
  1750. Contribution of the advancedย GLYCATIONย end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar โ€ฆ
  1751. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advancedย GLYCATIONย endproducts: an overview of current clinical studies, evidence โ€ฆ
  1752. Non-enzymaticย GLYCATIONย of proteins: a cause for complications in diabetes
  1753. Receptor for advancedย GLYCATIONย end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
  1754. Advancedย GLYCATIONย end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways
  1755. Advancedย GLYCATIONย end products activate Smad signaling via TGFโ€ฮฒโ€dependent andโ€independent mechanisms: implications for diabetic renal and vascular disease
  1756. Role of receptor for advancedย GLYCATIONย end-products and signalling events in advancedย GLYCATIONย end-product-induced monocyte chemoattractant protein-1 โ€ฆ
  1757. Enhanced expression of receptor for advancedย GLYCATIONย end products in chronic kidney disease
  1758. Articular chondrocytes express the receptor for advancedย GLYCATIONย end products: potential role in osteoarthritis
  1759. Mass spectrometry for the study of proteinย GLYCATIONย in disease
  1760. Accumulation of advancedย GLYCATIONย end products, measured as skin autofluorescence, in renal disease
  1761. Receptor for advancedย GLYCATIONย end products is involved in impaired angiogenic response in diabetes
  1762. The receptor for advancedย GLYCATIONย end products and its ligands: a new inflammatory pathway in lung disease?
  1763. The expression of advancedย GLYCATIONย endproduct receptors in rpe cells associated with basal deposits in human maculas
  1764. GLYCATIONย and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control โ€ฆ
  1765. Circulating levels of soluble receptor for advancedย GLYCATIONย end products in Alzheimer disease and vascular dementia
  1766. Stimulation of glucose utilization and inhibition of proteinย GLYCATIONย and AGE products by taurine
  1767. Decreased endogenous secretory advancedย GLYCATIONย end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications
  1768. GLYCATIONย of lysineโ€containing dipeptides
  1769. Receptor for advancedย GLYCATIONย end products and its ligands: a journey from the complications of diabetes to its pathogenesis
  1770. Advancedย GLYCATIONย end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor
  1771. Increased methylglyoxal and advancedย GLYCATIONย end products in kidney from spontaneously hypertensive rats
  1772. Advancedย GLYCATIONย end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages
  1773. Advancedย GLYCATIONย endproducts in peripheral nerve in type 2 diabetes with neuropathy
  1774. Expression profiling of endogenous secretory receptor for advancedย GLYCATIONย end products in human organs
  1775. The role of mass spectrometry in the study of nonโ€enzymatic proteinย GLYCATIONย in diabetes: An update
  1776. Modulation of soluble receptor for advancedย GLYCATIONย end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
  1777. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advancedย GLYCATIONย end products
  1778. S100P stimulates cell proliferation and survival via receptor for activatedย GLYCATIONย end products (RAGE)
  1779. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advancedย GLYCATIONย end products
  1780. Receptor for advancedย GLYCATIONย end products and age-related macular degeneration
  1781. Reduced cell replication and induction of apoptosis by advancedย GLYCATIONย end products in rat Schwann cells
  1782. Advancedย GLYCATIONย endโ€products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
  1783. Cross-linking in collagen by nonenzymaticย GLYCATIONย increases the matrix stiffness in rabbit achilles tendon
  1784. Connective tissue growth factor plays an important role in advancedย GLYCATIONย end productโ€“induced tubular epithelial-to-mesenchymal transition: implications for โ€ฆ
  1785. Evaluation of advancedย GLYCATIONย end products and carbonyl compounds in patients with different conditions of oxidative stress
  1786. Benfotiamine prevents macro-and microvascular endothelial dysfunction and oxidative stress following a meal rich in advancedย GLYCATIONย end products in individuals โ€ฆ
  1787. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advancedย GLYCATIONย endproducts and protein modification
  1788. Advancedย GLYCATIONย end-products in patients with chronic alcohol misuse
  1789. Role of collagen enzymatic andย GLYCATIONย induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats
  1790. Circulating soluble receptor for advancedย GLYCATIONย end products is inversely associated with glycemic control and S100A12 protein
  1791. Decreased levels of soluble receptor for advancedย GLYCATIONย end products in patients with rheumatoid arthritis indicating deficient inflammatory control
  1792. Argpyrimidine, a methylglyoxal-derived advancedย GLYCATIONย end-product in familial amyloidotic polyneuropathy
  1793. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation andย GLYCATION
  1794. GLYCATIONย stimulates amyloid formation
  1795. Down-regulation of the receptor for advancedย GLYCATIONย end-products (RAGE) supports non-small cell lung carcinoma
  1796. Advancedย GLYCATIONย end product precursors impair ABCA1-dependent cholesterol removal from cells
  1797. Glyceraldehyde-derived advancedย GLYCATIONย end products in Alzheimerโ€™s disease
  1798. Effect of advancedย GLYCATIONย end-products on gene expression and synthesis of TNF-ฮฑ and endothelial nitric oxide synthase by endothelial cells
  1799. GLYCATION, ageing and carnosine: are carnivorous diets beneficial?
  1800. Soluble levels of receptor for advancedย GLYCATIONย endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?
  1801. Effect of lipid peroxides and antioxidants onย GLYCATIONย of hemoglobin: an in vitro study on human erythrocytes
  1802. Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advancedย GLYCATIONย end products
  1803. Expression of receptor for advancedย GLYCATIONย end products and HMGB1/amphoterin in colorectal adenomas
  1804. Effect of advancedย GLYCATIONย end products on accelerated apoptosis of retinal capillary cells under in vitro conditions
  1805. GLYCATIONย increases human annulus fibrosus stiffness in both experimental measurements and theoretical predictions
  1806. Evidence for independent heritability of theย GLYCATIONย gap (glycosylation gap) fraction of HbA1c in nondiabetic twins
  1807. Trabecular microfracture and the influence of pyridinium and non-enzymaticย GLYCATION-mediated collagen cross-links
  1808. Advancedย GLYCATIONย end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway
  1809. GLYCATIONย inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes
  1810. A novel advancedย GLYCATIONย index and its association with diabetes and microangiopathy
  1811. Improvement of functional properties of whey protein isolate throughย GLYCATIONย and phosphorylation by dry heating
  1812. Positive association of serum levels of advancedย GLYCATIONย end products with thrombogenic markers in humans
  1813. Extracellularย GLYCATIONย crosslinks: prospects for removal
  1814. Impaired retinal angiogenesis in diabetes: role of advancedย GLYCATIONย end products and galectin-3
  1815. Effects of oxidative modifications induced by theย GLYCATIONย of bovine serum albumin on its structure and on cultured adipose cells
  1816. Proteinย GLYCATION, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimerโ€™s disease and link to cognitive impairment
  1817. Advancedย GLYCATIONย endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
  1818. Possible participation of advancedย GLYCATIONย end products in the pathogenesis of colorectal cancer in diabetic patients
  1819. Expression of the receptor of advancedย GLYCATIONย end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing โ€ฆ
  1820. Impact of Maillard typeย GLYCATIONย on properties of beta-lactoglobulin
  1821. Advancedย GLYCATIONย end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor ฮฒ-independent โ€ฆ
  1822. Naphthopyrone glucosides from the seeds of Cassia tora with inhibitory activity on advancedย GLYCATIONย end products (AGEs) formation
  1823. Analysis of proteinย GLYCATIONย products by MALDIโ€TOF/MS
  1824. Reductions in degree of mineralization and enzymatic collagen cross-links and increases inย GLYCATION-induced pentosidine in the femoral neck cortex in cases of โ€ฆ
  1825. GLYCATIONย free adduct accumulation in renal disease: the new AGE
  1826. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advancedย GLYCATIONย end-products
  1827. Elevated serum levels of N ฮต-carboxymethyl-lysine, an advancedย GLYCATIONย end product, are associated with proliferative diabetic retinopathy and macular โ€ฆ
  1828. Blockade of receptor for advancedย GLYCATIONย end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
  1829. Characterization of advancedย GLYCATIONย end products: mass changes in correlation to side chain modifications
  1830. Advanced-GLYCATIONย end products in insulin-resistant states
  1831. Clinical studies of advancedย GLYCATIONย end product inhibitors and diabetic kidney disease
  1832. Increased serum concentrations of soluble receptor for advancedย GLYCATIONย endproducts in patients with type 1 diabetes
  1833. High serum levels of advancedย GLYCATIONย end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a โ€ฆ
  1834. Expression of receptor for advancedย GLYCATIONย end products (RAGE) and MMP-9 in human pancreatic cancer cells.
  1835. Advancedย GLYCATIONย endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response
  1836. Accumulation of advancedย GLYCATIONย end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress
  1837. Increased serum levels of the specific advancedย GLYCATIONย end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 โ€ฆ
  1838. Ascorbic acid,ย GLYCATION, glycohemoglobin and aging
  1839. Activation of receptor for advancedย GLYCATIONย end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes
  1840. Type IV collagen is transcriptionally regulated by Smad1 under advancedย GLYCATIONย end product (AGE) stimulation
  1841. Key role of Src kinase in S100B-induced activation of the receptor for advancedย GLYCATIONย end products in vascular smooth muscle cells
  1842. Inhibitory effect of some selected nutraceutic herbs on LDLย GLYCATIONย induced by glucose and glyoxal
  1843. Pigment epithelium-derived factor inhibits advancedย GLYCATIONย end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated โ€ฆ
  1844. Soluble receptor for advancedย GLYCATIONย end products triggers a proinflammatory cytokine cascade via ฮฒ2 integrin Macโ€1
  1845. Advancedย GLYCATIONย end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes
  1846. Protection againstย GLYCATIONย and similar post-translational modifications of proteins
  1847. High levels of soluble receptor for advancedย GLYCATIONย end products may be a marker of extreme longevity in humans
  1848. High levels of dietary advancedย GLYCATIONย end products transform low-dersity lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in โ€ฆ
  1849. Protein and low molecular mass thiols as targets and inhibitors ofย GLYCATIONย reactions
  1850. Effect of buformin and metformin on formation of advancedย GLYCATIONย end products by methylglyoxal
  1851. Receptor for advancedย GLYCATIONย end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine
  1852. Inhibition of human endothelial cell nitric oxide synthesis by advancedย GLYCATIONย end-products but not glucose: relevance to diabetes
  1853. Effect of advancedย GLYCATIONย end-products on cell proliferation and cell death
  1854. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advancedย GLYCATIONย end product cross-link breaker ALT-711 via a protein kinase C-ฮฑ โ€ฆ
  1855. Rapid method for the preparation of an AGEโ€BSA standard calibrator using thermalย GLYCATION
  1856. โ€ฆย GLYCATIONย end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advancedย GLYCATIONย โ€ฆ
  1857. Diabรจte sucrรฉ, stress oxydant et produits deย GLYCATIONย avancรฉe
  1858. A comparison of the glycosylation gap and hemoglobinย GLYCATIONย index in patients with diabetes
  1859. Below the Radar: Advancedย GLYCATIONย End Products that Detour โ€œaround the sideโ€: Is HbA1c not an accurate enough predictor of long term progression and โ€ฆ
  1860. The advancedย GLYCATIONย end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis
  1861. Yeast proteinย GLYCATIONย inโ€ƒvivo by methylglyoxal: Molecular modification of glycolytic enzymes and heat shock proteins
  1862. Serum levels of advancedย GLYCATIONย end products are associated with in-stent restenosis in diabetic patients
  1863. Association of expression of receptor for advancedย GLYCATIONย end products and invasive activity of oral squamous cell carcinoma
  1864. Relationship between the expression of advancedย GLYCATIONย end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy
  1865. Increased proteinย GLYCATIONย in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
  1866. Advancedย GLYCATIONย End Products Activate a Chymase-Dependent Angiotensin IIโ€“Generating Pathway in Diabetic Complications
  1867. GLYCATIONย and advancedย GLYCATIONย end-products in laboratory experiments in vivo and in vitro
  1868. Advancedย GLYCATIONย end products and oxidative stress are increased in chronic allograft nephropathy
  1869. Advancedย GLYCATIONย end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes
  1870. Atorvastatin decreases serum levels of advancedย GLYCATIONย end products (AGEs) in patients with type 2 diabetes
  1871. Autofluorescence characterization of advancedย GLYCATIONย end products of hemoglobin
  1872. Candesartan reduced advancedย GLYCATIONย end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice
  1873. From benefit to damage. Glutamate and advancedย GLYCATIONย end products in Alzheimer brain
  1874. Expression of a novel secreted splice variant of the receptor for advancedย GLYCATIONย end products (RAGE) in human brain astrocytes and peripheral blood โ€ฆ
  1875. Advancedย GLYCATIONย End Products in Diabetesโ€Associated Atherosclerosis and Renal Disease: Interventional Studies
  1876. Increased pentosidine, an advancedย GLYCATIONย end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric โ€ฆ
  1877. Increased expression of receptor for advancedย GLYCATIONย end products by synovial tissue macrophages in rheumatoid arthritis
  1878. Constituents of the roots of Pueraria lobata inhibit formation of advancedย GLYCATIONย end products (AGEs)
  1879. The role of reactive oxygen species in TNFฮฑ-dependent expression of the receptor for advancedย GLYCATIONย end products in human umbilical vein endothelial โ€ฆ
  1880. Are food advancedย GLYCATIONย end products toxic in biological systems?
  1881. Effects of sterilization, packaging, and storage on vitamin C degradation, protein denaturation, andย GLYCATIONย in fortified milks
  1882. Processing of proteinย GLYCATION, oxidation and nitrosation adducts in the liver and the effect of cirrhosis
  1883. Synergistic action of advancedย GLYCATIONย end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic โ€ฆ
  1884. Pathological roles of advancedย GLYCATIONย end product receptors SRโ€A and CD36
  1885. Elevation of Nฮต-(carboxymethyl) lysine-modified advancedย GLYCATIONย end products in chronic liver disease is an indicator of liver cirrhosis
  1886. Increased proteinย GLYCATIONย in fructosamine 3-kinase-deficient mice
  1887. Decreased levels of advancedย GLYCATIONย end-products in patients with Gilbert syndrome.
  1888. The role of advancedย GLYCATIONย in reduced organic cation transport associated with experimental diabetes
  1889. Puerariafuran, a new inhibitor of advancedย GLYCATIONย end products (AGEs) isolated from the roots of Pueraria lobata
  1890. Genotoxicity of advancedย GLYCATIONย end products: involvement of oxidative stress and of angiotensin II type 1 receptors
  1891. Proteinย GLYCATIONย in Saccharomyces cerevisiae Argpyrimidine formation and methylglyoxal catabolism
  1892. Advancedย GLYCATIONย end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts
  1893. Advancedย GLYCATIONย end products can induce glial reaction and neuronal degeneration in retinal explants
  1894. Advancedย GLYCATIONย end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy
  1895. GLYCATION, glycoxidation and diabetes mellitus
  1896. S100 protein translocation in response to extracellular S100 is mediated by receptor for advancedย GLYCATIONย endproducts in human endothelial cells
  1897. Advancedย GLYCATIONย end products increase collagen-specific chaperone protein in mouse diabetic nephropathy
  1898. Advancedย GLYCATIONย end-products and peritoneal sclerosis
  1899. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advancedย GLYCATIONย end-product, tissue factor and TNF-ฮฑ
  1900. Significance of proximal tubular metabolism of advancedย GLYCATIONย end products in kidney diseases
  1901. Advancedย GLYCATIONย endโ€products in sickle cell anaemia
  1902. Carnosine protects against the inactivation of esterase induced byย GLYCATIONย and a steroid
  1903. Role of vitamin E-coated membrane in reducing advancedย GLYCATIONย end products in hemodialysis patients: a pilot study
  1904. Site specificity ofย GLYCATIONย and carboxymethylation of bovine serum albumin by fructose
  1905. Identification of the receptor for advancedย GLYCATIONย end products in synovial tissue of patients with rheumatoid arthritis
  1906. Bimodal effect of advancedย GLYCATIONย end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids
  1907. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advancedย GLYCATIONย end products
  1908. Increased expression of advancedย GLYCATIONย end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats
  1909. An in Vitro Approach to the Chronological Aging of Skin byย GLYCATIONย of the Collagen: The Biological Effect ofย GLYCATIONย on the Reconstructed Skin Model
  1910. The advancedย GLYCATIONย end product Nฮต-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney โ€ฆ
  1911. GLYCATIONย of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells
  1912. Increased proteinย GLYCATIONย in cirrhosis and therapeutic strategies to prevent it
  1913. Lipoic acid improves glucose utilisation and prevents proteinย GLYCATIONย and AGE formation
  1914. Blockade of the receptor for advancedย GLYCATIONย end products attenuates acetaminophenโ€induced hepatotoxicity in mice
  1915. Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advancedย GLYCATIONย end-products in renal transplant โ€ฆ
  1916. Advancedย GLYCATIONย endโ€products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factorโ€induced ICAMโ€1 expression โ€ฆ
  1917. Advancedย GLYCATIONย end products modulate the maturation and function of peripheral blood dendritic cells
  1918. Highโ€fat diet enhances visceral advancedย GLYCATIONย end products, nuclear Oโ€Glcโ€Nac modification, p38 mitogenโ€activated protein kinase activation and apoptosis
  1919. Identification of mouse orthologue of endogenous secretory receptor for advancedย GLYCATIONย end-products: structure, function and expression
  1920. Nonenzymaticย GLYCATIONย of DNA nucleosides with reducing sugars
  1921. Angiotensin II augments advancedย GLYCATIONย end product-induced pericyte apoptosis through RAGE overexpression
  1922. Solidโ€stateย GLYCATIONย of ฮฒโ€lactoglobulin by lactose and galactose: localization of the modified amino acids using mass spectrometric techniques
  1923. Suppression of nNOS expression in rat enteric neurones by the receptor for advancedย GLYCATIONย endโ€products
  1924. Aminophospholipidย GLYCATIONย and its inhibitor screening system: a new role of pyridoxal 5โ€ฒ-phosphate as the inhibitor
  1925. Evidence for inactivation of cysteine proteases by reactive carbonyls viaย GLYCATIONย of active site thiols
  1926. A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advancedย GLYCATIONย end-products
  1927. Depression of progenitor cell function by advancedย GLYCATIONย endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes
  1928. Pigment epithelium-derived factor (PEDF) prevents diabetes-or advancedย GLYCATIONย end products (AGE)-elicited retinal leukostasis
  1929. Differential effects of โ€œadvancedย GLYCATIONย endproductsโ€ and ฮฒ-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y
  1930. Concentrations of pentosidine, an advancedย GLYCATIONย end-product, in umbilical cord blood
  1931. Polymorphisms of the receptor of advancedย GLYCATIONย endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients
  1932. Telmisartan inhibits expression of a receptor for advancedย GLYCATIONย end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of โ€ฆ
  1933. Effect of limited solid-stateย GLYCATIONย on the conformation of lysozyme by ESI-MSMS peptide mapping and molecular modeling
  1934. Advancedย GLYCATIONย endproducts: implications for accelerated atherosclerosis in diabetes
  1935. Two immunochemical assays to measure advancedย GLYCATIONย end-products in serum from dialysis patients
  1936. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advancedย GLYCATIONย end products by โ€ฆ
  1937. Hepatocyte growth factor protects human endothelial cells against advancedย GLYCATIONย end products-induced apoposis
  1938. Chemoselective synthesis of peptides containing major advancedย GLYCATIONย endโ€products of lysine and arginine
  1939. In vitroย GLYCATIONย of human immunoglobulin G
  1940. Lowโ€Molecular Weight Advancedย GLYCATIONย End Products: Markers of Tissue AGE Accumulation and More?
  1941. Evaluation of the site specific proteinย GLYCATIONย and antioxidant capacity of rare sugarโˆ’ protein/peptide conjugates
  1942. Antioxidants and an inhibitor of advancedย GLYCATIONย ameliorate death of retinal microvascular cells in diabetic retinopathy
  1943. Characterisation of the advancedย GLYCATIONย endproduct receptor complex in the retinal pigment epithelium
  1944. Effect of advancedย GLYCATIONย end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells.
  1945. Receptor for advancedย GLYCATIONย end products is a promising target of diabetic nephropathy
  1946. Inhibition by L-arginine and spermidine of hemoglobinย GLYCATIONย and lipid peroxidation in rats with induced diabetes
  1947. C-Reactive protein upregulates receptor for advancedย GLYCATIONย end products expression in human endothelial cells
  1948. Gender-related differences in advancedย GLYCATIONย endproducts, oxidative stress markers and nitric oxide synthases in rats
  1949. Green tea impedes dyslipidemia, lipid peroxidation, proteinย GLYCATIONย and ameliorates Ca2+-ATPase and Na+/K+-ATPase activity in the heart of streptozotocin โ€ฆ
  1950. The effects of valsartan on the accumulation of circulating and renal advancedย GLYCATIONย end products in experimental diabetes
  1951. Expression of the receptor for advancedย GLYCATIONย end products in Huntingtonโ€™s disease caudate nucleus
  1952. Advancedย GLYCATIONย end product in diabetic rat skeletal muscle in vivo
  1953. Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advancedย GLYCATIONย end-products
  1954. Advancedย GLYCATIONย end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction
  1955. Low molecular weight advancedย GLYCATIONย end products predict mortality in asymptomatic patients receiving chronic haemodialysis
  1956. Intrinsic toxicity of glucose, due to non-enzymaticย GLYCATION, is controlled in-vivo by deGLYCATIONย systems including: FN3K-mediated deGLYCATIONย of fructosamines and โ€ฆ
  1957. Substrates modified by advancedย GLYCATIONย end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet โ€ฆ
  1958. The amphoterin (HMGB1)/receptor for advancedย GLYCATIONย end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and โ€ฆ
  1959. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advancedย GLYCATIONย end products (AGEs) may be a promising biomarker for early detection of โ€ฆ
  1960. Tissueโ€Specific Variation inย GLYCATIONย of Proteins in Diabetes: Evidence for a Functional Role of Amadoriase Enzymes
  1961. Advancedย GLYCATIONย end-products (AGEs) in hyperglycemic patients
  1962. Highโ€dose thiamine therapy counters dyslipidemia and advancedย GLYCATIONย of plasma protein in streptozotocinโ€induced diabetic rats
  1963. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advancedย GLYCATIONย end products links oxidative stress to altered retinal โ€ฆ
  1964. Analysis of proteinย GLYCATIONย products by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
  1965. The breakdown of preformed advancedย GLYCATIONย end products reverses erectile dysfunction in streptozotocinโ€induced diabetic rats: Preventive versus curative โ€ฆ
  1966. Immunohistochemical localization of advancedย GLYCATIONย end products in pinguecula
  1967. Relation between development of nephropathy and the p22phox C242T and receptor for advancedย GLYCATIONย end product G1704T gene polymorphisms in type 2 โ€ฆ
  1968. Nifedipine inhibits gene expression of receptor for advancedย GLYCATIONย end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
  1969. Regulation of inducible nitric oxide synthase expression in advancedย GLYCATIONย end productโ€“stimulated RAW 264.7 cells: the role of heme oxygenase-1 and โ€ฆ
  1970. Changes inย GLYCATIONย and oxidation markers in patients starting peritoneal dialysis: a pilot study
  1971. Advancedย GLYCATIONย End Products/Peptides: An in Vivo Investigation
  1972. GLYCATION-induced inactivation of NADP+-dependent isocitrate dehydrogenase: implications for diabetes and aging
  1973. Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advancedย GLYCATIONย end products formation
  1974. Susceptibility of brain microvascular endothelial cells to advancedย GLYCATIONย end products-induced tissue factor upregulation is associated with intracellular reactive โ€ฆ
  1975. Advancedย GLYCATIONย end product free adducts are cleared by dialysis
  1976. Genomic damage in end-stage renal failure: potential involvement of advancedย GLYCATIONย end products and carbonyl stress
  1977. Receptor for advancedย GLYCATIONย endproduct (RAGE)โ€“mediated nuclear factorโ€ฮบB activation in vasculitic neuropathy
  1978. Peroxisome proliferator-activated receptor ฮณ down-regulates receptor for advancedย GLYCATIONย end products and inhibits smooth muscle cell proliferation in a diabetic โ€ฆ
  1979. Therapeutic effect of green tea extract on advancedย GLYCATIONย and crossโ€linking of collagen in the aorta of streptozotocin diabetic rats
  1980. Bridging advancedย GLYCATIONย end product, receptor for advancedย GLYCATIONย end product and nitric oxide with hormonal replacement/estrogen therapy in โ€ฆ
  1981. The advancedย GLYCATIONย end-product Nษ›-(carboxymethyl) lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
  1982. C16, a novel advancedย GLYCATIONย endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats1
  1983. Differential expression of receptors for advancedย GLYCATIONย endโ€products in peritoneal mesothelial cells exposed to glucose degradation products
  1984. Expression and purification of recombinant human receptor for advancedย GLYCATIONย endproducts in Escherichia coli
  1985. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advancedย GLYCATIONย end products
  1986. Advancedย GLYCATIONย end products and hyperglycaemia
  1987. Advancedย GLYCATIONย and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy
  1988. Theโˆ’ 374A allele of the receptor for advancedย GLYCATIONย end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with โ€ฆ
  1989. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advancedย GLYCATIONย end products in endothelial cells
  1990. Hydrazine compounds inhibitย GLYCATIONย of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low โ€ฆ
  1991. Conversion of arginine into ornithine by advancedย GLYCATIONย in senescent human collagen and lens crystallins
  1992. GLYCATIONย of CD59 impairs complement regulation on erythrocytes from diabetic subjects
  1993. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advancedย GLYCATIONย end products
  1994. Identification of monoclonal antibody of advancedย GLYCATIONย end products
  1995. Receptor for advancedย GLYCATIONย end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing
  1996. Hepatic clearance of advancedย GLYCATIONย end products (AGEs)โ€”myth or truth?
  1997. Blockade of angiotensin II receptors reduces the expression of receptors for advancedย GLYCATIONย end products in human endothelial cells
  1998. In Vitro Nonenzymaticย GLYCATIONย Enhances the Role of Myoglobin as a Source of Oxidative Stress
  1999. Clinical implications of Nฮตโ€(carboxymethyl)lysine, advancedย GLYCATIONย end product, in children and adolescents with type 1 diabetes
  2000. Collagenย GLYCATIONย and its role in fracture properties of bone
  2001. GLYCATIONย of Proteins in Escherichia Coli: Effect of Nutrient Broth Ingredients onย GLYCATION
  2002. Induction of reactive oxygen species and cell survival in the presence of advancedย GLYCATIONย end products and similar structures
  2003. Renal accumulation and clearance of advancedย GLYCATIONย end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and โ€ฆ
  2004. Therapeutic potentials of unicellular green alga Chlorella in advancedย GLYCATIONย end product (AGE)-related disorders
  2005. A comparative study of lens proteinย GLYCATIONย in various forms of cataract
  2006. Advancedย GLYCATIONย end product (age) inhibitors and their therapeutic implications in diseases.
  2007. โ€ฆ and reduced viability of Alzheimerโ€™s disease neuronal cybrids is reproduced by ฮฒ-amyloid peptide acting through receptor for advancedย GLYCATIONย end products (RAGE โ€ฆ
  2008. Amino acids injure mesangial cells by advancedย GLYCATIONย end products, oxidative stress, and protein kinase C
  2009. Effects of in Vitroย GLYCATIONย on Fe3+ Binding and Fe3+ Isoforms of Transferrin
  2010. Immunochemical crossreactivity of antibodies specific for โ€œadvancedย GLYCATIONย endproductsโ€ with โ€œadvanced lipoxidation endproductsโ€
  2011. Effect of phosphate buffer on the kinetics ofย GLYCATIONย of proteins
  2012. Study on the effect of garlic on the in vitro albuminย GLYCATIONย reaction
  2013. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advancedย GLYCATIONย end products
  2014. Advancedย GLYCATIONย and oxidation products in patients with atherosclerosis
  2015. GLYCATIONย of caseinate by fructose and fructoโ€oligosaccharides during controlled heat treatment in the โ€˜dryโ€™state
  2016. Skin autofluorescence, a marker of advancedย GLYCATIONย end products and oxidative stress, is increased in recently preeclamptic women
  2017. Effects of advancedย GLYCATIONย end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy
  2018. Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation andย GLYCATIONย in Japanese type 2 diabetic subjects: blood pressure-independent effect of โ€ฆ
  2019. Exploring the antioxidant property of bioflavonoid quercetin in preventing DNAย GLYCATION: A calorimetric and spectroscopic study
  2020. An oral load of the earlyย GLYCATIONย compound lactuloselysine fails to accumulate in the serum of uraemic patients
  2021. Expression and purification of the soluble isoform of human receptor for advancedย GLYCATIONย end products (sRAGE) from Pichia pastoris
  2022. Effect of nitric oxide-cGMP-dependent protein kinase activation on advancedย GLYCATIONย end-productโ€“induced proliferation in renal fibroblasts
  2023. Differential effect of estrogen receptor alpha and beta agonists on the receptor for advancedย GLYCATIONย end product expression in human microvascular โ€ฆ
  2024. Signalling pathways involved in retinal endothelial cell proliferation induced by advancedย GLYCATIONย end products: inhibitory effect of gliclazide
  2025. Dietary bread crust advancedย GLYCATIONย end products bind to the receptor for AGEs in HEKโ€293 kidney cells but are rapidly excreted after oral administration to healthy โ€ฆ
  2026. Developmental expression of receptor for advancedย GLYCATIONย end products (RAGE), amphoterin and sulfoglucuronyl (HNKโ€1) carbohydrate in mouse cerebellum and โ€ฆ
  2027. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advancedย GLYCATIONย โ€ฆ
  2028. Advancedย GLYCATIONย end-product induces fractalkine gene upregulation in normal rat glomeruli
  2029. N-Terminal pyrazinones: a new class of peptide-bound advancedย GLYCATIONย end-products
  2030. Rheumatoid arthritis: links with cardiovascular disease and the receptor for advancedย GLYCATIONย end products
  2031. Nonenzymaticย GLYCATIONย at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies
  2032. Advancedย GLYCATIONย end-products downregulating intervertebral disc cell production of proteoglycans in vitro
  2033. Effect ofย GLYCATIONย of hemoglobin on its interaction with trifluoperazine
  2034. Advancedย GLYCATIONย end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous โ€ฆ
  2035. Oxidative stress and proteinย GLYCATIONย in patients with chronic obstructive pulmonary disease
  2036. Evidence for the role of lipid peroxides onย GLYCATIONย of hemoglobin and plasma proteins in non-diabetic asthma patients
  2037. Advancedย GLYCATIONย end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36
  2038. a-Series gangliosides mediate the effects of advancedย GLYCATIONย end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal โ€ฆ
  2039. Effect of high-dose thiamine and pyridoxine on advancedย GLYCATIONย end products and other oxidative stress markers in hemodialysis patients: a randomized placebo โ€ฆ
  2040. Advancedย GLYCATIONย endโ€productโ€induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRKโ€49F cells
  2041. Diabetes mellitus exacerbates advancedย GLYCATIONย end product accumulation in the veins of end-stage renal failure patients
  2042. Pentoxyphylline and propentophylline are inhibitors of TNF-ฮฑ release in monocytes activated by advancedย GLYCATIONย endproducts
  2043. Pigment epithelium-derived factor (PEDF) inhibits advancedย GLYCATIONย end product (AGE)-induced C-reactive protein expression in hepatoma cells by โ€ฆ
  2044. Age-dependent expression of advancedย GLYCATIONย end product receptor genes in the human heart
  2045. Age-related loss in bone toughness is explained by non-enzymaticย GLYCATIONย of collagen
  2046. In vitro nonenzymaticย GLYCATIONย of DNA nucleobases: an evaluation of advancedย GLYCATIONย end products under alkaline pH
  2047. Redox-related cytotoxic responses to different caseinย GLYCATIONย products in Caco-2 and Int-407 cells
  2048. Reassessing the increasedย GLYCATIONย of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides
  2049. Leptin and connective tissue growth factor in advancedย GLYCATIONย endโ€productโ€induced effects in NRKโ€49F cells
  2050. GLYCATION-induced inactivation of antioxidant enzymes and modulation of cellular redox status in lens cells
  2051. Urinary excretion of advancedย GLYCATIONย endproducts in patients with type 2 diabetes and various stages of proteinuria
  2052. Advancedย GLYCATIONย end products induce death of retinal neurons via activation of nitric oxide synthase
  2053. Oxidative stress and non-enzymaticย GLYCATIONย in IgA nephropathy.
  2054. A novel method to quantify in vivo transferrinย GLYCATION: applications in diabetes mellitus
  2055. โ€ฆ inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advancedย GLYCATIONย end products (RAGE)
  2056. The effect of non-enzymaticย GLYCATIONย of extracellular matrix proteins on axonal regeneration in vitro
  2057. Effect ofย GLYCATIONย on stability and kinetic parameters of thermostable glucoamylase from Aspergillus niger
  2058. Nuclear factor-ฮบB and advancedย GLYCATIONย end-products expression in lacrimal glands of aging rats
  2059. Advancedย GLYCATIONย end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells THIS ARTICLE HAS BEEN RETRACTED
  2060. Minodronate, a nitrogen-containing bisphosphonate, inhibits advancedย GLYCATIONย end product-induced vascular cell adhesion molecule-1 expression in endothelial โ€ฆ
  2061. Nitrite-modified extracellular matrix proteins deleteriously affect retinal pigment epithelial cell function and viability: a comparison study with nonenzymaticย GLYCATIONย โ€ฆ
  2062. Glucose metabolism, advancedย GLYCATIONย endproducts, and cognition
  2063. Cytotoxicity of acetaldehydeโ€derived advancedย GLYCATIONย endโ€products (AAโ€AGE) in alcoholicโ€induced neuronal degeneration
  2064. Mechanism of advancedย GLYCATIONย end products-induced hyperpermeability in endothelial cells
  2065. Advancedย GLYCATIONย end product is implicated in amyloidโ€related kidney complications
  2066. Effect of buffer carbonate and arsenate on the kinetics ofย GLYCATIONย of human hemoglobin
  2067. ฮต-GLYCATION, APP and Aฮฒ in ageing and Alzheimer disease: a hypothesis
  2068. Polyclonal antibodies inhibit theย GLYCATIONโ€induced inactivation of bovine Cu, Znโ€superoxide dismutase
  2069. Apoptotic killing of fibroblasts by matrix-bound advancedย GLYCATIONย endproducts
  2070. Detection of DNAโ€bound advancedย GLYCATIONย endโ€products by immunoaffinity chromatography coupled to HPLCโ€diode array detection
  2071. Screening of Korea Traditional Herbal Medicines with Inhibitory Activity on Advancedย GLYCATIONย End Products (AGEs) Formation
  2072. N2-carboxyethyl-2โ€ฒ-deoxyguanosine, a DNAย GLYCATIONย marker, in kidneys and aortas of diabetic and uremic patients
  2073. GLYCATIONย of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation: Part III: Application of proteomic analysis to the manufacture of โ€ฆ
  2074. Influence of hemodialysis membrane permeability on serum levels of advancedย GLYCATIONย end products (AGEs) and homocysteine metabolites.
  2075. Monitoring the effect of glucosamine and glyceraldehydeย GLYCATIONย on the secondary structure of human serum albumin and immunoglobulin G: An analysis based on โ€ฆ
  2076. Renoprotective and Lipidโ€Lowering Effects of LR Compounds, Novel Advancedย GLYCATIONย End Product Inhibitors, in Streptozotocinโ€Induced Diabetic Rats
  2077. Can advancedย GLYCATIONย end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
  2078. Advancedย GLYCATIONย end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation โ€ฆ
  2079. Interaction between the polyol pathway and non-enzymaticย GLYCATIONย on mesangial cell gene expression
  2080. Cardiovascular risk in patients with end-stage renal disease: a potential role for advancedย GLYCATIONย end products
  2081. Chemistry and Biological Effects of Melanoidins and Glyceraldehydeโ€Derived Pyridinium as Advancedย GLYCATIONย End Products
  2082. Compounds that combine aldose reductase inhibitory activity and ability to prevent theย GLYCATIONย (glucation and/or fructation) of proteins as putative โ€ฆ
  2083. The roles of proteinย GLYCATION, glycoxidation, and advancedย GLYCATIONย end-product formation in diabetes-induced atherosclerosis
  2084. Inhibitory effects of amlodipine and fluvastatin on the deposition of advancedย GLYCATIONย end products in aortic wall of cholesterol and fructose-fed rabbits
  2085. Overexpression of receptor of advancedย GLYCATIONย end products hypersensitizes cells for amyloid beta peptide-induced cell death
  2086. Insulin resistance and enhanced proteinย GLYCATIONย in men with prehypertension
  2087. Pentosidine, an advancedย GLYCATIONย endproduct, and arthritis
  2088. Advancedย GLYCATIONย end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression
  2089. Flavonols from Houttuynia cordata with proteinย GLYCATIONย and aldose reductase inhibitory activity
  2090. Interaction between the polyol pathway and non-enzymaticย GLYCATIONย on aortic smooth muscle cell migration and monocyte adhesion
  2091. In vitroย GLYCATIONย of human IgG and its effect on interaction with anti-IgG
  2092. Meniscal material properties are minimally affected by matrix stabilization using glutaraldehyde andย GLYCATIONย with ribose
  2093. Immunolocalization of lipid peroxidation/advancedย GLYCATIONย end products in amyloid A amyloidosis
  2094. A matrixโ€assisted laser desorption/ionization mass spectrometry study of the nonโ€enzymaticย GLYCATIONย products of human globins in diabetes
  2095. Association of advancedย GLYCATIONย end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor โ€ฆ
  2096. Nonโ€enzymatic modelย GLYCATIONย reactionsโ€”a comprehensive study of the reactivity of a modified arginine with aldehydic and diketonic dicarbonyl compounds by โ€ฆ
  2097. The effect of packed red blood cell storage on arachidonic acid and advancedย GLYCATIONย end-product formation
  2098. Impact of in vivoย GLYCATIONย of LDL on platelet aggregation and monocyte chemotaxis in diabetic Psammomys obesus
  2099. The effect ofย GLYCATIONย on the chemical and enzymatic stability of the endogenous opioid peptide, leucineโ€“enkephalin, and related fragments
  2100. Advancedย GLYCATIONย end products: a possible link to angiotensin in an animal model
  2101. Advancedย GLYCATIONย endproduct modified basement membrane attenuates endothelin-1 induced [Ca 2+] i signalling and contraction in retinal microvascular โ€ฆ
  2102. Advancedย GLYCATIONย end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature
  2103. Immunological consequences of methamphetamine proteinย GLYCATION
  2104. Advancedย GLYCATIONย end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner
  2105. Advancedย GLYCATION: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy
  2106. The complexity of non-enzymaticย GLYCATIONย product sets of human globins
  2107. Inhibition by advancedย GLYCATIONย end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
  2108. Glyceraldehyde-derived advancedย GLYCATIONย end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes
  2109. Increased expression of tissue factor and receptor for advancedย GLYCATIONย end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus โ€ฆ
  2110. Detection of dideoxyosone intermediates ofย GLYCATIONย using a monoclonal antibody: characterization of major epitope structures
  2111. Mass spectrometry of advancedย GLYCATIONย end products
  2112. Paradox of circulating advancedย GLYCATIONย end product concentrations in patients with congestive heart failure and after heart transplantation
  2113. Effects of aspirin onย GLYCATION, glycoxidation, and crosslinking of collagen
  2114. Phototransformations of advancedย GLYCATIONย end products in the human eye lens due to ultraviolet A light irradiation
  2115. Receptor of advancedย GLYCATIONย end product (RAGE) expression in the minor salivary glands of patients with Sjoห grenโ€™s syndrome: a preliminary study
  2116. Earlyย GLYCATIONย products of endothelial plasma membrane proteins in experimental diabetes
  2117. Protective ability and binding affinity of captopril towards serum albumin in an in vitroย GLYCATIONย model of diabetes mellitus
  2118. Histone H1 as a reporter protein to investigateย GLYCATIONย in bacteria
  2119. Effects of Glucose and ฮฑโ€Tocopherol on Lowโ€Density Lipoprotein Oxidation andย GLYCATION
  2120. Nonenzymaticย GLYCATIONย affects bone fracture by modifying creep and inelastic properties of collagen
  2121. Advancedย GLYCATIONย end products accelerate atherosclerosis via enhancement of oxidative stress
  2122. โ€ฆ in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobinย GLYCATIONย at specific sites
  2123. The effect ofย GLYCATIONย of CD59 on complement-mediated cytolysis
  2124. The Gly82Ser polymorphism of the receptor of advancedย GLYCATIONย end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population
  2125. Advancedย GLYCATIONย endproducts in the development of osteoarthritis
  2126. Capillary electrophoretic analysis of advancedย GLYCATIONย endproducts formed from the reaction of reducing sugars with the amino group of glucosamine
  2127. GLYCATIONย and RAGE: Common links in the pathogenesis of microvascular and macrovascular complications of diabetes
  2128. Troglitazone inhibits long-termย GLYCATIONย and oxidation of low-density lipoprotein
  2129. Cloning and characterization of the canine receptor for advancedย GLYCATIONย end products
  2130. Green tea polyphenols inhibit advancedย GLYCATIONย end product-induced rat vascular smooth muscle cell proliferation.
  2131. Enzymeย GLYCATIONย influences product yields during oligosaccharide synthesis by reverse hydrolysis
  2132. 2-ammonio-6-(3-oxidopyridinium-1-yl) hexanoate (OP-lysine) is a newly identified advancedย GLYCATIONย end product in cataractous and aged human lenses
  2133. Intactย GLYCATIONย end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide
  2134. Effect of non-enzymaticย GLYCATIONย on aluminium-induced lipid peroxidation of human high density lipoproteins (HDL)
  2135. 2, 3-Dimethoxy-5-methyl-1, 4-benzoquinones and 2-methyl-1, 4-naphthoquinones:ย GLYCATIONย inhibitors with lipid peroxidation activity
  2136. In vitro screening of nonenzymeย GLYCATIONย inhibitor
  2137. Antioxidant effect of Turmeric and saffron on the oxidation of hepatocytes, LDL and non-enzymaticย GLYCATIONย of hemoglobin
  2138. The induction of surface ฮฒ-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advancedย GLYCATIONย end products
  2139. Experimental effect of Puerarin on the formation of advancedย GLYCATIONย end products and expression of RAGE in the arota of diabetic rats [J]
  2140. Processing Advancedย GLYCATIONย End Productโ€Modified Albumin by the Renal Proximal Tubule and the Early Pathogenesis of Diabetic Nephropathy
  2141. Towards the control and inhibition ofย GLYCATIONโ€”the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study
  2142. Protective effects of carnosine and relative compounds on DNA cleavage by advancedย GLYCATIONย end products
  2143. GLYCATIONย of caseinmacropeptide
  2144. โ€ฆ expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advancedย GLYCATIONย endproduct-specific receptor โ€ฆ
  2145. Analysis of serum of patients with Alzheimerโ€™s disease for the level of advancedย GLYCATIONย end products
  2146. Detection and determination of glyceraldehyde-derived advancedย GLYCATIONย end product
  2147. Nonenzymaticย GLYCATIONย causes loss of toughening mechanisms in human cancellous bone
  2148. GLYCATION-induced inactivation of aspartate aminotransferase, effect of uric acid
  2149. Magnesium-dependent phosphatase-1 is a protein-fructosamine-6-phosphatase potentially involved inย GLYCATIONย repair
  2150. Constituents of the stems of Rumex japonicus with advancedย GLYCATIONย end products (AGEs) and rat lens aldose reductase (RLAR) inhibitory activity
  2151. Nonenzymaticย GLYCATIONย of plasma proteins in smokers
  2152. Isolation and identification of 5-methyl-imidazolin-4-one derivative as glyceraldehyde-derived advancedย GLYCATIONย end product
  2153. Effects of Advancedย GLYCATIONย End Products on Ezrinโ€Dependent Functions in LLCโ€PK1 Proximal Tubule Cells
  2154. AU-rich elements in the mRNA 3โ€ฒ-untranslated region of the rat receptor for advancedย GLYCATIONย end products and their relevance to mRNA stability
  2155. Theโ€“429 T/C andโ€“374 T/A gene polymorphisms of the receptor of advancedย GLYCATIONย end products gene (RAGE) are not risk factors for coronary artery disease in โ€ฆ
  2156. The experimental study of Radix Puerariae inhibitingย GLYCATIONย in rats induced by D-galactose
  2157. Expression of receptor for advancedย GLYCATIONย end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 โ€ฆ
  2158. Olmesartan medoxomil, a newly developed angiotensin II type 1 receptor antagonist, protects against renal damage in advancedย GLYCATIONย end product (age)-injected โ€ฆ
  2159. Influence of nonโ€enzymatic glycosylation (GLYCATION) of pea (Pisum sativum) albumins on their enzymatic hydrolysis
  2160. Involvement of caspase-10 in advancedย GLYCATIONย end-product-induced apoptosis of bovine retinal pericytes in culture
  2161. Quantitation of N2-[1-(1-Carboxy)ethyl]folic Acid, a Nonenzymaticย GLYCATIONย Product of Folic Acid, in Fortified Foods and Model Cookies by a Stable Isotope Dilution โ€ฆ
  2162. The fructosamine 3-kinase knockout mouse: a tool for testing theย GLYCATIONย hypothesis of intracellular protein damage in diabetes and aging
  2163. Hepatocyte growth factor protects against apoptosis induced by advancedย GLYCATIONย end products in endothelial cells.
  2164. Evidence that high-doseL-arginine may be inappropriate for use by diabetic patients as a prophylactic blocker of methylglyoxalย GLYCATION
  2165. Endogenous secretory receptor for advancedย GLYCATIONย end product levels are inversely associated with HbA1c in type 2 diabetic patients
  2166. GLYCATIONย Does Not Alter LDLโ€Induced Secretion of Tissue Plasminogen Activator and Plasminogen Activator Inhibitorโ€1 from Human Aortic Endothelial Cells
  2167. Decrease in the glyceraldehyde derived advancedย GLYCATIONย end products in the sera of patients with Vogt-Koyanagi-Harada disease
  2168. GLYCATIONย of human IgG induces structural alterations leading to changes in its interaction with anti-IgG
  2169. Maillardย GLYCATIONย of Peptides Containing the (N ฮฑ His) Ac Chelator for 99m Tc (CO) 3 Labeling
  2170. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advancedย GLYCATIONย end product (AGE)-related disorders
  2171. Lipid peroxidation, advancedย GLYCATIONย end products and antioxidant status in patients on dialysis
  2172. Renoprotective effects of azelnidipine, a dihydropyridine-based calcium antagonist in advancedย GLYCATIONย end product (AGE)-injected rats.
  2173. Synthesis, tandem MS-and NMR-based characterization, and quantification of the carbon 13-labeled advancedย GLYCATIONย endproduct, 6-N-carboxymethyllysine
  2174. Blockade by nifedipine of advancedย GLYCATIONย end product-induced CD40-CD40 ligand interaction in endothelial cells.
  2175. Possible involvement of cross-linking advancedย GLYCATIONย endproducts in long-term CAPD peritoneal degeneration
  2176. Non-enzymaticย GLYCATIONย of type I collagen: Effects of aging
  2177. Effect of extracellular matrixย GLYCATIONย on dermal fibroblast
  2178. Correlation between molecular weight of plasma albumin determined with mass spectrometry andย GLYCATIONย indices in factory workers
  2179. GLYCATIONย of proteins in Escherichia coli. Interference of strain diversity and growth conditions withย GLYCATION
  2180. Advancedย GLYCATIONย end products (AGEs) and renal failure
  2181. Activation of receptor for advancedย GLYCATIONย end products: a mechanism for monocyte-mediated inflammation in chronic renal failure
  2182. Modeling of Protein and Aminophospholipidย GLYCATIONย Using Low Molecular Weight Analogs. A Comparative Study
  2183. Proteins modified withย GLYCATIONย or oxidation products accelerate atherosclerosis in experimental hypercholesterolemic rabbits
  2184. The Mechanism of Advancedย GLYCATIONย End Products-Induced Morphological Changes of Tight Junction in Endothelial Cell
  2185. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advancedย GLYCATIONย end product.
  2186. Advancedย GLYCATIONย endproducts (AGE) and their role in the pathogenesis of chronic complications of diabetes mellitus
  2187. In vacuoย GLYCATIONย of enzymes: A novel approach for increasing enzyme stability
  2188. Cell culture efforts to reduceย GLYCATIONย in recombinant humanized antibody
  2189. Advancedย GLYCATIONย and advanced oxidation protein products: The effect of peritoneal dialysis
  2190. Trehalose and 6-aminohexanoic acid stabilize and renature glucose-6-phosphate dehydrogenase inactivated byย GLYCATIONย and by guanidinium hydrochloride
  2191. Detection of AGE-Lipids In Vivo:ย GLYCATIONย and Carboxymethylation of Aminophospholipids in Red-Cell Membranes
  2192. The haemoglobinย GLYCATIONย index is reproducible in dysglycaemic individual but is not explained by postโ€challenge plasma glucose levels
  2193. Evidence of biomembrane lipidย GLYCATION
  2194. Expression and function of receptors for advancedย GLYCATIONย end products in bovine corneal endothelial cells
  2195. Activation of receptors for advancedย GLYCATIONย endproducts (RAGEs) in human monocytes
  2196. Comparing inhibition effects of four drugs on ADM and advancedย GLYCATIONย endproducts in rats [J]
  2197. Advancedย GLYCATIONย end products in intervertebral discs and hip joint capsules: Correlation with senile amyloid?
  2198. In vacuoย GLYCATIONย of proteins
  2199. Molecular mechanism of diabetic retinopathy: role of advancedย GLYCATIONย end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy
  2200. Proteins of Thermus thermophilus Are Resistant toย GLYCATIONโ€Induced Protein Precipitation: An Evolutionary Adaptation to Life at Extreme Temperatures?
  2201. Effects of tonifying shen recipe on advancedย GLYCATIONย end products, amyloid-beta peptide in telencephalon and hippocampus of ovariectomized rats
  2202. Effects of Advancedย GLYCATIONย End-products on Expression of Peroxisome Proliferator Activated Receptor-ฮณ mRNA in Cultured Human Vascular Endothelial Cells [J]
  2203. Pharmacological blockade of the receptor for advancedย GLYCATIONย endproducts (RAGE) improves ageโ€related endothelial dysfunction in rats
  2204. The role ofย GLYCATIONย and glycoxidation of low-density lipoproteins in foam cell formation.
  2205. The effect of turmeric, cardamom and ginger on in vitro albuminย GLYCATION
  2206. Screening of natural resources with inhibitory activity on free radicals and advancedย GLYCATIONย end products (AGEs) formation
  2207. The Effect of Advancedย GLYCATIONย End Products on Macrophage Matrix Metalloproteinase-9 Activity and the Intervention Effect of Simvastatin
  2208. AGE (Advancedย GLYCATIONย end products) receptors in ageโ€“related macular degeneration
  2209. Cellular receptors for advancedย GLYCATIONย endproducts
  2210. Advancedย GLYCATIONย endproducts enhance proliferation, but not tube formation in choroidal microvascular endothelial cells
  2211. Advancedย GLYCATIONย end-product cross-link breakers: a novel therapeutic pathway for cardiovascular disease
  2212. Advancedย GLYCATIONย end product (AGE)โ€immunoreactive materials in chronic prurigo patients receiving a longโ€standing haemodialysis
  2213. Catalytic aspects of theย GLYCATIONย hot spots of proteins
  2214. The Effects of Melatonin On The Oxidative Stress, Proteinย GLYCATION, Microalbuminuria and Lipid Profile In Type II Diabetes Mellitus
  2215. Sodium ferulate inhibits nonenzymaticย GLYCATIONย of myocardial tissue in diabetic rats [J]
  2216. Effects of advancedย GLYCATIONย end products on oxidative stress in endothelial cells
  2217. Advancedย GLYCATIONย end products accumulate in the diabetic gallbladder
  2218. Effects of advancedย GLYCATIONย end products on the activity of NF-kappaB and the expression of fibronectin mRNA in the endothelial cells in aged rats
  2219. Site-specific and random fragmentation of Cu, Zn-superoxide dismutase (Cu, Zn-SOD) byย GLYCATIONย reaction: implication of reactive oxygen species
  2220. Structure and function of the metal-binding protein S100B and its interaction with the receptor for advancedย GLYCATIONย end products
  2221. Effects of carvedilol and metoprolol on plasma advancedย GLYCATIONย end products (AGE) and advanced oxidation protein products (AOPP) in patients with chronic heart โ€ฆ
  2222. Advancedย GLYCATIONย end products and pseudoexfoliationโ€“correlation between clinical outcome and histological findings
  2223. The aldose reductase activity in lens extracts protects, but does not prevent, theย GLYCATIONย of lens proteins by L-Threose
  2224. The changes of advancedย GLYCATIONย end products in a rat liver fibrosis model and the interventional effect of aminoguanidin
  2225. Evaluation of Advancedย GLYCATIONย Endโ€“Products in Diabetic and Inherited Canine Cataracts
  2226. Non-invasive assessment of advancedย GLYCATIONย end products, markers of oxidative stress, in recently preeclamptic women
  2227. Effects of advancedย GLYCATIONย end products on activity and expression of eNOS in human umbilical vein endothelial cells
  2228. Inhibition of proteinย GLYCATIONย by skins and seeds of the muscadine grape
  2229. Elevated Level of Imidazolone and Pyrraline, Major Components of Advancedย GLYCATIONย End Products, in the Vitreous Fluid of Patients With Diabetic Retinopathy
  2230. Relationship between Serum Advancedย GLYCATIONย End Products Levels of Diabetic Mothers and Adverse Cardiovascular Function of Newborn Infants
  2231. GLYCATION, Oxidation, and Glycoxidation of Short-and Long-Lived Proteins and the Pathogenesis of Diabetic Complications
  2232. Non-enzymaticย GLYCATIONย for the processing of type I collagen gels for cartilage tissue engineering
  2233. The Correlation Between Serum Advancedย GLYCATIONย End Products and Nitric Oxide Levels in Type 2 Diabetes and Chronic Complications of Diabetes
  2234. Correlative study of advancedย GLYCATIONย end products (AGE) and diabetic skin with microangiopathy
  2235. Scattering model of whole blood at hemoglobinย GLYCATIONย monitored by refractive index measurement with OCT
  2236. The relative oxidation,ย GLYCATIONย and crosslinking activity of glucose and ascorbic acid in vitro
  2237. Chemical modification induced byย GLYCATIONย increased lysine binding site activity of human serum lipoprotein (a)
  2238. The experimental study of angiogenes effect of puerarin on the chick embryo chorioallantoic membrane induced by advancedย GLYCATIONย endproducts
  2239. Inhibitory effects of extracts from Ginkgo biloba and grape seed on the generation of advancedย GLYCATIONย end products in vitro
  2240. Proteolysis of the receptor for advancedย GLYCATIONย end products by matrix metalloproteinases
  2241. Pattern of CTGF mRNA expression induced by advancedย GLYCATIONย end products in mesangial cells [J]
  2242. Transient cytosolic free calcium changes in cultured neonatal rat cardiac myocytes in response to advancedย GLYCATIONย end-product treatment
  2243. Accelerated Aging in Glaucoma: Immunohistochemical Assessment of Advancedย GLYCATIONย Endโ€“Products in the Human Retina and Optic Nerve Head
  2244. Vitamin C mediates lens crystallin aging byย GLYCATIONย in a humanized transgenic mouse model
  2245. Effects of perindopril on expression of transformation growth factor-ฮฒ type receptorโ…ก in cultured human vascular endothelial cells by advancedย GLYCATIONย end products
  2246. The effect of non-enzymaticย GLYCATIONย of keratins on the physical properties of plantar epidermis in Type II diabetic and non-diabetic individuals
  2247. Nonenzymaticย GLYCATIONย reaction of folate with reducing sugars: A case study on [6S]-5-methyltetrahydrofolate and fructose
  2248. Diabetic cataract:ย GLYCATIONย of the molecular chaperone ฮฑ-crystallin and its binding to the membrane protein MIP26
  2249. Effects of advancedย GLYCATIONย end products on protein and mRNA expression of macrophage inflammatory protein-1ฮฑ in cultured human umbilical vein endothelial โ€ฆ
  2250. Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advancedย GLYCATIONย end products
  2251. Inhibitory effects of total flavones of buckwheat flower on the non-enzymaticย GLYCATIONย of proteins in vivo and in vitro
  2252. 135: Interruption of the Receptor for Advancedย GLYCATIONย End product pathway attenuates pulmonary reperfusion injury
  2253. P-194: Effect of calcium channel blocker, azelnidipine onย GLYCATIONย in patients with essential hypertension
  2254. New pathways for the metabolism of fructosamines and otherย GLYCATIONย products in bacteria
  2255. Advancedย GLYCATIONโ€“New AGE Focus for Diabetes
  2256. Proteinย GLYCATIONย and Eye Diseases
  2257. Should we reconsider the advancedย GLYCATIONย end product issue in hemodialysis patients?
  2258. In vitroย GLYCATIONย of human IgG and its effect on interaction with anti-IgG
  2259. Immunohistochemical localization of advancedย GLYCATIONย end products in pinguecula.
  2260. Advancedย GLYCATIONย end products and senile dementia
  2261. Advancedย GLYCATIONย endproducts act as an initiator of skin tumors in mice
  2262. GLYCATIONย products in diabetic urineโ€”What do they mean?
  2263. ADVANCEDย GLYCATIONย END-PRODUCTS AND DIABETIC RENAL DISEASE
  2264. GLYCATIONย and physiological mechanisms of its prevention in Alzheimerโ€™s disease
  2265. Advancedย GLYCATIONย Endproducts In Periodontal Disease
  2266. The relationship between the advancedย GLYCATIONย ends products and the diabetes nephropathy [J]
  2267. Animal model ofย GLYCATIONย induced by Dโ€“galactose
  2268. Studies on the formation, metabolism andย GLYCATIONย reactions of endogenous and exogenous alpha-oxoaldehydes in uraemia.
  2269. Skin autofluorescence and advancedย GLYCATIONย endproducts
  2270. Effects of advancedย GLYCATIONย end products on osteoblastic cells
  2271. Effect of quercetin on generation of advancedย GLYCATIONย end products in vitro
  2272. Examination of Site Specificity ofย GLYCATIONย of Alcohol Dehydrogenase by Computer Modeling
  2273. GLYCATIONย of human IgG induces structural alterations leading to changes in its interaction with Anti-IgG
  2274. Animal model ofย GLYCATIONย induced by D-galactose
  2275. Effects of crocetin on formation of advancedย GLYCATIONย end products and expression of releptor for advancedย GLYCATIONย and prodmts protein in diabetic rats
  2276. Osteoblast apoptosis is induced by an advancedย GLYCATIONย enproduct
  2277. Serum Advancedย GLYCATIONย Endproducts (AGE) Correlate With Cognition in the Very Elderly
  2278. An investigation of the effect of advancedย GLYCATIONย on age-related RPE dysfunction.
  2279. Hypertension and Atherosclerosis: Advancedย GLYCATIONย End Productsโ€”A Common Link
  2280. Serum levels of advancedย GLYCATIONย endproducts are associated with the development of acute coronary syndrome in diabetic patients
  2281. Deposition of Advancedย GLYCATIONย End Products in Climatic Droplet Keratopathy
  2282. High Serum Level of Pentosidine, an Advancedย GLYCATIONย End Product (AGE), is a Risk Factor of Patients with Heart Failure
  2283. Changes of Anticomplememt Function of Human Mutant CD59 before and afterย GLYCATION
  2284. Advancedย GLYCATIONย End Products (AGEs) related complications in diabetic nephropathy
  2285. Advancedย GLYCATIONย end products in urine: Are some sugar-derived products better than others?
  2286. Genderโ€related differences in advancedย GLYCATIONย endproducts and oxidative stress markers in rats
  2287. Effects of advancedย GLYCATIONย end products on the expression of ICAM-1 and VCAM-1 in ECV-304 cells
  2288. Effects of advancedย GLYCATIONย end products on expression and activity of PAI-1 in rat renal cortex
  2289. Immunological Approach to Advancedย GLYCATIONย End Products of the Maillard Reaction
  2290. Effects of Arctium Fruit and Its Extracts on Renocorticalย GLYCATIONย End Products in Rats
  2291. Role of lipid peroxidation and proteinย GLYCATIONย in non diabetic pediatric nephrotic syndrome
  2292. Role of Advancedย GLYCATIONย in Bloodโ€“Retinal Barrier Dysfunction During Diabetes
  2293. Serum levels of advancedย GLYCATIONย end products are associated with in-stent restenosis in diabetic patients
  2294. The Impact ofย GLYCATIONย on the Anti-inflammatory Properties of High Density Lipoproteins in vivo
  2295. Advancedย GLYCATIONย end Products are Associated With Diabetic Peripheral Macrovascular Complications
  2296. GLYCATIONย of Ubiquitin May Underlie the Molecular Mechanism of Diabetic Cataract
  2297. Biochemical and biophysical characterization of hemoglobin-advancedย GLYCATIONย end product and its relevance to diabetes mellitus
  2298. Inhibition of Inflammation due to Advancedย GLYCATIONย Endโ€products by Pentoxifylline
  2299. Determination of in vivo transferrinย GLYCATIONย in diabetes mellitus: A novel method of quantification
  2300. Endocytosis of Advancedย GLYCATIONย End Products in Bovine Choriocapillary Endothelial Cells
  2301. The effect of exogenous advancedย GLYCATIONย end products on the alteration of visual evoked potential in the rats
  2302. Leptin and connective tissue growyh factor in advancedย GLYCATIONย end-product efects in NRK-49F cells.
  2303. โ€ฆ of receptor of advancedย GLYCATIONย endproducts, nuclear factor-? B double gene antisense RNA on productions of inflammatory factor treated by advancedย GLYCATIONย โ€ฆ
  2304. Fibrinogenย GLYCATIONย and glycaemic control in type 2 diabetic subjects
  2305. Efects of Non-Surgical periodontal therapy without the use of chemotherapeutics on proteinย GLYCATION
  2306. Effect of ROS-generating system on nonenzymatic proteinย GLYCATION
  2307. Capillary Zone Electrophoresis study of the in vitro albuminย GLYCATIONย process
  2308. Once More, With Feeling: Hobblingย GLYCATION-detecting protein restores feeling in diabetic mice
  2309. GLYCATIONย OF PROTEINS IN ESCHERICHIA COLI: DETECTION OF GLYCATING COMPOUNDS USING HISTONE H1 AS A SUBSTRATE
  2310. Nurture vs. nature in diabetic vasculopathy: roles of advancedย GLYCATIONย endproducts and the receptor for them
  2311. โ€ฆ of receptor of advancedย GLYCATIONย endproducts, nuclear factor-ฮบB double gene antisense RNA on productions of inflammatory factor treated by advancedย GLYCATIONย โ€ฆ
  2312. Effects of in vitroย GLYCATIONย on iron (III)-binding and iron (III)-isoforms of transferrin
  2313. GLYCATIONโ€“Induced Aggregation of Lens Proteins by the Oxidation Products of Ascorbic Acid
  2314. In Vitro Quantitation of Advancedย GLYCATIONย Endproducts in Porcine Dermis using Raman Spectroscopy
  2315. The Accumulation of Advancedย GLYCATIONย End Products in the Retinal Pigment Epithelium and in Bruchโ€™s membrane of human donors.
  2316. EFFECTS OF VITAMIN C AND VITAMIN E ON RECEPTORS OF ADVANCEDย GLYCATIONย END PRODUCTS IN EXPERIMENTAL DIABETIC RATS [J]
  2317. Aminoguanidine Increases Hydrogen Peroxide Formation duringย GLYCATIONย In Vitro
  2318. Do advancedย GLYCATIONย end products and glucose induce similar signaling events in mesangial cells?
  2319. GLYCATIONย OF COLLAGEN: THE INFLUENCE OF AMINOGUANIDINE AND CU 2 IN THE FORMATION OF FLUORESCENT AGEs
  2320. A Survey of Advancedย GLYCATIONย Endproduct Receptors Expressed by Human Retinal Pigment Epithelial Cells in situ
  2321. Endogenous secretory receptor for advancedย GLYCATIONย endproducts in non-small cell
  2322. Chemopreventive activity of natural source compounds against advancedย GLYCATIONย endproduct induced carcinogenesis.
  2323. Advancedย GLYCATIONย endproducts and oxidative stress from the neutrophil respiratory burst
  2324. Evaluation of advancedย GLYCATIONย end-products in diabetic and inherited canine cataracts
  2325. Reduced Pericyte Adhesion and Death on Advancedย GLYCATIONย Endproduct (Age)โ€“Modified Substrate
  2326. Effects of advancedย GLYCATIONย end products on peroxisome proliferator activated receptor-? mRNA expression in rat renal cortex
  2327. Advancedย GLYCATIONย end products induce proliferation of vascular smooth muscle cells and antagonism of drugs
  2328. Modulation of proliferation and function of progenitor cells by diabetes and age associated advancedย GLYCATIONย endproducts (AGEs)
  2329. Advancedย GLYCATIONย Dependent Formation of Modified ฮฑ-Crystallin and High Molecular Weight Aggregates
  2330. GLYCATIONย of Proteins in Escherichia coli. Detection of Glycating Compounds Using Histone Hi as a Substrate
  2331. The effect of exogenous advancedย GLYCATIONย end products on the expreesion of monocyte chemotactic protein-1 in the healthy ratsโ€™ retina
  2332. Effect of high concentration glucose and advancedย GLYCATIONย end products on MIP-1# alpha# mRNA expression in cultured human umbilical vein endothelial cells
  2333. Reducing Sugars Induce Apoptosis in Pancreatic ฮฒ-Cells by Provoking Oxidative Stress via aย GLYCATIONย Reaction
  2334. Use of fluorescence and near-infrared spectroscopies for noninvasive measurement of skin-collagen Advancedย GLYCATIONย Endproducts: a feasibility study
  2335. Galectinโ€“3 mediates advancedย GLYCATIONย endproduct (AGE)โ€“induced breakdown of the bloodโ€“retinal barrier
  2336. Advancedย GLYCATIONย End Product and Amadori Product Are Increased and Related to Apoptosis in the Human Diabetic Retina.
  2337. 2P052 Solution Structure of Variable-type Domain of Receptor for Advancedย GLYCATIONย Endproducts (29. Protein structure and dynamics (II), Poster Session, Abstract โ€ฆ
  2338. Screening breaker of advanced-GLYCATIONย end-product cross-links by enzyme-linked immunosorbent assay method in vitro
  2339. MOLECULAR ANALYSIS OF RECEPTOR FOR ADVANCEDย GLYCATIONย END-PRODUCTS ISOFORMS EXPRESSED IN TISSUES AND CELL LINES.: 123
  2340. Effects of advancedย GLYCATIONย end products on the expression of peroxisome proliferator-activated receptors in endothelial cells
  2341. Advancedย GLYCATIONย End Products (AGEs)-Mediated Cell Growth of Human Acute Myelogenous Leukemia Via Mitogen-Activated Protein (MAP) Kinase Pathways.
  2342. Study of serum advancedย GLYCATIONย endproducts and endothelium-dependent vasodilation function in patients both with coronary artery disease and type 2 diabetes
  2343. ADVANCEDย GLYCATIONย END PRODUCTS MEDIATE ANG II-DEPENDENT PRO-INFLAMMATORY RESPONSES IN A TRANSGENIC RAT MODEL: 2C. 5
  2344. Association of Soluble Receptor for advancedย GLYCATIONย end product (sRAGE) with increasing central aortic stiffness in hypertensive patients
  2345. Advancedย GLYCATIONย end-product-induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells.
  2346. Prokaryotic expression and activity identification of recombinant human soluble receptor for advancedย GLYCATIONย end products
  2347. Advancedย GLYCATIONย endproduct modified basement membrane attenuates endothelin-1 induced [Ca2+]
  2348. Advancedย GLYCATIONย End Products Increases U937 Macrophages Expression of Scavenger Receptor Class B Type I
  2349. Effect of advancedย GLYCATIONย end product receptor signal transduction on MCP-1 expression of podocyte induced by carboxymethyllysine
  2350. Inhibitory effects of extracts from {\sl Ginkgo biloba} and grape seed on the generation of advancedย GLYCATIONย end products {\sl in vitro}
  2351. The effect ofย GLYCATIONย of culture medium on phagocytic and respiratory burst of peritoneal macrophages from Balb/c mice
  2352. Advancedย GLYCATIONย endproducts analysis of glucosamine with reducing sugars, DNA nucleosides and serum proteins
  2353. Inhibition of green tea polyphenols on proliferation of rat vascular smooth muscle cells stimulated by advancedย GLYCATIONย end products
  2354. Advancedย GLYCATIONย Impairs Endothelial Progenitor Cell Attachment and Repair in a New Model of Retinal Vascular Endothelial Injury
  2355. Modulation of nicotine and advancedย GLYCATIONย end product (AGE) mediated effects by the antioxidant glutathione (G) in fibroblasts
  2356. Receptor for advancedย GLYCATIONย end products (RAGE) in pulmonary fibrosis
  2357. The deposition of advancedย GLYCATIONย endproducts (AGEs) in renal tissue and association of AGEs with phenotypic changes in renal cells in diabetic nephropathy
  2358. Advancedย GLYCATIONย end products induce actin rearrangement and subsequent hyperpermeability in endothelial cells
  2359. Macrophage Scavenger Receptor Mediates The Endocytic Uptake of Advancedย GLYCATIONย End Products (AGEs)
  2360. Conformational Transitions andย GLYCATIONย of Serum Albumin in Patients with Minimal-Change Glomerulopathy
  2361. Regulation of adhesion molecule expression on retinal capillary endothelium by exposure to high glucose: a role for advancedย GLYCATIONย endโ€“products (AGEs)?
  2362. RACEMIZTION OF ASPARTIC ACID AND NON-ENZYMATICย GLYCATIONย OF HUMAN INTERVERTEBRAL DISC CONSTITUENTS AS MEASURES OF โ€ฆ
  2363. 2-Ammonio-6-(3-oxidopyridinium-1-yl) hexanoate (OP-lysine) is a newly identified advancedย GLYCATIONย end product in cataractous and aged human lenses. Vol. 279 โ€ฆ
  2364. Inhibitory effects of total extract and flavonols from hardy rubber tree (Eucommia ulmoides Oliver) leaves on theย GLYCATIONย of hemoglobin
  2365. Advancedย GLYCATIONย end products (AGES) stimulate NADPH dependent oxidant stress in cultured neonatal rat myocytes
  2366. Role of Advancedย GLYCATIONย End Products in TGF-ฮฒ1 and Fibronectin Expression in Mesangial Cells Cultured under High Glucose
  2367. Insulin Accelerates the Endocytic Uptake and Degradation of Advancedย GLYCATIONย End-Products Mediated by The Macrophage Scavenger Receptor
  2368. Advancedย GLYCATIONย end products and thiobarbituric acid reactive substance in gingival tissues of diabetic and non-diabetic patients with chronic periodontitis
  2369. Advancedย GLYCATIONย end products (AGEs) exacerbate NAFLD progression to liver fibrosis via receptor for AGEs (RAGE) in high fat fed mice
  2370. Advancedย GLYCATIONย end products and thiobarbituric acid reactive substance in gingival tissues of diabetic and non-diabetic patients with chronic periodontitis
  2371. The inflammatory and immunogenic properties of the receptor for advancedย GLYCATIONย end products and its ligand, high mobility group box chromosomal โ€ฆ
  2372. Inhibition of Diabetic Leukostasis and Bloodโ€“Retinal Barrier Breakdown With a Soluble Form of a Receptor for Advancedย GLYCATIONย End Products
  2373. Superoxide Mediates Through ERK Signaling TGF-ฮฒ1 Expression in Rat Kidney Proximal Tubule Epithelial Cells Treated with Advancedย GLYCATIONย End Products
  2374. Effects of advancedย GLYCATIONย end products on expression of scavenger receptor class B type I (SR-BI) in U937 macrophages
  2375. Combined soluble receptor for advancedย GLYCATIONย endproducts (sRAGE) with cytotoxic chemotherapy effectively reduces metastatic tumor growth in a spontaneous โ€ฆ
  2376. Essential role of receptor for advancedย GLYCATIONย end products (RAGE) in the inflammatory response and mucosal injury after hemorrhagic shock (HS)
  2377. SUPPRESSION OF ADVANCEDย GLYCATIONย AND LIPOXIDATION END PRODUCTS BY AN ANGIOTENSIN II TYPE-1 RECEPTOR BLOCKER IN ESSENTIAL โ€ฆ
  2378. Exposure of Retinal Pigment Epithelium (RPE) to Advancedย GLYCATIONย Endproduct (AGE)โ€“Modified Substrate in vitro Alters RPE Lysosomal Capacity and Leads to โ€ฆ
  2379. Food Advancedย GLYCATIONย Endproducts (AGE) Acutely Induce Postprandial Impairment of Microvascular Function in Patients with Type 2 Diabetes Mellitus (T2DM), an โ€ฆ
  2380. Small Interfering RNA (siRNA) Targeting Receptor for Advancedย GLYCATIONย End Products (RAGE) Downregulates Stromal Cell Derived Factor 1 (SDF-1) in โ€ฆ
  2381. โ€ฆ V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ: Advancedย GLYCATIONย end product intervention โ€ฆ
  2382. 18 Advancedย GLYCATIONย End Products in Clinical Nephrology
  2383. 3.3 INHIBITON OF PROTEINย GLYCATIONย AND ADVANCEDย GLYCATIONย END PRODUCTS BY FOODSTATEยฎ VITAMIN C AND OTHER VITAMINS AND โ€ฆ
  2384. 2โ€“Guanidinoethyl Mercaptan Derivatives as Potent Inhibitors ofย GLYCATIONโ€“Mediated Protein Crosslinking
  2385. 298 INVERSE RELATIONSHIP BETWEEN ADVANCEDย GLYCATIONย END PRODUCTS AND GLUTATHIONE IN SICKLE CELL ANEMIA
  2386. โ€ฆ , hemodynamic and clinical improvements among patients with advanced heart failure treated with Alagebrium (a novel oral advancedย GLYCATIONย end-product crosslink โ€ฆ
  2387. โ€ฆ DIABETES MELLITUS BY EPLERENONE: RELATIONSHIP BETWEEN MINERALOCORTICOID RECEPTOR, ADVANCEDย GLYCATIONย END PRODUCT RECEPTOR โ€ฆ
  2388. โ€ฆ of Renin-Angiotensin System (RAS) Inhibits Increased Matrix Metalloproteinase-9 Expression and Apoptosis Induced by Advancedย GLYCATIONย End Products (AGE) and โ€ฆ
  2389. Advancedย GLYCATIONย endproducts: what is their relevance to diabetic complications?
  2390. The role of advancedย GLYCATIONย end products in progression and complications of diabetes
  2391. The road to advancedย GLYCATIONย end products: a mechanistic perspective
  2392. Advancedย GLYCATIONย end products and insulin resistance
  2393. Advancedย GLYCATIONย end products, diabetes and ageing
  2394. Role of advancedย GLYCATIONย end products in diabetic neuropathy
  2395. The clinical relevance of assessing advancedย GLYCATIONย endproducts accumulation in diabetes
  2396. Advancedย GLYCATIONย end products and diabetic foot disease
  2397. Dietary advancedย GLYCATIONย endproducts (AGEs) and their health effectsโ€“PRO
  2398. Advancedย GLYCATIONย endโ€products (AGEs) and heart failure: pathophysiology and clinical implications
  2399. Possible involvement of advancedย GLYCATIONย end-products (AGEs) in the pathogenesis of Alzheimerโ€™s disease
  2400. Advancedย GLYCATIONย end-products and arterial stiffness in hypertension
  2401. Mechanisms of disease: advancedย GLYCATIONย end-products and their receptor in inflammation and diabetes complications
  2402. Advancedย GLYCATIONย end-products (AGEs): involvement in aging and in neurodegenerative diseases
  2403. Novel inhibitors ofย GLYCATIONย and AGE formation
  2404. Advancedย GLYCATIONย end products (AGEs) and their involvement in liver disease
  2405. Advancedย GLYCATIONย end products and cardiovascular disease
  2406. Circulating glycotoxins and dietary advancedย GLYCATIONย endproducts: two links to inflammatory response, oxidative stress, and aging
  2407. GLYCATIONย during storage and administration of monoclonal antibody formulations
  2408. Receptor for advancedย GLYCATIONย endproducts and atherosclerosis: from basic mechanisms to clinical implications
  2409. Calcitriol blunts the deleterious impact of advancedย GLYCATIONย end products on endothelial cells
  2410. Food-derived advancedย GLYCATIONย end products (AGEs): a novel therapeutic target for various disorders
  2411. Inhibition of proteinย GLYCATIONย by extracts of culinary herbs and spices
  2412. GLYCATIONย as an atherogenic modification of LDL
  2413. Collagen, cross-linking, and advancedย GLYCATIONย end products in aging human skeletal muscle
  2414. High serum level of pentosidine, an advancedย GLYCATIONย end product (AGE), is a risk factor of patients with heart failure
  2415. Evidence against dietary advancedย GLYCATIONย endproducts being a risk to human health
  2416. A review of glycated albumin as an intermediateย GLYCATIONย index for controlling diabetes
  2417. Clinical and prognostic value of advancedย GLYCATIONย end-products in chronic heart failure
  2418. Advancedย GLYCATIONย endproducts in chronic heart failure
  2419. A study inย GLYCATIONย of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior
  2420. Plasma receptor for advancedย GLYCATIONย end products and clinical outcomes in acute lung injury
  2421. Advancedย GLYCATIONย end products in renal failure: an overview
  2422. Effects of non-enzymaticย GLYCATIONย on cancellous bone fragility
  2423. Advancedย GLYCATIONย endproducts: a biomarker for age as an outcome predictor after cardiac surgery?
  2424. Role of advancedย GLYCATIONย end products (AGEs) and oxidative stress in diabetic retinopathy
  2425. Collagenย GLYCATIONย triggers the formation of aged skin in vitro
  2426. A role for the receptor for advancedย GLYCATIONย end products in idiopathic pulmonary fibrosis
  2427. Prevention of non-enzymicย GLYCATIONย of proteins by dietary agents: prospects for alleviating diabetic complications
  2428. Dietary advancedย GLYCATIONย end productsโ€“a risk to human health? A call for an interdisciplinary debate
  2429. Compensatory secondary structure alterations in proteinย GLYCATION
  2430. Receptor for advancedย GLYCATIONย end products (RAGEs) and experimental diabetic neuropathy
  2431. Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advancedย GLYCATIONย endproducts
  2432. Methylglyoxal and advancedย GLYCATIONย endproducts: new therapeutic horizons?
  2433. Role of advancedย GLYCATIONย end products in hypertension and atherosclerosis: therapeutic implications
  2434. The role of the receptor for advancedย GLYCATIONย end-products in lung fibrosis
  2435. In vitroย GLYCATIONย and antigenicity of soy proteins
  2436. Elevated levels of serum advancedย GLYCATIONย end products in patients with nonโ€alcoholic steatohepatitis
  2437. Advancedย GLYCATION: a novel outlook on atherosclerosis
  2438. Effect ofย GLYCATIONย on ฮฑ-crystallin structure and chaperone-like function
  2439. Advancedย GLYCATION: implications in tissue damage and disease
  2440. Advancedย GLYCATIONย end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
  2441. The extracellular region of the receptor for advancedย GLYCATIONย end products is composed of two independent structural units
  2442. Receptor for advancedย GLYCATIONย end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
  2443. Unveiling aย GLYCATIONย hot spot in a recombinant humanized monoclonal antibody
  2444. The LC/MS analysis ofย GLYCATIONย of IgG molecules in sucrose containing formulations
  2445. Non-enzymaticย GLYCATIONย of bone collagen modifies osteoclastic activity and differentiation
  2446. Advancedย GLYCATIONย of apolipoprotein AI impairs its anti-atherogenic properties
  2447. Receptor for advancedย GLYCATIONย end products activation injures primary sensory neurons via oxidative stress
  2448. Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication forย GLYCATION-induced hemoglobin modification
  2449. Advancedย GLYCATIONย end products increases matrix metalloproteinase-1,-3, and-13, and TNF-ฮฑ in human osteoarthritic chondrocytes
  2450. Collagen maturity,ย GLYCATIONย induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
  2451. The impact ofย GLYCATIONย on apolipoprotein AI structure and its ability to activate lecithin: cholesterol acyltransferase
  2452. Dicarbonyls linked to damage in the powerhouse:ย GLYCATIONย of mitochondrial proteins and oxidative stress
  2453. Advancedย GLYCATIONย end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease
  2454. Advancedย GLYCATIONย endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
  2455. Effects of low-and high-advancedย GLYCATIONย endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes โ€ฆ
  2456. Structural basis for pattern recognition by the receptor for advancedย GLYCATIONย end products (RAGE)
  2457. The dicarbonyl proteome: proteins susceptible to dicarbonylย GLYCATIONย at functional sites in health, aging, and disease
  2458. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advancedย GLYCATIONย end products, and myocyte resting tension
  2459. Advancedย GLYCATIONย end products enhance the proliferation and activation of hepatic stellate cells
  2460. GLYCATIONย of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogenย GLYCATION
  2461. Oxidative stress and advancedย GLYCATIONย in diabetic nephropathy
  2462. Receptor for advancedย GLYCATIONย end products is subjected to protein ectodomain shedding by metalloproteinases
  2463. Accumulation of advancedย GLYCATIONย endproducts in patients with systemic lupus erythematosus
  2464. Aged garlic extract and S-allyl cysteine prevent formation of advancedย GLYCATIONย endproducts
  2465. Elevation of soluble form of receptor for advancedย GLYCATIONย end products (sRAGE) in diabetic subjects with coronary artery disease
  2466. Reconstructed skin modified byย GLYCATIONย of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-GLYCATIONย molecules
  2467. Inhibition of NADPH oxidase prevents advancedย GLYCATIONย end productโ€“mediated damage in diabetic nephropathy through a protein kinase C-ฮฑโ€“dependent pathway
  2468. Single oral challenge by advancedย GLYCATIONย end products acutely impairs endothelial function in diabetic and nondiabetic subjects
  2469. Endothelial dysfunction in patients with chronic kidney disease results from advancedย GLYCATIONย end products (AGE)-mediated inhibition of endothelial nitric oxide โ€ฆ
  2470. Advancedย GLYCATIONย end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis
  2471. Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advancedย GLYCATIONย endproducts in tissue damage
  2472. Vimentin is the specific target in skinย GLYCATION: structural prerequisites, functional consequences, and role in skin aging
  2473. Role of soluble receptor for advancedย GLYCATIONย end products on endotoxin-induced lung injury
  2474. Effects of advancedย GLYCATIONย end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes
  2475. Advancedย GLYCATIONย end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes
  2476. Fructose consumption and consequences forย GLYCATION, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
  2477. Formation of the molten globule-like state during prolongedย GLYCATIONย of human serum albumin
  2478. Increased serum levels of advancedย GLYCATIONย endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population โ€ฆ
  2479. Role of advancedย GLYCATIONย end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice
  2480. GLYCATIONย inhibitory activity and the identification of an active compound in Plantago asiatica extract
  2481. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advancedย GLYCATIONย endproducts
  2482. Immunohistochemical localization of advancedย GLYCATIONย end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries
  2483. Advancedย GLYCATIONย and lipoxidation end productsโ€“amplifiers of inflammation: the role of food
  2484. Accelerated aging in glaucoma: immunohistochemical assessment of advancedย GLYCATIONย end products in the human retina and optic nerve head
  2485. Structural andย GLYCATIONย site changes of albumin in diabetic patient with very high glycated albumin
  2486. Serum levels of sRAGE, the soluble form of receptor for advancedย GLYCATIONย end products, are associated with inflammatory markers in patients with type 2 โ€ฆ
  2487. Advancedย GLYCATIONย end product homeostasis: exogenous oxidants and innate defenses
  2488. Increased serum advancedย GLYCATIONย endโ€products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
  2489. Involvement of advancedย GLYCATIONย end products in the pathogenesis of diabetic complications: the protective role of regular physical activity
  2490. Metformin reverts deleterious effects of advancedย GLYCATIONย end-products (AGEs) on osteoblastic cells
  2491. A soluble form of the receptor for advancedย GLYCATIONย endproducts (RAGE) is produced by proteolytic cleavage of the membraneโ€bound form by the sheddase a โ€ฆ
  2492. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advancedย GLYCATIONย end products
  2493. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobinย GLYCATION
  2494. A novel nutraceutical property of select sorghum (Sorghum bicolor) brans: inhibition of proteinย GLYCATION
  2495. Regulation of advancedย GLYCATIONย end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells
  2496. Characterization of nonenzymaticย GLYCATIONย on a monoclonal antibody
  2497. Advancedย GLYCATIONย end-product accumulation and associated protein modification in type II skeletal muscle with aging
  2498. Receptor for advancedย GLYCATIONย end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial โ€ฆ
  2499. Advancedย GLYCATIONย endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor
  2500. Effects of advancedย GLYCATIONย end products on renal fibrosis and oxidative stress in cultured NRK-49F cells
  2501. Receptor for Advancedย GLYCATIONย Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging
  2502. Free radical scavenging, anti-GLYCATIONย and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum
  2503. Agents that block advancedย GLYCATIONย end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular โ€ฆ
  2504. Receptor for advancedย GLYCATIONย end products (RAGE): a novel therapeutic target for diabetic vascular complication
  2505. Advancedย GLYCATIONย and ROS: a link between diabetes and heart failure
  2506. Proteinย GLYCATIONย inhibitors from the fruiting body of Phellinus linteus
  2507. The hemoglobinย GLYCATIONย index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial
  2508. Advancedย GLYCATIONย end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor
  2509. Oxidative stress and proteinย GLYCATIONย in primary hypothyroidism. Male/female difference
  2510. Comparative LCโ€“MS/MS profiling of free and protein-bound early and advancedย GLYCATION-induced lysine modifications in dairy products
  2511. Receptor for advancedย GLYCATIONย end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress
  2512. Protective effect of (โˆ’)-epigallocatechin gallate against advancedย GLYCATIONย endproducts-induced injury in neuronal cells
  2513. Monitoring of blood proteinsย GLYCATIONย by refractive index and spectral measurements
  2514. GLYCATIONย by ascorbic acid oxidation products leads to the aggregation of lens proteins
  2515. In skeletal muscle advancedย GLYCATIONย end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for โ€ฆ
  2516. Opposing effects of bisphosphonates and advancedย GLYCATIONย end-products on osteoblastic cells
  2517. Advancedย GLYCATIONย of type I collagen and fibronectin modifies periodontal cell behavior
  2518. Modulation of insulin action by advancedย GLYCATIONย endproducts: a new player in the field
  2519. Skin autofluorescence, a marker for advancedย GLYCATIONย end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease
  2520. Distribution of the receptor for advancedย GLYCATIONย end products in the human male reproductive tract: prevalence in men with diabetes mellitus
  2521. Advancedย GLYCATIONย end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways
  2522. Convergence and amplification of toll-like receptor (TLR) and receptor for advancedย GLYCATIONย end products (RAGE) signaling pathways via high mobility group B1 โ€ฆ
  2523. Receptor for advancedย GLYCATIONย end products (RAGE)โ€”soluble form (sRAGE) and gene polymorphisms in patients with breast cancer
  2524. Advancedย GLYCATIONย end-products induce cell cycle arrest and hypertrophy in podocytes
  2525. Inhibitors of aldose reductase and advancedย GLYCATIONย end-products formation from the leaves of Stelechocarpus cauliflorus RE Fr.
  2526. Carnosine and its constituents inhibitย GLYCATIONย of low-density lipoproteins that promotes foam cell formation in vitro
  2527. Thiazolidinedione increases serum soluble receptor for advancedย GLYCATIONย end-products in type 2 diabetes
  2528. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advancedย GLYCATIONย endproducts formation, and oxidative stress
  2529. Anti-inflammatory effects of the advancedย GLYCATIONย end product inhibitor LR-90 in human monocytes
  2530. Inhibitors of advancedย GLYCATIONย end products (AGEs): potential utility for the treatment of cardiovascular disease
  2531. Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advancedย GLYCATIONย end product precursors on tau aggregation and filament formation
  2532. Dietary advancedย GLYCATIONย endproducts and oxidative stress: in vivo effects on endothelial function and adipokines
  2533. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advancedย GLYCATIONย endproducts (RAGE)โ€“an introduction
  2534. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advancedย GLYCATIONย endproducts
  2535. Detergency effects of nanofibrillar amyloid formation onย GLYCATIONย of human serum albumin
  2536. Receptor for advancedย GLYCATIONย end products expression on T cells contributes to antigen-specific cellular expansion in vivo
  2537. Proteinย GLYCATIONย in vivo: functional and structural effects on yeast enolase
  2538. GLYCATIONย associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects
  2539. Confocal Raman microscopy can quantify advancedย GLYCATIONย end product (AGE) modifications in Bruchโ€™s membrane leading to accurate, nondestructive prediction of โ€ฆ
  2540. Plasma protein advancedย GLYCATIONย end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with โ€ฆ
  2541. Solution Structure of the Variable-Type Domain of the Receptor for Advancedย GLYCATIONย End Products: New Insight into AGEโˆ’RAGE Interaction,
  2542. Implication of receptor for advancedย GLYCATIONย end product (RAGE) in pulmonary health and pathophysiology
  2543. Decreased formation of advancedย GLYCATIONย end-products in peritoneal fluid by carnosine and related peptides
  2544. An in vitro model to test the contribution of advancedย GLYCATIONย end products to bone biomechanical properties
  2545. Propagation of proteinย GLYCATIONย damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine
  2546. The expression of receptor for advancedย GLYCATIONย end products is associated with angiogenesis in human oral squamous cell carcinoma
  2547. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advancedย GLYCATIONย end products) immunoglobulin domains
  2548. GLYCATIONย and phosphorylation of ฮฒ-lactoglobulin by dry-heating: Effect on protein structure and some properties
  2549. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advancedย GLYCATIONย end products
  2550. The combination of high glucose and advancedย GLYCATIONย end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced โ€ฆ
  2551. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advancedย GLYCATIONย end-products
  2552. Anthraquinones from the seeds of Cassia tora with inhibitory activity on proteinย GLYCATIONย and aldose reductase
  2553. Receptor for advancedย GLYCATIONย endproducts mediates neutrophil migration across intestinal epithelium
  2554. Induction of apoptosis of ฮฒ cells of the pancreas by advancedย GLYCATIONย endโ€products, important mediators of chronic complications of diabetes mellitus
  2555. GLYCATIONย of paraoxonaseโ€1 inhibits its activity and impairs the ability of highโ€density lipoprotein to metabolize membrane lipid hydroperoxides
  2556. Combination therapy with the advancedย GLYCATIONย end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or โ€ฆ
  2557. The role of advancedย GLYCATIONย end-products (AGEs) in the development of vascular diabetic complications
  2558. Methylglyoxal induces advancedย GLYCATIONย end product (AGEs) formation and dysfunction of PDGF receptorโ€ฮฒ: implications for diabetic atherosclerosis
  2559. Collagen in its fibrillar state is protected fromย GLYCATION
  2560. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advancedย GLYCATIONย end products (sRAGE) in diabetes
  2561. A new advancedย GLYCATIONย inhibitor, LR-90, prevents experimental diabetic retinopathy in rats
  2562. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advancedย GLYCATIONย endproducts
  2563. Characterization ofย GLYCATIONย adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
  2564. A novel function of the receptor for advancedย GLYCATIONย end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC
  2565. Induction of novel cytokines and chemokines by advancedย GLYCATIONย endproducts determined with a cytometric bead array
  2566. Soluble Receptor for advancedย GLYCATIONย end products (RAGE) is a prognostic factor for heart failure
  2567. Increasedย GLYCATIONย of hemoglobin in chronic renal failure patients and its potential role of oxidative stress
  2568. Decreased plasma levels of soluble receptor for advancedย GLYCATIONย end products in mild cognitive impairment
  2569. Weight increase is associated with skeletal muscle immunostaining for advancedย GLYCATIONย end products, receptor for advancedย GLYCATIONย end products, and oxidation โ€ฆ
  2570. Receptor for advancedย GLYCATIONย end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-ฮฒ-mediated cortical synaptic โ€ฆ
  2571. Advancedย GLYCATIONย end-product pentosidine accumulates in various tissues of rats with high fructose intake.
  2572. Immunoglobulinย GLYCATIONย with fructose: a comparative study
  2573. Consequential alterations in haemoglobin structure uponย GLYCATIONย with fructose: prevention by acetylsalicylic acid
  2574. Receptor for advancedย GLYCATIONย end productsโ€”soluble form and gene polymorphisms in chronic haemodialysis patients
  2575. Glutaraldehyde is an effective cross-linker for production of antibodies against advancedย GLYCATIONย end-products
  2576. Aspirin inhibits the formation of pentosidine, a cross-linking advancedย GLYCATIONย end product, in collagen
  2577. Accumulation of free adductย GLYCATION, oxidation, and nitration products follows acute loss of renal function
  2578. Advancedย GLYCATIONย endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts
  2579. L-Carnitine inhibits proteinย GLYCATIONย in vitro and in vivo: evidence for a role in diabetic management
  2580. Effect of metformin administration on plasma advancedย GLYCATIONย end product levels in women with polycystic ovary syndrome
  2581. The receptor for advancedย GLYCATIONย end products (RAGE) system in women with intraamniotic infection and inflammation
  2582. Do advancedย GLYCATIONย end products contribute to the development of long-term diabetic complications?
  2583. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advancedย GLYCATIONย end-product-mediated renal injury in streptozotocin-treated diabetic rats
  2584. Clinical relevance of advancedย GLYCATIONย endproducts for vascular surgery
  2585. Application of mass spectrometry for the detection ofย GLYCATIONย and oxidation products in milk proteins
  2586. Gly82Ser polymorphism of the receptor for advancedย GLYCATIONย end products is associated with an increased risk of gastric cancer in a Chinese population
  2587. Advancedย GLYCATIONย end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
  2588. Effect of advancedย GLYCATIONย endproducts on gene expression profiles of human dermal fibroblasts
  2589. Arguing for the motion: yes, RAGE is a receptor for advancedย GLYCATIONย endproducts
  2590. Serum levels of soluble form of receptor for advancedย GLYCATIONย end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in โ€ฆ
  2591. Antioxidant properties of soy proteinโ€“fructooligosaccharideย GLYCATIONย systems and its hydrolyzates
  2592. Chemical constituents of the style of Zea mays L. withย GLYCATIONย inhibitory activity
  2593. Advancedย GLYCATIONย end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines
  2594. Advancedย GLYCATIONย end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina
  2595. Advancedย GLYCATIONย end products induce in vitro crossโ€linking of ฮฑโ€synuclein and accelerate the process of intracellular inclusion body formation
  2596. Plasma receptor for advancedย GLYCATIONย end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation
  2597. Aldose reductase and advancedย GLYCATIONย endproducts inhibitory effect of Phyllostachys nigra
  2598. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advancedย GLYCATIONย end products and potentiates inflammation with highly homologous but โ€ฆ
  2599. Receptor for advancedย GLYCATIONย end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix
  2600. Advancedย GLYCATIONย end products (AGEs) and cardiovascular disease (CVD) in diabetes
  2601. Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advancedย GLYCATIONย end products in cultured mouse โ€ฆ
  2602. Proteomic analysis defines altered cellular redox pathways and advancedย GLYCATIONย end-product metabolism in glomeruli of db/db diabetic mice
  2603. Advancedย GLYCATIONย endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes
  2604. Circulating advancedย GLYCATIONย end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte โ€ฆ
  2605. Advancedย GLYCATIONย of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy
  2606. Erigeroflavanone, a Flavanone Derivative from the Flowers of Erigeron annuus with Proteinย GLYCATIONย and Aldose Reductase Inhibitory Activity
  2607. Metformin reduces endothelial cell expression of both the receptor for advancedย GLYCATIONย end products and lectin-like oxidized receptor 1
  2608. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advancedย GLYCATIONย end products by suppressing generation of reactive oxygen species
  2609. Inhibition of advancedย GLYCATIONย and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes
  2610. In vivo time-resolved autofluorescence measurements to test forย GLYCATIONย of human skin
  2611. Association of the Gly82Ser polymorphism in the receptor for advancedย GLYCATIONย end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory โ€ฆ
  2612. Interactions of the advancedย GLYCATIONย end product inhibitor pyridoxamine and the antioxidant ฮฑ-lipoic acid on insulin resistance in the obese Zucker rat
  2613. Nonโ€enzymaticย GLYCATIONย of type I collagen diminishes collagenโ€“proteoglycan binding and weakens cell adhesion
  2614. Spectroscopic studies of the effects ofย GLYCATIONย of human serum albumin on L-Trp binding
  2615. Demonstration of the cytotoxic effect of Advancedย GLYCATIONย Endproducts (AGE-s)
  2616. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advancedย GLYCATIONย endproducts
  2617. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advancedย GLYCATIONย end-products (TAGE) in early detection of Alzheimerโ€™s disease
  2618. Cytotoxicity of advancedย GLYCATIONย endproducts in human micro-and astroglial cell lines depends on the degree of proteinย GLYCATION
  2619. Blockade of receptor for advancedย GLYCATIONย end product attenuates pulmonary reperfusion injury in mice
  2620. Receptors for advancedย GLYCATIONย end products and their physiological and clinical significance
  2621. Possible link of food-derived advancedย GLYCATIONย end products (AGEs) to the development of diabetes
  2622. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advancedย GLYCATIONย endproducts
  2623. Skin-autofluorescence, a measure of tissue advancedย GLYCATIONย end-products (AGEs), is related to diastolic function in dialysis patients
  2624. Pigment-epithelium-derived factor suppresses expression of receptor for advancedย GLYCATIONย end products in the eye of diabetic rats
  2625. Serum levels of soluble form of receptor for advancedย GLYCATIONย end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects
  2626. Advancedย GLYCATIONย endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-ฮบB and extracellular signal-regulated โ€ฆ
  2627. Soluble receptor for advancedย GLYCATIONย end products in multiple sclerosis: a potential marker of disease severity
  2628. Restricted intake of dietary advancedย GLYCATIONย end products retards renal progression in the remnant kidney model
  2629. Dehydroepiandrosterone administration counteracts oxidative imbalance and advancedย GLYCATIONย end product formation in type 2 diabetic patients
  2630. โ€ฆ is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advancedย GLYCATIONย end โ€ฆ
  2631. Inhibition of nonโ€enzymaticย GLYCATIONย by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays)
  2632. Albumin competitively inhibitsย GLYCATIONย of less abundant proteins
  2633. Receptor for advancedย GLYCATIONย end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma
  2634. Increased serum advancedย GLYCATIONย end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy
  2635. Effect of green tea extract on advancedย GLYCATIONย and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats
  2636. The expression of the receptor forย GLYCATIONย endproducts (RAGE) in oral squamous cell carcinomas
  2637. Pathobiological role of advancedย GLYCATIONย endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy
  2638. Increased serum endogenous secretory receptor for advancedย GLYCATIONย end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function
  2639. Effect of longโ€term orlistat treatment on serum levels of advancedย GLYCATIONย endโ€products in women with polycystic ovary syndrome
  2640. Role of maltol in advancedย GLYCATIONย end products and free radicals: in-vitro and in-vivo studies
  2641. Olmesartan blocks advancedย GLYCATIONย end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression
  2642. Expression of the receptor for advancedย GLYCATIONย end products in oligodendrocytes in response to oxidative stress
  2643. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advanceย GLYCATIONย end products and its proinflammatory ligand S100A12
  2644. A neutralizing antibody against receptor for advancedย GLYCATIONย end products (RAGE) reduces atherosclerosis in uremic mice
  2645. Advancedย GLYCATIONย end products in pregnancies complicated with diabetes mellitus or preeclampsia
  2646. Developmental expression of the receptor for advancedย GLYCATIONย end-products (RAGE) and its response to hyperoxia in the neonatal rat lung
  2647. Inhibition of proteinย GLYCATIONย by skins and seeds of the muscadine grape
  2648. Analysis and biological relevance of advancedย GLYCATIONย endโ€products of DNA in eukaryotic cells
  2649. Plantar fascia thickness, a measure of tissueย GLYCATION, predicts the development of complications in adolescents with type 1 diabetes
  2650. Effect of non-enzymaticย GLYCATIONย on esterase activities of hemoglobin and myoglobin
  2651. GLYCATIONย improves the thermostability of trypsin and chymotrypsin
  2652. Inhibitory effect of vanillic acid on methylglyoxal-mediatedย GLYCATIONย in apoptotic Neuro-2A cells
  2653. The effect of peptideย GLYCATIONย on local secondary structure
  2654. Advancedย GLYCATIONย End Products of DNA: Quantification of N2-(1-Carboxyethyl)-2โ€ฒ-deoxyguanosine in Biological Samples by Liquid Chromatography โ€ฆ
  2655. Analysis of DNA-bound advancedย GLYCATIONย end-products by LC and mass spectrometry
  2656. A novel class of advancedย GLYCATIONย inhibitors ameliorates renal and cardiovascular damage in experimental rat models
  2657. Inhibition of advancedย GLYCATIONย end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?
  2658. Immunohistochemical demonstration of advancedย GLYCATIONย end products and the effects of advancedย GLYCATIONย end products in ossified ligament tissues in vitro
  2659. Advancedย GLYCATIONย end products and the absence of premature atherosclerosis in glycogen storage disease Ia
  2660. Expression of the receptor of advancedย GLYCATIONย end products in the gingival tissue of smokers with generalized periodontal disease and after nornicotine induction in โ€ฆ
  2661. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advancedย GLYCATIONย end products: evidence for the multiple-hit agent?
  2662. Soluble receptor for advancedย GLYCATIONย end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and โ€ฆ
  2663. Angiotensin II receptor blocker inhibits abnormal accumulation of advancedย GLYCATIONย end products and retinal damage in a rat model of type 2 diabetes
  2664. Serum level of advancedย GLYCATIONย end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population
  2665. Advancedย GLYCATIONย end product deposits in climatic droplet keratopathy
  2666. Aldoseโ€Reductaseโ€ and Proteinโ€GLYCATIONโ€Inhibitory Principles from the Whole Plant of Duchesnea chrysantha
  2667. Nonโ€enzymaticย GLYCATIONย of chondrocyteโ€seeded collagen gels for cartilage tissue engineering
  2668. Effect of taurine on advancedย GLYCATIONย end products-induced hypertrophy in renal tubular epithelial cells
  2669. Lung level of HMBG1 is elevated in response to advancedย GLYCATIONย end productโ€enriched food in vivo
  2670. Detection of feto-maternal infection/inflammation by the soluble receptor for advancedย GLYCATIONย end products (sRAGE): results of a pilot study
  2671. Proteinย GLYCATIONย and methylglyoxal metabolism in yeast: finding peptide needles in protein haystacks
  2672. DNA damage duringย GLYCATIONย of lysine by methylglyoxal: assessment of vitamins in preventing damage
  2673. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advancedย GLYCATIONย end-products.
  2674. Beneficial effects of C36, a novel breaker of advancedย GLYCATIONย endproducts crossโ€links, on the cardiovascular system of diabetic rats
  2675. Effects of phosphatidylethanolamineย GLYCATIONย on lipidโ€“protein interactions and membrane protein thermal stability
  2676. Assaying soluble forms of receptor for advancedย GLYCATIONย end products
  2677. GLYCATIONย damage targets glutamate dehydrogenase in the rat liver mitochondrial matrix during aging
  2678. Measurement of advancedย GLYCATIONย endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non โ€ฆ
  2679. Peroxyl radicals are essential reagents in the oxidation steps of the Maillard reaction leading to generation of advancedย GLYCATIONย end products
  2680. Adverse effects of advancedย GLYCATIONย end products on embryonal development
  2681. Effects of cross-link breakers,ย GLYCATIONย inhibitors and insulin sensitisers on HDL function and the non-enzymaticย GLYCATIONย of apolipoprotein AI
  2682. Receptor for advancedย GLYCATIONย end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis
  2683. Advancedย GLYCATIONย index and its association with severity of diabetic retinopathy in type 2 diabetic subjects
  2684. Reduced systemic advancedย GLYCATIONย end products in children receiving peritoneal dialysis with low glucose degradation product content
  2685. Receptor for advancedย GLYCATIONย end products (RAGE) mediates neuronal differentiation and neurite outgrowth
  2686. Associated links among mtDNAย GLYCATION, oxidative stress and colony sectorization in Metarhizium anisopliae
  2687. Protective effect of Withania somnifera (Solanaceae) on collagenย GLYCATIONย and cross-linking
  2688. Inhibitory effect of GSPE on RAGE expression induced by advancedย GLYCATIONย end products in endothelial cells
  2689. Induction of receptor for advancedย GLYCATIONย end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis โ€ฆ
  2690. Expression of receptor for advancedย GLYCATIONย end products in sarcoid granulomas
  2691. โ€ฆ candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advancedย GLYCATION, oxidative stress and โ€ฆ
  2692. Kinetic analysis on the sensitivity of glucose-or glyoxal-induced LDLย GLYCATIONย to the inhibitory effect of Psidium guajava extract in a physiomimic system
  2693. GLYCATIONย of a lysine-containing tetrapeptide by d-glucose and d-fructoseโ€”influence of different reaction conditions on the formation of Amadori/Heyns products
  2694. Site-selective proteinย GLYCATIONย and PEGylation
  2695. Specific siRNA targeting the receptor for advancedย GLYCATIONย end products inhibits experimental hepatic fibrosis in rats
  2696. Pigment epithelium-derived factor (PEDF) ameliorates advancedย GLYCATIONย end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 โ€ฆ
  2697. Raman spectroscopy of advancedย GLYCATIONย end products (AGEs), possible markers for progressive retinal dysfunction
  2698. Protein seeding of gold nanoparticles and mechanism ofย GLYCATIONย sensing
  2699. Possible involvement of tobacco-derived advancedย GLYCATIONย end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former โ€ฆ
  2700. Endogenous secretory receptor for advancedย GLYCATIONย end products in nonโ€“small cell lung carcinoma
  2701. Studies on N-Terminalย GLYCATIONย of Peptides in Hypoallergenic Infant Formulas:โ€‰ Quantification of ฮฑ-N-(2-Furoylmethyl) Amino Acids
  2702. Investigation of pathways of advancedย GLYCATIONย endโ€products accumulation in macrophages
  2703. Skin advancedย GLYCATIONย end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9)
  2704. Sinomenine inhibits activation of rat retinal microglia induced by advancedย GLYCATIONย end products
  2705. Advancedย GLYCATIONย end products and sorbitol in blood from differently compensated diabetic dogs
  2706. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advancedย GLYCATIONย end products through activation of โ€ฆ
  2707. Serum levels of soluble form of receptor for advancedย GLYCATIONย end products (sRAGE) may reflect tissue RAGE expression in diabetes
  2708. Advancedย GLYCATIONย end products and receptors in Fuchsโ€™ dystrophy corneas undergoing Descemetโ€™s stripping with endothelial keratoplasty
  2709. The formation of argpyrimidine in glyceraldehyde-relatedย GLYCATION
  2710. โ€ฆ glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advancedย GLYCATIONย end product inhibitors
  2711. Modification of vimentin: a general mechanism of nonenzymaticย GLYCATIONย in human skin
  2712. Evaluation of advancedย GLYCATIONย end-products in diabetic and inherited canine cataracts
  2713. Receptor for advancedย GLYCATIONย end product expression in experimental diabetic retinopathy
  2714. Genomic damage and malignancy in end-stage renal failure: do advancedย GLYCATIONย end products contribute?
  2715. The structural modification of DNA nucleosides by nonenzymaticย GLYCATION: an in vitro study based on the reactions of glyoxal and methylglyoxal with 2 โ€ฆ
  2716. Advancedย GLYCATIONย End Products Upregulate Cโ€reactive Protein Synthesis by Human Hepatocytes Through Stimulation of Monocyte ILโ€6 and ILโ€1ฮฒ Production
  2717. Inhibitors of advancedย GLYCATIONย endโ€products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats
  2718. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albuminย GLYCATION
  2719. Detection and determination of glyceraldehyde-derived pyridinium-type advancedย GLYCATIONย end product in streptozotocin-induced diabetic rats
  2720. Concentrations of receptor for advancedย GLYCATIONย end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without โ€ฆ
  2721. Relationship between proinsulin-to-insulin ratio and advancedย GLYCATIONย endproducts in Japanese type 2 diabetic subjects
  2722. The HMG-CoA reductase inhibitor cerivastatin lowers advancedย GLYCATIONย end products in patients with type 2 diabetes
  2723. Endogenous secretory receptor for advancedย GLYCATIONย end-products and cardiovascular disease in end-stage renal disease
  2724. Effect of pyridoxamine (K-163), an inhibitor of advancedย GLYCATIONย end products, on type 2 diabetic nephropathy in KK-Ay/Ta mice
  2725. Pigment epithelium-derived factor (PEDF) prevents advancedย GLYCATIONย end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its โ€ฆ
  2726. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advancedย GLYCATIONย end products, are related to the cognitive โ€ฆ
  2727. Increased pentosidine, an advancedย GLYCATIONย endโ€product, in urine and tissue reflects disease activity in inflammatory bowel diseases
  2728. Effect of protocatechualdehyde on receptor for advancedย GLYCATIONย end products and TGF-ฮฒ1 expression in human lens epithelial cells cultured under diabetic โ€ฆ
  2729. Validation of Hemoglobinย GLYCATIONย Models Using Glycemia Monitoring In Vivo and Culturing of Erythrocytes In Vitro
  2730. Decreased levels of soluble receptor for advancedย GLYCATIONย end products in patients with primary Sjรถgrenโ€™s syndrome
  2731. Evaluating the extent of protein damage in dairy products: simultaneous determination of early and advancedย GLYCATIONโ€induced lysine modifications
  2732. Advancedย GLYCATIONย as a basis for understanding retinal aging and noninvasive risk prediction
  2733. Studies on the Effect of Amadoriase from Aspergillus fumigatus on Peptide and Proteinย GLYCATIONย In Vitro
  2734. Glyceraldehyde-derived advancedย GLYCATIONย end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats
  2735. Telmisartan inhibits advancedย GLYCATIONย end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome โ€ฆ
  2736. Pregnancy-associated plasma protein a and soluble receptor for advancedย GLYCATIONย end products after kidney transplantation
  2737. Blockade of the advancedย GLYCATIONย end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial โ€ฆ
  2738. Enhancement of epithelial sodium channel expression in renal cortical collecting ducts cells by advancedย GLYCATIONย end products
  2739. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advancedย GLYCATIONย end products
  2740. The binding of advancedย GLYCATIONย end products to cell surfaces can be measured using bead-reconstituted cellular membrane proteins
  2741. Unchanged serum levels of advancedย GLYCATIONย endproducts in patients with liver disease
  2742. Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of theย GLYCATIONย gap for mechanism of risk prediction
  2743. Effects of Compounds Isolated from the Fruits of Rumex japonicus on the Proteinย GLYCATION
  2744. Effects of advancedย GLYCATIONย end product modification on proximal tubule epithelial cell processing of albumin
  2745. GLYCATIONย of lowโ€density lipoprotein results in the timeโ€dependent accumulation of cholesteryl esters and apolipoprotein Bโ€100 protein in primary human monocyte โ€ฆ
  2746. Kinetic study of the reaction of glycolaldehyde with twoย GLYCATIONย target models
  2747. Inhibiting albuminย GLYCATIONย attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
  2748. A novel inhibitor of advancedย GLYCATIONย and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia
  2749. Methylglyoxal inhibitsย GLYCATION-mediated loss in chaperone function and synthesis of pentosidine in ฮฑ-crystallin
  2750. Extracellular superoxide released from mitochondria mediates mast cell death by advancedย GLYCATIONย end products
  2751. In vitroย GLYCATIONย of brain aminophospholipids by acetoacetate and its inhibition by urea
  2752. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advancedย GLYCATIONย end products following hypoxia/ischemia
  2753. Advancedย GLYCATIONย end products, oxidative stress and metalloproteinases are altered in the cerebral microvasculature during aging
  2754. Endogenous secretory receptor for advancedย GLYCATIONย endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes
  2755. Inhibition of advancedย GLYCATIONย end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
  2756. Constituents of the flowers of Erigeron annuus with inhibitory activity on the formation of advancedย GLYCATIONย end products (AGEs) and aldose reductase
  2757. Advancedย GLYCATIONย end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.
  2758. Development of receptor for advancedย GLYCATIONย end productsโ€“directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis
  2759. Reduced expression of endogenous secretory receptor for advancedย GLYCATIONย endproducts in hippocampal neurons of Alzheimerโ€™s disease brains
  2760. Rosiglitazone reduces angiotensin II and advancedย GLYCATIONย end product-dependent sustained nuclear factor-ฮบB activation in cultured human proximal tubular โ€ฆ
  2761. Identification of AGE-precursors and AGE formation inย GLYCATION-induced BSA peptides
  2762. Non-enzymatic interactions of glyoxylate with lysine, arginine, and glucosamine: a study of advanced non-enzymaticย GLYCATIONย like compounds
  2763. Formation mechanisms of melanoidins and fluorescent pyridinium compounds as advancedย GLYCATIONย end products
  2764. Nonenzymaticย GLYCATIONย of guanosine 5โ€ฒ-triphosphate by glyceraldehyde: an in vitro study of AGE formation
  2765. Effects of advancedย GLYCATIONย end productsโ€inductor glyoxal and hydrogen peroxide as oxidative stress factors on rat retinal organ cultures and neuroprotection by UK โ€ฆ
  2766. Proteinย GLYCATIONย and endothelium dysfunction
  2767. Rosiglitazone prevents advancedย GLYCATIONย end productsโ€“induced renal toxicity likely through suppression of plasminogen activator inhibitor-1
  2768. Advancedย GLYCATIONย endproducts induce a proliferative response in vascular smooth muscle cells via altered calcium signaling
  2769. Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advancedย GLYCATIONย end โ€ฆ
  2770. Assay validation and biological variation of serum receptor for advancedย GLYCATIONย end-products
  2771. TRC4149 a novel advancedย GLYCATIONย end product breaker improves hemodynamic status in diabetic spontaneously hypertensive rats
  2772. Advancedย GLYCATIONย end-product-induced mitogenesis is dependent on Janus kinase 2-induced heat shock protein 70 in normal rat kidney interstitial fibroblast cells
  2773. โ€ฆ Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advancedย GLYCATIONย End โ€ฆ
  2774. Advancedย GLYCATIONย end products inhibit production and activity of matrix metalloproteinase-2 in human umbilical vein endothelial cells
  2775. Simultaneous determination of the advancedย GLYCATIONย end product N ษ›-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope โ€ฆ
  2776. Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advancedย GLYCATIONย end products
  2777. Advancedย GLYCATIONย end products serve as ligands for lectinโ€like oxidized lowโ€density lipoprotein receptorโ€1 (LOXโ€1): biochemical and binding characterizations โ€ฆ
  2778. Advancedย GLYCATIONย end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors
  2779. Fetal hemoglobin: assessment ofย GLYCATIONย and acetylation status by electrospray ionization mass spectrometry
  2780. Dihydroxyacetoneโ€induced death is accompanied by advancedย GLYCATIONย endproduct formation in selected proteins of Saccharomyces cerevisiae and Caenorhabditis โ€ฆ
  2781. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advancedย GLYCATIONย end-product (AGE)-induced monocyte chemoattractant protein-1 expression in โ€ฆ
  2782. Endogenous secretory receptor for advancedย GLYCATIONย endproducts as a novel prognostic marker in chondrosarcoma
  2783. Pigment epithelium-derived factor (PEDF) blocks advancedย GLYCATIONย end product (AGE)-induced angiogenesis in vitro
  2784. โ€ฆ of peroxisome proliferator-activated receptor-ฮณ2 gene is associated with plasma levels of soluble rage (receptor for advancedย GLYCATIONย endproducts) and the โ€ฆ
  2785. Involvement of inducible nitric oxide synthase and receptor for advancedย GLYCATIONย end products in periapical granulomas
  2786. Endogenous soluble receptor for advancedย GLYCATIONย endproducts is increased in preeclampsia
  2787. Screening of Korean herbal medicines with inhibitory activity on advancedย GLYCATIONย end products (AGEs) formation (II)
  2788. Model studies on proteinย GLYCATION: influence of cysteine on the reactivity of arginine and lysine residues toward glyoxal
  2789. Therapeutic interruption of advancedย GLYCATIONย in diabetic nephropathy: do all roads lead to Rome?
  2790. Inhibition of renin-angiotensin system and advancedย GLYCATIONย end products formation: a promising therapeutic approach targeting on cardiovascular diseases
  2791. In vitro nonenzymaticย GLYCATIONย of guanosine 5โ€ฒ-triphosphate by dihydroxyacetone phosphate
  2792. Enhancedย GLYCATIONย of hemoglobin and plasma proteins is associated with increased lipid peroxide levels in non-diabetic hypertensive subjects
  2793. GLYCATIONย Methods for Bombesin Analogs Containing the (NฮฑHis)Ac chelator for 99mTc(CO)3 Radiolabeling
  2794. Serum Levels of the Advancedย GLYCATIONย End Products Nฮต-Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II โ€ฆ
  2795. Photosensitizing activity of advancedย GLYCATIONย endproducts on tryptophan, glucose 6โ€phosphate dehydrogenase, human serum albumin and ascorbic acid evaluated โ€ฆ
  2796. Analyses of the in vitro non-enzymaticย GLYCATIONย of peptides/proteins by matrix-assisted laser desorption/ionization mass spectrometry
  2797. Mass spectrometry to detect the site specificity of advancedย GLYCATION/lipoxidation end-product formation on protein: some challenges and solutions
  2798. Relationship between theโˆ’ 374T/A receptor of advancedย GLYCATIONย end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal โ€ฆ
  2799. GLYCATIONย does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: The response to glycated and nonglycated BSA is lost in metabolic โ€ฆ
  2800. Hepatic expression of galectin-3 and receptor for advancedย GLYCATIONย end products in patients with liver disease
  2801. The association of advancedย GLYCATIONย end-products with glutathione status
  2802. Receptor for advancedย GLYCATIONย end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
  2803. Receptor for advancedย GLYCATIONย end product polymorphisms and type 2 diabetes: the CODAM study
  2804. Role of the specifically targeted lysine residues in theย GLYCATIONย dependent loss of chaperone activity of ฮฑA-and ฮฑB-crystallins
  2805. Urinary excretion of fluorescent advancedย GLYCATIONย end products (AGEs) in the elderly
  2806. GLYCATIONย of plasma lipoprotein lipid membrane and screening for lipidย GLYCATIONย inhibitor
  2807. Positive correlation between vitreous levels of advancedย GLYCATIONย end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently โ€ฆ
  2808. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advancedย GLYCATIONย end product (AGE)-related disorders
  2809. Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advancedย GLYCATIONย end products (hsRAGE) in โ€ฆ
  2810. Determination of glyceraldehyde formed in glucose degradation andย GLYCATION
  2811. A novel pleiotropic effect of atorvastatin on advancedย GLYCATIONย end product (AGE)-related disorders
  2812. Study on anti-oxidation and inhibitory effect on nonenzymaticย GLYCATIONย reaction of fermentation extract from biotransformation of Ginkgo biloba L.(EGB) by Hericium โ€ฆ
  2813. Nifedipine, a calcium-channel blocker, inhibits advancedย GLYCATIONย end-product-induced expression of monocyte chemoattractant protein-1 in human cultured โ€ฆ
  2814. Does renal function influence plasma levels of advancedย GLYCATIONย and oxidation protein products in patients with chronic rheumatic diseases complicated by โ€ฆ
  2815. Macronutrients, advancedย GLYCATIONย end products, and vascular reactivity
  2816. Advancedย GLYCATIONย end-products in senile diabetic and non-diabetic patients with cardiovascular complications
  2817. Preparation of nucleotide advancedย GLYCATIONย endproductsโ€”imidazopurinone adducts formed byย GLYCATIONย of deoxyguanosine with glyoxal and methylglyoxal
  2818. Carboxylic acid drug-induced DNA nicking in HEK293 cells expressing human UDP-glucuronosyltransferases: role of acyl glucuronide metabolites andย GLYCATIONย โ€ฆ
  2819. A possible involvement of crosstalk between advancedย GLYCATIONย end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase โ€ฆ
  2820. MMP9 is involved inย GLYCATIONย end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline
  2821. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advancedย GLYCATIONย end-product Nษ› โ€ฆ
  2822. Advancedย GLYCATIONย end products and their receptors elevate the activity of endothelin-1 in rat cavernosum
  2823. Up-regulation of the receptor for advancedย GLYCATIONย end product (RAGE) in esophageal cancer and down-regulation in lung cancer and their relationship to โ€ฆ
  2824. CHANGES IN REDOX RATIO AND PROTEINย GLYCATIONย IN PRECATARACTOUS LENS FROM FRUCTOSEโ€FED RATS: EFFECTS OF EXOGENOUS lโ€CARNITINE
  2825. Involvement of Na+/H+ exchanger 1 in advancedย GLYCATIONย end products-induced proliferation of vascular smooth muscle cell
  2826. Nโ€terminalย GLYCATIONย of Proteins and Peptides in Foods and in Vivo: Evaluation of Nโ€(2โ€Furoylmethyl) Valine in Acid Hydrolyzates of Human Hemoglobin
  2827. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advancedย GLYCATIONย end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator โ€ฆ
  2828. Effect ofย GLYCATIONย on the structure and dynamics of DNA: a critical spectroscopic approach
  2829. Amplifiers of systemic inflammation-the role advancedย GLYCATIONย and and lipoxidation end products in foods
  2830. In vitroย GLYCATIONย of Hemoglobin by Acetone and-hydroxibutirate
  2831. Advancedย GLYCATIONย end-product-inhibited cell proliferation and protein expression of ฮฒ-catenin and cyclin D1 are dependent on glycogen synthase kinase 3ฮฒ in LLC โ€ฆ
  2832. Advancedย GLYCATIONย and lipoxidation end productsโ€“amplifiers of inflammation: the role of food
  2833. Inhibition of advancedย GLYCATIONย by flavonoids. A nutritional implication for preventing diabetes complications?
  2834. Impact of glucose levels on advancedย GLYCATIONย end products in hemodialysis
  2835. Constituents of the seeds of Cornus officinalis with inhibitory activity on the formation of advancedย GLYCATIONย end products (AGEs)
  2836. Preparation of advancedย GLYCATIONย end products in vitro
  2837. Increasedย GLYCATIONย of hemoglobin and plasma proteins in normotensive, non-diabetic obese Indian subjects: putative role of lipid peroxides
  2838. Fructoseโ€induced Nโ€terminalย GLYCATIONย of enkephalins and related peptides
  2839. Nฮต-(Carboxymethyl)Lysine, a Major Advancedย GLYCATIONย End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma
  2840. Preparation of mannanโ€“protein conjugates using highโ€temperatureย GLYCATION
  2841. The โˆ’374A allele of the receptor for advancedย GLYCATIONย end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes โ€ฆ
  2842. Retinol up-regulates the receptor for advancedย GLYCATIONย endproducts (RAGE) by increasing intracellular reactive species
  2843. Endproducts and receptor of advancedย GLYCATIONย and lipoxidation (AGE, ALE, RAGE) and chronic diseasesโ€“a food perspective
  2844. Self-vaccination by methamphetamineย GLYCATIONย products chemically links chronic drug abuse and cardiovascular disease
  2845. An ellagic acid rhamnoside from the roots of Potentilla discolor with proteinย GLYCATIONย and rat lens aldose reductase inhibitory activity
  2846. Co-injury effects of advancedย GLYCATIONย end products and homocysteine on endothelial cells
  2847. Association of serum carboxymethyl-lysine, a dominant advancedย GLYCATIONย end product, with anemia in adults: the Baltimore Longitudinal Study of Aging
  2848. Editorial [Advancedย GLYCATIONย End Products (AGEs) and their Receptor (RAGE) in Health and Disease Executive Editor: Sho-ichi Yamagishi]
  2849. Localization of the ezrin binding epitope for advancedย GLYCATIONย endproducts
  2850. Effects of 12-month valsartan therapy onย GLYCATIONย and oxidative stress markers in type 2 diabetic subjects with hypertension
  2851. In vitro effect of ฮฑ-tocopherol, ascorbic acid and lycopene on low density lipoproteinย GLYCATION
  2852. 17ฮฒโ€OESTRADIOL PARTIALLY ATTENUATES THE INHIBITION OF NITRIC OXIDE SYNTHASEโ€3 BY ADVANCEDย GLYCATIONย ENDโ€PRODUCTS IN HUMAN โ€ฆ
  2853. Proteinย GLYCATIONย and cataract: a conformational disease
  2854. Flavan-3-ols from Ulmus davidiana var. japonica with inhibitory activity on proteinย GLYCATION
  2855. The morphological changes of vascular endothelial cadherin in human umbilical vein endothelial cells induced by advancedย GLYCATIONย end products
  2856. Atorvastatin inhibits advancedย GLYCATIONย end products (AGE)-induced C-reactive expression in hepatoma cells by suppressing reactive oxygen species generation
  2857. Advancedย GLYCATIONย endproduct-induced diabetic complications
  2858. Immunogenicity of advancedย GLYCATIONย end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantation
  2859. Regulation of Src homology 2โ€“containing protein tyrosine phosphatase by advancedย GLYCATIONย end products: the role on atherosclerosis in diabetes
  2860. The HLA 8.1 ancestral haplotype is strongly linked to the C allele ofโˆ’ 429T> C promoter polymorphism of receptor of the advancedย GLYCATIONย endproduct (RAGE) gene โ€ฆ
  2861. Inihbition of Proteinย GLYCATIONย with Varying Concentrations of Lysine
  2862. โ€ฆ impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advancedย GLYCATIONย โ€ฆ
  2863. Advancedโ€GLYCATIONย end products (AGEs) derived from glycated albumin suppress early ฮฒ1โ€adrenergic preconditioning
  2864. โ€ฆ and fluorine-18 radiolabeling of recombinant S100 proteinsโ€”potential probes for molecular imaging of receptor for advancedย GLYCATIONย endproducts (RAGE) in vivo
  2865. โ€ฆ (3-[4, 5-dimethylthioazol-2-yl]-2, 5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advancedย GLYCATIONย โ€ฆ
  2866. The RAGE connection to diabetes and atherosclerosis: an intertwined web of advancedย GLYCATIONย and inflammation
  2867. A patient with hyperglycaemia and normal HbA Ic due to impairedย GLYCATION.
  2868. Method for chronological recording of antigen appearance in human head-hair shafts and its use for monitoringย GLYCATIONย products in diabetes
  2869. Alteration of the thermodynamic characteristics of corneal collagen denaturation as a result of nonenzymaticย GLYCATION
  2870. The effect of nonenzymaticย GLYCATIONย on the stability and conformation of two deoxyoligonucleotide duplexes: A spectroscopic analysis by circular dichroism
  2871. Impairment effect and mechanism of advancedย GLYCATIONย end products on hippocampi rats
  2872. Association of Gly82Ser polymorphism of receptor for advancedย GLYCATIONย end products gene in a type 2 diabetic Chinese population
  2873. Puerarol from the roots of Pueraria lobata inhibits the formation of advancedย GLYCATIONย end products (AGEs) in vitro
  2874. Physiology of the skin: the impact ofย GLYCATIONย on the skin, part 2
  2875. Monitoring the effect of glyoxal and methylglyoxalย GLYCATIONย on the secondary structure of human serum albumin: an analysis based on CD, ESIโ€MALDIโ€TOF/MS โ€ฆ
  2876. Can tryptophan oxidation lead to lower tryptophan level in diabetes? A commentary onโ€ Propagation of proteinย GLYCATIONย damage involves modification of tryptophan โ€ฆ
  2877. Rutin metabolites as powerful inhibitors of advancedย GLYCATIONย end products
  2878. Establishment of An Analyzing Approach for Advancedย GLYCATIONย End Products Formed in Vitro by Flow Injection Assay [J]
  2879. Correlation of low molecular weight advancedย GLYCATIONย end products and nitric oxide metabolites with chronic complications in type 1 diabetic patients
  2880. Increased reactive oxygen species in endothelial cells stimulated by advancedย GLYCATIONย end products mediated by NADPH oxidase
  2881. The Role of Advancedย GLYCATIONย in Diabetic Retinopathy
  2882. Non-enzymaticย GLYCATIONย in diabetic complications
  2883. Effect of advancedย GLYCATIONย end products on injuring of rat renal microvascular endothelial cells and protective effect of probucol
  2884. Telmisartan blocks advancedย GLYCATIONย end product (AGE)-induced plasminogen activator inhibitor-1 (PAI-1) gene expression in endothelial cells via activation of โ€ฆ
  2885. Effects of Shenkangwan on renal advancedย GLYCATIONย end products and their receptor expression in early diabetic nephropathy rats [J]
  2886. Cardiac troponin T and advancedย GLYCATIONย end-products in hemodialysis patients
  2887. Effect of treatment with anti-receptor for advancedย GLYCATIONย end products antibody on multiple organ dysfunction and mortality in rats after severe thermal injury
  2888. โ€ฆ of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advancedย GLYCATIONย end products/inducible nitric โ€ฆ
  2889. What is the influence of renal function on the prognostic value of advancedย GLYCATIONย end-products and sRAGE in heart failure?
  2890. Letter by Connelly et al regarding article,โ€œDiastolic stiffness of the failing diabetic heart: importance of fibrosis, advancedย GLYCATIONย end products, and myocyte resting โ€ฆ
  2891. Effecs of Advancedย GLYCATIONย end products (AGEs) on Diabetic Microangiopathy [J]
  2892. Comment on: Lachin et al.(2007) The Hemoglobinย GLYCATIONย Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control โ€ฆ
  2893. Mutant mice provide new insight into the role of (mis-)ย GLYCATIONย in IgA nephropathy and other glomerular diseases
  2894. Comment on: Thallas-Bonke et al.(2008) Inhibition of NADPH Oxidase Prevents Advancedย GLYCATIONย End Productโ€“Mediated Damage in Diabetic Nephropathy โ€ฆ
  2895. Oxidative damage to DNA and lipids: correlation with proteinย GLYCATIONย in patients with type 1 diabetes
  2896. Effect of advancedย GLYCATIONย end products on the content of nitric oxide and the activity of nitric oxide synthase in rat cavernosum
  2897. โ€ฆ dependent DNA Immune complex mediated cell activation by High Mobility Group Box Protein 1 (HMGB1) and Receptor for Advancedย GLYCATIONย End products (RAGE โ€ฆ
  2898. Advancedย GLYCATIONย end-products and mechanical properties are altered in cortical bone of beagle dogs following 1-year treatment with high-doses, but not โ€ฆ
  2899. Nucleophilic compounds decrease advancedย GLYCATIONย end products (AGEs) from ascorbic acid in the hSVCT2 transgenic mouse model of lenticular aging
  2900. Study on the Effects of Catechin, Caffeine and Gallic Acid on In Vitroย GLYCATIONย Reaction of Albumin
  2901. GLYCATIONย Mechanism of D-Galactose-Induced Kidney Injury in Rats and Its Drug Intervention [J]
  2902. A possible mechanism for link between advancedย GLYCATIONย end products and the development of osteoarthritis
  2903. Amount of Nฯ‰-(Carboxymethyl)Arginine Generated in Collagen and Bovine Serum Albumin duringย GLYCATIONย Reactions is Significantly Different
  2904. Clinical significance of serum concentrations of advanced oxidation protein products and advancedย GLYCATIONย end products in patients with acute coronary syndrome
  2905. Correlation between the expression of high mobility group box 1 and receptor for advancedย GLYCATIONย end products and the onset of pre-eclampsia
  2906. P4โ€389: An oral antagonist of the receptor for advancedย GLYCATIONย end products (RAGE) is safe and wellโ€tolerated in the treatment of Alzheimerโ€™s disease: Results from โ€ฆ
  2907. Effect of succinic acid monoethyl ester on hemoglobinย GLYCATIONย and tail tendon collagen properties in type 2 diabetic rats
  2908. Effects of Jiejufushenning on advancedย GLYCATIONย end products in serum and expression of receptor for advancedย GLYCATIONย end products in kidney in diabetic rats
  2909. Impact of plasma proteinย GLYCATIONย on lipid profile in diabetics with and without complications.
  2910. Clinical and prognostic value of advancedย GLYCATIONย end-products (AGEs) in chronic heart failure
  2911. Clinical significance of serum advancedย GLYCATIONย end products in coronary artery disease patients with metabolic syndrome [J]
  2912. Study on the nonenzymaticย GLYCATIONย of nucleosides/nucleotides and proteins with sugars: An in vitro investigation of advancedย GLYCATIONย endproducts (AGEs) โ€ฆ
  2913. The effects of caspase-3 in apoptosis of cultured retinal microvascular pericytes induced by advancedย GLYCATIONย end products
  2914. Inhibitory effect of some acetyl esters and acetamides onย GLYCATIONย of the histone H1
  2915. The Effect of Advancedย GLYCATIONย End Products on Primary Culture of Neonatal Rat Kidney Cells
  2916. Inhibition of Proteinย GLYCATIONย by Dietary Agents: Implications in the Prevention of Diabetic Ocular Complications
  2917. Biochemical effects of proteinย GLYCATIONย by methylglyoxal in Saccharomyces cerevisiae
  2918. The immunocytochemical location of exogenous advancedย GLYCATIONย end products on the expression of vascular endothelial growth factor in the rats [J]
  2919. Chemopreventive activity of natural source compounds against advancedย GLYCATIONย endproduct induced carcinogenesis
  2920. Response to Comment on: Lachin et al.(2007) The Hemoglobinย GLYCATIONย Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the โ€ฆ
  2921. Increased Advancedย GLYCATIONย End-Products (AGEs) in Trabecular Meshwork of Patients With Primary and Secondary Glaucoma
  2922. Effects of advancedย GLYCATIONย end products on proliferation and apotosis of human renal tubular epithelial cells [J]
  2923. Advancedย GLYCATIONย end-products (AGEs) in the anterior chamber angle of patients with glaucoma
  2924. THE ROLE OF FOOD INย GLYCATIONย AND LIPOXIDATION OF END PRODUCTSANDโ€“AMPLIFIERS OF INFLAMMATION
  2925. Effects of advancedย GLYCATIONย end products on insulin-like growth factor-1 expression in rat mesangial cells [J]
  2926. Expression of receptor for advancedย GLYCATIONย end products in pancreatic stellate cells of rats [J]
  2927. Earlyย GLYCATIONย of Critical Fibronectin domains inhibits human dermal fibroblast migration
  2928. Increased serum advancedย GLYCATIONย end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy
  2929. Effect of advancedย GLYCATIONย end-products on the gene expression of osteoprotegerin in cultured rat vascular smooth muscle cells [J]
  2930. Inhibition of proteinย GLYCATIONย by polyphenolic extracts of culinary herbs and spices
  2931. EFFECT OF GRAPE SEED PROANTHOCYANIDIN ON ADVANCEDย GLYCATIONย END PRODUCTSINDUCED TUMOR NECROSIS FACTOR-ฮฑ SECRETION IN โ€ฆ
  2932. Role of receptor for advancedย GLYCATIONย end products (RAGE) in brain ischemia injury and its mechanisms
  2933. Pentosidine and soluble receptor for advancedย GLYCATIONย end-product (RAGE) are important prognostic factors independent of renal function in heart failure
  2934. Crocetin reduces expression of receptor for advancedย GLYCATIONย end products (RAGE) on endothelial cells induced by AGE
  2935. Research on advancedย GLYCATIONย endproducts detecting methods
  2936. Response to Letter Regarding Article,โ€œDiastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advancedย GLYCATIONย End Products, and Myocyte Resting โ€ฆ
  2937. Advancedย GLYCATIONย and lipoxidation end-products amplify inflammation. The role of a healthy diet
  2938. Evidence for independent heritability of theย GLYCATIONย gap (glycosylation gap) fraction of HbA1c in nondiabetic twins: response to Cohen et al.
  2939. Studies on proteinย GLYCATION
  2940. Establishment of a real-time quantitative polymerase chain reaction for detection of human receptor for advancedย GLYCATIONย end products (RAGE) mRNA and its โ€ฆ
  2941. DEPRESSANT EFFECT OF SILYBIN-PHOSPHATIDYLCHOLINE COMPOUND (SPC) ON ADVANCEDย GLYCATIONย END PRODUCTS (AGEs) IN ALLOXAN โ€ฆ
  2942. Editorial [Receptor for Advancedย GLYCATIONย Endproducts (RAGE): Coming Full Circle in Unraveling the Pathogenesis of Chronic Disease Guest Editor: Ann Marie โ€ฆ
  2943. Erythropoietin (Epo) Protects Retinal Neurons From Advancedย GLYCATIONย End Products (AGEs)-Induced Apoptosis via Erk and AKT Pathways
  2944. HMGB1 is an early mediator of inflammation and may be negatively regulated by soluble receptor for advancedย GLYCATIONย end products in experimental endotoxinemia โ€ฆ
  2945. THE EFFECTS OF EXTRACT GINGKO BILOBA THE INHIBITION OF NONENZYMATICย GLYCATIONย AND OXIDATION IN MYO-CARDIAL TISSUE OF TYPE 2 โ€ฆ
  2946. No evidence for advancedย GLYCATIONย endproducts in cancer
  2947. Anti-GLYCATIONย Activities from Various Agricultural Products
  2948. The receptor for advancedย GLYCATIONย endproducts and S100A11 modulate pathologic chondrocyte differentiation and dysregulated cartilage matrix catabolism โ€ฆ
  2949. The orgin of advancedย GLYCATIONย endproducts and development of diabetic complications
  2950. Lysine as an Inhibito of Proteinย GLYCATIONย in an In Vitro System
  2951. The role of advancedย GLYCATIONย end products in periodontal diseases [J]
  2952. Non-invasive measurement of advancedย GLYCATIONย end products in patients with cerebral infarction
  2953. Application of spectral method for monitoring of hemoglobinย GLYCATION
  2954. Influence of flavonols as in vitro on low density lipoproteinย GLYCATION
  2955. Diabetic retinopathy: fromย GLYCATIONย to clinical aspects
  2956. The role of advancedย GLYCATIONย end products in brain aging
  2957. ROLE OF ADVANCEDย GLYCATIONย END PRODUCTS (AGES) IN CELL GROWTH AND DEATH
  2958. Accumulation of advancedย GLYCATIONย end products in canine atherosclerosis
  2959. โ€ฆ anti-glucose oxidase antibodies or the F (ab)โ€ฒ 2/F (ab)โ€ฒ fragments derived therefrom protects both the enzyme and antibody/antibody fragments againstย GLYCATION
  2960. Enzymes involved in the repair ofย GLYCATIONย by sugar phosphates
  2961. Monitoring of hemoglobinย GLYCATIONย using spectral and refraction measurements
  2962. Herb and spice extracts inhibit proteinย GLYCATION
  2963. Accumulation of advancedย GLYCATIONย end products in intensive care patients
  2964. New insights into the pathogenic role of advancedย GLYCATIONย in diabetic retinopathy
  2965. Mechanism of Advancedย GLYCATIONย End Products Induced Oxidative Effects in Cultured ECV304 Cells
  2966. Quantitative Analysis ofย GLYCATIONย Sites on HSA by 18 o-Labelling MALDI-TOF MS
  2967. Assessing the potential of carboxylic acids as inhibitors ofย GLYCATION
  2968. GLYCATIONย of platelet derived growth factor: relevance to diabetic wound healing
  2969. The analysis of avian plasma for theย GLYCATIONย of serum albumin
  2970. Examination of advancedย GLYCATIONย end-products in children with type 1 diabetes
  2971. GLYCATIONย May Cause Slower Insulin Releases than C-Peptides: A Theoretical Approach.
  2972. Long-standing diabetes in Africa and recent ideas about advancedย GLYCATIONย end products: 39 patients in Dakar
  2973. OCT activity andย GLYCATIONย damage in rat liver mitochondria
  2974. Actions of Advancedย GLYCATIONย Endproducts (AGE) on coronary artery vascular smooth muscle cells
  2975. 26: The soluble form of the receptor for advancedย GLYCATIONย end-products (sRAGE), a decoy for rage, is increased in the serum level of women with severe โ€ฆ
  2976. Rosiglitazone inhibits expression of acyl-coenzyme A: cholesterol acyltransferase-1 in THP-1 macrophages induced by advancedย GLYCATIONย end-productsโ‹†
  2977. Advancedย GLYCATIONย End Products in Polycystic Ovarian Syndrome
  2978. INHIBITORY ACTIVITY OF VITAMIN C ON THE SUSCEPTIBILITY OF ALBUMIN TOย GLYCATIONย REACTION
  2979. Advancedย GLYCATIONย endproduct analysis of GTP and ATP with reducing sugars
  2980. GLYCATIONย Mechanism of Brain Damage Induced by D-Galactose in Rats
  2981. Glutaraldehyde is an effective cross-linker for production of antibodies against advancedย GLYCATIONย end-products
  2982. Urinary excretion of fluorescent advancedย GLYCATIONย end products (AGEs) in the elderly
  2983. Do green tea polyphenols inhibit proteinย GLYCATION?
  2984. The Effect of Advancedย GLYCATIONย End Product Inhibition on the Development of Diabetic Encephalopathy in Rats
  2985. Impact of interaction of advancedย GLYCATIONย end product and its receptor on podocytes apoptosis
  2986. BLOCKADE OF ADVANCEDย GLYCATIONย IN CHRONIC ALLOGRAFT DYSFUNCTION: 1371
  2987. Impact ofย GLYCATIONย on duodenal digestibility of Bowman-Birk inhibitors
  2988. Advancedย GLYCATIONย End Products Increase Matrix Metalloproteinases in Human Osteoarthritic Chondrocytes
  2989. Effect Donglian Capsule on Nonenzymatic Proteinย GLYCATIONย in Diabetes Melitus Rat
  2990. Effects of advancedย GLYCATIONย end-products on differentiation of vascular endothelial cells from bone marrow stem cells of mice
  2991. EFFECT OF ADVANCEDย GLYCATIONย END PRODUCTS ON THE EXPRESSION OF ADIPONECTIN IN 3T3-L1 ADIPOCYTES [J]
  2992. Role of Advancedย GLYCATIONย Products with Oxidative Stress in Resistance Artery Dysfunction in Type 2 Diabetic mice
  2993. OXIDATIVE DAMAGE TO DNA AND LIPIDS: CORRELATION WITH PROTEINย GLYCATIONย IN PATIENTS WITH TYPE 1 DIABETES
  2994. In-Vitro Studies on banana flower and stem as the inhibitors of formation of Advancedย GLYCATIONย End Products (AGEs)
  2995. Relationship between receptor for advancedย GLYCATIONย end products and preeclampsia
  2996. Effect of advancedย GLYCATIONย end products on expression of vascular endothelial growth factor in cultured rabbit retinal M? ller cells
  2997. LC-MS Analysis of Markers for Advancedย GLYCATIONย Endprocducts-Protein/Peptides Adducts
  2998. Biochemical effects of proteinย GLYCATIONย by methylglyoxal in Saccharomyces cerevisiae
  2999. Advancedย GLYCATIONย Endprocucts Is Involved in the Development of Age-Associated Glomeruloselerosis through Growth Arrest Specific Gene 6.
  3000. Advancedย GLYCATIONย Endproducts on Bruchโ€™s Membrane Can Be Detected by Raman Microscopy and Correlate With Chronological Age
  3001. Effects of non-enzymaticย GLYCATIONย on the biomechanical behavior of bone
  3002. The effect of advancedย GLYCATIONย end products (AGE) breaker, alagebrium on the cardiac structural and functional change in type I diabetic rat model
  3003. Badania kliniczne i doล›wiadczalne w chorobach serca, pล‚uc i naczyล„ Advancedย GLYCATIONย end products (AGE) in the pathogenesis of ischaemic cardiomyopathy in โ€ฆ
  3004. Inhibition effects of Alpina officicarum on the formation of advancedย GLYCATIONย end products and the activity of aldose reductase
  3005. Co-effects of human cytomegalovirus infection and advancedย GLYCATIONย end products on vascular endothelial cells
  3006. Non-enzymaticย GLYCATIONย of fibrillin-1.
  3007. Effect of alcoholic extraction of the Cornel on advancedย GLYCATIONย end products and DNA damage induced by D-gal in aging rats [J]
  3008. The Effects of Advancedย GLYCATIONย End Products (AGEs) on Primary Human Microvascular Retinal Endothelial Cells (HMRECs)
  3009. Does a high protein diet induce renal dysfunction via activation of the advancedย GLYCATIONย pathway?
  3010. Decreased plasma levels of soluble receptor for advancedย GLYCATIONย end-products in patients with essential hyperโ€ฆ
  3011. C Reactive Protein Increases the Expression of Receptor for Advancedย GLYCATIONย End-products in Human Endothelial Cells
  3012. HOTSPOTS SITES FORย GLYCATIONย OF HUMAN SERUM ALBUMIN AND EFFECT ON FUNCTIONAL ACTIVITY AND DEGRADATION
  3013. A novel inhibitor of advancedย GLYCATIONย and endoplasmic reticulum stress reduces infarct volume in rat transient focal ischemia
  3014. Effect of advancedย GLYCATIONย end products on the oxidative damage of PC12 cells induced by amyloid beta protein 25-35 [J]
  3015. EXPRESSION OF SOCS GENE IN RENAL TUBULAR CELLS INDUCED BY ADVANCEDย GLYCATIONย END PRODUCTS (AGEs)
  3016. Elevated serum advancedย GLYCATIONย end products and poor grip strength in older communityโ€dwelling women
  3017. Endocytosis of Advancedย GLYCATIONย End Products in Bovine Retinal Pigment Epithelial Cells
  3018. Production of advancedย GLYCATIONย end products from the glycosylation of avian serum albumin
  3019. EVALUTION OF EFFECT OF ฮฑ-TOCOPHEROL, ASCORBIC ACID AND LYCOPENE ON LOW DENSITY LIPOPROTEINย GLYCATIONย BY MODEL SYSTEM IN VITRO
  3020. Pathobiological role of advancedย GLYCATIONย endproducts via MAPK dependent pathway in the diabetic vasculopathy
  3021. ADVANCEDย GLYCATIONย END-PRODUCTS (AGES) IN DEVELOPMENT OF ISCHEMIC AND DILATED CARDIOMYOPATHY IN PATIENTS WITH DIABETES โ€ฆ
  3022. Immunohistochemical Study of the Receptor for Advancedย GLYCATIONย End Products in Alzheimerโ€™s Disease Optic Nerves
  3023. Metformin Improves HDL-Mediated Cholesterol Efflux Through the Inhibition of HDLย GLYCATION.
  3024. Thermalย GLYCATIONย of chicken egg white cystatin
  3025. Advancedย GLYCATIONย End Products (AGEs) Cause ฮฒ-Cell Dysfunction in Mice by Impairing Mitochondrial Function.
  3026. Effect of advancedย GLYCATIONย end products on the human gingival fibroblast proliferation and type I collagen synthesis
  3027. Structural characterization of the receptor for advancedย GLYCATIONย end products reveals a two domain modular architecture
  3028. Effect of Advancedย GLYCATIONย End Product on Cellular Proliferation and Expression of Plasminogen Activator Inhibitor-1 in Rat Vascular Smooth Muscle Cell
  3029. Serum advancedย GLYCATIONย end-products in saudi women with polycystic ovary syndrome: a prospective study
  3030. The ratio of proteinย GLYCATIONย versus its ligand activity to AGE-receptors: are AGE-receptors really working as AGE-receptors in vivo?
  3031. Insulin resistance and oxidative stress induce advancedย GLYCATIONย end products formation in patients with clinical and subclinical hypothyroidism
  3032. P100-S Analyses of In Vitro Non-Enzymaticย GLYCATIONย of Normal and Variant Hemoglobins by MALDI-TOF Mass Spectrometry
  3033. Effect of taurine on advancedย GLYCATIONย end products-induced hypertrophy in renal tubular epithelial cells
  3034. Advancedย GLYCATIONย Endproducts (AGEs) Directly Damage the Myocardium by Reducing Calcium Transients via NADPH Oxidase
  3035. P36. An Analysis of Collagen Cross Linking via Nonenzymaticย GLYCATIONย in the Intervertebral Disc
  3036. Association of endogenous secretory receptor for advancedย GLYCATIONย end products with carotid atherosclerosis in type 2 diabetes mellitus
  3037. Inhibition of Aldose Reductase, Proteinย GLYCATIONย and Delay of Diabetic Cataract in Rats by Rutin
  3038. Effect of advancedย GLYCATIONย end products on the gene expression of EMMPRIN in human renal mesangial cells
  3039. Effects of advancedย GLYCATIONย end products on peroxisome proliferator activated receptor-ฮณ mRNA expression in rat renal cortex [J]
  3040. Functional analysis of the susceptibility haplotype in the Receptor for Advancedย GLYCATIONย End-products gene and its role in the hyperglycemia-driven pathology
  3041. Raman Spectroscopic Evaluation of Advancedย GLYCATIONย & Lipoxidation Adducts in RPE
  3042. Inhibitory effects of compounds isolated from Thuja orientalis on human recombinant aldose reductase and advancedย GLYCATIONย end-products
  3043. Targeted Imaging of Peripheral Angiogenesis in Type-1 Diabetes Demonstrates Impairment of Alpha-v Integrin Activation Associated withย GLYCATION.
  3044. Amplifiers of systemic inflammation-the role advancedย GLYCATIONย and lipoxidation end products in foods
  3045. Effect of valsartan on expression of receptor for advancedย GLYCATIONย end-products in renal tissues of diabetic rats
  3046. The Glyoxalase System Modulates Advancedย GLYCATIONย Mediated Pathology in Retinal Mรผller Glia
  3047. Expression of Receptor for Advancedย GLYCATIONย end-products (RAGE) and the Relation of Metastatic Activity in Gastric Carcinomasโ€ฒ tissue
  3048. Receptor for Advancedย GLYCATIONย Endproducts Amplifies Vascular Inflammation Elicited by a Periodontal Pathogen
  3049. Hydrolyzable tannins from the cores of Cornus officinalis with inhibitory activity in vitro on the formation of advancedย GLYCATIONย end products (AGEs)
  3050. Expression of Receptor for Advancedย GLYCATIONย Endproduct in Pheoehromocytoma PC12 Cells and Its Effect on Cell Injury under Condition of Oxygen-Glucose โ€ฆ
  3051. Reduced expression of endogenous secretory receptor for advancedย GLYCATIONย endproducts in hippocampal neurons
  3052. Effects of tetramethylpyrazine on expression of vascular endothelium growth factor induced by advancedย GLYCATIONย end products on retinal pigment epithelium
  3053. Protection of Rat Retinal Neurons From Apoptosis Induced by Glyoxal-Mediated Formation of Advancedย GLYCATIONย End Products (Ages) in vitro
  3054. Advancedย GLYCATIONย Endproduct โ€œAGEโ€ Accumulation in Elderly Hypertensive Canines: Correlation with Effects of AGE Crosslink Breaker
  3055. Rosiglitazone ameliorates the effect of advancedย GLYCATIONย end products on plasminogen activator inhibitor 1 in rat glomerular mesangial cells
  3056. Metabolism Of Advancedย GLYCATIONย End Products (AGEs) By The Polyol Pathway Enzyme-Aldose Reductase Decreases AGE Accumulation In Diabetes
  3057. Evidence for Independent Heritability of theย GLYCATIONย Gap (Glycosylation Gap) Fraction of HbA1c in Nondiabetic Twins: Response to Nuttall
  3058. On the expression of fractalkine by rosiglitazone in human renal mesangial cells induced by advancedย GLYCATIONย end products
  3059. Antioxidant activity of mengkudu fruit juice (Morinda citrifolia) and the role as an inhibitor of advancedย GLYCATIONย and products (AGES) by glycosilation reaction
  3060. Nonenzymaticย GLYCATIONย of guanosine 5โ€ฒโ€triphosphate (GTP) by dihydroxyacetone phosphate (DHAP): an in vitro study of AGE formation
  3061. Response to Letter Regarding Article,โ€œDiastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advancedย GLYCATIONย End Products, and Myocyte โ€ฆ
  3062. Proteomic Analysis of Advancedย GLYCATIONย Endproduct (AGE)-Modified Proteins in Mรผller Cells During High Glucose Exposure: Implications for Macroglial Dysfunction โ€ฆ
  3063. Advancedย GLYCATIONย end-product-induced mitogenesis is dependent on Janus kinase 2-induced heat shock protein 70 in normal rat kidney interstitial fibroblast cells.
  3064. SKIN AUTOFLUORESCENCE, AS A MARKER OF ACCUMULATION OF ADVANCEDย GLYCATIONย ENDPRODUCTS AND OF CUMULATIVE STRESS, IS NOT โ€ฆ
  3065. The alteration of thermodynamic characteristics of corneal tissue collagen denaturation as the result of the non-enzymaticย GLYCATION
  3066. Possible role of HMG CoA reductase inhibitor on the oxidative stress induced by advancedย GLYCATIONย endproducts (AGEs) in vascular smooth muscle cell of diabetic โ€ฆ
  3067. Treatment With Nitric Oxide (NO) Donors or Pioglitazone Improves CD34+ Cell Dynamics on Advancedย GLYCATIONย End Product (AGE) Modified Basement Membrane
  3068. Possible Role of HMG CoA Reductase Inhibitor on the Oxidative Stress induced by Advancedย GLYCATIONย Endproducts (AGEs) in Vascular Smooth Muscle Cell (VSMC) โ€ฆ
  3069. Enhanced cellular oxidant stress by the interaction of advancedย GLYCATIONย endproducts-modified hemoglobin with monocytes bearing CD163 receptors
  3070. Advancedย GLYCATIONย end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3 beta in โ€ฆ
  3071. Consequences of the interaction of amyloid beta with amyloid binding alcohol dehydrogenase and the receptor for advancedย GLYCATIONย end products
  3072. Reduced expression of endogenous secretory receptor for advancedย GLYCATIONย endproducts in hippocampal neurons of Alzheimerโ€™s disease brains
  3073. Vascular Endothelial Growth Factor (VEGF) and Advancedย GLYCATIONย End Products (AGEs) Overexpression in the Retina and Serum and Lens Opacities of โ€ฆ
  3074. ACUTE KAWASAKI DISEASE IS ASSOCIATED WITH REVERSE REGULATION OF SOLUBLE RECEPTOR FOR ADVANCEDย GLYCATIONย END PRODUCTS (SRAGE โ€ฆ
  3075. Expression of Receptor for Advancedย GLYCATIONย End Product mRNA and Protein in Cultured Hepatic Stellate Cells Inhibited by Specific Small Interfering RNA
  3076. Receptor for Advancedย GLYCATIONย End Products (RAGE) Plays an Integral Role in Non-Diabetic Atherosclerosis and Oxidized LDL Stimulation
  3077. Influence ofย GLYCATIONย (non-enzymatic glycosylation) on antigenicity of soy (Glycine max) and pea (Pisum sativum) 7S globulin
  3078. S100A6 Promotes Myocyte Survival by Interacting with the Receptor for Advancedย GLYCATIONย End Products and Activating Akt
  3079. The combination of high glucose and advancedย GLYCATIONย end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced โ€ฆ
  3080. Structural insights into signal-transducing proteins: Regulation of the EF-hand protein S100A2 and activation of the Receptor for Advancedย GLYCATIONย Endproducts
  3081. Targeted Inactivation of Receptor for Advancedย GLYCATIONย Products Reduced Oxidative LDL-Induced Inflammation and Atherosclerosis in Non-Diabetic LDL Receptor โ€ฆ
  3082. Fundus Autofluorescence in a Rabbit Model of Age-Related Macular Degeneration Induced by Advancedย GLYCATIONย End Product Microspheres as Imitation Lipofuscin
  3083. The Structural Modification of Nucleosides by Nonโ€enzymaticย GLYCATION: A Study Based on The in vitro Interactions of Glyoxal and Methylglyoxal with DNA Purines and โ€ฆ
  3084. Reactive oxygen species (ROS) and advancedย GLYCATIONย end products (AGE)โ€induced ERK5โ€SUMOylation antagonizes antiโ€inflammatory effect of shear stress in โ€ฆ
  3085. Receptor for advanced-GLYCATIONย end products inhibits myocardin function and induces msx2-dependent osteoblastic differentiation of vascular smooth muscle cells
  3086. Activation of Receptor for Advanced-GLYCATIONย End Products (Rage) Induces Notch-msx2-Dependent Osteoblastic Differentiation of Vascular Smooth Muscle Cells
  3087. Involvement of Na {sup+}/H {sup+} exchanger 1 in advancedย GLYCATIONย end products-induced proliferation of vascular smooth muscle cell
  3088. 5. Crucial involvement of advancedย GLYCATIONย end-products in experimental diabetes-associated arterial elastocalcinosis.
  3089. Response to Comment on: Thallas-Bonke et al.(2008) Inhibition of NADPH Oxidase Prevents Advancedย GLYCATIONย End Productโ€“Mediated Damage in Diabetic โ€ฆ
  3090. Su. 70. The Receptor for Advancedย GLYCATIONย End Products (RAGE) is Associated with the Tumor Cell Response to Stress
  3091. 103: Is the receptor for advancedย GLYCATIONย end products (RAGE) involved in preterm birth?
  3092. Flavan-3-ols from the roots of Actinidia arguta inhibit the formation of advancedย GLYCATIONย end products (AGEs) in vitro
  3093. High mobility group box 1, receptor for advancedย GLYCATIONย end products and IkappaB kinase are potential pharmacological targets in cerebral ischemia
  3094. 264: In severe preeclampsia, activation of the receptor for advancedย GLYCATIONย end-products (RAGE) system occurs independent of antigenic N-carboxymethyl-lysine โ€ฆ
  3095. hnRNP K-Mediated Regulation of COX-2 Expression in Monocytes by Ligation of the Receptor for Advancedย GLYCATIONย End Products (RAGE).
  3096. Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and its Regression by BMP-7 and Advancedย GLYCATIONย End-Product Inhibitors
  3097. 766: Evidence for participation of high mobility group box 1 protein (HMGB1) in activation of receptor for advancedย GLYCATIONย end-products (RAGE) and toll-like โ€ฆ
  3098. Histone H1 studies: 1) in vivo evidence of nuclear protein damage; 2) in vitro studies of natural productย GLYCATIONย inhibitors
  3099. Fluorine-18 radiolabeling of S100/calgranulins: a potential approach for characterization of receptors for advancedย GLYCATIONย endproducts in vivo
  3100. โ€ฆ -CT Imaging Demonstrates Impairment of Matrix Metalloproteinases Activation in Ischemic Peripheral Angiogenesis in Type-1 Diabetes Associated withย GLYCATION
  3101. Nrf2/ARE mediated activation of HO-1 by advancedย GLYCATIONย endproducts in bovine aortic endothelial cells: involvement of JNK and NADPH oxidase
  3102. 2-Deoxy-D-Ribose Produces Oxidative Damage Through Mechanisms of Proteinย GLYCATIONย in Pancreatic ฮฒ-Cells.
  3103. Poster 185: Effects of Insulin and Endurance Exercise on Accumulation of Advancedย GLYCATIONย Endproduct in Skeletal Muscle of Rats with Diabetes Mellitus
  3104. Advancedย GLYCATIONย endโ€products and the kidney
  3105. Advancedย GLYCATIONย end products in foods and a practical guide to their reduction in the diet
  3106. Dietary advancedย GLYCATIONย end products and aging
  3107. Does accumulation of advancedย GLYCATIONย end products contribute to the aging phenotype?
  3108. Hyperglycemia andย GLYCATIONย in diabetic complications
  3109. Advancedย GLYCATIONย end products, oxidative stress and diabetic nephropathy
  3110. Advancedย GLYCATIONย end-products: implications for diabetic and non-diabetic nephropathies
  3111. Nutrition and aging skin: sugar andย GLYCATION
  3112. The role of advancedย GLYCATIONย end products in retinal ageing and disease
  3113. Advancedย GLYCATIONย end-products and bone fractures
  3114. The sour side of neurodegenerative disorders: the effects of proteinย GLYCATION
  3115. The Maillard reaction in the human body. The main discoveries and factors that affectย GLYCATION
  3116. Rutin metabolites: novel inhibitors of nonoxidative advancedย GLYCATIONย end products
  3117. Trends in advancedย GLYCATIONย end products research in diabetes mellitus and its complications
  3118. Characterization of type I collagen gels modified byย GLYCATION
  3119. Significance of advancedย GLYCATIONย end products in aging-related disease
  3120. Soluble form of a receptor for advancedย GLYCATIONย end products (sRAGE) as a biomarker.
  3121. Inhibitory effects of guava (Psidium guajava L.) leaf extracts and its active compounds on theย GLYCATIONย process of protein
  3122. The receptor for advancedย GLYCATIONย end products (RAGE) and the lung
  3123. Comparison of anti-GLYCATIONย capacities of several herbal infusions with that of green tea
  3124. A perspective on the Maillard reaction and the analysis of proteinย GLYCATIONย by mass spectrometry: probing the pathogenesis of chronic disease
  3125. The receptor for advancedย GLYCATIONย endproducts (RAGE) and cardiovascular disease
  3126. Advancedย GLYCATIONย end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes
  3127. Inhibitory effects of Chrysanthemum species extracts on formation of advancedย GLYCATIONย end products
  3128. Changes in non-enzymaticย GLYCATIONย and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate
  3129. RAGE (Receptor for Advancedย GLYCATIONย Endproducts), RAGE ligands, and their role in cancer and inflammation
  3130. Identification and relative quantification of specificย GLYCATIONย sites in human serum albumin
  3131. Advancedย GLYCATIONย endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advancedย GLYCATIONย endproducts mediate โ€ฆ
  3132. Advancedย GLYCATIONย end products accumulate in the reproductive tract of men with diabetes
  3133. Reaction ofย GLYCATIONย and human skin: the effects on the skin and its components, reconstructed skin as a model
  3134. Soluble receptor for advancedย GLYCATIONย end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
  3135. Neoformation of antioxidants inย GLYCATIONย model systems treated under subcritical water extraction conditions
  3136. Advancedย GLYCATIONย end products strongly activate platelets
  3137. The effect ofย GLYCATIONย on foam and structural properties of ฮฒ-lactoglobulin
  3138. Antioxidative activity, polyphenolic content and anti-GLYCATIONย effect of some Thai medicinal plants traditionally used in diabetic patients
  3139. Advancedย GLYCATIONย end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells
  3140. Oxidative damage to DNA and lipids: correlation with proteinย GLYCATIONย in patients with type 1 diabetes
  3141. Advancedย GLYCATIONย end-products enhance calcification in vascular smooth muscle cells
  3142. Elevated serum advancedย GLYCATIONย end products and poor grip strength in older community-dwelling women
  3143. Processing of type I collagen gels using nonenzymaticย GLYCATION
  3144. Accumulation of advancedย GLYCATIONย end products and chronic complications in ESRD treated by dialysis
  3145. Non-enzymaticย GLYCATIONย of proteins: from diabetes to cancer
  3146. Plasma advancedย GLYCATIONย end products are decreased in obese children compared with lean controls
  3147. Advancedย GLYCATIONย end products and receptorโ€“oxidative stress system in diabetic vascular complications
  3148. Effect ofย GLYCATIONย on the gastrointestinal digestibility and immunoreactivity of bovine ฮฒ-lactoglobulin
  3149. Tissue-advancedย GLYCATIONย end product concentration in dialysis patients
  3150. Collagenย GLYCATIONย alters neovascularization in vitro and in vivo
  3151. Protection against loss of innate defenses in adulthood by low advancedย GLYCATIONย end products (AGE) intake: role of the antiinflammatory AGE receptor-1
  3152. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advancedย GLYCATIONย end products (RAGE) and RAGE ligands
  3153. Serum carboxymethylโ€“lysine, an advancedย GLYCATIONย end product, is associated with increased aortic pulse wave velocity in adults
  3154. Advancedย GLYCATIONย end-products induce tubular CTGF via TGF-ฮฒโ€“independent Smad3 signaling
  3155. Nonenzymaticย GLYCATIONย impairs the antiinflammatory properties of apolipoprotein AI
  3156. Inhibitory effects of microalgal extracts on the formation of advancedย GLYCATIONย endproducts (AGEs)
  3157. PROGRESS IN UREMIC TOXIN RESEARCH: Highlights and Hotspots of Proteinย GLYCATIONย in Endโ€Stage Renal Disease
  3158. Homodimerization is essential for the receptor for advancedย GLYCATIONย end products (RAGE)-mediated signal transduction
  3159. Interactions between advancedย GLYCATIONย end-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors โ€ฆ
  3160. Advancedย GLYCATIONย end products increase endothelial permeability through the RAGE/Rho signaling pathway
  3161. Advancedย GLYCATIONย endproduct (AGE) accumulation and AGE receptor (RAGE) upโ€regulation contribute to the onset of diabetic cardiomyopathy
  3162. GLYCATIONย of PDGF results in decreased biological activity
  3163. Advancedย GLYCATIONย end products enhance amyloid precursor protein expression by inducing reactive oxygen species
  3164. Advancedย GLYCATIONย end products as biomarkers and gerontotoxinsโ€“a basis to explore methylglyoxal-lowering agents for Alzheimerโ€™s disease?
  3165. Effects of heating andย GLYCATIONย of ฮฒ-lactoglobulin on its recognition by IgE of sera from cow milk allergy patients
  3166. Effects of atorvastatin on serum soluble receptors for advancedย GLYCATIONย end-products in type 2 diabetes
  3167. Advancedย GLYCATIONย end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women
  3168. Immunological detection of fructose-derived advancedย GLYCATIONย end-products
  3169. Relationship of an advancedย GLYCATIONย end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study
  3170. Advancedย GLYCATIONย end product (AGE) accumulation on Bruchโ€™s membrane: links to age-related RPE dysfunction
  3171. Regular moderate exercise reduces advancedย GLYCATIONย and ameliorates early diabetic nephropathy in obese Zucker rats
  3172. Advancedย GLYCATIONย end products (AGEs) activate mast cells
  3173. Astragalosides isolated from the root of astragalus radix inhibit the formation of advancedย GLYCATIONย end products
  3174. Advancedย GLYCATIONย end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK
  3175. Receptor for advancedย GLYCATIONย end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications
  3176. Proteinย GLYCATIONย inhibitory activities of Lawsonia inermis and its active principles
  3177. Cancer malignancy is enhanced by glyceraldehyde-derived advancedย GLYCATIONย end-products
  3178. The receptor for advancedย GLYCATIONย end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
  3179. Effects ofย GLYCATIONย of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells
  3180. Plasma levels of receptor for advancedย GLYCATIONย end products, blood transfusion, and risk of primary graft dysfunction
  3181. Association between circulating soluble receptor for advancedย GLYCATIONย end products and atherosclerosis: observations from the Dallas Heart Study
  3182. Antihyperglycemic activity and inhibition of advancedย GLYCATIONย end product formation by Cuminum cyminum in streptozotocin induced diabetic rats
  3183. Advancedย GLYCATIONย end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways
  3184. Skin autofluorescence as a measure of advancedย GLYCATIONย endproduct deposition: a novel risk marker in chronic kidney disease
  3185. Chondroprotective effects and mechanisms of resveratrol in advancedย GLYCATIONย end products-stimulated chondrocytes
  3186. Deletion of the receptor for advancedย GLYCATIONย end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse
  3187. Anti-GLYCATIONย activity of gold nanoparticles
  3188. Dihydrochalcones: Implication in resistance to oxidative stress and bioactivities against advancedย GLYCATIONย end-products and vasoconstriction
  3189. Alternative splicing of the murine receptor for advancedย GLYCATIONย endโ€products (RAGE) gene
  3190. Non-enzymaticย GLYCATIONย alters microdamage formation in human cancellous bone
  3191. Analysis of proteinย GLYCATIONย using phenylboronate acrylamide gel electrophoresis
  3192. Higher plasma soluble receptor for advancedย GLYCATIONย end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in โ€ฆ
  3193. Advancedย GLYCATIONย end products in senile diabetic and nondiabetic patients with cataract
  3194. Role of the receptor for advancedย GLYCATIONย end products in hepatic fibrosis
  3195. Phenolic content and in vitro inhibitory effects on oxidation and proteinย GLYCATIONย of some Thai medicinal plants
  3196. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advancedย GLYCATIONย end โ€ฆ
  3197. Rapidย GLYCATIONย with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells
  3198. Increasedย GLYCATIONย and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin
  3199. Receptor for advancedย GLYCATIONย end products: its role in Alzheimerโ€™s disease and other neurological diseases
  3200. Association between carotid diameter and the advancedย GLYCATIONย endproduct N ฮต-Carboxymethyllysine (CML)
  3201. Advancedย GLYCATIONย end-products affect transcription factors regulating insulin gene expression
  3202. GLYCATIONย of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
  3203. The effects ofย GLYCATIONย on the binding of human serum albumin to warfarin and L-tryptophan
  3204. Atorvastatin decreases serum levels of advancedย GLYCATIONย endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness โ€ฆ
  3205. Recent advances in the recovery and improvement of functional proteins from fish processing byโ€products: use of proteinย GLYCATIONย as an alternative method
  3206. Receptor for advancedย GLYCATIONย end products is detrimental during influenza A virus pneumonia
  3207. Advancedย GLYCATIONย end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2
  3208. Receptor for advancedย GLYCATIONย end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.
  3209. โ€ฆย GLYCATIONย end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advancedย GLYCATIONย โ€ฆ
  3210. GLYCATIONย and phosphorylation of ฮฑ-lactalbumin by dry heating: Effect on protein structure and physiological functions
  3211. Advancedย GLYCATIONย end product (AGE) modified proteins in tears of diabetic patients
  3212. โ€ฆย GLYCATIONย end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advancedย GLYCATIONย โ€ฆ
  3213. Advancedย GLYCATIONย end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
  3214. Formyline, a newย GLYCATIONย compound from the reaction of lysine and 3-deoxypentosone
  3215. Receptors for advancedย GLYCATIONย end-products targeting protect against hyperoxia-induced lung injury in mice
  3216. Advancedย GLYCATIONย end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages
  3217. Circulating soluble receptor for advancedย GLYCATIONย end products is inversely associated with body mass index and waist/hip ratio in the general population
  3218. Effects of plantโ€derived polyphenols on TNFโ€ฮฑ and nitric oxide production induced by advancedย GLYCATIONย endproducts
  3219. The receptor for advancedย GLYCATIONย end products impairs host defense in pneumococcal pneumonia
  3220. Hyperglycaemia-induced pro-inflammatory responses by retinal Mรผller glia are regulated by the receptor for advancedย GLYCATIONย end-products (RAGE)
  3221. Kaempferol modulates pro-inflammatory NF-ฮบB activation by suppressing advancedย GLYCATIONย endproducts-induced NADPH oxidase
  3222. Decrease in serum levels of advancedย GLYCATIONย end-products by short-term lifestyle modification in non-diabetic middle-aged females
  3223. Evaluation of ฮฑ-glucosidase, ฮฑ-amylase and proteinย GLYCATIONย inhibitory activities of edible plants
  3224. Possible involvement of advancedย GLYCATIONย end products in periodontal diseases
  3225. Quantitative measurement of specific biomarkers for protein oxidation, nitration andย GLYCATIONย in Arabidopsis leaves
  3226. Advancedย GLYCATIONย end products and their circulating receptors and level of kidney function in older community-dwelling women
  3227. Molecular susceptibility toย GLYCATIONย and its implication in diabetes mellitus and related diseases
  3228. Anti-receptor for advancedย GLYCATIONย end products therapies as novel treatment for abdominal aortic aneurysm
  3229. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advancedย GLYCATIONย end products
  3230. Inhibitory effect of the cree traditional medicine wiishichimanaanh (Vaccinium vitisโ€idaea) on advancedย GLYCATIONย endproduct formation: identification of active โ€ฆ
  3231. Plasma carboxymethylโ€lysine, an advancedย GLYCATIONย end product, and allโ€cause and cardiovascular disease mortality in older communityโ€dwelling adults
  3232. Amyloid-dependent triosephosphate isomerase nitrotyrosination inducesย GLYCATIONย and tau fibrillation
  3233. Proteinย GLYCATIONย inhibitory activity of wheat bran feruloyl oligosaccharides
  3234. Preventive effects of chebulic acid isolated from Terminalia chebula on advancedย GLYCATIONย endproduct-induced endothelial cell dysfunction
  3235. Effects of alagebrium, an advancedย GLYCATIONย endโ€product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL โ€ฆ
  3236. Soluble receptor for advancedย GLYCATIONย end products in physiological and pathological pregnancy
  3237. GLYCATIONย of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II
  3238. Analysis of advancedย GLYCATIONย endproducts in dairy products by isotope dilution liquid chromatographyโ€“electrospray tandem mass spectrometry. The particular case โ€ฆ
  3239. Role of the receptor for advancedย GLYCATIONย end products (RAGE) in inflammation
  3240. Receptor for advancedย GLYCATIONย end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury
  3241. Advancedย GLYCATIONย end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
  3242. Association of polymorphism in the receptor for advancedย GLYCATIONย end products (RAGE) gene with circulating RAGE levels
  3243. Advancedย GLYCATIONย end products in patients with cerebral infarction
  3244. Short-term low calorie diet intervention reduces serum advancedย GLYCATIONย end products in healthy overweight or obese adults
  3245. GLYCATIONย Endproducts, Soluble Receptor for Advancedย GLYCATIONย Endproducts and Cytokines in Diabetic and Nonโ€diabetic Pregnancies
  3246. S100B Interaction With the Receptor for Advancedย GLYCATIONย End Products (RAGE) A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction
  3247. Advancedย GLYCATIONย end products inhibit the expression of collagens type I and III by human gingival fibroblasts
  3248. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advancedย GLYCATIONย end products and oxidative stress in alloxan โ€ฆ
  3249. Smooth muscle cell pathophysiology and advancedย GLYCATIONย end products (AGEs)
  3250. Advancedย GLYCATIONย endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways
  3251. ERM protein moesin is phosphorylated by advancedย GLYCATIONย end products and modulates endothelial permeability
  3252. Hemoglobinย GLYCATIONย index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients
  3253. Regulation of advancedย GLYCATIONย end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
  3254. Citrus Fruit Extracts Reduce Advancedย GLYCATIONย End Products (AGEs)- and H2O2-Induced Oxidative Stress in Human Adipocytes
  3255. The formation of intracellular glyceraldehyde-derived advancedย GLYCATIONย end-products and cytotoxicity
  3256. Soluble receptors for advancedย GLYCATIONย end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention
  3257. Advancedย GLYCATIONย End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine โ€ฆ
  3258. Decreased plasma levels of soluble receptor for advancedย GLYCATIONย endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
  3259. Serum levels of soluble receptor for advancedย GLYCATIONย end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk โ€ฆ
  3260. Evidence for activation of Toll-like receptor and receptor for advancedย GLYCATIONย end products in preterm birth
  3261. Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advancedย GLYCATIONย end product formation by trapping of methylglyoxal
  3262. Circulating soluble receptor of advancedย GLYCATIONย end product inversely correlates with atherosclerosis in patients with chronic kidney disease
  3263. Advancedย GLYCATIONย end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy
  3264. Ribosylation rapidly induces ฮฑ-synuclein to form highly cytotoxic molten globules of advancedย GLYCATIONย end products
  3265. Phase I clinical studies of the advancedย GLYCATIONย end-product (AGE)-breaker TRC4186
  3266. Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-ฮฑ production in a receptor for advancedย GLYCATIONย end product-dependent manner
  3267. Identifying advancedย GLYCATIONย end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in โ€ฆ
  3268. Transport of the advancedย GLYCATIONย end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1
  3269. Misconceptions about high-fructose corn syrup: is it uniquely responsible for obesity, reactive dicarbonyl compounds, and advancedย GLYCATIONย endproducts?
  3270. Low serum level of the endogenous secretory receptor for advancedย GLYCATIONย end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of โ€ฆ
  3271. Red blood cell adhesion in diabetes mellitus is mediated by advancedย GLYCATIONย end product receptor and is modulated by nitric oxide
  3272. The inhibition of advancedย GLYCATIONย end-products-induced retinal vascular permeability by silver nanoparticles
  3273. Monocyte CD147 is induced by advancedย GLYCATIONย end products and high glucose concentration: possible role in diabetic complications
  3274. Seasonal phytochemical variation of anti-GLYCATIONย principles in lowbush blueberry (Vaccinium angustifolium)
  3275. Blockade of PKC-beta protects HUVEC from advancedย GLYCATIONย end products induced inflammation
  3276. Androgens associated with advancedย GLYCATIONย end-products in postmenopausal women
  3277. Diabetes impairs hippocampal function via advancedย GLYCATIONย end product mediated new neuron generation in animals with diabetes-related depression
  3278. Aging, proteotoxicity, mitochondria,ย GLYCATION, NAD+ and carnosine: possible inter-relationships and resolution of the oxygen paradox
  3279. Pyridoxamine, an inhibitor of advancedย GLYCATIONย end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice
  3280. Biologic variability in plasma glucose, hemoglobin A1c, and advancedย GLYCATIONย end products associated with diabetes complications
  3281. Receptor for Advancedย GLYCATIONย End Products Facilitates Host Defense during Escherichia coliโ€“Induced Abdominal Sepsis in Mice
  3282. Plasma levels of advancedย GLYCATIONย end products are associated with haemolysisโ€related organ complications in sickle cell patients
  3283. GLYCATIONย isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma
  3284. Glycated albumin, a precursor of advancedย GLYCATIONย endโ€products, upโ€regulates NADPH oxidase and enhances oxidative stress in human endothelial cells โ€ฆ
  3285. Apical-to-basolateral transport of amyloid-ฮฒ peptides through blood-brain barrier cells is mediated by the receptor for advancedย GLYCATIONย end-products and is โ€ฆ
  3286. Effect of circulating soluble receptor for advancedย GLYCATIONย end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in โ€ฆ
  3287. Elevated levels of the receptor for advancedย GLYCATIONย end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in โ€ฆ
  3288. Monitoring of malting process by characterization ofย GLYCATIONย of barley protein Z
  3289. Advancedย GLYCATIONย end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells
  3290. Monoacylglycerol (MAG)-oleic acid has stronger antioxidant, anti-atherosclerotic, and proteinย GLYCATIONย inhibitory activities than MAG-palmitic acid
  3291. Receptor for advancedย GLYCATIONย end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease
  3292. Advancedย GLYCATIONย end-products suppress neuropilin-1 expression in podocytes
  3293. Blockade of advancedย GLYCATIONย end product formation attenuates bleomycin-induced pulmonary fibrosis in rats
  3294. Precursor of advancedย GLYCATIONย end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD (P) H oxidase 4
  3295. Serumโ€soluble receptor for advancedย GLYCATIONย end product levels in patients with amyotrophic lateral sclerosis
  3296. Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advancedย GLYCATIONย endproducts in ovaries of reproductively-aged mice.
  3297. Advancedย GLYCATIONย end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia
  3298. Blockage of receptor for advancedย GLYCATIONย end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice
  3299. Metformin restores impaired HDL-mediated cholesterol efflux due toย GLYCATION
  3300. Amyloid ฮฒ interaction with receptor for advancedย GLYCATIONย end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood โ€ฆ
  3301. Low levels of soluble receptor for advancedย GLYCATIONย end products in non-ST elevation myocardial infarction patients
  3302. Pigment epithelium-derived factor inhibits advancedย GLYCATIONย end product-elicited mesangial cell damage by blocking NF-ฮบB activation
  3303. Mass spectrometry characterization of theย GLYCATIONย sites of bovine insulin by tandem mass spectrometry
  3304. Proteomic studies on receptor for advancedย GLYCATIONย end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
  3305. HbA1c and serum levels of advancedย GLYCATIONย and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus
  3306. Receptor for advancedย GLYCATIONย end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury
  3307. Microglial receptor for advancedย GLYCATIONย end product-dependent signal pathway drives ฮฒ-amyloid-induced synaptic depression and long-term depression โ€ฆ
  3308. Soluble receptor for advancedย GLYCATIONย end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
  3309. Beneficial effects of cinnamon proanthocyanidins on the formation of specific advancedย GLYCATIONย endproducts and methylglyoxal-induced impairment on glucose โ€ฆ
  3310. Expression of advancedย GLYCATIONย end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis
  3311. ATP-dependent mechanism protects spectrin againstย GLYCATIONย in human erythrocytes
  3312. Non-enzymaticย GLYCATIONย of proteins: from diabetes to cancer
  3313. PPARฮณ-mediated advancedย GLYCATIONย end products regulation of neural stem cells
  3314. A novel role for the Receptor for Advancedย GLYCATIONย End-products in neural progenitor cells derived from adult SubVentricular Zone
  3315. Receptor for advancedย GLYCATIONย end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse
  3316. Lipoproteinย GLYCATIONย in atherogenesis
  3317. Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and proteinย GLYCATIONย in vitro
  3318. Advancedย GLYCATIONย end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow โ€ฆ
  3319. Irbesartan inhibits advancedย GLYCATIONย end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression
  3320. The role of the receptor for advancedย GLYCATIONย end-products in a murine model of silicosis
  3321. Plasma advancedย GLYCATIONย endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes
  3322. Elevated plasma and alveolar levels of soluble receptor for advancedย GLYCATIONย endproducts are associated with severity of lung dysfunction in ARDS patients
  3323. Combined immunoelectron microscopic and computer-assisted image analyses to detect advancedย GLYCATIONย end-products in human myocardium
  3324. Advancedย GLYCATIONย end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells
  3325. Receptor for advancedย GLYCATIONย endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells
  3326. Serum carboxymethyl-lysine, a dominant advancedย GLYCATIONย end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging
  3327. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advancedย GLYCATIONย end products (RAGE) transcript forms
  3328. Anti-GLYCATIONย effect of mixed herbal extract in individuals with pre-diabetes mellitus a double-blind, placebo-controlled, parallel group study
  3329. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of proteinย GLYCATIONย in the disease process
  3330. Non-enzymaticย GLYCATIONย induces structural modifications of myoglobin
  3331. Studies on the impact ofย GLYCATIONย on the denaturation of whey proteins
  3332. A new perspective on therapeutic inhibition of advancedย GLYCATIONย in diabetic microvascular complications: common downstream endpoints achieved through โ€ฆ
  3333. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenicย GLYCATIONย on aortic collagen
  3334. 3, 5-Di-O-caffeoyl-epi-quinic acid from the leaves and stems of Erigeron annuus inhibits proteinย GLYCATION, aldose reductase, and cataractogenesis
  3335. Plasma levels of soluble receptor for advancedย GLYCATIONย end products are associated with endothelial function and predict cardiovascular events in nondiabetic โ€ฆ
  3336. Advancedย GLYCATIONย endproducts induce photocrosslinking and oxidation of bovine lens proteins through typeโ€I mechanism
  3337. Positive association of serum levels of advancedย GLYCATIONย end products and high mobility group boxโ€“1 with asymmetric dimethylarginine in nondiabetic chronic โ€ฆ
  3338. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation andย GLYCATIONย under pathophysiological concentrations of glucose in vitro
  3339. Role of zinc along with ascorbic acid and folic acid during long-term in vitro albuminย GLYCATION
  3340. Internalization of the receptor for advancedย GLYCATIONย end products (RAGE) is required to mediate intracellular responses
  3341. Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advancedย GLYCATIONย endproducts in vascular smooth muscle cells of diabetic โ€ฆ
  3342. Detection ofย GLYCATIONย sites in proteins by high-resolution mass spectrometry combined with isotopic labeling
  3343. Functional and molecular properties of calcium precipitated soy glycinin and the effect ofย GLYCATIONย with ฮบ-carrageenan
  3344. Drugs of abuse that mediate advancedย GLYCATIONย end product formation: a chemical link to disease pathology
  3345. Small-dense LDL and LDLย GLYCATIONย in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes
  3346. Ectodomain shedding of the receptor for advancedย GLYCATIONย end products: a novel therapeutic target for Alzheimerโ€™s disease
  3347. Inhibitors of Aldose Reductase and Formation of Advancedย GLYCATIONย End-Products in Moutan Cortex (Paeonia suffruticosa)
  3348. Scopoletin from the flower buds of Magnolia fargesii inhibits proteinย GLYCATION, aldose reductase, and cataractogenesis ex vivo
  3349. Homoisoflavanones from Polygonatum odoratum rhizomes inhibit advancedย GLYCATIONย end product formation
  3350. Expression of senescence-associated ฮฒ-galactosidase (SA-ฮฒ-Gal) by human skin fibroblasts, effect of advancedย GLYCATIONย end-products and fucose or rhamnose-rich โ€ฆ
  3351. Pigment epithelium-derived factor inhibits advancedย GLYCATIONย end products-induced retinal vascular permeability
  3352. Receptor for advancedย GLYCATIONย end products in donor lungs is associated with primary graft dysfunction after lung transplantation
  3353. Advancedย GLYCATIONย endproducts and rat dental implant osseointegration
  3354. Carboxymethyl-lysine, an advancedย GLYCATIONย end product, and decline of renal function in older community-dwelling adults
  3355. Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advancedย GLYCATIONย end products and rat lens aldose reductase in vitro
  3356. Ethanol and water extract of purple sweet potato exhibits anti-atherosclerotic activity and inhibits proteinย GLYCATION
  3357. The polyphenolics in the aqueous extract of Psidium guajava kinetically reveal an inhibition model on LDLย GLYCATION
  3358. Oxidative stress mediates protein kinase C activation and advancedย GLYCATIONย end product formation in a mesangial cell model of diabetes and high protein diet
  3359. Advancedย GLYCATIONย end products increase transglutaminase activity in primary porcine tenocytes
  3360. Blockade of renin-angiotensin system attenuates advancedย GLYCATIONย end products-mediated signaling pathways
  3361. Comparison of distinct protein isoforms of the receptor for advancedย GLYCATIONย end-products expressed in murine tissues and cell lines
  3362. Effects of trace elements on albumin and lipoproteinย GLYCATIONย in diabetic retinopathy
  3363. Accumulation of advancedย GLYCATIONย end (AGEs) products in intensive care patients: an observational, prospective study
  3364. Use of human vascular tissue microarrays for measurement of advancedย GLYCATIONย endproducts
  3365. Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled proteinย GLYCATION
  3366. Receptor for advancedย GLYCATIONย end products is upregulated in optic neuropathy of Alzheimerโ€™s disease
  3367. Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due toย GLYCATIONย and fatty acids
  3368. Quantitative analysis ofย GLYCATIONย sites on human serum albumin using 16O/18O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass โ€ฆ
  3369. Expression of receptor for advancedย GLYCATIONย end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma
  3370. Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advancedย GLYCATIONย end products
  3371. Levels of soluble receptor for advancedย GLYCATIONย end products in acute ischemic stroke without a source of cardioembolism
  3372. Positive association of circulating levels of advancedย GLYCATIONย end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population
  3373. Reactive immunization suppresses advancedย GLYCATIONย and mitigates diabetic nephropathy
  3374. C-reactive protein (CRP) up-regulates expression of receptor for advancedย GLYCATIONย end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells โ€ฆ
  3375. Microwave-assisted Maillard reactions for the preparation of advancedย GLYCATIONย end products (AGEs)
  3376. Flavonoids from the leaves of Thuja orientalis inhibit the aldose reductase and the formation of advancedย GLYCATIONย endproducts
  3377. Effects of nitric oxide and antioxidants on advancedย GLYCATIONย end products-induced hypertrophic growth in human renal tubular cells
  3378. Mutagenic Potential of DNAย GLYCATION: Miscoding by (R)- and (S)-N2-(1-Carboxyethyl)-2โ€ฒ-deoxyguanosine
  3379. Modulation of the cellular expression of circulating advancedย GLYCATIONย end-product receptors in type 2 diabetic nephropathy
  3380. Association of 1704G/T and G82S polymorphisms in the receptor for advancedย GLYCATIONย end products gene with diabetic retinopathy in Chinese population
  3381. Genetic predisposition to advancedย GLYCATIONย end products toxicity is related to prognosis of chronic hemodialysis patients
  3382. Anti-GLYCATIONย and anti-albuminuric effects of GLY-230 in human diabetes
  3383. Circulating levels of advancedย GLYCATIONย end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) โ€ฆ
  3384. Vitamin B6 metabolism in chronic kidney diseaseโ€“relation to transsulfuration, advancedย GLYCATIONย and cardiovascular disease
  3385. Expression of high-mobility group box 1 and of receptor for advancedย GLYCATIONย end products in chronic obstructive pulmonary disease
  3386. Advancedย GLYCATIONย endโ€products, antiโ€hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction
  3387. Role of Toll-like receptors 2 and 4, and the receptor for advancedย GLYCATIONย end products in high-mobility group box 1โ€“induced inflammation in vivo
  3388. Effects of glucose and advancedย GLYCATIONย end products on oxidative stress in MIN6 cells
  3389. Advancedย GLYCATIONย end productsโ€induced apoptosis attenuated by PPARฮด activation and epigallocatechin gallate through NFโ€ฮบB pathway in human embryonic โ€ฆ
  3390. Increased cation conductance in human erythrocytes artificially aged byย GLYCATION
  3391. Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advancedย GLYCATIONย end products (AGEs)
  3392. C-reactive protein upregulates receptor for advancedย GLYCATIONย end products expression and alters antioxidant defenses in rat endothelial progenitor cells
  3393. Hepatocyte growth factor prevents advancedย GLYCATIONย end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial โ€ฆ
  3394. โ€ฆ โ€derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advancedย GLYCATIONย end products (AGEs)
  3395. Salvia reuterana extract prevents formation of advancedย GLYCATIONย end products: an in vitro study
  3396. Maillard reaction of proteins and advancedย GLYCATIONย end products (AGEs) in food
  3397. Advancedย GLYCATIONย end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of โ€ฆ
  3398. Inhibitory activity of advancedย GLYCATIONย endproducts (AGE) formation of edible plants for development of anti-wrinkle ingredients
  3399. Advancedย GLYCATIONย end products downregulates peroxisome proliferator-activated receptor ฮณ expression in cultured rabbit chondrocyte through MAPK pathway
  3400. Advancedย GLYCATIONย end products and C-peptideโ€”modulators in diabetic vasculopathy and atherogenesis
  3401. โ€ฆ , an angiotensinโ€converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advancedย GLYCATIONย endโ€productโ€mediated โ€ฆ
  3402. The different isoforms of the receptor for advancedย GLYCATIONย end products are modulated by pharmacological agents
  3403. Low levels of plasma soluble receptor for advancedย GLYCATIONย end products are associated with severe leukoaraiosis in acute stroke patients
  3404. Neuropathy induced by exogenously administered advancedย GLYCATIONย endโ€products in rats
  3405. Crosstalk between calcium, amyloid ฮฒ and the receptor for advancedย GLYCATIONย endproducts in Alzheimerโ€™s disease
  3406. Advancedย GLYCATIONย end products enhance monocyte activation during human mixed lymphocyte reaction
  3407. GLYCATIONย and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications
  3408. Advancedย GLYCATIONย endโ€products activate extracellular signalโ€regulated kinase via the oxidative stressโ€EGF receptor pathway in renal fibroblasts
  3409. Modulation of high sensitivity C-reactive protein by soluble receptor for advancedย GLYCATIONย end products
  3410. Nifedipine inhibits advancedย GLYCATIONย end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator โ€ฆ
  3411. PLC/CAMK IVโ€“NF-ฮบB involved in the receptor for advancedย GLYCATIONย end products mediated signaling pathway in human endothelial cells
  3412. Molecular study of receptor for advancedย GLYCATIONย endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue โ€ฆ
  3413. Anti-GLYCATIONย effect of spices and chilies uses in traditional mexican cuisine
  3414. Quantitation of markers of protein damage byย GLYCATION, oxidation, and nitration in peritoneal dialysis
  3415. Mechanical ventilation during experimental sepsis increases deposition of advancedย GLYCATIONย end products and myocardial inflammation
  3416. Circulating soluble receptor for advancedย GLYCATIONย end-product levels are decreased in patients with calcific aortic valve stenosis
  3417. Effects of puerarin on receptor for advancedย GLYCATIONย end products in nephridial tissue of streptozotocin-induced diabetic rats
  3418. Advancedย GLYCATIONย end products (AGEs) in diabetes
  3419. Serum leptin, but not adiponectin and receptor for advancedย GLYCATIONย end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and โ€ฆ
  3420. Improvement of functional properties of egg white protein throughย GLYCATIONย and phosphorylation by dry-heating
  3421. Accumulation of advancedย GLYCATIONย end products in canine atherosclerosis
  3422. Glucagon-like peptide-1 (GLP-1) inhibits advancedย GLYCATIONย end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing โ€ฆ
  3423. An ฮฑ-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advancedย GLYCATIONย end products (AGEs) in patients with type 2 โ€ฆ
  3424. Advancedย GLYCATIONย end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis
  3425. Advancedย GLYCATIONย end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes
  3426. Dietary phenolic acids attenuate multiple stages of proteinย GLYCATIONย and highโ€glucoseโ€stimulated proinflammatory ILโ€1ฮฒ activation by interfering with chromatin โ€ฆ
  3427. Utilization of the linear mode of MALDIโ€TOF mass spectrometry in the study ofย GLYCATIONย during the malting process
  3428. Increased concentration of two different advancedย GLYCATIONย end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of โ€ฆ
  3429. The association between theโˆ’ 374T/A polymorphism of the receptor for advancedย GLYCATIONย endproducts gene and blood pressure and arterial stiffness is modified by โ€ฆ
  3430. Flavonoid glycosides from the leaves of Uvaria rufa with advancedย GLYCATIONย end-products inhibitory activity
  3431. Enrichment of Amadori products derived from the nonenzymaticย GLYCATIONย of proteins using microscale boronate affinity chromatography
  3432. Thioredoxinย GLYCATION: A novel posttranslational modification that inhibits its antioxidant and organ protective actions
  3433. Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advancedย GLYCATIONย end products in type 2 diabetes mellitus patients
  3434. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princes on rat lens aldose reductase and on the formation of advancedย GLYCATIONย end โ€ฆ
  3435. High plasma levels of the soluble receptor for advancedย GLYCATIONย endproducts in patients with symptomatic carotid atherosclerosis
  3436. GLYCATIONย of ovalbumin in solid-state by conductive and microwave heating
  3437. Soluble receptor for advancedย GLYCATIONย end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis
  3438. Association between serum levels of the soluble receptor (sRAGE) for advancedย GLYCATIONย endproducts (AGEs) and their receptor (RAGE) in peripheral blood โ€ฆ
  3439. Tissue-specific expression profiling of receptor for advancedย GLYCATIONย end products and its soluble forms in esophageal and lung cancer
  3440. Relation between polymorphisms of receptor for advancedย GLYCATIONย end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy โ€ฆ
  3441. Nifedipine, a calcium channel blocker, inhibits advancedย GLYCATIONย end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) โ€ฆ
  3442. GLYCATIONย sites in neoglycoglycoconjugates from the terminal monosaccharide antigen of the Oโ€PS of Vibrio cholerae O1, serotype Ogawa, and BSA revealed by โ€ฆ
  3443. Inhibitory effect of fermentation byproducts on formation of advancedย GLYCATIONย end-products
  3444. Hyperglycemia attenuates acute permeability response to advancedย GLYCATIONย end products in retinal microvasculature
  3445. INFLUENCE OF NONENZYMATIC GLYCOSYLATION (GLYCATION) OF PEA PROTEINS (PISUM SATIVUM) ON THEIR SUSCEPTIBILITY TO ENZYMATIC โ€ฆ
  3446. Involvement of advancedย GLYCATIONย end-products, pentosidine and Nษ›-(carboxymethyl) lysine, in doxorubicin-induced cardiomyopathy in rats
  3447. Endocytosis of advancedย GLYCATIONย end-products in bovine choriocapillaris endothelial cells
  3448. Green tea polyphenol epigallocatechin-3-gallate inhibits advancedย GLYCATIONย end product-induced expression of tumor necrosis factor-ฮฑ and matrix โ€ฆ
  3449. Neutralization of receptor for advancedย GLYCATIONย end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis
  3450. Therapeutic effects of modified Danggui Sini Decoction on plasma level of advancedย GLYCATIONย end products in patients with Wagner grade 0 diabetic foot: a โ€ฆ
  3451. The effects of the receptor for advancedย GLYCATIONย end products (RAGE) on bone metabolism under physiological and diabetic conditions
  3452. Nifedipine, a calcium channel blocker, inhibits inflammatory and fibrogenic gene expressions in advancedย GLYCATIONย end product (AGE)-exposed fibroblasts via โ€ฆ
  3453. Study on the effect of vitamin C on the in vitro albuminย GLYCATIONย reaction
  3454. Advancedย GLYCATIONย end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells โ€ฆ
  3455. Independent determinants of soluble form of receptor for advancedย GLYCATIONย end products in elderly hypertensive patients
  3456. Advancedย GLYCATIONย end products induce T cell apoptosis: Involvement of oxidative stress, caspase and the mitochondrial pathway
  3457. Does hepatitis C increase the accumulation of advancedย GLYCATIONย end products in haemodialysis patients?
  3458. Characterization of anti-advancedย GLYCATIONย end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products
  3459. Alagebrium chloride, a novel advancedย GLYCATIONย end-product cross linkage breaker, inhibits neointimal proliferation in a diabetic rat carotid balloon injury โ€ฆ
  3460. Advancedย GLYCATIONย of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction
  3461. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advancedย GLYCATIONย end-products and circulating DNA in patients with acute โ€ฆ
  3462. Aggregation and self assembly of non-enzymaticย GLYCATIONย of collagen in the presence of amino guanidine and aspirin: an in vitro study
  3463. Receptor of advancedย GLYCATIONย end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes
  3464. Flavan-3-ols having a ฮณ-lactam from the roots of Actinidia arguta inhibit the formation of advancedย GLYCATIONย end products in vitro
  3465. Epigallocatechin gallate (EGCG) binds to low-density lipoproteins (LDL) and protects them from oxidation andย GLYCATIONย under high-glucose conditions mimicking โ€ฆ
  3466. Oxidative stress-associated rise of hepatic proteinย GLYCATIONย increases inflammatory liver injury in uncoupling protein-2 deficient mice
  3467. Insulin resistance is an independent correlate of high serum levels of advancedย GLYCATIONย end products (AGEs) and low testosterone in non-diabetic men
  3468. Ligands of the receptor for advancedย GLYCATIONย end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli โ€ฆ
  3469. The 1.5 ร… crystal structure of human receptor for advancedย GLYCATIONย endproducts (RAGE) ectodomains reveals unique features determining ligand binding
  3470. Effect of elementary and advancedย GLYCATIONย products of nisin on its preservative efficacy and digestibility
  3471. Anthraquinones from the roots of Knoxia valerianoides inhibit the formation of advancedย GLYCATIONย end products and rat lens aldose reductase in vitro
  3472. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advancedย GLYCATIONย endproducts, and oxidative stress in โ€ฆ
  3473. Study of Nonenzymaticย GLYCATIONย of Transferrin and its Effect on Ironโ€“Binding Antioxidant Capacity
  3474. Monitoring of early and advancedย GLYCATIONย in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes โ€ฆ
  3475. Circulating levels of a soluble form of receptor for advancedย GLYCATIONย end products and high-mobility group box chromosomal protein 1 in patients with acute โ€ฆ
  3476. Regulation of alternative splicing of the receptor for advancedย GLYCATIONย endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear โ€ฆ
  3477. Reduced formation of advancedย GLYCATIONย endproducts via interactions between glutathione peroxidase 3 and dihydroxyacetone kinase 1
  3478. RETRACTED: Pigment epithelium-derived factor inhibits advancedย GLYCATIONย end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells
  3479. Nษ›-(carboxymethyl) lysine linkage to ฮฑ-synuclein and involvement of advancedย GLYCATIONย end products in ฮฑ-synuclein deposits in an MPTP-intoxicated mouse model
  3480. Vitamin C and urea inhibit the formation of advancedย GLYCATIONย end products in vitro
  3481. Pathological role of D-amino acid-containing proteins and advancedย GLYCATIONย end products in the development of age-related macular degeneration
  3482. โ€ฆ chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advancedย GLYCATIONย end โ€ฆ
  3483. Insulin prevents latent skin lesions by inhibiting the generation of advancedย GLYCATIONย end products in streptozotocin-induced diabetic rats
  3484. Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advancedย GLYCATIONย end products
  3485. High-mobility group B1 (HMGB1) and receptor for advancedย GLYCATIONย end-products (RAGE) expression in canine lymphoma
  3486. Minimum stable structure of the receptor for advancedย GLYCATIONย end product possesses multi ligand binding ability
  3487. Advancedย GLYCATIONย end products (AGEs) damaged IgG, a target for circulating autoantibodies in patients with type 1 diabetes mellitus
  3488. Modulation of advancedย GLYCATIONย end products by candesartan in patients with diabetic kidney disease-a dose-response relationship study
  3489. Ciprofloxacin inhibits advancedย GLYCATIONย end productsโ€induced adhesion molecule expression on human monocytes
  3490. Advancedย GLYCATIONย end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft โ€ฆ
  3491. COXโ€2 and iNOS are critical in advancedย GLYCATIONย end productโ€activated chondrocytes in vitro
  3492. โ€ฆ -ฮณ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advancedย GLYCATIONย end products and โ€ฆ
  3493. Intra-coronary administration of soluble receptor for advancedย GLYCATIONย end-products attenuates cardiac remodeling with decreased myocardial transforming growth โ€ฆ
  3494. Repairing extracellular aging andย GLYCATION
  3495. Up-regulation in receptor for advancedย GLYCATIONย end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro
  3496. Interaction of zinc, ascorbic acid, and folic acid inย GLYCATIONย with albumin as protein model
  3497. Immunohistochemical detection of advancedย GLYCATIONย end products in human bladder with specific monoclonal antibody
  3498. Linking the advancedย GLYCATIONย endproducts/receptor for advancedย GLYCATIONย endproducts pathway in diabetics with inflammation and topical antiinflammatory โ€ฆ
  3499. Involvement of the receptor for advancedย GLYCATION-end products (RAGE) in ฮฒ-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in โ€ฆ
  3500. GLYCATIONย of wood frog (Rana sylvatica) hemoglobin and blood proteins: in vivo and in vitro studies
  3501. Cytotoxic effect of advancedย GLYCATIONย end products
  3502. Elevated serum advancedย GLYCATIONย end products and their circulating receptors are associated with anaemia in older community-dwelling women
  3503. Differential expressions of the receptor for advancedย GLYCATIONย end products in prostate cancer and normal prostate
  3504. Relationship of a dominant advancedย GLYCATIONย end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal โ€ฆ
  3505. Age-related increase of prostaglandin D2 synthase concentration andย GLYCATIONย in ovine cerebrospinal fluid
  3506. Two new dihydrofuranoisoflavanones from the leaves of Lespedeza maximowiczi and their inhibitory effect on the formation of advancedย GLYCATIONย end products
  3507. Advancedย GLYCATIONย end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2
  3508. Advancedย GLYCATIONย end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity
  3509. Advancedย GLYCATIONย end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2ฮฑ and phosphatidylinositol 4 โ€ฆ
  3510. GLYCATIONย end products
  3511. Prostaglandin E2 inhibits advancedย GLYCATIONย end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human โ€ฆ
  3512. Non-enzymaticย GLYCATIONย of human fibrillin-1
  3513. Associations ofโˆ’ 374T/A polymorphism of receptor for advancedย GLYCATIONย end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary โ€ฆ
  3514. Inhibitory effects of ฮฒ-cyclodextrin and trehalose on nanofibril and AGE formation duringย GLYCATIONย of human serum albumin
  3515. Advancedย GLYCATIONย end product accumulation in rho0 cells without a functional respiratory chain
  3516. Effect of nicotine on advancedย GLYCATIONย end product-induced immune response in human monocytes
  3517. Screening of Korean herbal medicines with inhibitory activity on advancedย GLYCATIONย end products (AGEs) formation (III)
  3518. Glucagon-like peptide-1 counteracts the detrimental effects of Advancedย GLYCATIONย End-Products in the pancreatic beta cell line HIT-T 15
  3519. Influence ofย GLYCATIONย of wheat albumins and globulins on their immunoreactivity and physicochemical properties
  3520. Therapeutic intervention in diseases with advancedย GLYCATIONย end products in their pathogenesis
  3521. Role of pyridoxamine in the formation of the Amadori/Heyns compounds and aggregates during theย GLYCATIONย of ฮฒ-lactoglobulin with galactose and tagatose
  3522. Age-and passage-dependent upregulation of fibroblast elastase-type endopeptidase activity. Role of advancedย GLYCATIONย endproducts, inhibition by fucose-and โ€ฆ
  3523. Proteinย GLYCATION, insulin sensitivity and pancreatic beta cell function in high-risk, non-diabetic, first degree relatives of patients with type 2 diabetes.
  3524. Labile A1C is inversely correlated with the hemoglobinย GLYCATIONย index in children with type 1 diabetes
  3525. Translational aspects of bone qualityโ€”vertebral fractures, cortical shell, microdamage andย GLYCATION: a tribute to Pierre D. Delmas
  3526. 7-O-Galloyl-D-sedoheptulose Is a Novel Therapeutic Agent against Oxidative Stress and Advancedย GLYCATIONย Endproducts in the Diabetic Kidney
  3527. Reduced endogenous secretory receptor for advancedย GLYCATIONย end products (esRAGE) in young people with type 1 diabetes developing microalbuminuria
  3528. Advancedย GLYCATIONย end products and antioxidant status in nondiabetic and streptozotocin induced diabetic rats: effects of copper treatment
  3529. Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advancedย GLYCATIONย endproducts: heparinโ€™s effect on binding
  3530. Expression of advancedย GLYCATIONย end products and related molecules in diabetic fibrovascular epiretinal membranes
  3531. Impaired transcription factor interplay in addition to advancedย GLYCATIONย end products suppress podocalyxin expression in high glucose-treated human podocytes
  3532. GLYCATIONย pattern of peptides condensed with maltose, lactose and glucose determined by ultraviolet matrixโ€assisted laser desorption/ionization tandem mass โ€ฆ
  3533. Soluble receptor for advancedย GLYCATIONย end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis โ€ฆ
  3534. Screening of herbal medicines from China and Vietnam with inhibitory activity on advancedย GLYCATIONย end products (AGEs) formation (IV)
  3535. Influence ofย GLYCATIONย and pepsin hydrolysis on immunoreactivity of albumin/globulin fraction of herbicide resistant wheat line
  3536. Advancedย GLYCATIONย end products down-regulate gap junctions in human hepatoma SKHep 1 cells via the activation of Src-dependent ERK1/2 and JNK/SAPK/AP1 โ€ฆ
  3537. Discovery of rifampicin as a new anti-glycating compound by matrix-assisted laser desorption/ionization mass spectrometry-based insulinย GLYCATIONย assay
  3538. Expression of advancedย GLYCATIONย endโ€product receptors in the cochlea
  3539. ฮฒ2-adrenoceptor stimulation inhibits advancedย GLYCATIONย end products-induced adhesion molecule expression and cytokine production in human peripheral blood โ€ฆ
  3540. GLYCATIONย of proteins: their analysis and physiological aspects
  3541. Lowโ€Density Lipoprotein Levels are One of the Independent Determinants of Circulating Levels of Advancedย GLYCATIONย End Products in Nondiabetic Subjects
  3542. XLF-III-43, a novel coumarinโ€“aspirin compound, prevents diabetic nephropathy in rats via inhibiting advancedย GLYCATIONย end products
  3543. Modulation of advancedย GLYCATIONย endproduct synthesis by kynurenines in human lens proteins
  3544. Histamine inhibits adhesion molecule expression in human monocytes, induced by advancedย GLYCATIONย end products, during the mixed lymphocyte reaction
  3545. Increased accumulation of advancedย GLYCATIONย endproducts in patients with Wegenerโ€™s granulomatosis
  3546. Different role of advancedย GLYCATIONย end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2
  3547. Quality of diet, screened by the Mediterranean diet quality index and the evaluation of the content of advancedย GLYCATIONย endproducts, in a population of high school โ€ฆ
  3548. Functional analysis of the common haplotype in the receptor for advancedย GLYCATIONย end-products gene previously identified as a susceptibility factor for diabetic โ€ฆ
  3549. Advancedย GLYCATIONย end products and acute myocardial infarction
  3550. Histamine inhibits advancedย GLYCATIONย end products-induced adhesion molecule expression on human monocytes
  3551. The breakdown of preformed peritoneal advancedย GLYCATIONย end products by intraperitoneal alagebrium
  3552. Immunofluorescence detection of advancedย GLYCATIONย end products (AGEs) in cookies and its correlation with acrylamide content and antioxidant activity
  3553. Open tubular capillary electrochromatography: a useful microreactor for collagen Iย GLYCATIONย and interaction studies with low-density lipoprotein particles
  3554. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advancedย GLYCATIONย end products in vitro
  3555. The anti-apoptotic activity of albumin for endothelium is inhibited by advancedย GLYCATIONย end products restricting intramolecular movement
  3556. Relevance of apoptosis and tolerance to hypoxic stress in cells transfected with receptor for advancedย GLYCATIONย end products (RAGE)
  3557. Evidence for the presence ofย GLYCATIONย adducts in protein therapeutics
  3558. N-Terminal 2, 3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advancedย GLYCATIONย endproduct (AGE) formation
  3559. Relationship between impairedย GLYCATIONย and the N-terminal structure of the Hb Gรถrwihl [ฮฒ5 (A2) Proโ†’ Ala] variant
  3560. Inhibiting LDLย GLYCATIONย ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in โ€ฆ
  3561. Reactivity of rare sugar D-allose duringย GLYCATIONย of human serum albumin
  3562. Ne {open}-(carboxymethyl) lysine linkage to ฮฑ-synuclein and involvement of advancedย GLYCATIONย end products in ฮฑ-synuclein deposits in an MPTP-intoxicated mouse โ€ฆ
  3563. Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advancedย GLYCATIONย endproduct hydroimidazolone
  3564. 2-Deoxy-D-ribose induces cellular damage by increasing oxidative stress and proteinย GLYCATIONย in a pancreatic ฮฒ-cell line
  3565. Pigment epithelium-derived factor (PEDF) inhibits diabetes-or advancedย GLYCATIONย end product (AGE)-induced platelet CD40 ligand overexpression in rats
  3566. Technology of advancedย GLYCATIONย endproducts fluorescence measurement and precorrection
  3567. GLYCATIONย of aspartate aminotransferase by methylglyoxal, effect of hydroxycitric and uric acid
  3568. Application of fluorescence spectrum technology in the detecting for advancedย GLYCATIONย endproducts
  3569. Preventive effects of Rosa rugosa root extract on advancedย GLYCATIONย end product-induced endothelial dysfunction
  3570. Characterization ofย GLYCATIONย sites on human serum albumin using mass spectrometry
  3571. Scavenging effects of dietary flavonoids on reactive dicaronyl species and their possible implications on the inhibition of the formation of advancedย GLYCATIONย โ€ฆ
  3572. Increased receptor for advancedย GLYCATIONย endproducts immunocontent in the cerebral cortex of vitamin A-treated rats
  3573. Association of the receptor for advancedย GLYCATIONย end products (RAGE)-374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 โ€ฆ
  3574. Advancedย GLYCATIONย endproducts in sepsis and mechanical ventilation: extra or leading man?
  3575. Canadian diabetes association national nutrition committee technical review: advancedย GLYCATIONย end-products in diabetes management
  3576. Inhibitory Effects of eel (Anguilla japonica) extracted carnosine on Proteinย GLYCATION
  3577. Novel application of surface plasmon resonance biosensor chips for measurement of advancedย GLYCATIONย end products in serum of Zucker diabetic fatty rats
  3578. Visfatin and endogenous secretory receptor for advancedย GLYCATIONย end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis
  3579. Phenolic content and in vitro inhibitory effects on oxidation and proteinย GLYCATIONย of some thai medicinal plants
  3580. Maillard reaction of ribose 5-phosphate generates superoxide andย GLYCATIONย products for bovine heart cytochrome c reduction
  3581. Apparatus for detecting advancedย GLYCATIONย Endproducts fluorescence of skin
  3582. Effect of arginine onย GLYCATIONย and stability of recombinant human interferon-gamma
  3583. GLYCATIONย of LDL is an important atherogenic modification and opposed by paraoxonase-rich HDL
  3584. Prostaglandin E2 inhibits advancedย GLYCATIONย end product-induced adhesion molecule expression on monocytes, cytokine production, and lymphocyte proliferation โ€ฆ
  3585. Plasma proteinย GLYCATIONย in diabetic nephropathy
  3586. Study of lysozymeย GLYCATIONย reaction by mass spectrometry and NMR spectroscopy
  3587. Role of protein kinase C in advancedย GLYCATIONย end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells
  3588. Impaired glucose tolerance, angiopathy and advancedย GLYCATIONย end products [J]
  3589. Advancedย GLYCATIONย End-Products Increase Calcification in Rat Vascular Smooth Muscle Cells [J]
  3590. Design of advancedย GLYCATIONย endproducts fluorescence spectrum detecting system
  3591. Advancedย GLYCATIONย end products, rage, and aging
  3592. In Situ Gelableย GLYCATION-Resistant Hydrogels Composed of Gelatin and Oxidized Alginate
  3593. Covalent binding antibodies suppress advancedย GLYCATION: on the innate tier of adaptive immunity
  3594. Inhibitory Effects of Ethanol Extract from Toona sinensis Leaves on the Formation of Protein Non-enzymaticย GLYCATIONย in vitro
  3595. GLYCATIONย of mitochondrial proteins, oxidative stress and aging
  3596. Effect of Acetyl Salicyilic Acid onย GLYCATIONย and Mutability of Escherichia Coli Chromosomal DNA
  3597. Biological variation ofย GLYCATIONย and mean blood glucose have greater influence on Hba1c levels in type 1 young diabetic patients than glucose instability
  3598. Advancedย GLYCATIONย end products alters functions of end othelial progenitor cells in vitro [J]
  3599. GLUT-1 expression in bovine retinal capillary endothelial cells and pericytes exposed to advancedย GLYCATIONย end products
  3600. Plasma proteinย GLYCATIONย status in Pakistan type 2 diabetic patients with or without nephropathy
  3601. CHANGES IN THE STABILITY AND KINETIC PARAMETERS UP ONย GLYCATIONย OF THERMOSTABLE ฮฑโ€AMYLASE FROM BACILLUS SUBTILIS
  3602. Prokaryotic expression of receptor for advancedย GLYCATIONย end product and screening of its interaction proteins [J]
  3603. Diet high in advancedย GLYCATIONย end products exacerbates pulmonary inflammatory response and impairs lung compliance in mice following gastric aspiration
  3604. Comparison of solidโ€stateย GLYCATIONย of whey proteins through Maillard reaction between microwave and conductive heating
  3605. Effects of short-term streptozotocin-induced diabetes and vitamin C on platelet non-enzymaticย GLYCATION
  3606. Advancedย GLYCATIONย End Products in Histone H1 In Vivo
  3607. Effects of advancedย GLYCATIONย end products on expressions of EMMPRIN and MMP-2 in mouse osteoblasts
  3608. Intake of advancedย GLYCATIONย endproducts: Role in the development of diabetic complications
  3609. Comparative study of serum/plasmaย GLYCATIONย and lipid peroxidation of young patients with type 1 diabetes mellitus in relation to glycemic compensation and the โ€ฆ
  3610. The effects of advancedย GLYCATIONย end products and homocystein on the expression of vascular cell adhesion molecule-1 via NADPH oxidase in human umbilical vein โ€ฆ
  3611. The Receptor For Advancedย GLYCATIONย End-Products (RAGE) exerts renoprotective effects via the AT-2 receptor in Diabetic Nephropathy
  3612. Low serum level of the endogenous secretory receptor for advancedย GLYCATIONย end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of โ€ฆ
  3613. Effects of advancedย GLYCATIONย end products on proliferation and apoptosis of human heptical cell line LO2 [J]
  3614. A Study of Pioglitazone Biokinetics, Renal Clearance and its Effect onย GLYCATIONย Level
  3615. Evidence for Excretion ofย GLYCATIONย Agents from E. Coli Cells During Growth
  3616. The Receptor for Advancedย GLYCATIONย End Products (RAGE) Activates Ras and NFฮบ-ฮฒ in Pulmonary Epithelial Cells Exposed to Cigarette Smoke.
  3617. Non-Invasive Method for Detecting Skin Autofluorescence of Advancedย GLYCATIONย End Products
  3618. Effect of isoflurane on advancedย GLYCATIONย end products and oxidative stress in rat brain
  3619. Effects of advancedย GLYCATIONย end products on the expression of urotensin in rat NRK-52E cells
  3620. Experimental Study on Advancedย GLYCATIONย end Products Induced Proliferation of Ratโ€™s Vascular Smooth Muscle Cells in Vitro [J]
  3621. Determination of advancedย GLYCATIONย end-products on IgG in liver cirrhosis.
  3622. Identification of methylglyoxal-lowering agents for the treatment of advancedย GLYCATIONย end products-related diseases
  3623. The Proโ€Adipogenic Effect of Advancedย GLYCATIONย Endโ€Products (AGEs) in Adipogenesis
  3624. Role of advancedย GLYCATIONย end products and nitric oxide in patients with diabetic peripheral neuropathy [J]
  3625. Advancedย GLYCATIONย Endproducts Alters Functions in Endothelial Progenitor Cells Through Oxidant Stress [J]
  3626. Effect of Alpinia officinarum on the Formation of Advancedย GLYCATIONย Endproducts and Aldose Reductase Activity
  3627. Self-Made Monoclonal Antibodies Detect Diabetic Rat Kidney and Heartย GLYCATIONย End Products [J]
  3628. Activation of RAGE/STAT3 axis by advancedย GLYCATIONย endproducts in vascular remodeling diseases
  3629. Effect of Advancedย GLYCATIONย End Products on Expression of Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 [J]
  3630. A pathophysiologic evaluation of the receptor for advancedย GLYCATIONย end products (RAGE) in the lung
  3631. Improved methods for quantifying plasma protein advancedย GLYCATIONย end products as biomarkers for age-related macular degeneration
  3632. Effect of advancedย GLYCATIONย end products of different concentration on the expression of Fractalkine in human tubular epithelial cells [J]
  3633. 99mTc-Labeled anti-receptor for advancedย GLYCATIONย endproducts polyclonal antibody F (abโ€™) 2 fragments
  3634. Effects of Advancedย GLYCATIONย End Products on Activity and Expression of Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells and the Protective Effects โ€ฆ
  3635. Effect of depside salt from salvia miltiorrhizae in repairing advancedย GLYCATIONย end products-induced late endothelial progenitor cell dysfunction and its molecular โ€ฆ
  3636. Letter by Hartog et al Regarding Article,โ€ Advancedย GLYCATIONย End Products Accumulate in Vascular Smooth Muscle and Modify Vascular but Not Ventricular โ€ฆ
  3637. The Effect of Advancedย GLYCATIONย End Products on the Expression of Matrix Metalloproteinase Inducer and the Activity of Matrix Metalloproteinase-9 in Cultured Mouse โ€ฆ
  3638. Adiponectin suppression of advancedย GLYCATIONย endproducts induced CD40 high expression in human umbilical vein endothelial cells
  3639. Comparison of inhibitory activities of advancedย GLYCATIONย end products and angiotension-I-converting enzyme by the extract from wild and cultured Inonotus Obliquus โ€ฆ
  3640. Relationship between plasma level of endogenous secretory receptor of advancedย GLYCATIONย end products and oxidative stress in diabetic patients with hypertension
  3641. Common pathogenetic features between calcific aortic stenosis and atherosclerosis: role of receptor for advancedย GLYCATIONย end-products
  3642. Lens and skin proteinย GLYCATION, lipid peroxidation and glutathione levels in vitamin C administered diabetic rats.
  3643. Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and proteinย GLYCATION
  3644. Oxidative stress, advancedย GLYCATIONย end products and residual renal function in the rat model of unilateral ureteral obstruction: effects of phlogenzym and losartan
  3645. Advancedย GLYCATIONย end products induce expression of PAI-1 in cultured human proximal tubular epithelial cells through NADPH oxidase dependent pathway
  3646. Receptor for advancedย GLYCATIONย end products is associated with systemic and organ-specific severity of acute lung injury and acute respiratory distress syndrome
  3647. Globular adiponectin protects human umbilical endothelial cells against apoptosis induced by advancedย GLYCATIONย end products through increasing adiponectin โ€ฆ
  3648. Microarray-Based Gene Set Analysis: Pathway Analysis of Advancedย GLYCATIONย Endproduct (AGEs) or Amyloid Beta (Aฮฒ) Stimulation of Human RPE in vitro
  3649. Inhibiting low-density lipoproteinย GLYCATIONย ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation โ€ฆ
  3650. CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease: enzymatic and non-enzymaticย GLYCATIONย or oxidation induced โ€ฆ
  3651. Advancedย GLYCATIONย end products and food
  3652. Deletion of bone marrow derived receptor for advancedย GLYCATIONย end-products (RAGE) does not attenuate plaque formation but inhibits plaque progression in a โ€ฆ
  3653. Antiโ€GLYCATIONย Effect of Gold Nanoparticles
  3654. Increasedย GLYCATIONย and Oxidative Damage to
  3655. Quantitative analysis of proteinย GLYCATIONย in clinical samples
  3656. OxiSelectโ„ข Advancedย GLYCATIONย End Product (AGE) ELISA Kit
  3657. Estrogen Attenuates the Inhibition of Nitric Oxide Synthase Type 3 Induced by Advancedย GLYCATIONย End-Products [J]
  3658. Non-enzymaticย GLYCATIONย Effects of Aging
  3659. Role of advancedย GLYCATIONย end products and nitric oxide in patients.
  3660. Advancedย GLYCATIONย and Inflammatory Phenomena in Renal Transplantation
  3661. Metabolic syndrome in dialyzed patients. Advancedย GLYCATIONย end-products, adipocytokines, and principles of treatment
  3662. Novel neutraceutical properties of some Sri Lankan traditional rice: Inhibition of proteinย GLYCATIONย and breaking of cross links of advancedย GLYCATIONย end products
  3663. Preparation and identification of monoclonal antibody of advancedย GLYCATIONย end products
  3664. Comparison of Anti-GLYCATIONย Capacities of Several Herbal Infusions with that of Green Tea
  3665. IDENTIFICATION OF NEW ADVANCEDย GLYCATIONย END PRODUCTS INHIBITORS: DEVELOPMENT OF A 96-WELL PLATE SCREENING
  3666. GLYCATIONย sites in neoglycoglycoconjugates from the terminal monosaccharide antigen of the O-PS of Vibrioโ€ฆ
  3667. Hypertension enhances haemoglobinย GLYCATIONย in diabetics
  3668. Effect of fatty acid binding on theย GLYCATIONย of human serum albumin
  3669. Cancer andย GLYCATIONโ€“Using Human Tissue Culture Model to Probe the Metabolic Effects ofย GLYCATIONย Flux
  3670. The effect of advancedย GLYCATIONย end products on biological activity of hepatic stellate cell
  3671. Quercetin as an Inhibitor of Proteinย GLYCATION
  3672. Study of hemoglobin and human serum albuminย GLYCATION
  3673. The effect of advancedย GLYCATIONย end products on biological activity of hepatic stellate cell
  3674. Effects of hexue Composita on advancedย GLYCATIONย and products in kidneys of diabetic rats [J]
  3675. Advancedย GLYCATIONย End Products (AGES): Pathological Entanglement
  3676. A Novel Biomaterial for the Targeted Removal of Advancedย GLYCATIONย End Products from Blood
  3677. Leukozytenrekrutierung in โ€žReceptor for Advancedย GLYCATIONย Endproducts โ€œgendefizienten Mรคusen in vivo
  3678. Clinical observations on correlation between advancedย GLYCATIONย end products and coronary heart disease or diabetes
  3679. Effect of Advancedย GLYCATIONย End-products on High Gluclose Induced Transdifferentiation in NRK-52E Cells
  3680. Advancedย GLYCATIONย End Products in Patients with Leukoaraiosis
  3681. Automating a 96-well microtiter plate assay for advancedย GLYCATIONย end-products inhibitors or inducers identification: application to the screening of a small natural โ€ฆ
  3682. The correlation of serum level of advancedย GLYCATIONย end products and the expression of receptor for advancedย GLYCATIONย end products in white blood cells with senile โ€ฆ
  3683. Ruhuang Preparation on Advancedย GLYCATIONย Endproducts (AGEs) in Cirrhotic Rats
  3684. Association Between Diet-Induced Advancedย GLYCATIONย End Products, AMD and Cataract
  3685. Banked RBCs Increase Endothelial Cell Oxidative Stress through Advancedย GLYCATIONย Endproducts.
  3686. Effect of advancedย GLYCATIONย end products on aortic structure and function in diabetic rats
  3687. Estimation of Advancedย GLYCATIONย End Products in Saliva of Diabetic Patients
  3688. Levels of serum advancedย GLYCATIONย endproducts and its clinical significance in patients of diabetes mellitus with hepatic dysfunction
  3689. Advancedย GLYCATIONย End Products Impair Function of Endothelial Progenitor Cells
  3690. Study of nonenzymaticย GLYCATIONย of transferring and its effect on iron-binding antioxidant capacity
  3691. Formation of advancedย GLYCATIONย end products (AGE) in vitro and their impact on adipocyte function
  3692. A Rapid Method for Identifyingย GLYCATIONย Sites in Therapeutic Proteins by Isotopic Labeling with 13C6-glucose
  3693. Effect of nicotine on advancedย GLYCATIONย end products-induced immune
  3694. Study of Damaging Effect of Exogenous Advancedย GLYCATIONย End Products on Vascular Endothelial Cell in Vitro
  3695. Advancedย GLYCATIONย Endproducts (AGEs) Favor LDL Retention in the Fundus
  3696. Physico-Chemical Changes of Human Serum Albumin During in Vivo and in Vitroย GLYCATIONย Processes
  3697. Advancedย GLYCATIONย end products (AGEs) and high glucose in endothelial cells: gene expression analysis
  3698. A Research on Lysozyme, Advancedย GLYCATIONย End-products (AGEs) and Diabetic Complications [J]
  3699. Effects ofย GLYCATIONย on Dynamic Mechanical Properties and Penetration of Articular Cartilage
  3700. Role of Advancedย GLYCATIONย End Products and Vascular Endothelial Growth Factor in Pathophysiology of Diabetic Retinopathy
  3701. Advancedย GLYCATION; non-enzymatic but relatively specific reaction more than expected?
  3702. D-ribose can induce proteinย GLYCATIONย and AGEs generation in vivo
  3703. ADVANCEDย GLYCATIONย END PRODUCTS AND THEIR RECEPTOR RAGE IN SYSTEMIC AUTOIMMUNE DISEASES
  3704. Effect of Advancedย GLYCATIONย End Products on the Activity of Na~+/H~+ Exchanger 1 of Vascular Smooth Muscle Cell in Rat
  3705. Induction of Advancedย GLYCATIONย End Products and Alterations of the Tensile Properties of Articular cartilage
  3706. Relationship between advancedย GLYCATIONย end-products, inflammatory factors and diffuse coronary artery disease in patients with diabetes mellitus
  3707. Advancedย GLYCATIONย end product precursors in diabetes: a crucial link between oxidative stress and inflammation?
  3708. Stability of whey protein derived peptides upon severe proteinย GLYCATION
  3709. Advancedย GLYCATIONย Endproducts Induce Photocrosslinking and Oxidation of Bovine Lens Proteins Through Type-I Mechanism
  3710. Effect ofย GLYCATIONย in the presence or absence of soluble wheat proteins on major whey allergens
  3711. Receptor for advancedย GLYCATIONย end-products: Expression and signaling
  3712. Outcomes of blood purification on clearance of serum advancedย GLYCATIONย end products and beta 2-microglobulin
  3713. Mechanisms of disordered cell cycle in keratinocytes mediated by advancedย GLYCATIONย end products
  3714. Proteinย GLYCATIONย and methylglyoxal metabolism in Parkinsonโ€™s disease
  3715. Promoting effect of receptor for advancedย GLYCATIONย end product in periodontitis
  3716. A preliminary report on ageโ€related elevations of saliva advancedย GLYCATIONย endproducts (AGEs) and arNOX
  3717. Expressions of advancedย GLYCATIONย end products and their receptors in keloid.
  3718. Collagenย GLYCATIONย Promotes Myofibroblast Differentiation
  3719. GLYCATIONย induced modification and identification of AGEs-precursors and AGEs in human serum albumin
  3720. Effects of Saengjihwangeum-ja Extracts on the Expression of Inflammatory Response in Human Monocyte Cells Induced by Advancedย GLYCATIONย End Product
  3721. Correlation betweenย GLYCATIONย End Product Receptor, P-Selectin and Preeclampsia
  3722. Concentration time profiles of plasma pentosidine in healthy volunteers following a breakfast rich in advancedย GLYCATIONย end products
  3723. Advancedย GLYCATIONย end-products (ages) in transplanted heart pathology of patients with or without diabetes mellitus type 2 (DM)
  3724. Advancedย GLYCATIONย End-Products, Release Of Their Soluble Receptors (es And SRAGE) And Relationship To CRP After Surgery Necessitating Cardiopulmonary โ€ฆ
  3725. Receptors for Advancedย GLYCATIONย Endproducts Cause Decreased Collateral Vessel Formation in the Face of Uncontrolled Diabetes
  3726. Effect of Advancedย GLYCATIONย End Products on Inducing Rat Retinal Microvascular Endothelial Cells to Form New Blood Vessels
  3727. Effects of metformin on the proliferation of vascular smooth muscle cells induced by advancedย GLYCATIONย end products
  3728. Effect of advancedย GLYCATIONย end-products on high gluclose inducing oxidative stress in NRK-52E and inhibited by probucol
  3729. Effect of advancedย GLYCATIONย end products on dilation of rat skeletal muscle arterioles
  3730. Detection of trace amount soluble receptor for advancedย GLYCATIONย end-productin in human CSF.
  3731. Advancedย GLYCATIONย End Products Stimulate Vascular Endothelial Growth Factor Production From Human Airway Epithelial Cells In Vitro And In Vivo
  3732. Soluble receptors for advancedย GLYCATIONย end products as predictors of restenosis following percutaneous coronary intervention
  3733. Decreased plasma levels of soluble receptor for advancedย GLYCATIONย endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
  3734. Mechanism of advancedย GLYCATIONย end products-stimulated phosphorylation of ERM protein in human umbilical vein endothelial cells
  3735. Non-enzymaticย GLYCATIONย weakens trabecular bone and may influence changes in bone quality
  3736. ADVANCEDย GLYCATIONย END-PRODUCTS (AGES) IN LATE PATHOLOGY OF TRANSPLANTED HEART IN PATIENTS WITH OR WITHOUT DIABETES MELLITUS โ€ฆ
  3737. Advancedย GLYCATIONย Endproducts (ages) Modulate Some but Not All Retinal Neuroglial Alterations During Diabetes With Links to a Pro-Inflammatory Phenotype
  3738. GLYCATIONย of Lipoproteins and the Role of High Density Lipoprotein and Paraoxonase-1
  3739. Expression of Advancedย GLYCATIONย Receptor Products (RAGE) after Cerebral Ischemia
  3740. The Isolation of the Receptor for Advancedย GLYCATIONย Endโ€Products from Avian Vasculature
  3741. GLYCATIONย and Oxidation: the causes of nephropathic, neuropathic and cardiovascular diabetic pathologies
  3742. Proteinย GLYCATIONย and methylglyoxal metabolism in Parkinsonโ€™s disease
  3743. Inhibition of glutathione on vascular smooth muscle cell proliferation mediate by advancedย GLYCATIONย end products
  3744. Soluble Receptor for Advancedย GLYCATIONย Endproducts (sRAGE) Induces Human Monocyte Survival and Differentiation (38.23)
  3745. Effects of advancedย GLYCATIONย end products on the expression of VEGF and NF-ฮบB in cultured human RPE cells
  3746. Covalent binding antibodies suppress advancedย GLYCATION: on the innate tier of adaptive
  3747. Effects of irbesartan on renal advancedย GLYCATIONย end products and their receptor in rats with early diabetic nephropathy
  3748. Effects of advancedย GLYCATIONย end products on tubule-like structure formation and collapse in cardiac microvascular endothelial cells and their mechanisms
  3749. Inhibition of the advancedย GLYCATIONย endproducts receptor (RAGE) protects pancreatic beta cell
  3750. Correlation of the receptor of advancedย GLYCATIONย end-products and angiogenesis in nasopharyngeal carcinoma
  3751. Tissue advancedย GLYCATIONย endproducts in two populations associated with increased oxidative stress: Normal in cirrhosis but elevated in haemodialysis patients
  3752. Association of polymorphisms in receptor for advancedย GLYCATIONย end products gene with diabetic retinopathy
  3753. The effect of amioguanidine and baicalin on tissue nonenzymaticย GLYCATIONย and retinal apoptosis in diabetic rats
  3754. Effects of isoflurance on learning and memory function and receptor for advancedย GLYCATIONย end products expression of hippocampus in rats
  3755. Effect of advancedย GLYCATIONย end products on secretion of MMP-2 in cultured mouse embryo/fetus calvaria fibroblasts
  3756. Effects of isoflurane on expression of receptor for advancedย GLYCATIONย endproducts in hippocampus in rats
  3757. THE INFLUENCE OF SERUM ENDOGENOUS SECRETORY ADVANCEDย GLYCATIONย END-PRODUCTS RECEPTOR ON ARTERIAL ELASTICITY IN PATIENTS โ€ฆ
  3758. Direct Myocardial Actions of Advancedย GLYCATIONย Endproducts (AGEs) on Cytosolic Calcium Transients Mediated Through Reactive Oxygen Species
  3759. Effects of advancedย GLYCATIONย end products on proliferation and differentiation of neural precursor cells from embryonic rat hippocampus
  3760. Chronic Alcohol Ingestion Decreases Protein Expression of the Receptor for Advancedย GLYCATIONย End Products in the Rat Lung.
  3761. Advancedย GLYCATIONย end products (AGEs) up-regulate the expressions of nuclear factor-kB and cyclooxygenase-2 in rat cardiac microvascular endothelial cells โ€ฆ
  3762. Effects of Genistin on Oxidative Stress State and Expression of TGF-ฮฒ_1 in Advancedย GLYCATIONย End-Products Stimulated SD Rat Renal Mesangial Cells
  3763. Effect of Advancedย GLYCATIONย Endproducts on Human Smooth Muscle Cell proliferation by Coโ€culture System with Endothelium and Monocytes.
  3764. Effects of advancedย GLYCATIONย end products on the expressions of ฮฒ1-integrin and focal adhesion kinase (FAK)
  3765. Tissue Advancedย GLYCATIONย End-products Are Associated With Diastolic Dysfunction and Aerobic Exercise Capacity in Diabetic Patients With Heart Failure
  3766. Effects of advancedย GLYCATIONย end products on expressions of EMMPRIN and MMP-2 in mouse osteoblasts.
  3767. Advancedย GLYCATIONย end products increased angiopoietin-1 expression via oxidative stress and NF-ฮบB pathways in cultured NRK-49F cells
  3768. Characterizing the advancedย GLYCATIONย endproducts formation of proteins and nucleotides by methylglyoxal and glyoxal
  3769. The effects of aminoguanidine on tissue nonenzymaticย GLYCATIONย and kidney apoptosis in diabetic rats
  3770. Advancedย GLYCATIONย Endproducts (AGEs) Modulate Microglial Activation and Link to Proinflammatory Pathology During Diabetic Retinopathy
  3771. Advancedย GLYCATIONย Endproducts Regulate CD40 Expression in the Human Umbilical Vein Endothelial Cell via LOX-1
  3772. ALBUMINURIA IS ACCOMPANIED BY INCREASED CIRCULATING SOLUBLE RECEPTOR FOR ADVANCEDย GLYCATIONย END PRODUCTS IN HYPERTENSIVE โ€ฆ
  3773. Receptor for advancedย GLYCATIONย endproducts (RAGE) regulates รŸ-catenin function and chemosensitivity in pancreatic cancer cells
  3774. Inhibitory effects of the compounds isolated from Purple corn on aldose reductase and advancedย GLYCATIONย end-products formation
  3775. The Dimerisation of the Receptor for Advancedย GLYCATIONย End-Products (RAGE) Is Essential for AGE-Induced Signaling in Diabetic Retinopathy
  3776. Effect of compound Chinese sour taste herbs on advancedย GLYCATIONย end products content and gene expression of their receptors in aorta of rats with type 2 diabetes โ€ฆ
  3777. The Role of the Receptor for Advancedย GLYCATIONย End Products (RAGE) in Idiopathic Pulmonary Fibrosis
  3778. Response to Letter Regarding Article,โ€œAdvancedย GLYCATIONย End Products Accumulate in Vascular Smooth Muscle and Modify Vascular but Not Ventricular Properties โ€ฆ
  3779. Receptor for advancedย GLYCATIONย end products protects against Klebsiella pneumoniae induced pneumonia in mice
  3780. C reactive protein induced the expression of the receptor for advancedย GLYCATIONย end products via NF-ฮบB
  3781. Comparing Effects of Aminoguanidine and Metformin on Lowering Advancedย GLYCATIONย Endproducts (AGEs) in STZโ€induced Diabetic Rats
  3782. Ligands of receptor for advancedย GLYCATIONย end-products in stable coronary artery disease: their potential contribution to atherogenesis exceeds beyond diabetes โ€ฆ
  3783. Establishing the links between the soluble receptor for advancedย GLYCATIONย end products, asymmetric dimethylarginine and low-grade inflammation in essential โ€ฆ
  3784. Advancedย GLYCATIONย end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
  3785. Post-Infarct Remodeling is Altered in Diabetes: Role for Receptor for Advancedย GLYCATIONย End-Products and S100B
  3786. โ€ฆ Advances in Hemoglobin A1c Measurement: Biologic Variability in Plasma Glucose, Hemoglobin A1c, and Advancedย GLYCATIONย End Products Associated with โ€ฆ
  3787. Receptor For Advancedย GLYCATIONย End-products Is A Marker Of Acute Lung Injury In Critically-ill Patients, Regardless Of Associated Sepsis
  3788. Inhibitory action of crocetin on the expression of E-selectin in bovine endothelial cells induced by advancedย GLYCATIONย end products
  3789. The effect of amioguanidine and baicalin on tissue nonenzymaticย GLYCATIONย and renal apoptosis in diabetic rats.
  3790. Arterial Stiffness and Urinary Albumin Excretion in Hypertension: The Emerging Role of the Soluble Receptor for Advancedย GLYCATIONย End Products
  3791. Advancedย GLYCATIONย End Products activate MMPโ€9 secretion in macrophage cells, the involvement of MAP Kinase and NFโ€kappaB signaling pathways
  3792. Low Serum Level of the Endogenous Secretory Receptor for Advancedย GLYCATIONย End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures โ€ฆ
  3793. Effects of PPAR-ฮณ activation on the expressions of TGF-ฮฒ and CTGF mRNA in rat mesangial cells induced by advancedย GLYCATIONย end products
  3794. Glyceraldehyde-derived advancedย GLYCATIONย end products decrease white adipose tissue weight and downregulate leptin, adiponectin, and macrophage marker
  3795. The Receptor for Advancedย GLYCATIONย End Products (RAGE) Is a Marker of Alveolar Epithelial Damage in ARDS.
  3796. Relation of Serum Levels of Endogenous Secretory Receptor for Advancedย GLYCATIONย End-products and Glycated Albumin to Coronary Artery Disease in Type 2 โ€ฆ
  3797. Plasma and alveolar fluid levels of Receptor for Advancedย GLYCATIONย Endproducts (RAGE) are associated with severity of ARDS
  3798. Terminalia bellerica (Belliric Myrobalan) stimulates the secretion and action of insulin and inhibits starch digestion and proteinย GLYCATION
  3799. Effects of grape seed proanthocyanidin extracts on advancedย GLYCATIONย end products and expression of bone morphogenetic protein-7 in diabetic nephropathy rats.
  3800. Effects of Ligustrazine on Expression of Extracellular Matrix in Human Proximal Renal Tubular Epithelial Cells Induced by Advancedย GLYCATIONย End Products
  3801. Circulating Levels and Dietary Intake of the Advancedย GLYCATIONย End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on โ€ฆ
  3802. Receptor for advancedย GLYCATIONย end products (RAGE) polymorphisms are associated with SLE, RA, and disease severity in lupus nephritis
  3803. Effect of peanut skin phenolics on pancreatic amylase activity and fructoseโ€mediated albuminย GLYCATION
  3804. Rosiglitazone attenuates advancedย GLYCATIONย end products induced endothelial progenitor cells dysfunction via upregulating Akt/eNOS signal pathways
  3805. Effect of C-RP on the expressions of receptor of advancedย GLYCATIONย end-products and monocyte chemoattractant protein-l in human saphenous vein endothelial cells โ€ฆ
  3806. Effect of storage on phytochemical stability, color, antioxidant activity, and inhibition of formation of fructose-induced advancedย GLYCATIONย endproducts of an โ€ฆ
  3807. The thiamine analogue and advancedย GLYCATIONย endproducts crosslink breaker ALT-711 does not interfere with transketolase activity
  3808. Conditional upโ€regulation of Receptors for Advancedย GLYCATIONย Endโ€Products (RAGE) in Alveolar Epithelium Causes Respiratory Distress and Perinatal Lethality
  3809. The Expression of Receptor Advancedย GLYCATIONย End-products and Type IV Collagen in Ovary Tissues of Women with Polycystic Ovary Syndrome
  3810. The role of scavenging antioxidants and the transcription factor NRF2 in protection against advancedย GLYCATIONย end products in a neuronal-derived cell line
  3811. Effect of Advancedย GLYCATIONย End Products on Expression of Urotensin โ…ก and G-Protein-Couple Receptor mRNAs in Rat Mesangial Cells
  3812. Effect of siRNA targeting TGF-ฮฒ inducible early gene on expression of advancedย GLYCATIONย end products-mediated Smad2 in renal tubular epithelial cells
  3813. Influence of C-type natriuretic peptide on expression of natriuretic peptide B receptor suppressed by advancedย GLYCATIONย end products and on post-receptor signal โ€ฆ
  3814. โ€ฆ RECEPTOR BLOCKER AND CALCIUM CHANNEL BLOCKER REDUCE THE EXPRESSION OF RECEPTOR FOR ADVANCEDย GLYCATIONย END-PRODUCTS IN โ€ฆ
  3815. Ligands of the receptor for advancedย GLYCATIONย end products (RAGE), including high mobility group box (HMGB) 1, limit bacterial dissemination during โ€ฆ
  3816. Diesel Particulate Matter Induces Receptor for Advancedย GLYCATIONย Endโ€Products (RAGE) Expression in Alveolar Epithelial Cells and Mediates an Inflammatory โ€ฆ
  3817. โ€ฆ ; Inhibitory Activity of Caffeoylquinic Acids from the Aerial Parts of Artemisia princeps on Rat Lens Aldose Reductase and on the Formation of Advancedย GLYCATIONย End โ€ฆ
  3818. Gly82Ser Polymorphism of the Receptor for Advancedย GLYCATIONย End Products Gene (RAGE) and the Endogenous Secretory RAGE (esRAGE) and its โ€ฆ
  3819. Proteomic Analysis of Advancedย GLYCATIONย End-Product (Age) Modified Proteins in High Glucose-Exposed Retinal Mรผller Glia: Evidence for Age-Mediated Cell โ€ฆ
  3820. โ€ฆ V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TM. Reduction of the accumulation of advancedย GLYCATIONย end products by โ€ฆ
  3821. Na~+/H~+ exchanger 1 and renal cortical injury induced by advancedย GLYCATIONย end products
  3822. e0305 The effect of profilin-1 on vascular injury caused by advancedย GLYCATIONย end products
  3823. Serum matrix metalloproteinase-9 and advancedย GLYCATIONย end-products in diabetic patients with or without diabetic foot problems
  3824. Quercetin-3-rutinoside, a flavonol glycoside from Teucrium polium suppresses advancedย GLYCATIONย end products (AGEs) formation: A structural study
  3825. 010 Advancedย GLYCATIONย end products induce functional impairment in neonatal rat cardiomyocytes through enhanced production of reactive oxygen species
  3826. 186. The Receptor for Advancedย GLYCATIONย End-Products (RAGE) Limits NK Activity
  3827. 702: Receptor for Advancedย GLYCATIONย End Products Expression in Lung Allograft Recipients with Primary Graft Dysfunction (PGD)
  3828. Effect of mitogen-activated protein kinase kinase 6-p38 alpha signal pathway on receptor for advancedย GLYCATIONย end-product expression in alveolar epithelial cells โ€ฆ
  3829. Analysis of the impact of heparin on the affinity of high mobility group box-1 protein and the receptor of advancedย GLYCATIONย end products by surface plasmon โ€ฆ
  3830. 210 GREEN TEA POLYPHENOL EPIGALLOCATECHIN-3-GALLATE (EGCG) INHIBITS ADVANCEDย GLYCATIONย END PRODUCTS-INDUCED EXPRESSION โ€ฆ
  3831. Role of microRNA-214-targeting PTEN in advancedย GLYCATIONย endproducts-induced apoptosis delay of monocytes (89.35)
  3832. 463 Autocrine regulation of receptor for advancedย GLYCATIONย endproducts (RAGE) by S100A4 promotes migration and invasion in A375 melanoma cells
  3833. Inhibition of advancedย GLYCATIONย endproduct formation by foodstuffs
  3834. Role of advancedย GLYCATIONย end products in cardiovascular disease
  3835. Theย GLYCATIONย of albumin: structural and functional impacts
  3836. Advancedย GLYCATIONย end products and neurodegenerative diseases: mechanisms and perspective
  3837. GLYCATIONย research in amino acids: a place to call home
  3838. Advancedย GLYCATIONย end products
  3839. GLYCATIONย stress and photo-aging in skin
  3840. An update on advancedย GLYCATIONย endproducts and atherosclerosis
  3841. Advancedย GLYCATIONย end products and diabetic cardiovascular disease
  3842. Susceptibility of LDL and its subfractions toย GLYCATION
  3843. Advancedย GLYCATIONย endproducts and their pathogenic roles in neurological disorders
  3844. Lipidย GLYCATIONย and proteinย GLYCATIONย in diabetes and atherosclerosis
  3845. Naturally occurring inhibitors against the formation of advancedย GLYCATIONย end-products
  3846. Molecular basis of arterial stiffening: role ofย GLYCATIONโ€“a mini-review
  3847. Advancedย GLYCATIONย end products: key players in skin aging?
  3848. Advancedย GLYCATIONย endproducts and their receptor RAGE in Alzheimerโ€™s disease
  3849. Pathological significance of mitochondrialย GLYCATION
  3850. Role of advancedย GLYCATIONย end products (AGEs) in osteoporosis in diabetes
  3851. Role of advancedย GLYCATIONย end products (AGEs) and oxidative stress in vascular complications in diabetes
  3852. Serum advancedย GLYCATIONย end products (AGEs) are associated with insulin resistance
  3853. Rates and impact of human antibodyย GLYCATIONย in vivo
  3854. GLYCATIONย a promising method for food protein modification: Physicochemical properties and structure, a review
  3855. Comparison of modification sites formed on human serum albumin at various stages ofย GLYCATION
  3856. Natural products as anti-GLYCATIONย agents: possible therapeutic potential for diabetic complications
  3857. Advancedย GLYCATIONย end product recognition by the receptor for AGEs
  3858. GLYCATIONย and insulin resistance: novel mechanisms and unique targets?
  3859. Advancedย GLYCATIONย endproducts: from precursors to RAGE: round and round we go
  3860. Advancedย GLYCATIONย end products affect growth and function of osteoblasts
  3861. Role of advancedย GLYCATIONย end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
  3862. Targeted reduction of advancedย GLYCATIONย improves renal function in obesity
  3863. Effect of dietary advancedย GLYCATIONย end products on mouse liver
  3864. Crosstalk between advancedย GLYCATIONย and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases
  3865. Advancedย GLYCATIONย end products are direct modulators of ฮฒ-cell function
  3866. Advancedย GLYCATIONย end product level, diabetes, and accelerated cognitive aging
  3867. Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albuminย GLYCATION
  3868. Advancedย GLYCATIONย end products and its receptor (RAGE) are increased in patients with COPD
  3869. GLYCATIONย products in infant formulas: chemical, analytical and physiological aspects
  3870. Advancedย GLYCATIONย end products (AGEs), oxidative stress and diabetic retinopathy
  3871. Antioxidant and anti-GLYCATIONย properties of Thai herbal teas in comparison with conventional teas
  3872. Controllingย GLYCATIONย of recombinant antibody in fedโ€batch cell cultures
  3873. Evidence for consistency of theย GLYCATIONย gap in diabetes
  3874. Advancedย GLYCATIONย end products, soluble receptor for advancedย GLYCATIONย end products, and risk of colorectal cancer
  3875. Gaps in theย GLYCATIONย gap hypothesis
  3876. Reduced soluble receptor for advancedย GLYCATIONย end-products in COPD
  3877. Higher plasma levels of advancedย GLYCATIONย end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year โ€ฆ
  3878. Characterization of site-specificย GLYCATIONย during process development of a human therapeutic monoclonal antibody
  3879. The novel function of advancedย GLYCATIONย end products in regulation of MMP-9 production
  3880. D-ribose inย GLYCATIONย and protein aggregation
  3881. Advancedย GLYCATIONย end-products and their receptor-mediated roles: inflammation and oxidative stress
  3882. Serum levels of advancedย GLYCATIONย end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects
  3883. Advancedย GLYCATIONย endproducts are increased in rheumatoid arthritis patients with controlled disease
  3884. Effects of alagebrium, an advancedย GLYCATIONย endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure
  3885. Relationship between advancedย GLYCATIONย end products and increased lipid peroxidation in semen of diabetic men
  3886. Evidence for a role of advancedย GLYCATIONย end products in atrial fibrillation
  3887. Early-and advanced non-enzymaticย GLYCATIONย in diabetic vascular complications: the search for therapeutics
  3888. Physicochemical studies onย GLYCATIONโ€induced structural changes in human IgG
  3889. Skin advancedย GLYCATIONย end product accumulation and muscle strength among adult men
  3890. The roles of glycated albumin as intermediateย GLYCATIONย index and pathogenic protein
  3891. Restriction of advancedย GLYCATIONย end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1
  3892. Role of advancedย GLYCATIONย endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
  3893. Septic shock is associated with receptor for advancedย GLYCATIONย end products ligation of LPS
  3894. Effects of sevelamer on HbA1c, inflammation, and advancedย GLYCATIONย end products in diabetic kidney disease
  3895. The diverse ligand repertoire of the receptor for advancedย GLYCATIONย endproducts and pathways to the complications of diabetes
  3896. Advancedย GLYCATIONย end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology
  3897. Cinnamic acid and its derivatives inhibit fructose-mediated proteinย GLYCATION
  3898. GLYCATIONย of whey protein to provide steric hindrance against thermal aggregation
  3899. Role of advancedย GLYCATIONย end products in hypertension and cardiovascular risk: human studies
  3900. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advancedย GLYCATIONย end products and oxidative stress in diabetic rats
  3901. Oral advancedย GLYCATIONย endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
  3902. Inhibitors of advancedย GLYCATIONย and endoplasmic reticulum stress
  3903. Advancedย GLYCATIONย end products in diabetes mellitus: mechanism of action and focused treatment
  3904. Inhibition of advancedย GLYCATIONย end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity
  3905. Advancedย GLYCATIONย end products, measured as skin autofluorescence and diabetes complications: a systematic review
  3906. Genistein inhibits advancedย GLYCATIONย end product formation by trapping methylglyoxal
  3907. Signal Transduction in Receptor for Advancedย GLYCATIONย End Products (RAGE)
  3908. Advancedย GLYCATIONย end products in diabetic and non-diabetic human subjects suffering from cataract
  3909. The receptor for advancedย GLYCATIONย end products is a central mediator of asthma pathogenesis
  3910. The expression of the receptor for advancedย GLYCATIONย endproducts (RAGE) is permissive for early pancreatic neoplasia
  3911. Receptor for advancedย GLYCATIONย end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
  3912. GLYCATIONย of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes
  3913. Low plasma albumin levels are associated with increased plasma proteinย GLYCATIONย and HbA1c in diabetes
  3914. Advancedย GLYCATIONย end products and diabetic retinopathy
  3915. Fisetin lowers methylglyoxal dependent proteinย GLYCATIONย and limits the complications of diabetes
  3916. GLYCATIONโ€altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and ageโ€related disease (in nondiabetics)
  3917. Advancedย GLYCATIONย end products inhibitors from Alpinia zerumbet rhizomes
  3918. GLYCATIONย and biomarkers of vascular complications of diabetes
  3919. Advancedย GLYCATIONย end-products induce injury to pancreatic beta cells through oxidative stress
  3920. Advancedย GLYCATIONย end-product Nษ›-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes
  3921. In situ accumulation of advancedย GLYCATIONย endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption
  3922. GLYCATIONย in diabetic nephropathy
  3923. Multiphoton spectral microscopy for imaging and quantification of tissueย GLYCATION
  3924. Catalase, a target ofย GLYCATIONย damage in rat liver mitochondria with aging
  3925. Hibiscus sabdariffa Polyphenolic Extract Inhibits Hyperglycemia, Hyperlipidemia, andย GLYCATION-Oxidative Stress while Improving Insulin Resistance
  3926. Involvement of advancedย GLYCATIONย end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy
  3927. Phytochemicals from berries and grapes inhibited the formation of advancedย GLYCATIONย endโ€products by scavenging reactive carbonyls
  3928. Modulation of physicochemical and conformational properties of kidney bean vicilin (phaseolin) byย GLYCATIONย with glucose: Implications for structureโ€“function โ€ฆ
  3929. Antioxidant, anti-GLYCATIONย and anti-inflammatory activities of phenolic constituents from Cordia sinensis
  3930. Inhibition of the formation of advancedย GLYCATIONย end products by thymoquinone
  3931. Participation of the receptor for advancedย GLYCATIONย end products in efferocytosis
  3932. Advancedย GLYCATIONย end-products, a pathophysiological pathway in the cardiorenal syndrome
  3933. Advancedย GLYCATIONย endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimerโ€™s disease
  3934. GLYCATIONย compounds in peanuts
  3935. ERK and Akt signaling pathways are involved in advancedย GLYCATIONย end product-induced autophagy in rat vascular smooth muscle cells
  3936. Comprehensive identification of glycated peptides and theirย GLYCATIONย motifs in plasma and erythrocytes of control and diabetic subjects
  3937. Anti-GLYCATIONย effect of gold nanoparticles on collagen
  3938. Effect of heating andย GLYCATIONย on the allergenicity of 2S albumins (Ara h 2/6) from peanut
  3939. Cathepsins D and L reduce the toxicity of advancedย GLYCATIONย end products
  3940. The role of receptor for advancedย GLYCATIONย endproducts (RAGE) in infection
  3941. Advancedย GLYCATIONย end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro
  3942. Glycated albumin is a usefulย GLYCATIONย index for monitoring fluctuating and poorly controlled type 2 diabetic patients
  3943. Up-regulated expression of advancedย GLYCATIONย end-products and their receptor in the small intestine and colon of diabetic rats
  3944. Advancedย GLYCATIONย end products induce a prothrombotic phenotype in mice via interaction with platelet CD36
  3945. Heterogeneousย GLYCATIONย of cancellous bone and its association with bone quality and fragility
  3946. Advancedย GLYCATIONย end products, diabetes, and the brain
  3947. Soluble receptor for advancedย GLYCATIONย end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study
  3948. Insulinย GLYCATIONย by methylglyoxal results in native-like aggregation and inhibition of fibril formation
  3949. โ€ฆ induces brain ฮฒ-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advancedย GLYCATIONย end products in brain โ€ฆ
  3950. The receptor for advancedย GLYCATIONย end products and acute lung injury/acute respiratory distress syndrome
  3951. Sodium nitrite de-stiffening of large elastic arteries with aging: role of normalization of advancedย GLYCATIONย end-products
  3952. Determination of advancedย GLYCATIONย endproducts by LC-MS/MS in raw and roasted almonds (Prunus dulcis)
  3953. Advanced-GLYCATION-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1
  3954. Inhibitory effects of Lemon balm (Melissa officinalis, L.) extract on the formation of advancedย GLYCATIONย end products
  3955. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advanceย GLYCATIONย end-products
  3956. Soluble form of the receptor for advancedย GLYCATIONย end products is a marker of acute lung injury but not of severe sepsis in critically ill patients
  3957. The relative contributions of non-enzymaticย GLYCATIONย and cortical porosity on the fracture toughness of aging bone
  3958. Role of advancedย GLYCATIONย on aggregation and DNA binding properties of ฮฑ-synuclein
  3959. Moderateย GLYCATIONย of serum albumin affects folding, stability, and ligand binding
  3960. Receptor for advancedย GLYCATIONย end products (RAGE) and implications for the pathophysiology of heart failure
  3961. Total soluble and endogenous secretory receptor for advancedย GLYCATIONย end products as predictive biomarkers of coronary heart disease risk in patients with type 2 โ€ฆ
  3962. Advancedย GLYCATIONย end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells
  3963. The role of advancedย GLYCATIONย end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction
  3964. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advancedย GLYCATIONย end products in โ€ฆ
  3965. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advancedย GLYCATIONย end-product levels
  3966. Evidence that serum levels of the soluble receptor for advancedย GLYCATIONย end products are inversely associated with pancreatic cancer risk: a prospective study
  3967. Alpha-synuclein deficiency leads to increased glyoxalase I expression andย GLYCATIONย stress
  3968. D-ribose induces cellular proteinย GLYCATIONย and impairs mouse spatial cognition
  3969. Rehmannia glutinosa suppresses inflammatory responses elicited by advancedย GLYCATIONย end products
  3970. Advancedย GLYCATIONย endโ€products inhibition improves endothelial dysfunction in rheumatoid arthritis
  3971. Advancedย GLYCATIONย endproducts and diabetes. Beyond vascular complications
  3972. Reference values for the Chinese population of skin autofluorescence as a marker of advancedย GLYCATIONย end products accumulated in tissue
  3973. Enhanced expression of receptor for advancedย GLYCATIONย end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
  3974. Tissue advancedย GLYCATIONย end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients
  3975. Potential clinical utility of advancedย GLYCATIONย end product cross-link breakers in age-and diabetes-associated disorders
  3976. Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advancedย GLYCATIONย end productโ€“receptor axis
  3977. Inhibition of advancedย GLYCATIONย end-product formation on eye lens protein by rutin
  3978. Increased accumulation of skin advancedย GLYCATIONย end products is associated with microvascular complications in type 1 diabetes
  3979. Pyridoxamine, advancedย GLYCATIONย inhibition, and diabetic nephropathy
  3980. Inhibition of the receptor for advancedย GLYCATIONย endproducts (RAGE) protects pancreatic ฮฒ-cells
  3981. The receptor of advancedย GLYCATIONย end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis
  3982. Differential effects of advancedย GLYCATIONย endโ€products on renal tubular cell inflammation
  3983. Role of advancedย GLYCATIONย end product receptors in the pathogenesis of diabetic retinopathy
  3984. Serum levels of advancedย GLYCATIONย endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes
  3985. Advancedย GLYCATIONย end products measured by skin autofluorescence in a population with central obesity
  3986. Advanced proteinย GLYCATIONย in psoriasis
  3987. Bioguided fractionation and isolation of natural inhibitors of advancedย GLYCATIONย end-products (AGEs) from Calophyllum flavoramulum
  3988. The role of receptor for advancedย GLYCATIONย end products (RAGE) in the proliferation of hepatocellular carcinoma
  3989. Plant-derived agents with anti-GLYCATIONย activity
  3990. Advancedย GLYCATIONย end products of human ฮฒ2 glycoprotein I modulate the maturation and function of DCs
  3991. Solution structure of the soluble receptor for advancedย GLYCATIONย end products (sRAGE)
  3992. Dietary advancedย GLYCATIONย end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus
  3993. Cyclopeptide alkaloids of Ziziphus oxyphylla Edgw as novel inhibitors of ฮฑ-glucosidase enzyme and proteinย GLYCATION
  3994. Activation of receptor for advancedย GLYCATIONย end products induces osteogenic differentiation of vascular smooth muscle cells
  3995. Chlorogenic acid inhibits the formation of advancedย GLYCATIONย end products and associated protein cross-linking
  3996. Calycosin protects HUVECs from advancedย GLYCATIONย end products-induced macrophage infiltration
  3997. Fat mass is inversely associated with serum carboxymethyl-lysine, an advancedย GLYCATIONย end product, in adults
  3998. Genotoxicity and immunogenicity of DNA-advancedย GLYCATIONย end products formed by methylglyoxal and lysine in presence of Cu2+
  3999. Insight into theย GLYCATIONย of milk proteins: an ESI-and MALDI-MS perspective
  4000. Molecular basis of maillard amide-advancedย GLYCATIONย end product (AGE) formation in vivo
  4001. Advancedย GLYCATIONย end products as environmental risk factors for the development of type 1 diabetes
  4002. Role of advancedย GLYCATIONย endproducts and potential therapeutic interventions in dialysis patients
  4003. Elevated serum levels of advancedย GLYCATIONย end products and their monocyte receptors in patients with type 2 diabetes
  4004. Inhibitory activity of coumarins from Artemisia capillaris against advancedย GLYCATIONย endproduct formation
  4005. Phlorotannins from Brown Algae (Fucus vesiculosus) Inhibited the Formation of Advancedย GLYCATIONย Endproducts by Scavenging Reactive Carbonyls
  4006. Advancedย GLYCATIONย end products: possible link between metabolic syndrome and periodontal diseases
  4007. Predictive value of advancedย GLYCATIONย end products for the development of post-infarction heart failure: a preliminary report
  4008. Advancedย GLYCATIONย end products promote proliferation of cardiac fibroblasts by upregulation of K Ca 3.1 channels
  4009. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advancedย GLYCATIONย end product, in adults: the Energetics Study
  4010. Impairment of human keratinocyte mobility and proliferation by advancedย GLYCATIONย end products-modified BSA
  4011. The soluble form of the receptor of advancedย GLYCATIONย endproducts increases after bariatric surgery in morbid obesity
  4012. Inhibitory effect of polysaccharides from pumpkin on advancedย GLYCATIONย end-products formation and aldose reductase activity
  4013. Estimation of theย GLYCATIONย gap in diabetic patients with stable glycemic control
  4014. Advancedย GLYCATIONย end products induce the expression of interleukin-6 and interleukin-8 by receptor for advancedย GLYCATIONย end product-mediated activation of โ€ฆ
  4015. Accumulation of tissue advancedย GLYCATIONย end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal โ€ฆ
  4016. Receptor for advancedย GLYCATIONย end-products signals through Ras during tobacco smokeโ€“induced pulmonary inflammation
  4017. Immunohistochemical distribution of advancedย GLYCATIONย end products (AGEs) in human osteoarthritic cartilage
  4018. Advancedย GLYCATIONย end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling
  4019. Metformin inhibits advancedย GLYCATIONย end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor โ€ฆ
  4020. Mรผller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advancedย GLYCATIONย end-products and advanced lipoxidation end โ€ฆ
  4021. Quantitative analysis ofย GLYCATIONย patterns in human serum albumin using 16O/18O-labeling and MALDIโ€“TOF MS
  4022. Water extracts of cinnamon and clove exhibits potent inhibition of proteinย GLYCATIONย and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in โ€ฆ
  4023. Advancedย GLYCATIONย end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients
  4024. Positive association between serum level of glyceraldehyde-derived advancedย GLYCATIONย end products and vascular inflammation evaluated by [18F] โ€ฆ
  4025. Effect of micronutrients on methylglyoxal-mediated in vitroย GLYCATIONย of albumin
  4026. Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advancedย GLYCATIONย endproducts, autophagy and vascular endothelial growth โ€ฆ
  4027. Advancedย GLYCATIONย urinary protein-bound biomarkers and severity of diabetic nephropathy in man
  4028. Accumulation of argpyrimidine, a methylglyoxal-derived advancedย GLYCATIONย end product, increases apoptosis of lens epithelial cells both in vitro and in vivo
  4029. Paradoxical function for the receptor for advancedย GLYCATIONย end products in mouse models of pulmonary fibrosis
  4030. Interaction between advancedย GLYCATIONย end products formation and vascular responses in femoral and coronary arteries from exercised diabetic rats
  4031. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advancedย GLYCATIONย end products (RAGE)
  4032. Inhibition of advancedย GLYCATIONย end-product formation by Origanum majorana L. in vitro and in streptozotocin-induced diabetic rats
  4033. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advancedย GLYCATIONย end product in mouse mesangial cells cultured in high glucose
  4034. Advancedย GLYCATIONย end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes
  4035. Advancedย GLYCATIONย endproducts in horses with insulin-induced laminitis
  4036. Effect of benfotiamine on advancedย GLYCATIONย endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy
  4037. The Receptor for Advancedย GLYCATIONย End-products (RAGE) protects pancreatic tumor cells against oxidative injury
  4038. Glycated lysine residues: a marker for non-enzymatic proteinย GLYCATIONย in age-related diseases
  4039. Proteolytic release of the receptor for advancedย GLYCATIONย end products from in vitro and in situ alveolar epithelial cells
  4040. Association of serum soluble receptor for advancedย GLYCATIONย end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)
  4041. Lack of the Receptor for Advancedย GLYCATIONย End-Products Attenuates E. coli Pneumonia in Mice
  4042. What is the role of the receptor for advancedย GLYCATIONย end productsโ€“ligand axis in liver injury?
  4043. Pravastatin inhibits advancedย GLYCATIONย end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level
  4044. Inflammatory effect of advancedย GLYCATIONย end products on human meniscal cells from osteoarthritic knees
  4045. Effect of milk proteinย GLYCATIONย and gastrointestinal digestion on the growth of bifidobacteria and lactic acid bacteria
  4046. Increased levels of soluble receptor for advancedย GLYCATIONย end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with โ€ฆ
  4047. Receptor for advancedย GLYCATIONย endproducts (RAGE) deficiency protects against MPTP toxicity
  4048. ELISA detection of hazelnut proteins: effect of proteinย GLYCATIONย in the presence or absence of wheat proteins
  4049. Targeting receptor for advancedย GLYCATIONย end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth
  4050. Levels of soluble advancedย GLYCATIONย end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot
  4051. Advancedย GLYCATIONย end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models
  4052. Interaction between glycated serum albumin and AGE-receptors depends on structural changes and theย GLYCATIONย reagent
  4053. Methylglyoxal, advancedย GLYCATIONย end products and autism: is there a connection?
  4054. Pinocembrin protects against ฮฒ-amyloid-induced toxicity in neurons through inhibiting receptor for advancedย GLYCATIONย end products (RAGE)-independent โ€ฆ
  4055. Increased receptor for advancedย GLYCATIONย end products in spermatozoa of diabetic men and its association with sperm nuclear DNA fragmentation
  4056. The functionalโˆ’ 374T/A polymorphism of the receptor for advancedย GLYCATIONย end products may modulate Crohnโ€™s disease
  4057. Advancedย GLYCATIONย end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease
  4058. Regulation of heparanase by albumin and advancedย GLYCATIONย end products in proximal tubular cells
  4059. Constituents with ฮฑ-glucosidase and advancedย GLYCATIONย end-product formation inhibitory activities from Salvia miltiorrhiza Bge.
  4060. Peripheral RAGE (receptor for advancedย GLYCATIONย endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response
  4061. Levels of oxidized LDL and advancedย GLYCATIONย end productsโ€“modified LDL in circulating immune complexes are strongly associated with increased levels of carotid โ€ฆ
  4062. Mutagenesis and Repair Induced by the DNA Advancedย GLYCATIONย End Product N2-1-(Carboxyethyl)-2โ€ฒ-deoxyguanosine in Human Cells
  4063. Puerarin inhibits the retinal pericyte apoptosis induced by advancedย GLYCATIONย end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress
  4064. Plasma levels of soluble receptor for advancedย GLYCATIONย end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid โ€ฆ
  4065. Activation of the receptor for advancedย GLYCATIONย end products system in women with severe preeclampsia
  4066. Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, proteinย GLYCATIONย and inhibiting adipocyte differentiation: an in vitro study
  4067. Role of Aฮฒ-receptor for advancedย GLYCATIONย endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral โ€ฆ
  4068. Cranberry phytochemicals inhibitย GLYCATIONย of human hemoglobin and serum albumin by scavenging reactive carbonyls
Related Posts

Ceramides

Isoflavones

Flavones

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping